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Kurzzusammenfassung
In dieser Arbeit wurde ein modulares Konzept zur Stabilisierung und Schaltung der
Struktur α-helikaler Proteine und Peptide untersucht. Zur Realisierung dieses Konzeptes
haben wir ein Fusionsprotein entwickelt, welches sich aus zwei Teilen zusammensetzt.
Der erste Teil besteht aus einem Protein mit einer stabilen helikalen Faltung und der
Möglichkeit, eine photoresponsive Einheit zur Manipulation der Struktur einzuführen.
Der zweite Teil wird von einer Peptidsequenz mit strukturabhängiger Aktivität gebildet.
Das Schaltmodul basiert auf dem 20 Aminosäuren langen Trp-cage Miniprotein, dessen
Struktur eine acht Aminosäuren lange N-terminalen α-Helix enthält. Die Faltung
wird durch hydrophobe Wechselwirkungen einer Tryptophan–Seitenkette mit mehreren
C-terminalen Aminosäuren induziert, was zu einer hoch stabilen, tertiären Faltung führt.
Zur Schaltung der Faltung haben wir in diese Struktur ein photoresponsives Molekül
eingeführt. In dieser Arbeit wurde N-Hydroxysuccinimid-Ester als reaktive Gruppe und
Azobenzol als Grundgerüst verwendet. Um diesen Schalter in den Trp-cage einzubinden,
waren verschiedene Ersetzungen und Modifikationen in der Sequenz notwendig um
eine selektive Verknüpfung zu gewährleisten. Die Verknüpfungsreaktion erweist sich als
hochgradig selektiv und führt mit guter Ausbeute zu einfach aufzureinigendem Produkt.
Die neue Trp-cage Sequenz und deren verlinkte Varianten wurden mit besonderem
Fokus auf die Struktur und den Einfluss des Linkers auf ebenjene spektroskopisch
charakterisiert.
Im zweiten Teil der Arbeit wurde eine Wiederholungseinheit des α-helikalen Antigefrier-
proteins „Type 1 HPLC6“ mit dem Trp-cage in einem Chimären-Konzept fusioniert.
Zur Verknüpfung und Korrelation der Sekundärstrukturen beider Proteine wurden ihre
Sequenzen überlappt, was zu einem Chimären-Protein führt. Dieses Protein lässt sich in
drei Abschnitte einteilen. Die Sequenz des Antigefrierproteins bildet den N-terminalen
Abschnitt, der mittlere Abschnitt enthält Sequenzen beider Proteine, während der
C-terminale Abschnitt aus der Trp-cage-Sequenz besteht. Nach diesem Prinzip ergeben
sich vier Kombinationsmöglichkeiten unter Berücksichtigung der Orientierung der
aktiven Seite des Antigefrierproteins und der Tertiärstruktur des Trp-cages. Alle vier
Varianten wurden zur Strukturbestimmung spektroskopisch charakterisiert. Darüber
hinaus wurde die Aktivität der vier Chimären-Proteine mittels Beobachtung des
Eiskristallwachstums in Gegenwart der Proteine bestimmt.
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Abstract
In this work, the concept of a modular approach to stabilize and switch the structure of
α-helical proteins and peptides was investigated. To achieve such, we designed a fusion
protein which consists of two parts. The first part, an independent protein module,
comprises a highly stable helical fold and the possibility to incorporate a light responsive
unit for manipulation of the structure. The second part consists of a peptide sequence
with a structure-dependent activity.
We used the 20 amino acid long Trp-cage miniprotein as basis for the stabilizing and
switching module. Its tertiary structure consists of an eight amino acid long N-terminal
α-helix, whose fold is induced by encapsulation of the eponymous tryptophan side
chain by several C-terminal residues. This results in a very stable tertiary fold of the
module. In order to introduce switchability into the miniprotein, we cross-linked the
Trp-cage with a photo responsive linker. In this work, we used N-hydroxysuccinimide
esters (NHS) as reactive groups for the cross-linking, which are reactive towards primary
amines (lysine residues), and azobenzene as the scaffold for a switchable linker. In
order to apply this cross-linking method, several replacements and modifications in
the Trp-cage sequence were required to ensure unambiguous linking. The cross-linking
reaction proved to be highly selective and yielded easily purifiable protein product. The
new Trp-cage and its cross-linked variants were spectroscopically characterized with
primary focus on structure, stability and the influence of the linker on the fold.
In the second part of this work, one repeat of the α-helical antifreeze protein AFP
"Type 1 HPLC6" was fused with the Trp-cage module using a chimera strategy. In order
to combine and correlate the secondary structure of the proteins, the sequences were
overlapped, resulting in a chimera protein. This protein comprises at the N-terminus
the sequence of the antifreeze protein, followed by a chimera region with a combination
of both sequences, and is completed by the C-terminal sequence of the Trp-cage. The
junction of the sequences is possible in four different ways altering the orientation of the
active side of the antifreeze protein relative to the tertiary structure of the Trp-cage. All
four variants were spectroscopically characterized in order to ascertain their structure.
Furthermore, the activity of the four chimera proteins was determined by observing the
ice crystal growth in presence of the proteins.
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31. Introduction
Proteins are important modules for every living being. They play key roles in most process
in cells. They may act as messenger,1 storage,2 or carrier (ion pumps3) molecules,
catalyze chemical reactions (enzymes)4 and are essential for the cells abilities to regulate
its metabolism,5 to communicate extracellularly6 or to move.7 This broad spectrum of
functions can be fulfilled due to their great structural diversity. Proteins can be assessed
at different structural levels, ranging from the primary up to the quaternary structure.
Table 1.1.: Categories for the 20 naturally occurring amino acids based on their side chains
propensity to be in contact with water. The amino acids are listed with the three-
and one-letter abbreviations.
Charged Polar Hydrophobic
Name Abbreviations Name Abbreviations Name Abbreviations
Arginine Arg R Asparagine Asn N Glycine Gly G
Lysine Lys K Glutamine Gln Q Alanine Ala A
Aspartic acid Asp D Histidine His H Valine Val V
Glutamic acid Glu E Serine Ser S Leucine Leu L
Threonine Thr T Isoleucine Ile I
Tyrosine Tyr Y Phenylalanine Phe F
Cysteine Cys C Proline Pro P
Methionine Met M
Tryptophan Trp W
The primary structure is defined by the sequence, which is the order of the 20 naturally
occurring amino acids. The amino acids differ in their side chains, ranging from a simple
proton to an aromatic indole ring, i.e. glycine (Gly, G) and tryptophan (Trp, W). They
may be grouped by the propensity of their side chains to interact with water. This results
in charged (bearing a positive or negative charge), polar but uncharged, and hydrophobic
groups (Table 1.1).
Scheme 1.1.: Scaffold of amino acids and the peptide bond with structure defining torsion
angles φ, ψ and ω highlighted in red.
The amino acids are covalently connected between the amine- and carboxyl function
resulting in the peptide bond (Scheme 1.1) and form the primary structure of proteins.
The lone pair of electrons located on the nitrogen is significantly delocalized, which gives
the group a partial double bond character. The bond is defined by the torsion angle
ω between the H-N-C-O atoms. In most peptide bonds, a torsion angle of ω = 180◦
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(trans) is preferred. An exception is the X-Pro peptide bond, in which the trans and
the cis configuration is nearly equal in energy. The torsion angles φ and ψ are flexible
and enable the polypeptide backbone to adopt certain conformations.
Figure 1.1.: Exemplary secondary structure elements. Left: α-helix. Right anti-parallel β-
sheet. Both structures are represented in cartoon style with amide backbone in
stick representation. Hydrogen bonds are displayed in yellow dashed lines.
The primary structure can fold from flexible, disordered, a random coiled chain into
locally regular conformations, driven by intramolecular hydrogen bonds. These "sec-
ondary structure elements" are defined by their hydrogen bonds between the backbone
amide and carboxyl groups. The most common secondary structure elements are the
α-helix with 3.6 amino acids per turn and the β-strand (Figure 1.1). In the α-helix,
hydrogen bonds between carbonyl groups and amides in backbone with a gap of four
are observed, which lead to a twisted backbone with torsion angles of φ = −57◦ and
ψ = −47◦. In the β-sheet, hydrogen bonds are observed between two or more peptide
chains. The β-sheet structure is defined by torsion angles for the backbone of φ = −80◦
and ψ = +150◦, which lead to a zig-zag structure of the backbone.8
The tertiary structure is the three dimensional arrangement of the polypeptide with one
or more secondary structure elements. The three dimensional arrangement is predom-
inantly driven by the hydrophobic effect involving the side chains of the amino acids.
Under physiological conditions, solvent water molecules are not able to form hydrogen
bonds to the hydrophobic side chains. As a result, stronger hydrogen bonds between the
water molecules around the hydrophobic side chain are observed. The water molecules
are ordered, which is an entropically unfavoured state. Folding of the protein into its
tertiary structure leads to encapsulation of hydrophobic side chains of the protein. Thus,
the hydrophobic regions are inaccessible to water and the tertiary structure is entropi-
cally driven by the hydrophobic effect.
The next and last structure level is based on the proteins ability to build up complexes
with each other, either homo-multimers or hetero-multimers. This enlarged three di-
mensional arrangement of tertiary structured proteins is the quaternary structure and is
facilitated by hydrophobic surface interactions as well as charged interactions.
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1.1. Antifreeze and Ice Binding Proteins
A unique and interesting class of proteins are antifreeze proteins (AFPs) or ice binding
proteins (IBPs). In the 1950s, P.F. Scholander suggested that Antarctic fish
have antifreeze agents in their blood as an explanation for their ability to survive in
sub-zero temperature habitats.9 In the year 1969, A.L. DeVries screened the blood
of Antarctic Notothenioid and found that the concentration of sodium chloride,
urea and free amino acids in the serum is indeed insufficient to explain the observed
freezing point. They discovered a glycoprotein, the antifreeze glycoprotein (AFGP), in
the Antarctic Notothenioid fishes that accounts for an additional freezing point
depression by 30%.10
Figure 1.2.: Overview of the structural diversity of different AFPs obtained from multiple
species.11–20
After this discovery, other AFPs have been detected and isolated not only from Antarctic
fish, but in many different species, such as bacteria, fishes, insects, fungi.21 They are
solely protein based, i.e. do not contain carbohydrate groups. The independent evolu-
tion of AFP in this variety of organisms naturally leads to a broad structural diversity
(Figure 1.2).11–20 AFP structures ranges from a simple helix with repeated sequence
(AFP Type 1) up to a globular lectin-type protein with united α-, β-fold and a non
repetitive sequence (AFP Type 2). Interestingly, AFPs have been identified with mul-
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tiple repetitive sequence elements, which lead to enlarged sequences. These molecules
fold as parallel β-helices (MpAFP, LpAFP). These proteins exhibit large, flat surfaces
that are responsible for their hyperactivity.
Despite the structural diversity, the mechanism of depressing the freezing point is as-
sumed to be similar for all AFPs. AFPs possess the ability to bind specifically and
selectively to the ice crystal’s surface. This process is quasi-irreversible, which means
that the AFPs do not desorb from the ice crystal surface once bound. The selective and
characteristic binding to the ice crystal is enabled by a steric complementarity between
the protein’s and ice crystal’s surface. To explain this ability, one has to look at the
structure of water in its crystalline form.
Figure 1.3.: Different ice crystal surfaces, which AFP can interact with. Yellow represents a
fraction of the basal plane (0001), red the primary prism plane (1010), green the
secondary prism plane (1120) and blue the pyramidal plane (2021).
Ice crystallizes under normal pressure as ice Ih in a hexagonal crystal form. In this form,
a water molecule serves as proton donor and acceptor (two acceptors and two donors).
Each water is surrounded by four water molecules in a tetrahedral arrangement. This
results in a conventional hexagonal crystal cell described by a hexagonal axis system
using three a-axis in a plane and a vertical c-axis. The crystal structure is described
with the Bravais-Miller indices, which results i.e. for the basal plane in an index of
0001, as it is orthogonal to the three a-axis and intersects with the vertical c-axis. In the
hexagonal ice crystal, several planes are present for an interaction with AFPs (colored
planes, Figure 1.3). The unique ability of AFPs to bind to the ice crystal planes leads
to a kinetic inhibition of the crystal’s growth rate of the covered plane. Depending on
the plane the AFP is bound to, the shape of the crystal is macroscopically changed.
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Figure 1.4.: The shape of an ice crystal in the presence of AFP Type 1. The AFP Type 1 binds
to the pyramidal plane (2021), resulting in an inhibition of the ice crystal’s growth
at these planes. The ice crystal has therefore a hexagonal bipyramidal geometry.
The first discovered AFGP binds to the six primary prism plane (1010, colored red).22
This inhibits the growth of ice primarily of these planes to be the slowest. The macro-
scopic shape of the ice crystal is then that of a hexagonal cylinder. The large, β-helical
AFPs (i.e. MpAFP) are able to bind in addition to the basal plane (0001), resulting in
crystals with hexagonal symmetries. The ability to bind to multiple surfaces (foremost
the basal plane) results in a significant increase in their activity (hyperactive AFP), as
the growth rate in the c-direction of the crystal is also inhibited. The AFP Type 1 has
a surface which matches the pyramidal plane (2021) of the ice crystal. This leads to an
hexagonal bipyramidal shaped crystal geometry (Figure 1.4). Overall, the macroscopic
shape of the ice crystal in the presence of AFP is therefore an ideal and simple measure
to assess the activity of AFPs.
AFPs also possess the ability to inhibit the recrystallization of ice crystals. In a system
of constant temperature and pressure, larger ice crystals can grow at the expense of the
smaller crystals. This effect is called Ostwald ripening and describes the tendency of
the system to optimize its energetic state. The small ice crystals exhibit a larger surface
area to volume ratio and a higher curvature compared to large ice crystals. Depending
on the curvature of the crystal’s surface, the freezing point of the crystals vary. A large
curvature leads to a locally increased freezing point, whereas a small curvature decreases
the local freezing point relative to the planar ice-water interface that determines the
global freezing point (Kelvin effect). Thus, in the re-crystallisation ripening small ice
crystals melt while the larger crystals grow. In the presence of AFP, the crystals’ growth
rate is depressed, which stabilizes ice crystals and inhibit the ice crystal recrystallization.
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Figure 1.5.: Right: Schematic view of the ice binding of AFP Type 1 to the 2021 ice surface.
The proteins (sketched as ellipse) bind to the ice surface. The ice crystal can grow
only in the free space not covered by the proteins (curved line). This resulting in
a hexagonal bipyramidal crystal structure.
The same principle is the physical basis for the best-known activity of AFPs, the freezing
point depression of its solutions.23,24 Ice crystals slightly below the (colligative) freezing
point in the presence of AFP are covered by the proteins (Figure 1.5). However, the
protein covers only portions of the ice crystal’s surface and the crystal can grow in-
between the proteins. This leads to a curved interface of ice and water. At this interface,
the freezing point is lowered, as it is thermodynamically disfavoured for water to adsorb
to a curved ice plane rather a plain. If the local freezing point reaches the temperature
of the solution, the crystal growth will stop. The same effect but in opposite direction
is observed at temperatures above the freezing point. The protein is still bound to the
ice crystal, thus the ice can melt only in the free space between the proteins. Melting
leads to an inverse curvature and the increase of the ice crystal’s melting point. The
difference between the melting point and freezing point of the ice crystal is called thermal
hysteresis (TH) and is used as the most distinctive characterization the activity of AFPs.
The separation of the freezing and melting point of a solution is in contrast to the
properties of a solution containing a solute, i.e. salt. In such systems, the freezing
point and melting point are equal and the variation of the freezing point depends on the
concentration of the solute and not on the type. Thus, the freezing point depression
is one of the three known colligative properties. In contrast, solutions containing AFPs
have separated freezing and melting points, which is a reflection of a kinetic growth
inhibition keeping ice and solution from reaching the thermodynamic equilibrium. This
is a meta stable state, and thus a non-colligative effect. Macroscopically, this effect
is easily observed (under a microscope). At temperatures below the non-colligative
freezing point, AFPs cannot inhibit the growth and the solution freezes completely. At
temperatures above the melting point, any formed ice crystal will melt. Crystals however,
will be stable at temperatures between the separated freezing and melting points. Ice
crystals will neither grow nor melt in this thermal hysteresis window, they are meta
stable.
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1.1.1. Antifreeze Protein Type 1
The winter flounder Pseudopleuronectes americanus exhibits several differ-
ent AFPs in its bodily fluids.25,26 The best studied one is the 37 amino acid long
α-helical AFP Type 1 isoform HPLC6 (Table 1.2 and Figure 1.6). This AFP has
served as model system for many years, due to its simple structure. The AFP Type
1 HPLC6 is able to bind to the pyramidal ice surface and inhibits the growth of
the ice crystal completely. This results in a macroscopically crystal morphology of a
hexagonal bipyramid with a characteristic c- to a-axis ratio of 2.2 : 1 and a TH of 1 ◦C.26
Table 1.2.: Sequence in one letter code of AFP Type 1 HPLC6.
AFP Type 1 HPLC6 D - TASDAAAAAAL - TAANAKAAAEL - TAANAAAAAAA - TAR-NH2
Figure 1.6.: Structure of AFP Type 1 HPLC6. The secondary structure is represented in ribbon
cartoon style and colored in rainbow from N-(blue) to C-terminus (red). Amino acid
side chains are represented in the stick style. Protein Data Bank (PDB) accession
code: 1WFA.11
The AFP Type 1 HPLC6 is an alanine rich protein with a triplicated eleven residue
motif: Thr-Ala-Ala-X-Ala-X-X-Ala-Ala-X-X. While X-positions can be any amino acid,
these are most frequently also alanines.27 The protein folds into a single, nearly perfectly
straight α-helix. This helix has only marginal stability and limited folding cooperativity,
as the protein is 100% folded only near the freezing points, and almost linearly unfold
with increase in temperature. In the folded conformation, the Thr residue and the
Ala residues with a separation of i,i + 4 (with i the residue counting from) and i,i + 8
respective to Thr of the repetitive motif form on one side of the helix a contiguous
hydrophobic surface, the active side of the protein28 (Figure 1.6). The distance of
the Thr residues match the spacing between oxygen atoms on the ice surface. This
results in a preferred binding to the 2021 ice plane in 1102 direction, which has been
experimentally determined and established.28,29 The opposite side of the AFP is more
hydrophilic and supports the protein’s solubility. The sequence is terminated N- and
C-terminally with an Asp and Arg, respectively, that serve as capping residues. At
physiological conditions, their charged side chains fold back towards the backbone and
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reduce an unfavoured interaction between the terminal charge and the dipole moment
of the helix, which further stabilizes the folded conformation.27,30
As the AFP Type 1 HPLC6 exhibits a repetitive motif, studies to determine the influence
of the length and helicity of the protein’s activity have been performed. In these studies
the sequence was shortened stepwise simultaneously from the N- and C-terminus.30 It
was shown that after shortening the sequence by three amino acids, the fold stability
and activity of the truncated protein was similar to the full length protein. By truncation
from 37 to 32 amino acids however, the helicity is decreased below 35%. This yields in a
significant decrease of the TH by 60% to 0.4 ◦C. Further truncation to 28 amino acids
(75% of the original number of residues) results in a helicity of 26.1%. For this protein,
no TH was observed, but notably an ice shaping effect was observed, as a macroscopic
hexagonal crystal morphology was formed. This length was taken to be the minimal
required sequence length for the activity of AFP Type 1 HPLC6.
In a second approach, the activity of one eleven amino acids long ice binding motif
was investigated.31 In order to stabilize the structure, the N- and C-terminal capping
residues were included (DTASD and TAR, respectively). Furthermore, a salt bridge was
introduced for increased stability.32 The orientation of the salt bridge was altered in
favour of the helical dipole moment, resulting in two 15 amino acid long peptides (15KE
and 15EK). Both peptides exhibit already a helical content of 62% and 58%, but a
complete abolishing of TH and ice binding properties, as round, disk-shaped ice crystals
were observed. In order to stabilize the structure of the peptide, the salt bridge of 15EK
was replaced by a lactam-bridge forming a covalent bond (15EKlac). This significantly
increased the helicity to 90%. The lactam-bridged 15EKlac displayed significant activity.
Upon freezing, the crystal forms a hexagonal bipyramid shape. These results show that
the activity is mainly structure and not length dependent.
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1.2. The Trp-cage
From the oral secretion of the Gila monster (Heloderma Suspectum) the Exendin-4,
a protein with a 50% sequence similarity to the helical glucagon-like-peptide-1 (GLP-1),
was isolated.33–35 Both proteins not only have sequential but also an activity similarity,
i.e. binding to the GLP-1 receptor and therefore regulating insulin production (anti-
diabetic actions).36
Table 1.3.: Sequence comparison of GLP-1 and Exendin-4 represented in one letter code. Similar
amino acids are marked in bold and the binding side is underlined.
GLP-1 HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2
Exendin-4 HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2
Figure 1.7.: Structure of the first Exendin-4 nuclear magnetic resonance (NMR)-structure
(PDB: 1JRJ35). The secondary structure is represented in cartoon style and the
amino acid side chains in stick style. Sequence similarities with GLP-1 are marked
in green and C-terminal extension of Exendin-4 in red.
Comparison of the sequences reveals that Exendin-4 is extended at the C-terminus by
ten and shortened at the N-terminus by six amino acids (Table 1.3). In contrast to the
solely helical structure of GLP-1, the Exendin-4 structure exhibits a C-terminal extension
consisting of a turn and a polyproline-II helix, resulting in a tertiary structured protein
(Figure 1.7). The C-terminal extension of Exendin-4 encapsulates the present Trp side
chain in the helix. This leads to a very stably folded C-terminus and stabilization of
the adjacent helix, which interacts with the GLP-1 receptor.37 The N-terminus itself
shows significant fraying, which may be necessary for insertion through the membrane.
Those structural features allow the Exendin-4 not only a longer half-life time in vitro, but
also enable better permeation into the cell and a stronger binding to the GLP-receptor
compared to GLP-1.38 Therefore, it is commercially used as a therapeutic agent for
diabetes type 2.
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Figure 1.8.: Model of the Trp-cage NMR structures of the sequence Tc5b with the lowest energy
(first model) (PDB accession code: 1L2Y39). The secondary structure is sketched
in ribbon cartoon style for the protein backbone and stick style for amino acid side
chains. The important amino acids for the cage fold are colored in red. The salt
bridge between Asp at position 9 and Arg at position 16 is colored in green.
The significant increase in fold stability of the Exendin-4 motivated the group of J.W.
Neidigh to look into the C-terminal folding motif. Based on the Exendin-4, they de-
signed a 20 amino acid long peptide by N-terminal truncation, the Trp-cage construct
Tc5b with the sequence NLYIQWLKDGGGRPPPS39 (Figure 1.8). The resulting mini-
protein is strikingly stably folded, but does not has an intrinsic function.40
In the miniprotein, the eponymous Trp side chain forms the inner core of a hydrophobic
cage including the polyproline-II-helix, the turn and the Tyr (marked in red Figure 1.8).
Furthermore, a salt bridge is present, stabilizing the tertiary arrangement between the
polyproline-II helix and the α-helix (marked in green).41,42
In a second round of sequence optimization, the different structural parts of the protein
were optimized.43 This study focused mainly on replacements in the helix. They demon-
strated that the most important residues are the Trp (position 6) and Tyr (position 3).
Tyr is necessary for shielding, but can be replaced by Leu and Phe with the expense of
stability. All other residues in the helix can be replaced with limited destabilizing effect,
but some even increase the protein’s stability.
Studies with nuclear magnetic resonance (NMR) and circular dichroism (CD) spec-
troscopy showed that depending on the replacements in the sequence, the helical fold
and cage fold can be separated and follow no stringent cooperative folding mechanism.
If the thermal melting point (TM ) differs more than 7 ◦C between the TM of helix and
cage, the folding is not cooperative, usually indicating an intrinsically stabilized helix
and an intermediate between the folded and unfolded state of the Trp-cage.
In addition to the optimization of the 20 amino acids, studies of N-terminal extensions
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of the Trp-cage were performed.44 An N-terminal insertion of six Ala leads to a stabi-
lization of the cage fold and notably, to a propagation of the N-terminal helical fold to
include the inserted Ala. In conclusion, the Trp-cage cannot only be modified within its
N-terminal helix, but also the existing helical fold propagates into N-terminal extensions.
Since the first publication, the Trp-cage protein has been used for molecular dynamics
(MD) simulations.45 Due to its unique and stable fold, it serves as a model system for
calculations aimed at optimizing force field parameters for protein simulations and in
calculations for assessing fold properties and folding mechanism pathways.46–49
1.3. Switching at the Molecular Level
Controlled motion or switching of properties can be found for many objects of daily use,
ranging from a simple light switch up to complex machines. Transferring the principle
of switching to a molecular level leads to the family of molecular switches. For a
molecular switch, a molecule has to fulfill several characteristics. First, a switch requires
two different electronic states, which differ in their properties, for example in their
conformation or configuration.50 These states have to be convertible into each other.
Furthermore, a switch has to respond to external stimuli (light, electricity, magnetism,
mechanical force), whereas the two states should not respond to the exact same
stimulus. Referring to light responsive molecular switches, the excitation wavelengths
of each conformer have to be separated. Another characteristic is the life-time of the
conformers; optimally both should be thermodynamically stable.
Three exemplary molecular scaffolds, which fulfill these characteristics, are azobenzene
and spiropyran.51,52 Both systems respond to light as external stimulus and exhibit
two conformations, which differ in their length among others. An advantage of these
systems are the easy accessible chemical modification and therefore possible tuning
of the photochromic properties. Foremost, this allows the covalent incorporation in
multiple materials. Since azobenzene was mainly used in this work, its characteristics
are discussed in more detail.
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Scheme 1.2.: Mechanism of the trans to cis isomerization of azobenzene. Top: rotational
mechanism around the "activated" N=N bond; Bottom: mechanism of inversion
at N-atom. Right: P and M enantiomer of the cis azobenzene.
Azobenzene was discovered in the year 193753 and ever since has been used due to
its favourable thermal stability54 and photochromic properties, i.e. nearly no photo
bleaching.55 Upon irradiation with ultra violet (UV) light at λ = 365nm, the molecule
can isomerize from the thermodynamic stable trans to the meta-stable cis form. From
the cis configuration, azobenzene can either thermodynamically relax back or can be
converted by irradiation with λ = 440nm to the trans state.56 Although the mecha-
nism is still discussed in the literature, two possibilities are commonly accepted for both
photochemical conversions: an out-of-the-plane rotational mechanism57 around the ac-
tivated azo group and an in-plane inversion mechanism at the nitrogen (Scheme 1.2).58
The switching process from the trans to cis configuration is bi-directional. Without
constraints, both possible cis enantiomers (P or M) are energetically equal. However,
by incorporating azobenzene in a chiral cyclic compound, the switching process may
become uni-directional upon irradiation and one enantiomer is favoured.59 This results
in an additional helicoidal chirality of these compounds.
These photochromic properties of the azobenzene lead to a high potential in photo-
mechanical applications. Incorporated in materials, the different properties of the
azobenzene can be used. In particular, the controlled motion is of great interest. Com-
bined with a liquid crystalline polymer, the characteristics of the bulk material can be
altered upon switching. Furthermore, a macroscopic effect in shape and length can be
observed. This can be used for artificial muscles or 3D motors.60
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1.3.1. Switching of Biopolymers
A special application of molecular switching is the structural control of proteins. With
the manipulation of structure, the related activity can be regulated. For that purpose,
a switchable molecule can be introduced in the biopolymers. A currently employed
strategy is the incorporation of bi-functionalized azobenzene on the amino acid’s side
chains.61 A major advantage of this strategy is the easy transfer to larger systems, i.e.
to the ∼24 kDa big trans membrane protein Cadherin controlling the ability of Ca2+
dependent adhesion62 or the photo control of the 60 kDa Shaker K ion channel for
potassium.63
Figure 1.9.: Concept of G. A. Woolley of azobenzene cross-linked to side chains. Left:
structure of iodoacetamide functionalized azobenzene derivative. Effective length
difference of connection points is ∼3 Å. Right: Peptide linked with iodacetamide
azobenzene via Cys side chains. With azobenzene in the trans configuration, it
stabilizes the secondary structure and in the cis configuration it destabilizes the
α-helix. Reprint with permission by the "Royal Society of Chemistry".64
Depending on the employed concept, the azobenzene can be incorporated in a manner
that the distance of the connection points matches the length of the trans or cis isomer.
In this state of the linker, the fold is induced and stabilized. The counterpart does not
match the distance (either too long or short) and therefore destabilizes the secondary
structure. This concept is reported for numerous α-helical peptides (Figure 1.9).64–66
With different substitution patterns of the azobenzene, the life-time of the cis isomer
can be tailored to various applications, and thus the life-time of the fold. Additional
advantage of a switchable protein is the ability to gain new insights in the folding process
and manipulation of the folding dynamics.65 This allows not only being able to switch
between a folded and unfolded or disrupted state, but also between two functional states.
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2. Motivation and Previous Work
The overall objective of this work is the transfer of the Woolley-type photo-switching
of protein conformation to a unique functional protein, the α-helical AFP Type 1.
Photo-control of the AFP structure should control its activity. While one can envision a
number of possible new applications of an AFP with switchable function, the ability to
modify the protein’s activity with high spatial and temporal resolution will be a potent
tool to study the still controversial mechanism of binding of AFP to the ice surface.
Figure 2.1.: Concept of a photo-switchable AFP Type 1 by H. Kobarg. The AFP Type
1 HPLC6 is cross-linked with a glyco-azobenzene (in collaboration with A.
Mueller). With azobenzene in trans configuration, the connection points match
the distance of a helical fold (top) of the AFP. Thus, the protein is active and can
bind to the ice surface. In the cis configuration of the linker, the structure of the
AFP is disrupted. This leads to reduction its ice binding ability (bottom).
H. Kobarg, in collaboration with A. Mueller (Lindhorst group), started this ap-
proach in our group.67 The original Woolley-type cross-linker comprises an azoben-
zene moiety as photochrome and iodoacetamides as reactive groups. (Figure 2.1). In
H. Kobarg’s design, additional carbohydrates are inserted for improved solubility of
the linker. This modification consequently increases the length of the linker, matching
the spacing between the residues i,i + 21 in contrast to the i,i + 7 spacing for the original
Woolley-linker. In the AFP sequence (Type 1 HPLC6), Cys residues were incorpo-
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rated in appropriate positions. The exact positions were chosen so that the linker does
not sterically interfere with the protein’s active site, i.e. the linker is placed opposite
to the ice binding side in the folded protein. With the azobenzene linker in the trans
configuration, the AFP helix can form and possibly may even be stabilized by the link-
age and should enable interaction of the protein with the ice surface. Upon irradiation,
the azobenzene linker isomerizes to its cis-configuration leading to a shortening of the
maximal linker length. Therefore the fold should be disrupted as the reduced linker
length is incompatible with 21 amino acids in six helical turns, resulting in a reduction
or abolishment of the AFP activity.
The implementation of the approach turned out to be very challenging in several aspects.
First, the synthesis of the AFP by Fluorenylmethyloxycarbonyl (Fmoc) based solid phase
peptide synthesis (SPPS) was difficult. The AFP sequence comprises a large number
of non-polar Ala residues and several long poly-alanine stretches occur. The achieved
synthesis yield for the wild type AFP (Type 1 HPLC6) was below 20% (H. Kobarg, un-
published). Incorporating Cys residues in the chosen positions for the cross-linking with
the azobenzene decreased the yield of the respective protein even further. In addition,
the purification of these crude proteins was difficult due to very close retention times
of product and by-product in reverse-phase (RP) high pressure liquid chromatography
(HPLC).
The cross-linking reaction at the thiol function of the cysteine residue created addi-
tional problems. The reaction requires a reductant to prevent cysteine oxidation and
disulfides formation. Unfortunately, the chosen reducing agent tris-(2-carboxyethyl)-
phosphin (TCEP) reacted with the cross-linker. In addition, the cross-linking reaction
itself was not selective. Both complications led to various side products that rendered
the product purification impossible.67
An additional unfavourable observation is that the obtained cross-linked AFP products
had unexpectedly low solubility in water. Once dissolved, solutions were not stable and
precipitations were observed over time. Possible reasons for this behavior could be a
combination of the hydrophobicities of protein sequence and cross-linker, as well impu-
rities of the cross-linking reaction.
Owing to the large number and severity complications encountered, this approach to
generate switchable AFPs was not pursued any further. Principally, the problems in the
Cys cross-linking reaction appeared solvable (for example by choosing a different reduc-
ing agent, conducting of the experiment under inert atmosphere and at high dilution of
both reactants). Similarly, the hydrophilicity of the linker can be further increased (albeit
attempts to incorporate the sulfonic-acid variant of the Woolley linker as published
failed68). However, incorporation of further carbohydrate units yield linkers with intrin-
sic flexibility and dimensions which are incompatible with the requirements for effective
switching and the length of the folded AFPs and are thus not applicable to this example.
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These optimizations require a great deal of work and possibly needed to be repeated for
every AFPs. Not only are these efforts individually significant, the results are expected
to depend on each other, and foremost on the sequence of the specific AFP used. Thus,
to a large extent, these optimizations would have to be repeated for each AFP peptide
linker combination. But foremost, these efforts would not solve the two other encoun-
tered significant problems, the high hydrophobicity/low solubility of the AFP that is a
main factor for the observed aggregation, and the synthetic difficulties to produce pure
AFP by SPPS in a sufficient yield. These are intrinsic to the AFP Type 1 sequence,
and cannot be changed in this sequence without affecting the protein’s activity. This
realization resulted in the generation of a completely new approach, in which the AFP
is coupled with a second protein unit that is easy to synthesize, has a high intrinsic sol-
ubility, and can be modified to be a switchable module. Fusion protein approaches are
widely known in biochemistry, e.g. green fluorescent protein (GFP) to render proteins’
fluorescence detectable,69 fusion proteins to enhance recombinant bacterial expression
(small ubiquitin-like modifier (SUMO),70 thioredoxin71). The challenge in our idea and
application, however, is to couple the structure of the AFP to the structural state of
the fusion partner, if one wishes to switch the AFP activity by affecting the fold of the
fusion partner. Our search for solutions to this problem lead to the identification of the
Trp-Cage mini-protein as the promising fusion protein.
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3. Concept
In the following work, a new concept for stabilizing and switching α-helical peptides is
presented. The concept follows a modular approach. In this approach, the functional
sequence, the α-helical protein, is not directly modified to achieve photo-control.
Rather, a protein module is attached, which comprises the light responsive unit.
Provided that the structural state of the protein module can be coupled with that of
the α-helical protein, this approach has the advantage that the switchable module
needs to be developed (designed and optimized) only once. Ideally, the sequence of
the functional α-helical proteins is not or only minimally altered, thus the approach
is sequence independent and can be applied to any helical peptide with a function
of interest simply by attaching the switching module. In other words, the modular
approach separates function and switching, and thus facilitates their independent
optimization.
Figure 3.1.: Model of the Trp-cage variant Tc10b. The secondary structure is presented in
cartoon style and colored in rainbow, starting at the N-terminus in blue and ending
at the C-terminus in red. The side chains are presented in stick style in colored
according the element (carbon in grey, nitrogen in blue and oxygen in red).
The Trp-cage mini-protein fulfils the demands on such a module (Figure 3.1). Its tertiary
structure consists of an eight residue N-terminal helix, which is induced by the encap-
sulation of the eponymous Trp side chain by the C-terminal loop. Owing to the tertiary
structure, the Trp-cage exhibits an unusually high stability and is the smallest folded
protein so far. The Trp-cage is known to be highly soluble. It has an unbiased sequence,
no extended hydrophobic sequence stretches and is known to be easily synthesized by
SPPS. The protein does not have an intrinsic function, and thus can be converted into
an otherwise functionless switching module.
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3.1. The Switch-Cage Module
The switching of the structure of the Trp-cage can be implemented in several ways.
The underlying strategy is the disturbance of the Trp-cage folding nucleus with an
associated solvent exposure of the Trp side chain. The approach should lead to an
unfolding of the protein, including the N-terminal α-helix. The dimensions of the
Trp-cage in relation to those of the linker allows several anchor points for the linker to
fulfill the strategy. It is possible to attach the i,i + 7 Woolley-linker to the helix to
switch the secondary structure. However, switching of the tertiary structure is possible.
From the dimensions of the Trp-cage, anchor points in the C-terminal Trp-cage loop
are also possible, however, most residues in this sequence are essential for the fold and
cannot be altered. Nevertheless, the C-terminal residue (position 20) is ideally suited
as attachment point, since it is known to accommodate other residues without effect
on the fold and, foremost, is in a crucial position in the tertiary structure. With the
second attachment point either at the beginning or the end of the N-terminal helix, two
different implementations of the strategy are obtained, in which a maximum geometric
change on the Pro-Pro-Pro (position 17-19) sequence in the C-terminal loop is exerted.
Figure 3.2.: Two different concepts for a switchable Trp-cage. Top: an azobenzene at a push
position between the N- and C-terminus; Bottom: an azobenzene at a pull position
between the C-terminus and the C-terminal end of the helix.
In the approach called "push-approach", the Trp-cage fold is disturbed by the azobenzene
in the trans configuration, as the linker length does not match the distance between the
anchor residues (Figure 3.2). In the opposite "pull approach", the azobenzene stabilizes
the fold in its trans configuration, as the linker length matches with the distance between
the anchor residues.
Both concept have the advantage that only one amino acid in the helix is needed as
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anchor residues, where again residue replacements are well tolerated. The pull-approach
has been implemented and studied by N. Preußke during his Masters-thesis, while
the push approach has been pursued in this study.
3.2. Concepts for Fusion
In a modular approach, two proteins are joined leading to a fusion protein. The fusion
concept is well known and utilized in particular with recombinant technology to enhance
bacterial expression. In this concept, spacer residues are added between the proteins
modules to ensure that the protein domains behave independently and do not affect
their fold and activities. This is achieved by adding spacers either sequentially in the
primary sequence or via side chains. Thus, the fusion protein exhibits independent fold-
ing domains and activity.
In our approach, however, we also wish to achieve synergistic properties in form of a
structural correlation or dependencies of the fold between the two joined modules. We
aim to use the properties of the Trp-cage (stability and solubility) and the biological ac-
tivity of peptides with α-helical propensity, resulting in a fusion protein with a stabilized
fold of the biological active peptide.
The fold of α-helices is known to be cooperative.72 Thus, by adding residues to an exist-
ing helical structure, hydrogen bonds between the peptide groups i,i + 4 are established,
leading to a propagation of the existing helix conformation to the added residue back-
bone conformation. As existing helix or helix nucleation point, the Trp-cage module can
be used. The Trp-cage exhibits in its tertiary structure a remarkably stable, non-fraying
N-terminal helix. Previous studies with the Trp-cage protein showed that the α-helical
fold, induced by the Trp-cage, is propagated to six, N-terminally added Ala residues
leading to a stable α-helix.44
The junction between the Trp-cage module and the biological active peptide with α-
helical propensity can be accomplished in two different strategies.
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Figure 3.3.: Concept for combining the Trp-cage with a biological active peptide sequence in
two alternative approaches: a) chimera (top) and b) direct fusion strategy (bot-
tom). The secondary structure is represented in cartoon ribbon style. The Trp-cage
residues are marked in red and the residues from the biological peptide in blue.
The simplest strategy is the N-terminal elongation of the Trp-cage sequence with the
peptide (Figure 3.3), thus a direct fusion. On the one hand, the Trp-cage fold should
not be influenced by this extension and able to fold in its tertiary structure. On the other
hand, the Trp-cage helix is stable and provides a structural nucleation point, thus this
helix is expected to be cooperatively propagated into the sequence of the fused peptide.
This should lead to an induced and stabilized helical fold of the biological active peptide.
The advantage of this strategy is that neither the peptide nor the Trp-cage sequence
need any further modifications. In addition, spacer residues between the Trp-cage and
the peptide can be inserted to control the orientation between the Trp-cage’s tertiary
structure and the peptide’s helix. This method is suitable for all peptides with helical
propensity.
The second strategy is to create a chimeric fusion protein. The idea is to impart prop-
erties from each protein into the resulting chimera. In contrast to the direct fusion
strategy, the sequence of the biological active peptide and the N-terminal helix of the
Trp-cage coincide, resulting in a reduction of the overall peptide length. To realize this
strategy, one needs to carefully consider for each residue in the chimera region, which
amino acid from which part of the sequence has to be included. From the Trp-cage
perspective the two aromatic residues of the Trp-cage Tyr and Trp are needed in the
appropriate positions in the helix. The other positions in the helix can either be the orig-
inal Trp-cage sequence or the biological active peptide, depending whether the position
is important for structure or activity of the AFP. At the C-terminal end of the chimera
protein, the Trp-cage fold is completed by addition of 12 residues (the cage loop, includ-
ing the polyproline-II-helix). The resulting chimera protein exhibits the tertiary structure
of the Trp-cage with an elongated helix. Thus, the protein can be divided in three parts,
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the N-terminal extension (biological active peptide sequence), chimera helix (Trp-cage
and biological active peptide sequence) and the cage loop (Trp-cage sequence). The
advantage of this strategy is that the overall protein length can be significantly reduced.
However, the relative orientation of the peptides’ active side to the tertiary fold of Trp-
cage has to be considered carefully, as both should not interfere with the each other.
This method is suitable for all peptides, which activity is located on a surface side of
the protein helix.
Hereinafter, the results for the Switch-cage module and fusion are presented separately
in two parts. In the first part, the Trp-cage fold is discussed in detail and the results
for introducing the ability of switching the Trp-cage are presented and discussed. In
the second part, the fusion of the Trp-cage with the AFP Type 1 HPLC6 sequence is
presented and discussed.

Part I.
The Switch-Cage Module
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1. The Trp-Cage Fold
The Trp-cage exhibits a unique and unusually stable fold for its small size. Since its
identification, numerous studies have aimed to optimize the fold stability, analyzing
almost every amino acid in the sequence for its effect.39,41,43,73,74 Thus, many variants
(> 40) have been described and are well characterized.
Table I.1.1.: Numbered Tc10b sequence in one letter code.
Numbering 1 6 11 16
Tc10b DAYAQ WLKDG GPSSG RPPPS
We selected the Trp-cage variant Tc10b (Table I.1.1) as starting molecule and reference.
Tc10b is a very stable variant with a thermal unfolding mid-point (melting point, TM )
of 56 ◦C at pH 7 and TM = 41 ◦C at pH 2.5. The pH dependency of the fold stability
originates in the presence of a salt bridge between residue 9 and 16 at neutral pH.
According to literature, Tc10b folds cooperatively and is 99.5% folded at 280K and pH
7.43
Tc10b was synthesized by Fmoc solid phase peptide synthesis and purified by HPLC
chromatography. The protein was characterized by NMR spectroscopy.
Figure I.1.1.: 1H-NMR spectrum of Tc10b at 298 K and pH 3 with enlargement of the indole
proton region.
The 1H NMR spectrum at pH 3 and 298K is characteristic for the presence of a folded
peptide and is typical for a Trp-cage. The eponymous Trp side chain at the center
of the structure is the driving force for folding. Its well separated indole proton W6
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at the downfield edge of the spectrum is a strong indicator for structure. The signal
of W6H is known to shift upfield. Here, W6H is observed at a chemical shift (δ)
of 9.75 ppm, indeed significantly shifted to high field compared to the random coil
shift of 10.22 ppm.75 A second good indicator for the presence of a folded protein
is the chemical shift dispersion of amide and aliphatic resonances. While this not
obvious from the shown 1H spectrum, NMR-assignments using 2D-MR experiments
determine structure based differences between resonance of amino acids of the same
type. Notably, all resonance frequencies match well the reported values for Tc10b.
A closer look at the indole proton region in the 1H NMR spectrum of Tc10b (inset,
Figure I.1.1) however reveals a general and severe problem. Besides the mentioned
upfield shifted signal of W6H of the folded Trp-cage, multiple additional and partially
broad W6H signals above 10 ppm are observed. The intensity ratio of all the
resonances relative to the folded signal is 1 : 3. As these resonances originate from
multiple partially or complete unfolded Trp-cage sequences, a significant proportion of
the protein (≈ 25%) is incorrectly folded. Therefore, it was very surprising that these
resonances have not been presented and discussed in detail in the literature on the
Trp-cage before. Only exception are two studies that briefly mention the observation of
a “second form”.39,41 Principally, the resonances could originate from by-products of the
synthesis as sequence deletions or early terminations would be expected to be unfolded.
This possibility, however, can be ruled out, as the synthesized protein was demonstrated
to be of high purity (HPLC-electron spray ionization (ESI)-mass spectrometry (MS),
> 95%). Thus, these resonances must originate from alternative conformations of
the protein. However, these must interconvert with the folded protein only slowly
on the NMR chemical shift time scale in order to yield separate sets of resonances
in the NMR spectrum. Slow conformational exchange transitions are rare in proteins
and principally not expected in a fast and cooperatively folding, small protein domain.
We contribute these conformations to the presence of four proline amino acids in the
Trp-cage sequence (as will be discussed in detail below), as X-Pro sequences are known
to undergo a slow trans/cis-peptide bond isomerization under specific circumstances.
1.1. The Folded Fraction
The secondary structure of folded proteins can easily be assessed by analyzing the chem-
ical shifts of Hα protons. These undergo typical upfield or downfield changes depending
on the backbone conformation of the respective amino acid. A straight forward method
for interpretation was developed by D. Wishart.76,77
CSD = δobs − δref (I.1.1)
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In this, the deviation of the observed chemical shift of the Hα from the reference random
coil shift is calculated (Equation I.1.1). The resulting chemical shift deviation (CSD) has
been shown to be secondary structure dependent. Thus, the CSD is often termed the sec-
ondary chemical shift. Negative CSD values (< 0.1 ppm) are indicative of helical back-
bone conformation. Conversely, positive values (> 0.1 ppm) indicate a β-conformation
for the respective residue. Thus, a plot of the CSD against the residue number facilitates
the determination and a presentation of the secondary structure present in proteins.
Figure I.1.2.: Chemical shift deviation plot of Hα-atoms in Tc10b at 298 K at pH 3 (black)
and pH 7 (red). The CSD of the Hα is represented as squares. The deviations
for the second Hα’ protons in glycines are depicted as diamonds. The dashed line
represents the cutoff for the presence of a helix. The expected fold is presented
above the plot in ribbon presentation. The vertical solid line separates the se-
quence region of the helix (residue 1-8) to the left from that of the Trp-cage loop
(residue 9-20) on the right.
The CSD plot is shown for Tc10b at 298 K and pH 3 and pH 7 (Figure I.1.2). The
Trp-cage fold generally can be divided in two parts: the N-terminal helix from residue 1
to 8 and a C-terminal cage loop that completes the fold (9-20).
The chemical shift deviation of the N-terminal residues from 1 to 8 of Tc10b is
continuously negative. Except for residue number 2, the limit for a helical structure is
exceeded for all residues. Notably, the CSD for residue 7 is particularly negative, which
is typical for the Trp-cage. Likely, that position experiences an aromatic-ring current
shift caused by the indole side chain of the preceding amino acid W6.
From residue 9 onwards, nearly all residues show CSD values larger than the significance
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limit of 0.1 ppm. Both positive and negative deviations are observed, further it is
notable that the sign of the CSD frequently changes between neighboring residues. This
behavior indicates the absence of classical (regular) secondary structure elements (no
sequence stretches of three or more residues with identical backbone conformation),
while the presence and magnitude of CSD manifest the presence of structure and
absence of conformational flexibility. This behavior is fully consistent with the loop
structure from residue 9-15 and the polyproline-II helix from residue 17-19 present in
this region of the Trp-cage. Remarkably, the CSD values for residue Gly 11 and Pro
18 are strongly negative. Again, this observation can be attributed to the ring-current
effect of the aromatic indole ring system of the Trp side chain. These CSDs are
therefore also a strong indicator for the close proximity between the respective residues
and the Trp side chain. The reflect the encapsulation of the Trp side chain by Gly 11
and Pro 18 that is typical of the Trp-cage tertiary structure. Thus, the CSDs of these
two residues are excellent markers for the Trp-cage fold.
A comparison of the CSD plots of Tc10b at pH 3 and 7 shows that the CSDs are
nearly identical. The region from residue 1 to 8 exhibits only minor changes in the
CSD values, indicating a similar stability of the α-helix. The cage loop also exhibits a
similar pattern at both pH values. However, the magnitude of Hα CSD of the marker
residues Gly 11 and Pro 18 is significantly larger at pH 7. This indicates that the cage
fold stability is higher at neutral pH, owing to the formation of a salt bridge between
the oppositely charged residues Asp 9 and Arg 16.
The observed chemical shifts for Tc10b at pH 3 and pH 7 are in good agreement with
the chemical shifts reported in the literature.43 For a complete unbiased assessment
of the tertiary structure of each analyzed variant, it is advantageous to not only
analyze the Hα protons, but also all additional side chain protons that are affected
characteristically in the Trp-cage fold. A method for this was established by Barua
et al.43 They selected for the representation of the helix the sum of the Hα-CSD from
residue 2-8 (sum of the chemical shift deviation (∆δ)). in order to describe the cage
loop, protons are selected, which show the most influence by the ring current of the
Trp side chain. These protons are the Hα of position 7, the Hα’ of Gly (11), the Hα
and Hβ’ of Pro (18), and the Hδ and Hδ’ of Pro (19). The CSD of these protons were
summed up and serve as reference for the cage loop. They decided to separate the helix
and the cage loop, as variants of the Trp-cage can possess an intrinsic stable helix, and
thus not a stringent cooperative folding between the helix and the cage loop.
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Table I.1.2.: CSD for selected protons in the structure representing the cage fold of Tc10b at
298 K at pH 3 and pH 7.
Cage Loop L7α G11α’ P18α P18β’ P19δ P19δ’
∆δ(ppm) Σ(ppm) χF (%)
pH 3 -0.83 -2.41 -1.67 -1.02 -0.34 -0.53 -6.79 71
pH 7 -0.90 -3.23 -2.15 -1.51 -0.44 -0.63 -8.87 92
Helix A2α Y3α A4α Q5α W6α L7α K8α
∆δ(ppm) Σ(ppm) χF (%)
pH 3 -0.045 -0.434 -0.22 -0.35 -0.37 -0.83 -0.28 -2.52 84
pH 7 -0.05 -0.46 -0.21 -0.42 -0.40 -0.90 -0.36 -2.80 94
Application of this method for the Trp-cage Tc10b at pH 3 and 298K results in a sum
of the CSD for the helix of ∆δhelix = −2.52 ppm and for the cage loop of ∆δcage =
−6.79 ppm, respectively. At pH 7, the sum for the helix is ∆δhelix = −2.80 ppm and
for the cage loop to ∆δcage = −8.87 ppm.
A comparison of the sums between the two pH values confirm the general observations
in the CSD plot. The helix shows only a small stabilization upon an increase in pH, the
cage loop show significant changes, reflecting the location of the stabilizing salt bridges.
The observed chemical shifts and the discussed CSDs (shift changes versus an unstruc-
tured reference point) have been interpreted with the underlying assumption that an
equilibrium between folded and unfolded conformation of a protein exists and that the
interconversion between these conformations is fast on the NMR time scale. Under
these conditions, the measured chemical shift is averaged over folded and unfolded con-
formation or, more precisely, all conformations present. This is in contrast to the slower
cis/trans proline conformational isomerizations that yield separate sets of resonances
due to the lack of signal averaging. See discussion in section below. Thus, with the
knowledge of chemical shifts for the folded state of the protein and the random coiled
reference shifts for the unfolded state, the position of the folding equilibrium, i.e. fraction
folded (χF ), of a protein can be determined. The published shifts of Tc10b at pH 7 and
280 K, where Tc10b is 99.5% folded, can thus be used in conjunction with the method
by Barua to determine the χF of the helix and the cage loop (Equation I.1.2).43
χF =
(
0.995 ∗ CSDobs
CSDref
)
(I.1.2)
Calculation of the fraction folded for Tc10b at 298 K yields in a value for χhelixF = 84%
and χcageF = 71% at pH 3 and χhelixF = 94% and χ
cage
F = 92% at pH 7 and 298 K.
This method is used in the following chapters for comparing the fold stabilities of all
Trp-cage variants that were synthesized in this project.
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1.2. The Unfolded Fractions
The folding dynamics of the Trp-cage is more complicated than expected based on
present literature results that suggest a completely cooperative two state folding mech-
anism. In the previous section, the chemical shift dependence of proton resonances in
the Trp-cage was interpreted in terms of an existing fast equilibrium between the folded
Trp-cage with an unfolded population that yields one averaged NMR resonance for both
states. This behavior is in agreement with the expectations for a two-state, cooperative
the folding mechanism of such a small protein folding unit and all literature results for
the Trp-cage. Our NMR results however reveal the presence of multiple conformational
equilibria that occur on distinct time-scales. These additional conformational equilibria
are manifested in the presence of multiple resonances for the W6H proton. Their
respective chemical shifts indicate that the resonances originate from partially folded or
completely unfolded conformations.
Multiple conformations in the unfolded state, in particular slow processes that lead to
separate resonances in the NMR spectrum, are unexpected for a small protein. All
conformational conversions are expected to occur on the fast NMR time scale and
should be included in the single, fast-average signal. In this disordered or “random coil”
state, interactions between atoms are nearly completely absent and energetic barriers
between conformers are small.
Scheme I.1.1.: Scaffold of X-Pro. The peptide bond of X-Pro can isomerize between cis and
trans.
An exception is the peptide bond. The peptide bond has a partially double bond char-
acter, thus it can either be in trans configuration (ω = 0◦) or in the cis configu-
ration (ω = 180◦). Usually, the energy difference between the two configurations is
high and energetically, the trans configuration favoured (with an approximate ratio of
1 : 1000). However, the X-Pro peptide bond is known to undergo a trans/cis isomer-
ization, as the energy differences between the two configurations is significantly smaller
as the Cα and Cδ offer nearly equal steric repulsion to the preceding carbonyl group
(Scheme I.1.1). Thus, about 2 − 80% of cis X-Pro and an exchange rate of the order
of 2.5 · 10−3 sec−1 have been observed in unstructured peptides containing a single Pro
residue when no tertiary interactions shift the equilibrium to one side.78–81 For the reason
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of latter, cis/trans-Pro isomers are often referred to as conformers rather than strictly
configuration isomers.
Scheme I.1.2.: Schematic view of the folding and unfolding equilibrium with the downstream
equilibrium of the cis-Pro ismoerization of the Trp-cage. In the unfolded, all
trans state of the Trp-cage, the X-Pro peptide bond can undergo a isomerization
to the cis configuration (indicated by c-PXX, with XX the number of the Pro
in the sequence), resulting in four different conformers. These conformers can
also undergo a isomerization, which leads to a total number of 15 unfolded
conformations with at least one X-Pro peptide bond in cis.
All four Pro peptide bonds in the folded Trp-cage are in the trans configuration. In
the unfolded, all trans state of the fast equilibrium, the X-Pro peptide bond can un-
dergo an isomerization from the trans to the cis configuration. With a X-Pro peptide
bond in cis configuration, the Trp-cage cannot refold correctly and this conformation is
trapped and extracted from the fast equilibrium. The Trp-cage sequence contains four
Pro residues, whereas each can undergo a isomerization to the cis configuration. In
this state, with a single X-Pro in cis configuration, the three remaining X-Pro can also
isomerize (Scheme I.1.2), leading to a total number of 15 possible conformations. In
order to estimate the population of unfolded conformations with at least one X-Pro in
the cis configuration, an average possibility of 5% cis for each X-Pro is assumed. With
this assumption, the probability for one X-Pro in the cis configuration in the Trp-cage
accumulates to 20%. The overall probability, including all four X-Pro and combinations,
is determined to be ≈ 23%. However, the total amount present in a folding equilibrium
and thus visible in the NMR, is also dependent on the population in the unfolded, all
trans conformation. Even at the thermal mid-point (equilibrium between folded and
unfolded), a probability of 5% per X-Pro isomerization leads to a observable ratio of
90 : 10 (folded and unfolded trans configuration to cis-Pro unfolded). However, with
an increased average probability of 20% per X-Pro isomerization, ratios of ≈ 60 : 40 are
possible at the thermal mid-point.
In order to prove this interpretation of the observed multiple unfolded conformations in
the NMR spectrum of Trp-cage (inset, Figure I.1.1) being accumulated configurations
with cis X-Pro peptide bonds, two approaches were pursued.
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The first approach exploits the fact that owing to the limited stability, proteins unfold
with increasing temperature. Following our hypotheses, an increase in unfolded equilib-
rium population should result and also lead to an increase in cis-unfolded conformers.
Thus, the intensity of resonances for unfolded conformers should grow at the expense
of the intensity of the folded conformer. This was tested for practical reasons not with
Tc10b, but a closely related variant of similar stability, our variant TcKKA (described
in detail in section 3.1). Its sequence Ac-DKYAQWLADGGPSSGRPPPK differs from
that of Tc10b in the amino acids highlighted in bold.
Figure I.1.3.: 1H NMR spectrum of the region of the W6H proton from 9.5 to 10.3 ppm of
TcKKA at pH 3 and 298 K. The sharp resonance at 9.75 ppm is the fast equilibrium
signal and its integral is taken as all trans configuration (blue box). The multiple
signals between 9.9 and 10.2 ppm are the cis-Pro unfolded signals and the area
integral represents the cis-unfolded.
A series of 1H NMR spectra of TcKKA from 278 K to 328 K in steps of 2 K at pH 3
was recorded and the ratio of the fast equilibrium resonances and the cis-Pro unfolded
resonances determined. For this, the W6H resonances are particularly suitable, since the
signals of the fast, all trans equilibrium and the cis-Pro conformations are well separated
(Figure I.1.3). As a result, the integral of the upfield shifted W6H resonance represents
the fast equilibrium signal of the all trans conformations (folded and unfolded) and the
overall intensity of the cis-Pro unfolded population is represented by the integral of
the area between 9.9 and 10.3 ppm. The sum of both integrals was normalized to 100
in order to remove intensity differences originating from NH proton exchange with the
solvent.
1.2. The Unfolded Fractions 37
Figure I.1.4.: Normalized intensity of the folded all trans (fast equilibrium, blue circles) and
unfolded (cis-Pro, red squares) conformations against temperature. The integral
of the folded conformation was determined for the upfield shifted W6H below
10 ppm and represents the Trp-cage fold in fast equilibrium of the folding and
unfolding process. For the representation of the unfolded cis-Pro conformations,
the integral of all W6H signals between 9.9 and 10.2 ppm is summed up.
A plot of the normalized intensity of the fast, all trans equilibrium (blue) and the
unfolded cis-Pro conformations (red) against the temperature highlights the relationship
between the conformations (Figure I.1.4). At low temperatures (278-286 K), the ratio
between the fast, all trans equilibrium and cis-Pro unfolded conformations is approxi-
mately constant (≈ 3 : 1). From 286 K on, the intensity of the fast equilibrium indole
signal decreases (all trans conformation), whereas the cis-Pro conformations increase.
This shows that upon thermal denaturation of the Trp-cage, the total amount of
cis-Pro unfolded conformations present in the sample also increases. Foremost, the fold
stability of the protein is in relation to the amount of cis-Pro unfolded conformations,
and thus it can be utilized as an additional stability criteria for new Trp-cage variants.
The second approach attempted to spectroscopically prove the direct exchange between
the all trans conformation and the cis-Pro unfolded conformations. For this, a
variant of a nuclear Overhauser effect (NOE) experiment was performed, the so called
transferred NOE (tr-NOE). This type of experiment is usually used for the investigation
of ligand-protein interactions.82 In this experiment, resonances of the protein are
selectively irradiated and saturated. Due to spin diffusion, this saturation is transferred
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and leads to the saturation of all protein resonances. In the case of binding a ligand,
this magnetization is also transferred from the protein to the ligand, thus proving
association of ligand and protein.
A particular advantage of this approach is that the saturation transfer can similarly be
observed in an exchange situation on a slow time scale. With this experiment, processes
involving two or more different states, such as isomerization, can be studied. For this
application, two requirements are needed. First, the states have to differ significantly
in their chemical shifts for a selective irradiation. Second, the exchange rate must be
faster than the relaxation of the magnetization. For the Trp-cage, both requirements
are clearly fulfilled for the W6H proton.
Figure I.1.5.: Enlarged W6H region of the 1D steady state tr-NOE of TcKKA at 298 K and
pH 3 between δ = 9.2 and 10.4 ppm. In the black spectrum the cis-Pro W6H
at 10.165 ppm (black mark) was selectively irradiated and is the on-resonance
spectrum. The red spectrum is the off-resonance reference spectrum with an
irradiation 9.300 ppm (red mark).
The experiment was performed as steady state version with a exchange time of 4 s.
Two separate spectra are recorded, one on-resonance- and one off-resonance-saturated
spectrum. In the on-resonance irradiation spectrum, one resonance of W6H of the
cis-Pro conformations was selectively irradiated and saturated (black spectrum, Fig-
ure I.1.5). During a delay, that serves as exchange time, the saturated conformation is
able to isomerize to the all trans state, which is included in the fast equilibrium signal
of W6H. The saturation of this cis-Pro conformation is thereby "transferred" and the
fast equilibrium signal of W6H should be partially saturated, i.e. reducing its signal.
In the off-resonance spectrum, a second part of the spectrum was selectively irradiated
with equal power. In order to reduce artefacts of imperfect selectivity, such as unwanted
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direct saturation of the fast equilibrium indole signal, the off-resonance spectrum was
recorded with irradiation equally distanced from the signal of the folded W6H. For bet-
ter visibility of the transferred magnetization, a difference spectrum between the off- and
on-resonance was calculated that shows a resonance line proportional to the saturation
transfer.
Figure I.1.6.: Enlargement of the 1D steady state tr-nuclear Overhauser effect spectroscopy
(NOESY) difference spectra of W6H in fast equilibrium between 9.60 and
9.85 ppm with on-resonance irradiation at 10.165 (black spectrum) and
10.110 ppm (red spectrum). The signal at 9.75 ppm (dashed box) depicts the
transferred signal from the respective cis-Pro species into the all-trans fast equi-
librium resonances.
Two cis-Pro unfolded conformations with resonances at 10.110 and 10.165 ppm were
chosen for the irradiation in the tr-NOE experiment, as they exhibit the highest intensity
and therefore the best chance to detect a transfer to the W6H in the fast equilibrium.
In both difference spectra, a signal at the resonance of W6H in the fast equilibrium
is observed (Figure I.1.6). This proves that from both cis-Pro unfolded conformations
magnetization is transferred to the all trans conformation. These conformations are in
exchange with the fast equilibrium signal. Thus, proving a slow process in the protein
folding. This is in excellent agreement with the above described hypothesis of unfolded
conformations with an X-Pro peptide bond in cis configuration.
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Figure I.1.7.: 1H,1H NOESY spectrum of our Trp-cage variant TcKKA at 328 K and pH 3.
Enlarged region of the W6H between δ = 9.80 and 10.15 ppm. The diagonal
peaks correspond to the peaks in the 1D NMR and the cross peak between
δ = 9.89 ppm and 10.04 ppm to the exchange between the fast equilibrium
signal and the unfolded cis-Pro conformation.
With increase in temperature, not only the total amount of unfolded conformations
increase but also the exchange rate between the trans and cis configuration of the X-
Pro peptide bond. This leads to the possibility to perform a 1H,1H NOESY experiment at
elevated temperature in order to show the exchange between the different conformations.
The 1H,1H NOESY experiment is usually used to determine short distances through
space in molecules. In this experiment, short mixing times (≈ 200ms) are used in
which magnetization between spins is transferred via dipolar coupling through space.
However, chemical exchange processes can also be observed, as they similarly transfer
magnetization from one resonance (or conformation) to another. In the recorded 1H,1H
NOESY spectrum, exchange cross peaks are observed between the W6H of the fast
equilibrium signal and unfolded cis-Pro signal (Figure I.1.7). The exchange cross peak
above the diagonal (top, left signal) describes the exchange from the cis-Pro unfolded
conformations to the all trans conformation and the cross peak below the exchange
from the all trans conformation to the cis-Pro unfolded conformations. All performed
experiments prove that a slow equilibrium is present in the Trp-cage folding, leading to
additional unfolded species, which are kinetically trapped and extracted from the fast
equilibrium between the folded and unfolded conformation.
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2. Link the Cysteine in the Trp-Cage with a Cross-Linker
The azobenzene linker introduced by Woolley has been successfully used in numerous
studies to switch the conformation of proteins. It comprises the azobenzene moiety and
two iodoacetamide functional groups. This group facilitates the chemoselective covalent
attachment to Cys- side chains of the proteins (Scheme I.2.1).
Scheme I.2.1.: Reaction scheme of cross-linking of Cys with iodo or bromo functionalized linker.
The iodide in the acetamide group represents an activated halide. Principally, the reac-
tion can also be performed with bromides in equivalent positions, i.e. bromo acetamides
or bromide in benzylic positions. The linking reaction is carried out under alkaline con-
ditions. As the Cys’s thiol group easily oxidizes and forms disulfide bridges under these
conditions, the presence of a reductant such as TCEP is required.
Table I.2.1.: The sequences of Trp-cage variants Tc5b and Tc10b presented in one letter code,
which are used in work. The differences between these variants are marked in bold.
Tc5b NLYIQWLKDGGPSSGRPPPS
Tc10b DAYAQWLKDGGPSSGRPPPS
The Trp-cage Tc5b, a variant possessing average stability, was chosen for the following
exploratory experiments (Table I.2.1). Tc5b and our reference variant Tc10b share 85%
sequence identity. Only three amino acids in the first turn of the N-terminal helix differ
between these two proteins. The sequence changes from Asp-Ala-Tyr-Ala in Tc10b to
Asn-Leu-Tyr-Ile in Tc5b, resulting in a destabilization of the fold by 14 ◦C (TM Tc5b:
of 42 ◦C , Tc10b: 56 ◦C).43
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Figure I.2.1.: 1H NMR spectrum of Tc5b at 298 K and pH 3 with enlargement of the indole
proton region.
Tc5b shows a typical 1H NMR spectrum at 298 K and pH 3 for a folded Trp-cage. The
signal of the encapsulated indole W6H is observed at δ = 9.85 ppm. Similar to other
Trp-cage variants, unfolded cis-Pro conformations lead to clearly visible signals of the
indole proton above 10 ppm. The ratio of the resonance intensities of the fast folding
equilibrium and the cis-Pro unfolded conformations is 69 : 31, which is comparable to
Tc10b.
At pH 8, i.e. the conditions of the linking reaction, the signal of the fast equilibrium
folded indole shifts upfield by 0.10 ppm to δ = 9.75 ppm. The interpretation of this
shift average yields a fraction folded of 93%, the ratio of the fast equilibrium signal to
cis-Pro unfolded signals changes to 81 : 19. Both values suggest the presence of a more
stable fold at neutral pH.
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Figure I.2.2.: CSD plot of the Hα atoms of Tc5b at pH 3 (black) and pH 8 (red). The Hα
CSD is represented as square and the Hα’ (Gly) as diamond. The dashed line
represents the cut-off for the presence of a helix. The solid line separates the
N-terminal helix (residue 1-8) from those of the Trp-cage loop (residue 9-20).
The Hα CSD plot confirms that Tc5b exhibits a cage fold (Figure I.2.2). Expectedly,
from residue 1 to 8 the chemical shift deviation is negative and confirms the helical
secondary structure. From residue 9 to the C-terminal end, the CSD shows the typical
distribution for the loop in the folded Trp-cage at both pH values. The protein is
characterized as folded with a higher stability at neutral pH, as the deviations for the
Hα protons increase in magnitude.
To determine the stability of the Trp-cage based on the fast equilibrium of folded and
unfolded conformation (with all X-Pro in trans configuration), the chemical shifts of
characteristic protons in the tertiary fold were assessed again by the method of Barua.
The sum of the CSDs of characteristic protons was calculated as described for Tc10b
and the folded fraction determined (Table I.2.2).
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Table I.2.2.: CSDs for selected protons in the cage structure representing the cage and helical
fold of Tc5b at 298 K (pH 3 and pH 8).
Cage Loop L7α G11α’ P18α P18β’ P19δ P19δ’
∆δ(ppm) Σ(ppm) χF (%)
pH 3 -0.60 -1.68 -0.78 -0.79 -0.19 -0.35 -4.39 46
pH 8 -0.81 -2.90 -1.90 -1.27 -0.38 -0.56 -7.82 81
Helix L2α Y3α I4α Q5α W6α L7α K8α
∆δ(ppm) Σ(ppm) χF (%)
pH 3 -0.05 -0.25 -0.30 -0.30 -0.25 -0.60 -0.26 -2.01 67
pH 8 -0.17 -0.36 -0.37 -0.39 -0.34 -0.81 -0.35 -2.79 93
Notably, the fractions folded of the helix and the cage loop differ significantly by 20%,
which is unexpected for a cooperative folding. Structurally interpreted, the secondary
structure (helix) of the Trp-cage is intrinsically stabilized and compared to the tertiary
structure (cage loop). As a result, the Trp-cage can exhibit a helical propensity in the
absence of the tertiary structure. A criterion for an intrinsically stable helix, and thus not
an exclusively cooperative folding mechanism, are the differences in the fraction folded
and the TM of helix and cage. If the difference of the latter is smaller than 7 ◦C , the
protein folds cooperatively.
The fraction folded of Tc5b at neutral pH is determined to be χcageF = 81% and
χhelixF = 93%. A comparison between Tc5b and Tc10b shows that under conditions of
the cross-linking reaction, the Trp-cage variant Tc5b exhibits a similar stability, making
this protein a suitable variant for reaction tests and optimizations.
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2.1. Introducing Cysteine Residues into Tc5b
The Trp-cage does not have any native Cys residues in its sequence. Therefore, the
only sequence alterations required for protein cross linking are the incorporation of two
cysteine amino acids. The best positions for their incorporation depend on the steric
properties of the chosen linker (mainly its length) and the employed concept for ef-
fective switching of the fold. Here, we pursue the push-concept with the linkers 4,4’-
iodoacetamide-azobenzene (Woolley linker) and 4,4’-dibromomethyl azobenzene.
Figure I.2.3.: Concept for a switchable Trp-cage with azobenzene in a push position between
the N- and C-terminus. The azobenzene linker destabilizes or disrupts the tertiary
structure of the Trp-cage in its trans configuration (left) and stabilizes structure
in its cis configuration (right).
In this concept, the azobenzene in the cis-configuration should match the distance be-
tween between the two anchor points, i.e. the two Cys-resides, in the folded conformation
(Figure I.2.3). With azobenzene in the trans conformation, the attachment points are
pushed apart, locally disturbing the structure of the protein. Ideally, this should lead
to an exposure of the Trp side chain to the solvent. As the fold of the Trp-cage is
hydrophobically driven by encapsulation of this side chain, its exposure should lead also
to a complete unfolding of the protein.
In order to identify the best positions for introducing of the two Cys residues, the length
of the linker and distance between possible connection points in the protein were deter-
mined in MD simulations of the two linkers.
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Figure I.2.4.: Top: Distance distribution of 4,4’-diiodoacetamide azobenzene (Woolley
linker) between C-6 and C-6’ for cis (red) and trans (black). Middle: Dis-
tance distribution 4,4’-dibromomethyl azobenzene between C-5 and C-5’ for cis
(red) and trans (black). Bottom: Distance distribution of Cys side chain γS of
Tc5b-L2C-S20C (red) and between W6-H and P18-Hβ’ as control (blue).
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MD simulations of the Woolley linker show an effective distance change between C-6
and C-6’ in the trans and cis isomer of 7 Å (17.5 Å in trans and 10.5 Å in cis (Figure I.2.4,
detailed information of the simulations can be found in the Experimental section 3.11).
4,4’-dibromomethyl azobenzene shows a higher rigidity and shorter distances for the cis
(7.6 Å) and for the trans (12.1 Å) isomer. This results in an effective length change of
3.5 Å.
In order to determine positions for the Cys residues in Tc5b, the published structure
was scanned for possible connection points matching the length of the linker. The best
positions were identified to be position 2 in the helix and position 20 at the C-terminus
for both linker lengths. Thus, MD simulations of a Trp-cage variant with the two Cys
residues in the appropriate positions were also performed and the distance between the
Cys side chains analyzed. During the simulation, the distance between W6-H and P18-
Hβ’ was monitored as control for the folded state of the protein (Figure I.2.4). The
distance distribution between the γS atoms of Cys at position 2 and 20 reveals that two
maxima are present. One distribution maximum is centered at 7.5 Å and the other one
at 10.0 Å.
Figure I.2.5.: The two major conformations of Tc5b-L2C-S20C observed in the MD simulation.
The Trp side chain is encapsulated during the simulation, but at the N-terminus
and C-terminus flexibility was observed. This is a result of interactions between
the Cys at position 2 and the C-terminus. This yields in a different conformation
of the first two N-terminal amino acids of the helix and thereby two minimum
structures.
At first, the two maxima (rather than one) in the distance distribution of side chains in
the Trp-cage appears surprising. An analysis of the simulated Trp-cage conformations
reveals their origin. At the beginning of the simulation, the helix is folded up to
the N-terminus (left, Figure I.2.5) with a backbone torsion angle of φ = −60◦ and
ψ = −35◦ of Cys at position 2. This results in shorter distances between the side
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chains (centered 7.5 Å). During the second half of the simulation, the position 2 torsion
angles change (φ = −150◦ and ψ = +36◦). While this results in a partially unfolding
of the first N-terminal loop of the helix, the tertiary structure of the cage remains folded
(right, Figure I.2.5). The increased distance and flexibility lead to the second maximum
with a average distance of 10.0 Å between the two Cys residues.
Each maximum in the distance distribution of the connection residues in the
Trp-cage matches the length of one photochromic linker in its cis conformation:
4,4’-dibromomethyl azobenzene with the maximum at 7.5 Å and the Woolley-linker
with the maximum at 10.0 Å. Furthermore, neither linker matches these distances in
their respective trans-configuration, and thus should fulfill the requirement for efficient
switching.
2.1.1. Tc5b-L2C-S20C
The double Cys replacement of the Trp-cage Tc5b at position 2 and 20 was synthesized
(by S. Rothemund, IZKF Leipzig, with detailed synthesis protocols of all variants
documented in the Appendix, subsection 1.1.2) and characterized by NMR spectroscopy.
Figure I.2.6.: 1H NMR spectrum of Tc5b-L2C-S20C at 298 K and pH 3 with magnification of
indole proton region.
The 1H NMR spectrum of Tc5b-L2C-S20C at 298 K and pH 3 indicates a destabilizing
effect of the Cys replacements (Figure I.2.6). The signal of the encapsulated indole pro-
ton W6H is observed at δ = 9.91 ppm, suggesting a higher faction unfolded in the fast
equilibrium population. Also, unfolded cis-Pro conformations are visible above 10 ppm.
Surprisingly, another defined, sharp signal for the W6H is observed. Its chemical shift
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of δ = 10.01 ppm is in-between the folded conformation and the unfolded cis-Pro con-
formations, thus it is unclear what nature this species has. Because of its visibility in
the NMR spectrum, it must be a species in slow exchange with the other conformers.
Thus, the resonance may also arise from an unusual cis-Pro conformer, for example a
partially folded one. Alternatively, the signal could originate in a side reaction of the
Cys side chain, an intra- and/or inter-molecular disulfide-bridge formation between the
two Cys residues. Disulfide bonds are known to occur in aqueous solution at neutral pH
(or above), when solvent accessible thiol groups are oxidized by oxygen present in the
solvent.
We first tested for this side reaction by changing the protein solution conditions and by
monitoring changes by 1H NMR spectra (Figure I.2.7).
Figure I.2.7.: 1H NMR spectra of Tc5b-L2C-S20C at 298 K and different pH values. Expansion
of indole proton region between δ = 9.8 and 10.3 ppm. Bottom to top: Tc5b-
L2C-S20C at pH 3 (black), pH 5 (red), pH 6 (blue), pH 7 (magenta) and pH 7
with addition of TCEP (green). The label free thiol describes the correctly folded
protein in fast equilibrium.
At pH 3, the three different signals of the indole proton W6H are observed as discussed
above. The novel, unexplained signal is clearly evident at δ = 10.01 ppm. By increasing
the pH to 5, the fast equilibrium signal (free thiol) at pH 3 vanishes and new signals
with high intensities are observed at δ = 10.02 ppm. By further increase of the pH,
the three NMR spectra remain unchanged except for slight chemical shift changes of
all resonances. This could suggest that already after the first pH change to 5 all pro-
tein reacted and oxidized. Thus, we added the reductant tris-(2-carboxyethyl)-phosphin
(TCEP) to the solution. The observed spectrum is identical to the initial spectrum at
pH 3, despite the difference in pH. This experiment series proves that disulfide oxida-
tion does indeed occur rapidly at pH 5, but is fully reversible upon addition of reducing
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agent. Second, it proves that the sharp resonance at 10.01 ppm persist in the presence
of reducing agent. This shows, that the additional, partially unfolded signal cannot be
attributed to a formation of intra or inter molecular disulfide bridges.
In order to test for the alternative explanation for the resonance at 10.01 ppm, we
pursued an amino acid replacement study using analogs aimed at detecting whether steric
interactions of the Cys residues could cause the observation of novel partially folded cis-
Pro Trp-cage conformation. In the Trp-cage variant Tc10b-21Gly, we introduced Cys at
position 20, replacing the native Ser residue. This, from a structural point conservative
replacement, leads to a Trp-cage variant that is determined to be correctly folded (for
complete data see Appendix, subsection 1.2.2). By the additional introduction of Cys
at position 2, a protein variant was obtained that yields a nearly identical 1H NMR
spectrum compared to that of Tc5b-L2C-S20C (Figure I.2.6), in particular showing the
additional sharp signal with shift of 10.01 ppm, in between the resonances of folded and
folded conformations of the Trp-cage.
In conclusion, these experiments revealed that the partially folded conformation is not
originated from a formation of disulfide bridges. The replacement study shows that the
replacement to Cys at position 2 in the helix leads to the partially folded conformation
and is attributed to a specific cis-Pro isomerization. As in the helix no Pro residues are
present, an influence to the isomerization of the Pro residues at the C-terminus (17-19),
due to a close proximity of the Cys side chain, is most likely. This hypotheses is in
accordance to observations made in Part II.
Although this variant exhibits a complex fold with two stable folded conformations, it
was used for cross-linking, with the aim of an associated simplification of the fold.
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2.2. Cross-Linking of Tc5b-L2C-S20C
The linking of Tc5b-L2C-S20C with the two photochromic cross-linkers was performed
following a procedure by Kumita and coworkers,83 which is described in detail in the
Experimental Section (section 2.1). TheWoolley-linker was provided by H. Kobarg
and 4,4’-dibromomethyl azobenzene by J. Strüben. The reaction was monitored
using HPLC, matrix assisted laser desorption ionization (MALDI) mass spectrometry
with a time of flight (ToF) mass separator, and NMR spectroscopy.
Scheme I.2.2.: Reaction scheme of cross-linking of Cys with iodo- or bromo-functionalized
linker. The activated alkyl halogen can react in a nucleophilic substitution
reaction with the deprotonated thiol to form a thio-ether.
The cross-linking reaction with the Woolley-linker or 4,4’-dibromomethyl azobenzene
is a non-selective reaction (Scheme I.2.2). Therefore, not only in the 1+1 product
(Trp-cage+ linker), but also a 1+2 (Trp-cage+ two linker molecules) with a hydrolized
reactive position of the linker or oligomeric products (2+2 and other combinations) can
be expected.
The cross-linking of the Trp-cage with these cross-linker turned out to be more compli-
cated than the literature suggested. Therefore, a great effort was put into optimizing the
reaction by varying solvent mixtures and conditions. However, the results were almost
identical, thus the results of a standard procedure is presented.
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Figure I.2.8.: Top: MALDI-ToF spectrum of the crude reaction solution of Tc5b-L2C-S20C with
the Woolley linker. m/z : [M + H]+ calculated for [Tc5b − L2C − S20C −
(azo) +H]+ 2468.1, found 2469.0 and [M +H]+ calculated for [Tc5b−L2C −
S20C − (azo)2(hydrolyzed) +H]+ 2797.1, found 2797.2.
Bottom: MALDI-ToF spectrum of the crude reaction solution of Tc5b-L2C-S20C
with the 4,4’-dibromomethyl azobenzene. m/z : [M+H]+ calculated for [Tc5b−
L2C −S20C +H]+ 2176.5, found 2474.5 and [M +H]+ calculated for [Tc5b−
L2C − S20C − (azo) +H]+ 2382.7, found 2382.7.
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With respect to the multiple cross-linking possibilities, at low reactant concentrations the
reaction should follow primarily yield the cyclized 1+1 product in, since the cyclization
reaction is an intramolecular ring closure. Therefore, the 1+1 product is favoured
compared to the products of one protein with two linker (1+ 2 product) or two proteins
with one linker (2+ 1 product). The MALDI-ToF spectrum of the reaction solution
with the Woolley-linker indicates a complete conversion of Tc5b-L2C-S20C. Mainly
the m/z peak for the desired cross-linked 1+1 product is observed. Beside this, peaks
of one protein with two cross-linkers in different hydrolyzed states (1+ 2 products) are
observed with significant intensities (Figure I.2.8).
In contrast, the cross-linking reaction with 4,4’-dibromomethyl azobenzene shows an
incomplete conversion and peaks of doubly linked protein (1+2) are not observed.
The reduced reaction rate and the enhanced selectivity can be fully explained by the
reduced solubility of 4,4’-dibromomethyl azobenzene compared to theWoolley-linker.
The linker shows only limited solubility in the reaction solution and mainly precipitates,
significantly reducing the concentration of the linker available for the reaction in the
solution.
Figure I.2.9.: Progress of the linking reaction between Tc5b-L2C-S20C and the Woolley
linker was monitored by HPLC. From bottom to top: Tc5b-L2C-S20C (black
chromatogram), reaction solution with a detection wavelength of 220nm (red
chromatogram) and 365nm (blue chromatogram).
Both cyclization reactions were also followed by HPLC. The HPLC profile of the re-
action mixture Trp-cage and Woolley-linker after reaction completion (Figure I.2.9)
shows one main product peak with a retention time (tR) of 18min. This was assigned
to the desired 1+1 cyclized product based on its MALDI spectrum (see Appendix,
Figure V.1.7). The reaction is complete (> 90%) as a peak of the starting material
(tR = 15.5min) was not observed. A clear peak for a 1+2 cross-linked product is
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also not apparent, despite its detection in the mixture characterized by MALDI (Fig-
ure I.2.8). However, very broad peaks between 14 to 17min and a peak at 20min
are noticeable. These originate from unreacted, hydrolyzed linker or linker side prod-
ucts. This is highlighted by measuring a subsequent HPLC profile obtained under nearly
identical conditions, which was recorded with a detection wavelength (λ) of 365nm.
At this wavelength, the aromatic linkers have a significant higher absorption coefficient.
The profile confirms that the assigned product peak is linked with an aromatic linker.
Further, the broad signals sharpen and the signal at 20min shows an increased intensity.
Thus, the peaks are assigned to side products of the aromatic linker.
Figure I.2.10.: Reaction progression of Tc5b-L2C-S20C and 4,4’-dibromomethyl azobenzene
monitored by HPLC. From bottom to top HPLC chromatograms of the reaction
mixture after t = 0 d (black chromatogram), 12 d (red chromatogram) with a
detection wavelength of λ = 220nm.
The reaction progress of Tc5b-L2C-S20C with 4,4’-dibromomethyl azobenzene was sim-
ilarly monitored by analytical HPLC with a detection wavelength λ = 220nm (Fig-
ure I.2.10). Besides the peak of Tc5b-L2C-S20C at tR = 9.5min, two minor peaks at
tR = 9.2min and tR = 9.9min were observed in the beginning of the reaction (black
chromatogram). Those peaks could not be identified with the equipment at that time.
After 12 days of reaction time (red chromatogram), most of the protein had reacted and
three peaks were apparent (tR = 10.0min, tR = 10.5min and tR = 14.0min). The
fraction with tR = 10.0min contains the correct cross-linked product. For the peak at
tR = 10.5min unambiguous assignment was not possible, but judged by the retention
time a multiple cross-linked side product, such as 1+2 or 2+2, is a plausible origin.
The third peak (tR = 14.0min) is assigned to the unreacted linker in its hydrolyzed
state as discussed for the other linker.
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The cross-linked proteins were purified and further characterized by NMR spectroscopy.
For both cross-linked Trp-cages, a low signal to noise ratio of the spectra is observed,
as only limited product quantities were available owing to the low yield (< 20%) of
the cyclization reaction. It is also clearly noticeable that the resonances of the protein
are broadened, which reduces the signal to noise ratio even further. These effects are
significantly more pronounced for the cross-linked Trp-cage with the Woolley-linker.
Its 1H NMR spectrum can be found in the Appendix (Figure V.1.8).
The NMR spectrum of Tc5b-L2C-S20C linked with 4,4’-dibromomethyl azobenzene has
a significantly better signal to noise ratio. This can be attributed to the increased selec-
tivity of the cross-linking reaction, and thus higher yield (≈ 40%) and higher concentra-
tion of the sample. Similar to the cross-linked Tc5b-L2C-S20C with Woolley-linker,
line-broadening is observed for the protein resonances (full spectra can be found in the
Appendix, Figure V.1.11). In order to show the effect of the cross-linker to the Trp-cage
fold in the trans or cis configuration, the focus is set to the indole proton region of
W6H between δ = 9.5 and 10.4 ppm.
Figure I.2.11.: Enlarged 1H NMR spectra between 9.5 and 10.4 ppm (indole proton region) of
Tc5b-L2C-S20C cross-linked with 4,4’-dibromomethyl azobenzene (top) in trans
(black) and cis (red) at 298 K and pH 3.
In the magnified indole proton region of W6H of the 1H NMR spectrum with the
linker in the trans configuration, three sharp signals are observed (Figure I.2.11). The
signal δ = 10.02 ppm is assigned to W6H of the Trp-cage in an unfolded conformation
judged by its chemical shift. The clear signal at δ = 10.05 ppm is assigned to a second
unfolded conformation of the Trp-cage. Judged by its chemical shift and intensity its
occurrence can be explained by a single cis-Pro unfolded conformation. The third signal
at 9.84 ppm is assigned to a W6H of the Trp-cage in its folded conformation. A folded
Trp-cage signal should only be observable if the sample contains already cis-azobenzene.
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This could have happened during the purification process, since several steps cannot be
performed exclusively in the dark.
Upon irradiation at λ = 365nm, the azobenzene is switched from the trans to the cis
configuration. This results in a significant decrease of intensity of the indole signal of
the unfolded Trp-cage at δ = 10.02 ppm. Simultaneously, the intensity of the folded
signal at 9.84 ppm increases, indicating an encapsulation of the Trp side chain, and
thus a refolding with the linker in the cis-configuration. However, the two signals of
the unfolded Trp-cage not only decrease in intensity, but also experience an upfield
shift and a line broadening. Furthermore, a significant signal loss is observed. Both
observations lead to the conclusion that the protein sample aggregated. Therefore, no
further experiments and assignments were possible.
The results of the cross-linking with the two azobenzene linker reveal that a slower
but more selective cross-linking reaction is of advantage, regarding the purification and
therefore yield. The changes in the 1H NMR spectra of azobenzene in the trans or
cis configuration indicate that the protein is influenced differently by each state. The
chemical shift of the W6H in both states is in good agreement with our aim to destabilize
the Trp-cage fold in the trans configuration of the linker and stabilizing its fold in its cis
configuration.
Scheme I.2.3.: Possible side reactions of TCEP (top, left) with the reactive group of theWool-
ley linker.
The aggregation of both cross-linked variants can be a result of the side-products of the
linker with the reducing agent TCEP (Scheme I.2.3). These by-products are soluble in
water and due to their variety not fully separable by purification by RP-HPLC. Evidence
for their presence in the protein samples are prominent signals of the linker in the NMR
spectra (spectra in the Appendix, Figure V.1.8, Figure V.1.11). Changes in solvents
(to methanol or dimethylsulfoxide, data not shown) or additional purification steps
could not diminish the linker contamination nor reduce the aggregation of the protein
product.
This hypotheses was later substantiated by experiments performed by H. Kobarg.67
After an upgrade of the HPLC with a simultaneous ESI-MS detection (see Appendix
2.2. Cross-Linking of Tc5b-L2C-S20C 57
section 3.2 for more details), additional peaks of the HPLC chromatograms were
observed and assigned. He showed various side reactions of the linker, i.e. hydrolysis,
reactions with reducing agent TCEP, leading to water soluble azobenzene. These
species exhibit similar retention times on the HPLC as the desired product. Therefore,
the purified samples still contained unreacted azobenzene, possibly causing the observed
aggregation.
Overall, these experiments suggest that control of the Trp-cage fold using this approach
with azobenzene cross-linker is principally possible. However, significant improvements
regarding the properties of the linking reaction, e.g. yield, elimination of soluble linker
by-products, ideally avoiding the use of a reductant, altogether, are necessary. Such
improvements are expected to also improve the protein behavior and reduce the sample
aggregation tendency.
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The results of cross-linking the Trp-cage between Cys residues revealed several impor-
tant observations. On the positive side, the selectivity of the cross-linking reaction
can be tuned by the solubility of the linker. With limited solubility the reaction is
slower, but significantly lower fractions of side products were observed. On the negative
side, we learned that the use of one specific reductant caused multiple problems. The
linker reacted with the reductant, leading to water soluble side-products that cause
significant difficulties in the purification. The major drawback of using Cys residues for
cross-linking is the occurrence of multiple (partially) folded species of the Trp-cage.
Scheme I.3.1.: Reaction scheme of cross-linking of Lys with N-hydroxysuccinimide ester func-
tionalized linker. The activated ester can react with primary amines to form a
peptide bond.
In order to overcome the substantial problems, we decided to pursue an alternative
cross-linking chemistry. A promising possibility appeared to be the linking chemistry
based on N-hydroxysuccinimide esters NHS (Scheme I.3.1). These esters are known to
react exclusively with primary amines, therefore lysine is the only reactive amino acid.84
A particular advantage using this chemistry is that the reaction proceeds without any
additional reagents, which largely reduces the possibility of side reactions.
For implementing this chemistry, we intended to use a more stable Trp-cage variant than
Tc05b to reduce the effect of possible unfavourable steric interactions upon including
the long Lys side chain. Therefore, the studies are based on the Trp-cage variant Tc10b
with a TM of 56 ◦C , elevated by 14 ◦C compared to Tc5b.
60 3. Link the Lysine in the Trp-Cage with a Cross-Linker
3.1. Trp-cage Variant for Cross-Linking Using NHS-Esters
Active esters are reactive towards primary amines. In order to apply this chemistry to
the Trp-cage, several replacements are necessary in the Tc10b sequence to incorporate
an azobenzene linker.
Table I.3.1.: Trp-cage sequence TcKKA for NHS based cross-linking. Replacements in the
sequence of Tc10b are marked in bold.
Tc10b DAYAQWLKDGGPSSGRPPPS
Tc-KKA Ac-DKYAQWLADGGPSSGRPPPK
First, the N-terminus has to be acetylated as it presents a primary amin functionality
that would compete for the linker. Secondly, a native Lys residue at position 8 needs to
be replaced. We chose Ala of Lys, as this replacement is known to be fold stabilizing.43
The connection points for the cross-linking were kept identical to our previous attempt
and Lys residues were introduced at position 2 and 20 to yield the variant TcKKA
(Table I.3.1).
The synthesis of Tc10b-Ac-A2K-K8A-S20K (TcKKA) is described in detail in the Ap-
pendix (Figure V.1.21, Table V.3.5). In the following, the folding properties of this
Trp-cage variant are discussed.
Figure I.3.1.: 1H NMR spectrum of TcKKA at 298 K and pH 3. Magnification of indole proton
region.
The 1H NMR spectrum (Figure I.3.1) indicates a well folded Trp-cage protein. The
signal of the indole proton W6H in the fast folding equilibrium state is observed at
δ = 9.75 ppm. The ratio between the fast equilibrium signal and the cis-Pro unfolded
indole signals is determined to be 69 : 31. Both observations are comparable to Tc10b
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and are clear evidence that all replacements are well accepted. Notably, the Lys residue
at position 2 does not cause alternative (partially) folded conformations in this variant.
Figure I.3.2.: CSD plot of the Hα atoms of TcKKA at pH 3. Hα as black squares and Hα’
diamonds. The dashed line represents the cutoff for the presence of a helix. The
vertical solid line separates the CSD of the helix (residue 1-8) to the left from
those of the Trp-cage loop (residue 9-20) on the right.
The Hα-CSD plot confirms that the variant TcKKA exhibits a Trp-cage fold (Fig-
ure I.3.2). As expected, the chemical shift deviations from residue 1 to 8 are negative.
This is evidence for the helical secondary structure. From residue 9 to the C-terminal
end, the CSDs show the expected distribution for the cage loop in the folded Trp-cage.
The characteristic high deviations for Gly (11) Hα’ and Pro (18) Hα, which are addi-
tionally influenced by the ring current of the encapsulated aromatic indole, are strong
evidence for the correct tertiary structure.
Table I.3.2.: CSDs for selected protons in the cage structure representing the cage fold of
TcKKA at 298 K at pH 3.
Cage Loop L7α G11α’ P18α P18β’ P19δ P19δ’
∆δ(ppm) Σ(ppm) χF (%)
pH 3 -0.82 -2.34 -1.62 -0.83 -0.34 -0.54 -6.48 67
pH 7.9 -0.96 -3.46 -2.31 -1.64 -0.45 -0.68 -9.49 99
Helix K2α Y3α A4α Q5α W6α L7α A8α
∆δ(ppm) Σ(ppm) χF (%)
pH 3 -0.16 -0.35 -0.22 -0.28 -0.36 -0.82 -0.21 -2.4 80
pH 7.9 -0.24 -0.46 -0.20 -0.37 -0.42 -0.96 -0.30 -2.95 99
The determination of the stability of the Trp-cage’s fast equilibrium folding at pH 3 and
298 K is accomplished again by evaluation of the CSDs of characteristic protons grouped
according to the tertiary structure (Table I.3.2). This results in χcageF = 67% for the
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cage loop and χhelixF = 80% for the helix. Both values are in the same range as for
Tc10b at similar conditions.
Furthermore, the fraction folded was determined for TcKKA at 274K and pH 7.9. At
these conditions, the fraction folded for both, helix and cage loop, are determined to
be > 99% and the highest values we have seen among all our protein variants. The
protein under these conditions is completely folded and very stable, which confirms that
all replacements and modifications are well accepted.
The orientations and interactions of the side chains of the introduced Lys residues are
of importance for the cyclization reaction. A measure for the environment of the Lys
side chains can be the chemical shift of the Lys ζH amino group. These chemical
shifts for the introduced Lys (2) and Lys (20) residues differ in the 1H NMR spectrum
(observed δK2ζ = 7.574 ppm and δK20ζ = 7.473 ppm) by 0.1 ppm. This indicates a
difference in their environment. One could speculate that the higher shift for Lys (2)
ζH originates in stronger hydrogen bonding of the amino function, for example with the
free C-terminal carboxy function. However, in protic solvents, multiple effects have an
influence on this shift (competing hydrogen bonds with the solvent, pH and temperature
effects) so that an unambiguous interpretation is difficult. Support for an interaction
between the Lys (2) side chain and the C-terminus can be derived from 1H,1H NOESY
NMR experiments. In this experiment, close proximity of protons can be detected. The
spectra 1H,1H NOESY spectra of TcKKA show cross peaks between the Lys (2) Hβ and
the Hδ of Pro at position 19. These two residues are in close contact, which would be
expected for a hydrogen bonded, conformationally restricted Lys side chain.
The stability of the fold is also characterized by the TM , the temperature of the half
point of protein denaturation. In order to determine the TM , a series of 2D 1H,1H
total correlation spectroscopy (TOCSY) experiments between 274.2K and 358K were
recorded and the representative shifts for the helix and cage loop were determined and
evaluated. For each temperature, the fraction unfolded (χU = 1 − χF ) was calcu-
lated. With increasing temperature, multiple forms, line-broadening and overlapping
with the residual water signal occurred. Foremost, with increasing temperature the
folding dynamics facilitates the presence of trans/cis Pro and the unfolded cis-Pro
conformations gain intensity and are more prominent in the sample compared to the
conformation in the fast folding equilibrium. As consequence, the chemical shifts could
only be determined unambiguously up to 338K. Noticeably, upon cooling TcKKA from
328K to 298K, the protein showed full reversibility of the fold.
y =
(
A1 −A2
1 + e(T−Tm)/dT
)
+A2 (I.3.1)
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The fraction unfolded in the fast equilibrium χU was plotted against the temperature
(Figure I.3.3) and a constrained Boltzmann fit (Equation I.3.1) was performed (Equa-
tion I.3.1). The lower and upper limit A1 and A2 were set to 0 or 1, respectively.
Figure I.3.3.: The fraction unfolded χU plotted against the temperature for N-terminal α-helix
(black squares) and the cage loop (red circles), both with a constrained Boltzmann
fit (black and red line).
The plot of the fraction unfolded against the temperature (Figure I.3.3) shows that at
low temperature both, the secondary structure (helix) and the tertiary structure (cage
loop), are > 90% folded. However, with increase in temperature we observe a small
slope for the thermal denaturation. Notably, the cage loop unfolds faster compared to
the helix, which leads to a lower melting point by > 10◦C. Both observations, the small
slope and the difference in the TM , show that the folding of TcKKA is not exclusively
cooperative.
Table I.3.3.: Melting points (TM ) of the helix and the cage loop of TcKKA, Tc10b and Tc10b-
K8A at acidic conditions (pH 3 for TcKKA and pH 2.5 for Tc10b and Tc10b-K8A,
Neidigh43).
Trp-cage TM(helix) (K(◦C)) TM(cage loop) (K(◦C))
TcKKA 332± 0.8 (59± 0.8) 318± 0.5 (45± 0.5)
Tc10b 317 (44) 312 (39)
Tc10b-K8A 325 (52) 319 (46)
Comparing the TM of TcKKA with (332K for the helix and 318K for the cage loop) to
those of Tc10b and the variant Tc10b-K8A43 shows that the replacements and modifica-
tions lead to a stabilization. The helix is markedly stabilized by 15 ◦C and 7 ◦C compared
to Tc10b and Tc10b-K8A, respectively. The TM value of the loop is unaltered compared
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to Tc10b-K8A, but elevated by 6 ◦C compared to Tc10b. This shows that our modified
Tr-cage exhibits a very stable fold. We therefore used this new Trp-cage variant for
establishing a new cross-linking method described in the following.
3.2. Cross-Linker with NHS Esters as Functional Group
Cross-linking the Trp-cage variant TcKKA requires a linker with a selective reactivity
towards primary amines, such as the Lys side chain. A functional group, which meets
this criteria is the N-hydroxysuccinimide ester.
Scheme I.3.2.: Scaffold of an azobenzene based photochromic linker with NHS functionalized
reactive groups for cross-linking (left) and Lomant’s Reagent (right).
Based on the azobenzene scaffold, a photo-switchable cross-linker with NHS groups
was designed and synthesized (see Experimental Section subsection 2.3.1 for details) for
cross-linking with TcKKA. In order to verify the design of the switchable cross-linker,
the length and the flexibility of the linker and Trp-cage side chains were determined by
MD simulations of 4,4’-dibenzoic acid azobenzene and the TcKKA.
The linker dithiobis(succinimidylpropionate) is known as Lomant’s Reagent (right
structure, Scheme I.3.2). It comprises two NHS ester functionalities and is commercially
available. This linker exhibits no photochromic switching properties and is fully flexible.
The spacer arm has a length of eight atoms, resulting in a maximum span of 12 Å.85
Furthermore, this linker has a disulfide bridge, which can be opened by reduction (with
common reductants, such as TCEP) and closed by oxidization (i.e. at high pH and
atmospheric oxygen). Lomant’s Reagent was chosen primarily to test and optimize
the reaction conditions for cross-linking the Trp-cage TcKKA. Moreover, it will reveal
possible sterical hindrances in the protein or the linker interferes with the Trp-cage
structure.
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Figure I.3.4.: Top: Distribution the distance between O-6 and O-6’ in MD calculations of
4,4’-dibenzoic acid azobenzene in the cis (red) and trans (black) configuration.
Bottom: Distance distribution of Lys side chain N of Tc10b-A2K-K8A-S20K
(TcKKA) (red) and the distance distribution between Trp 6 H and Pro 18 Hβ’
(blue) as control for the presence of the intact fold of the cage.
MD simulations were employed to assess the available distance between the reactive
groups of the azobenzene cross-linker (top, Figure I.3.4). In the trans configuration,
the linker has a narrow distribution around an average length of 13.3 Å. The distance
distribution of the cis configuration is significantly wider and centered at 8.5 Å. The
photoisomerization is thus expected to result in an effective change of distance of 4.8
Å.
A similar calculation was performed for the Trp-Cage focusing on the distance of the
reacting amino groups of Lys (2) and (20). The short distance of Pro 18 Hβ’ and
Trp 6 H was monitored as a control for the folded state of the protein. The distance
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distribution between the two N nitrogen atoms of the Lys residue at position 2 and
20 shows a distribution maximum at a distance of 10.5 Å. Unexpectedly for two long,
flexible and terminal side chains, the distribution has an asymmetric shape and a
shoulder (at 9.5 Å, bottom, Figure I.3.4), which suggest that the mobility of one (or
both) side chains is constrained and has two major conformations.
The distance distribution of the respective atoms in the cis-linker and the protein
almost completely overlap, the size of the linker matches and should be compatible
and support the folded Trp-cage state. On the other hand, due to the completely
separate distance distribution, the trans-linker is incompatible with the folded state of
the Trp-cage.
Figure I.3.5.: Representative structure of Tc10b-A2K-K8A-S20K (TcKKA) of the MD simula-
tion with highlighted Lys (2 and 20) Tyr (3) and Trp (6) in stick style. Carbon
is colored in grey, nitrogen in blue and oxygen in red. The secondary structure is
represented in cartoon style.
The unusual distribution shape for the protein prompted us to analyze the conformations
of the calculated structures and specifically the mobility of the Lys side chains in more
detail. Lys at position 20 (Figure I.3.5) does not experience any restraints and can move
freely. The amino function of the Lys side chain in the helix at position 2 frequently
interacts with the free, negatively charged C-terminal carboxy group in a preferred,
relative defined conformation. On the remaining structures, the side chain conformations
are very variable (flexibility), pointing away from the C-terminus. As a result, the distance
distribution between the N of both Lys side chains is shaped asymmetrically.
A putative interaction between the C-terminus and the Lys (2) side chain was already
suggested by the NMR data (discussed above). Thus, the MD simulation and NMR
experiments support each other.
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3.3. TcKKA Linked with the Lomant-Linker
The Trp-cage TcKKA was cross-linked with Lomant’s Reagent and purified as de-
scribed in the Experimental Section (section 2.2). The reaction was performed in a
1:1 mixture of buffered watera and dimethyl sulfoxide (DMSO). The Trp-cage and Lo-
mant’s Reagent are completely soluble in this solvent mixture, making the reaction
fast but not highly selective. Therefore, exclusive formation of the cyclic 1+ 1 product
cannot be expected, but also multiply linked species should form.
Figure I.3.6.: HPLC chromatogram of the reaction mixture of TcKKA with Lomant’s
Reagent prior purification with a detection wavelength λ = 220nm
The reaction progress was monitored by HPLC (Figure I.3.6). The profile shows multiple
peaks as expected. The main peak at tR = 13.0min is assigned to the cyclic 1+ 1
product based on its ESI-MS spectrum (see Appendix, (Figure V.1.23)). It is noticeable
that the product is well separated from the starting materials (tR = 12.2min (TcKKA)
and tR = 16.2min unreacted linker) and from all side products. Most of the side
product peaks can also be assigned, such as doubly linked Trp-cage or oligomers of
Trp-cage with the linker.
A specific advantage of Lomant’s Reagent as cross-linker is its disulfide bridge, as it
can be reduced and cleaved. The free thiols can also be re-oxidized, if done under very
dilute conditions of the protein, the disulfide bridge reforms selectively intra-molecularly,
and all oligomeric species are converted into the desired 1+1 product.
apH 7.2, 20 mM Phosphate buffered saline (PBS) and 1 M NaCl
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The (1+1) Lomant-linked TcKKA (TcKKA-Lomant) was purified and characterized
by NMR spectroscopy at 298 K and pH 3 (Figure I.3.7).
Figure I.3.7.: 1H-NMR spectrum of TcKKA linked with Lomant’s Reagent at 298 K and
pH 3. Magnification of indole proton region.
The 1H NMR spectrum (Figure I.3.7) of TcKKA-Lomant shows characteristics of a
folded Trp-cage and is comparable to the unlinked TcKKA. The signal of the indole
(W6H) of the folded Trp-cage is observed at δ = 9.66 ppm. In comparison to the
unlinked Trp-cage it is shifted upfield by 0.09 ppm. Further, the resonance for Pro (18)
Hβ’ is clearly visible with a strong upfield shift (δ = 0.62 ppm). The position of these
resonances indicate a stabilizing effect of the cross-linker on the protein fold.
Resonances for the cis-Pro unfolded species are also observed in the NMR spectrum.
These appear comparatively sharp, broad resonances are not apparent. This is likely due
to the low signal-to-noise ratio of the data, which also prevents the determination of a
cis-Pro unfolded to folded W6H intensity ratio.
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Figure I.3.8.: CSD plot for the Hα-atoms of TcKKA linked with Lomant’s Reagent at pH 3.
The Hα are represented as squares and Hα’ (Gly) as diamonds. The dashed line is
the cut-off for the presence of a helix. The solid line the separates the N-terminal
helix (residues 1-8) from those of the cage loop (residue 9-20).
Evaluating the secondary chemical shifts for the Hα (CSD plot) of TcKKA-Lomant
confirms the first impression of the 1H NMR spectrum (Figure I.3.8). From residue 2 to
8, the deviations of the Hα atoms of the linked Trp-cage are negative and exceed the
limit for the presence of a helical secondary structure. From residue 9 on, the typical
pattern for the C-terminal Trp-cage loop is observed. In particular, the Hα derivations
of Gly (11) (δ∆ = −3.063 ppm) Pro (18) (δ∆ = −2.051 ppm) are significantly upfield
shifted compared to the unlinked TcKKA. This is a clear evidence that the fold stability
is significantly increased.
Table I.3.4.: CSDs for selected protons representing the fold of TcKKA-Lomant at 298 K at
pH 3.
Cage Loop L7α G11α’ P18α P18β’ P19δ P19δ’
∆δ(ppm) Σ(ppm) χF (%)
-0.96 -3.06 -2.05 -1.28 -0.55 -0.73 -8.64 90
Helix K2α Y3α A4α Q5α W6α L7α A8α
∆δ(ppm) Σ(ppm) χF (%)
-0.22 -0.41 -0.23 -0.32 -0.43 -0.96 -0.24 -2.81 94
Analysis of the sums of the CSDs support the observation of a stabilizing effect
(Table I.3.4). This is particularly reflected in the fraction folded for the cage loop and
the helix, as they are significantly increased. In comparison to the unlinked TcKKA
(χcageF = 67% and χhelixF = 80%), the cross-linking results in a significant stabilization
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of both structural parts in the Trp-cage.
Scheme I.3.3.: Numbered scaffold of Lomant’s Reagent.
In order to investigate possible interactions of the linker and Trp-cage, the chemical
shifts of the linker were evaluated. The proton bearing ethylene groups of the Lomant
linker exhibit for each group (dashed and not dashed protons) only one set of signals
(H-1,1’: delta = 2.95 ppm; H-2,2’: delta = 2.76). The observed chemical shifts are
observed at in the expected region and exhibit coupling constants usually observed for
flexible alkyl chains. This can only occur, when the chemical environment is equal and
no interactions of the linker with the protein exist. Support for this is found by analysis
of 1H,1HNOESY experiments. For the spacer, close contacts to the protein’s residues
are not observed.
Figure I.3.9.: Representative model of TcKKA-Lomant of MD simulations. The secondary
structure is represented in cartoon style and the side chain of Tyr and Trp as well
the Lomant-linker in stick style. The helix is colored in red, the C-terminal cage
loop in blue and the Lomant-linker in green.
Using MD simulations of TcKKA-Lomant, a model for the cross-linked protein was
created (Figure I.3.9). The protein conformation was stable over the entire trajectory
showing no deleterious effect of the flexible linker on the protein stability. The linker is
positioned near the termini and placed well separated from any protein side chain. It is
located on the opposite side of the protein, relative to the tyrosine side chain and is
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distanced over 5 Å away from the Trp side chain and other. This position is consistent
with the NMR data.
The results display that the Trp-cage can be selectively cross-linked using NHS ester.
The linker does not interfere with the protein fold. Foremost, the results show that the
flexible linker even leads to a significant stabilization of the Trp-cage fold.
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4. TcKKA Linked with Azobenzene
Following the promising results of the cross-linking with Lomant’s Reagent, TcKKA
was linked and purified with the NHS functionalized azobenzene under similar conditions.
In contrast to Lomant’s Reagent, the NHS functionalized azobenzene possesses a
limited solubility and precipitated in the reaction solvent (a 1:1 buffered watera/DMSO
mixture). Owing to the limited concentration of the linker in solution, the reaction
rate is very slow resulting in total reaction time of 12 weeks. However, this leads to
a highly selective cross-linking, because at low protein and linker concentration, the
second step of the cyclization reaction occurs significantly faster intra-molecularly than
inter-molecularly. This step determines whether a cyclized 1+1 product or a 2+1
protein-linker product is obtained.
Figure I.4.1.: HPLC chromatogram of the reaction mixture of TcKKA with azobenzene prior
purification with a detection wavelength of 220nm.
In the HPLC-chromatogram of the crude reaction mixture prior to purification, three
major peaks are observed (Figure I.4.1). The peak at tR = 18.0min is assigned to
the protein starting material based on ESI-MS data. In the highest peak, the desired
1+1 cyclized product TcKKA-azo is observed (tR(TcKKA − azo) = 21.5min) and
in the peak at tR = 24.5min the doubly linked 1+2 side product is detected. This
profile is significantly simplified compared to the previous cross-linking attempts with
azobenzene. The 1+1 product is well separated from the side products and therefore
easily purified.
apH 7.2, 20 mM PBS and 1 M NaCl
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4.1. Properties of TcKKA-azo
For a protein, which is cross-linked with a photo-switchable linker, several aspects need to
be considered for its characterization. On the one hand, the photochromic properties,
such as switching efficiency, reversibility and relaxation, of the linker in the protein
environment are of interest, as they characterize the linker and provide first insights of
interactions between protein and linker.
Scheme I.4.1.: Scaffold of the switching of azobenzene linked to the Trp-cage. The cis-TcKKA-
azo (right) can exhibit an additional helical chirality (P or M), induced by the
linker.
On the other hand, the structural characteristics of the protein (and the linker) display
the influence of the cross-linker in its different states of trans- and cis-configuration
on the protein structure. In this context, the stereochemical aspects of the linker are
also important. The azobenzene cross-linker can induce additional chirality in its cis
configuration, as it exhibit two enantiomeric forms (Scheme I.4.1). While in azobenzene
compounds without constraints both enantiomers are energetically equal, in constrained
(i.e. cyclized) azobenzene compounds one enantiomer may be energetically preferred.
In the cross-linked Trp-cage cis-TcKKA-azo, the protein moiety is chiral. Thus, the ad-
ditional (P or M) chirality of the azobenzene causes the formation of two diastereomers.
In the presence of (steric) constraints, the energy of the two diastereomers may differ,
as well as the kinetics of the photoisomerization rates to the cis- or trans-form. leading
to different populations of the diastereomers.
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4.1.1. Photochromic Properties
The purified TcKKA-azo was first characterized by ultra violet and visible light (UV/vis)
spectroscopy (Figure I.4.2). In addition to the expected absorption at λ =∼ 200 nm
of the peptide bond and the absorption bands between λ = 250nm and λ = 300nm
(aromatic residues Tyr and Trp), bands are observed above λ = 300nm. For the
azobenzene linker, two absorption bands are expected, the intense pi, pi∗-transition in the
UV region and the significantly weaker n, pi∗-transition in the visible region.86 Differences
between the trans and the cis isomer can be observed for both transitions. In the
trans configuration, the pi, pi∗-transition is very intense, whereas the forbidden n, pi∗-
transition is much weaker. In the cis configuration, the pi, pi∗-transition is shifted to
shorter wavelengths and much weaker compared to the trans. In contrast, the n, pi∗-
transition is allowed, resulting in an increased in intensity.
Figure I.4.2.: UV/vis spectra of TcKKA-azo after irradiation to the PSS at λ = 450nm (blue
spectrum) and λ = 365nm (red spectrum) at 298 K and pH 3 and as comparison
the UV/vis spectrum of TcKKA-unlinked at pH 7.9 (dashed black line) with a
magnification between 225nm to 525nm.
For TcKKA-azo, UV/vis spectra were recorded after irradiation to the trans- photo sta-
tionary state (PSS) (no changes in the spectra observed) with an excitation wavelength
of 450nm (90% trans isomer). The commonly used excitation wavelength of 365nm
was used to reach the PSS of the cis isomer (40% cis isomer) (Figure I.4.2). In the spec-
trum of the PSS at 450nm, the intense pi, pi∗-transition band is observed at λ = 332nm
and the weak n, pi∗-transition band at λ ≈ 450nm. Upon irradiation to the PSS at
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365nm, the intensity of pi, pi∗-transition band diminishes and at λ = 432nm a band
is clearly observed. This absorption band is assigned to the n, pi∗-transition band of the
cis-isomer. It is notable that the shift is caused by the increased population of the cis
n, pi∗ band.
However, comparison of the maximum at λ = 332nm in the UV/vis spectrum after
irradiation at a wavelength of 450nm and the irradiation at λ = 365nm to the PSS
suggests that the excitation wavelength may not be efficient and need further optimiza-
tion to increase the trans to cis isomerization.
Figure I.4.3.: UV/vis spectra of TcKKA linked with azobenzene at pH 3. The spectra were
recorded in the PSS of TcKKA-azo after irradiation at λ = 450nm (black spec-
trum), at λ = 365nm (red spectrum), at λ = 340nm (blue spectrum) and
at λ = 350 (green spectrum) with a magnification between the λ = 225 and
λ = 525nm.
In order to improve the switching efficiency of the trans to the cis isomer, the excitation
wavelength of 365nm was successively changed towards the maximum of the trans-pi, pi∗
transition and the results followed by UV/vis spectroscopy. Adjustments of the wave-
length were accomplished by using a fluorescence spectrometer as it allows a continuous
change in the excitation wavelengths. In Figure I.4.3, UV/vis spectra of TcKKA-azo in
the PSS after irradiation with different wavelengths (λ = 450nm, 365nm, 350nm and
340nm) are shown. After irradiation with λ = 450nm, the azobenzene is converted to
90% into the trans configuration (determined by 1H NMR spectroscopy). Subsequent
irradiation at the commonly used wavelength of 365nm switches the azobenzene to the
4.1. Properties of TcKKA-azo 77
cis-isomer. The conversion at this wavelength is determined to be only 40%. By shifting
the excitation wavelength near to the absorption maximum of the pi, pi∗-transition of the
trans isomer to 340nm, the efficiency of the trans to cis isomerization is significantly
increased. However, optimal efficiency is achieved by irradiation at λ = 350nm. At
this wavelength, 30% trans configuration and 70% cis configuration are obtained in the
PSS.
Figure I.4.4.: Ratio of trans (black) and cis (red) linked TcKKA-azo. At integer values, the
sample was irradiated with λ = 365nm and in between with λ = 450nm.
Focusing on reversibility of the switching process, ten cycles with irradiation at
λ = 365nm for the trans to cis isomerization and irradiation at λ = 450nm
for the cis to trans isomerization were performed and followed by 1H NMR. The
ratio of TcKKA-azo with the linker in the trans and cis configuration was deter-
mined using the integral values of the indole proton W6H, which exhibits different
chemical shifts depending on the configuration of the linker. The sum of both
integrals was normalized to 100 (Figure I.4.4). As visualized in the plot, TcKKA-azo
can be irradiated multiple times without signs of aggregation, fatigue or photo-bleaching.
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Furthermore, the thermal relaxation behavior of TcKKA-azo from its cis to trans con-
figuration was investigated. Usually, azobenzene relaxes from cis to trans thermally.87
The rate depends on ring substitutions, solvent and temperature.
To determine the thermal back relaxation rate, NMR spectra were recorded and the
intensity differences over time evaluated. For our cross-linked variant TcKAA-azo in
the cis configuration, we did not observe any intensity changes over the course of
14 days at 1 ◦C. This reveals that TcKKA-azo exhibit a very long or absent thermal
back relaxation rate. Only by irradiation with λ = 450nm, a conversion to trans
configuration was possible. This property is contrary to observations by N. Preußke
during his Masters thesis. He followed the pull approach of Trp-cage conformational
switching, in which the azobenzene stabilizes in its trans configuration the protein
structure and disrupts the fold in the cis configuration. In this environment, the
cis-azobenzene cross-linker exhibits a thermal back relaxation of ≈ 18h.
The combined photochromic properties of TcKKA-azo indicate that the azobenzene
moiety is influenced by the protein fold of the Trp-cage. Thus, a detailed evaluation of
the structural properties of the linker and, foremost, protein fold will allow a delineation
of possible interactions between the azobenzene and the Trp-cage in the different
configurations of the linker.
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4.1.2. Structural Characterization of TcKKA-azo
For a first, overall assessment of the effect of the cis/trans configuration switch of
azobenzene on the Trp-cage fold, CD spectra were recorded at the PSS with irradiation
at λ = 450nm, λ = 365nm and λ = 350nm (Figure I.4.5). As comparison,
unlinked TcKKA at 1 ◦C in 0.1 M NH4HCO3 buffer at pH 7.9 is also shown. In the CD
spectrum of TcKKA, two minima are observed at λ = 208nm and λ = 222nm and
a steep ascent towards lower wavelengths (< 200nm). These three characteristics are
typical for proteins with helical content, and the shape and magnitude of the absorption
curve is consistent with a folded Trp-cage variant.
Figure I.4.5.: CD spectra of TcKKA linked with azobenzene at pH 3 and 298K after irradiation
at different wavelengths. After irradiation at a wavelength of 450nm (black), at
365nm (red) and 350nm (blue) and as comparison the CD spectrum of TcKKA-
unlinked at 274K and pH 7.9.
The cross-linked TcKKA-azo with azobenzene predominantly in its trans configuration
(PSS450) exhibits a spectrum with a minimum at λ = 208nm, whereas the minimum
at a wavelength of 222nm vanished. The ascent towards lower wavelengths is reduced
significantly. Both observations are interpreted as a reduction of (helical) structure in
the protein.
Upon irradiation at wavelengths of 365nm or 350nm, the azobenzene switches from its
trans to the cis configuration. With increasing fraction of cis-azobenzene in the sample
(40% and 70%, respectively), the minimum at a wavelength at 222nm is present and the
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ascent to lower wavelengths is increased. Both observations demonstrates an increase
in helicity of the sample and suggest that in the cis-azobenzene state the Trp-cage
refolds towards its native structure. This is a first evidence for structural effects of the
azobenzene on the Trp-cage.
However, since in CD spectroscopy the curves of the mixture components trans- and cis-
TcKKA-azo are averaged, we analyzed the PSS samples by NMR experiments performed
at 298 K and pH3, as in NMR the two isomers lead to a distinct set of resonances.
4.1.3. Structural Characterization of TcKKA-azo in trans Configuration
The NMR spectra for TcKKA-azo to characterize the trans configuration were recorded
at the PSS after irradiation at a wavelength of 450nm. In this state, 90% trans
azobenzene are present as determined by the ratio of the integral values of W6H.
Thereby, the trans state is represented by the intensity of resonance lines between
10.2 ppm and 9.9 ppm and the cis state by the intensity of the resonance at 9.8 ppm.
Figure I.4.6.: 1H NMR spectrum of TcKKA linked with azobenzene in the trans state after
irradiation at λ = 450nm at 298 K and pH 3 with magnification of the indole
proton region. Signals marked with an asterisk are unfolded W6H with Pro in
cis configuration.
The 1H NMR spectrum (Figure I.4.6) displays mainly an unfolded Trp-cage. The
indole proton resonance W6H of the fast equilibrium folding is shifted downfield to
δ = 10.11 ppm, indicating a deshielding of the Trp side chain. Furthermore, additional
unfolded indole signals, both downfield and upfield shifted relative to the main signal are
observed. Those signals are again assigned to unfolded conformations with cis-X-Pro
peptide bonds. Their summed intensity is more prominent in comparison to the respec-
tive intensity sum in the unlinked, folded TcKKA. This is in good agreement with the
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expectation that the probability of the trans / cis Pro isomerization is reflective of the
unfolded all-trans equilibrium unfolded population, thus depends on the fold stability.
A second major change is the upfield shift of the L7 δ and δ′ methyl groups in trans
TcKKA-azo, indicating a deshielding of the helical side of the Trp side chain relative
to unlinked TcKKA. Furthermore, it is observed that no additional prominent aromatic
resonances are present in contrast to the cross-linking experiments at Cys residues. This
confirms the successful purification and separation from the hydrolyzed linker.
Figure I.4.7.: CSD plot of the Hα atoms for TcKKA-azo at pH 3 with the azobenzene in its
trans configuration. The deviation of Hα are represented as squares and Hα’
(Gly) as diamonds. The dashed line represents the cut-off for a present helix.
The vertical solid line separates the N-terminal helix (residue 1-8) and the Trp-
cage loop (residue 9-20).
The chemical shifts of the Hα atoms for TcKKA-azo were evaluated (Figure I.4.7) for
the major of trans-azobenzene protein conformation. It is observed that the chemical
shift deviations of the N-terminal helix up to residue 8 are continuously negative and
exceed the helical limit. This shows that this region remains in a helical conformation
and does not unfold as expected. The magnitude of the CSDs even suggest an average
helical amount comparable to the helix in the folded Trp-cage. Based on the CSDs from
residue 9 onwards, it is however clear that the tertiary fold of the Trp-cage is disrupted
as all CSDs are small in their magnitude, including the characteristic deviations of Gly
(11) and Pro (18).
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Table I.4.1.: CSDs for selected protons in the cage structure representing the cage fold and the
helix of TcKKA-azo with the linker in its trans configuration at 298 K at pH 3.
Cage Loop L7α G11α’ P18α P18β’ P19δ P19δ’
∆δ(ppm) Σ(ppm) χF (%)
-0.63 -0.77 -0.09 -0.00 -0.04 -0.12 -1.58 17
Helix K2α Y3α A4α Q5α W6α L7α A8α
∆δ(ppm) Σ(ppm) χF (%)
-0.20 -0.38 -0.39 -0.33 -0.29 -0.63 -0.24 -2.45 82
The fraction folded determined by the sum of the CSD of fold-characteristic protons for
trans-TcKKA-azo quantify this observation(Table I.4.1). While the fraction unfolded
of the cage loop is only χcageF = 17%, the fraction folded for the helix remained
nearly unchanged with χhelixF = 82%, which is comparable to the unlinked TcKKA
(χhelixF = 80%).
These results display that the azobenzene linker in the trans state is able to disrupt the
tertiary structure of the Trp-cage, resulting in an unstructured cage loop (residue 9-20).
Surprisingly, the secondary structure element, the helix, remains folded, implying the
presence of a fold stabilizing effect on the helix, possibly by of the linker in its trans state.
Scheme I.4.2.: Numbered scaffold of the azobenzene incorporated in the Trp-cage.
In order to explain the unexpected high helical content after the successful unfolding of
the tertiary structure of the Trp-cage, the linker’s proton resonances in the trans state
were evaluated. We focused on the linker properties in the NMR spectra and noticed
the incorporated azobenzene exhibits unexpected chemical shifts. In trans, the phenyl
ring linked to Lys 2 exhibits chemical shifts of δ = 7.99 (H-2,2’) and 7.87 (H-3,3’)
ppm. The second ring linked to Lys 20 shows chemical shifts of δ = 7.37 (H-6,6’) and
7.65 (H-7,7’) ppm. The different chemical shifts are indicative for a different chemical
environment for the two phenyl rings in the "supposedly unfolded" state and implies an
interaction or influence between linker and protein and the presence of residual helical
structure.
Support for an interaction between the azobenzene linker and the protein is drawn from
1H,1HNOESY spectroscopy, in which close contacts between protons are observed. In
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this spectrum, we observed for the protons of the phenyl ring linked to residue Lys
(2) NOE cross peaks between H-2,2’ and the aromatic side chains, specifically to Y3
Hδ/Hδ’ and W6 ζH’ and ηH. In contrast, the second ring exhibits no NOE contacts
with proteins in the Trp-cage protein. These observations support the different chemical
shifts and can be interpreted as a partial shielding of the aromatic residues of the
protein by the linker, which implies the presence of residual structure in the unfolded
TcKKA state.
4.1.4. Structural Characterization of TcKKA-azo in the cis Configuration
By irradiating the sample at a wavelength of 365nm, the azobenzene linker isomerizes
from the trans to cis configuration and yields ≈ 40% cis-TcKKA-azo. By comparison
of the spectroscopic data for TcKKA-azo in its trans configuration, the resonances of
the cis configuration were unambiguously assigned by 2D NMR spectroscopy.
Figure I.4.8.: 1H NMR spectrum of TcKKA linked with azobenzene in the cis state at 298 K
and pH 3 with magnification of indole proton region. Signals marked with an
asterisk are W6H signals of the unfolded Trp-cage with Pro in cis.
In the 1H NMR spectrum, a prominent indole proton resonance at δ = 9.79 ppm is
observed (Figure I.4.8). Furthermore, the resonances for L7 δ and δ′ methyl groups
exhibit typical chemical shifts, comparable with the folded, unlinked Trp-cage. Both
observations can be interpreted as a shielding of the Trp side chain and therefore, the
presence of the Trp-cage’s tertiary structure.
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Figure I.4.9.: CSD plot of the Hα atoms of TcKKA-azo at pH 3 with the linker in its cis con-
figuration. Deviation of the Hα are represented as squares and Hα’ as diamonds.
The dashed line represents the cut-off for a present helix. The vertical solid line
separates the N-terminal helix from the cage loop. As comparison, the CSD of the
Hα atoms of the unlinked TcKKA are presented as hollow squares and diamonds.
The CSDs for TcKKA-azo with the linker in its cis configuration (Figure I.4.9, filled
squares and diamonds) show that the N-terminal part of the Trp-cage until residue 8
exhibits a helical structure. From residue 9 onwards, the typical distribution for a folded
Trp-cage loop is observed. Especially Gly (11) Hα’ and Pro (18) Hα exhibit a large
CSD shift, indicating the presence of the protein’s tertiary structure. A comparison with
the CSDs of the unlinked TcKKA (hollow squares and diamonds) reveal that not only
the expected distribution is observed (evidence for a fully and correctly folded Trp-cage
motif), but also that the linker has a stabilizing effect on the fold of Trp-cage leading
to increased CSDs in TcKKA-azo.
Table I.4.2.: CSDs for selected protons in the cage structure representing the cage loop and
helix of TcKKA-azo in cis at 298 K at pH 3.
Cage Loop L7α G11α’ P18α P18β’ P19δ P19δ’
∆δ(ppm) Σ(ppm) χF (%)
-0.95 -3.08 -1.88 -1.40 -0.47 -0.70 -8.47 88
Helix K2α Y3α A4α Q5α W6α L7α A8α
∆δ(ppm) Σ(ppm) χF (%)
-0.20 -0.50 -0.25 -0.34 -0.38 -0.95 -0.13 -2.75 92
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The analysis of the sum of the CSD for representative protons for the Trp-cage fold
leads to fractions folded for the Trp-cage loop and the helix (Table I.4.2). The
fraction folded of cis-TcKKA-azo is determined to be χhelixF = 92% for the helix and
χcageF = 88% for the cage loop. These values support the prior interpretations and ob-
servations, showing a cross-linked protein with expected and stabilized tertiary structure.
Scheme I.4.3.: Numbered scaffold of the azobenzene in cis incorporated in the Trp-cage.
In order to identify possible interactions of the linker in its cis configuration and the
protein, the chemical shifts of the linker were determined and evaluated. The phenyl
ring close to residue 2 exhibits chemical shifts of δ = 7.58 (H-2,2’) and 6.82 (H-3,3’)
ppm and the second ring linked to residue 20 has chemical shifts of δ = 7.64 (H-6,6’)
and 6.93 (H-7,7’) ppm. As both the chemical shift of both phenyl rings is almost
identical, a similar chemical environment can be expected for them. Furthermore, we
did not observe short distance contacts in the 1H,1HNOESY spectrum between the
protons of linker and the protein. Both aspects, the chemical shifts and the absence
of short distances, suggest a flexibility of the connection between the linker and the
protein (Lys residues) and an absence of a preferred or fixed conformation of the linker.
The azobenzene cross-linker in its cis configuration exhibit two enantiomeric forms (P
and M) in chiral and cyclized compounds, in which one resulting diastereomer may be
energetically preferred. This leads to an additional hellicoidal chirality. Indications for
the presence of such chirality can principally be observed in NMR and CD spectra. In the
NMR spectra, one would expect two different sets of resonances for each diastereomer.
With CD spectroscopy, the absorption in the UV region (300− 500nm) of azobenzene
can be utilized to detect and determine the chirality of the linker, as the diastereomers
absorb left- or right polarized light differently. If both diastereomers are equally present,
the effect will cancel out and a flat line is expected. We recorded such CD spectra for our
cross-linked Trp-cage, but due to the high concentration needed for such experiment, a
reliable measurement could not be achieved with the available protein amount. In the
NMR spectra of cis-TcKKA-azo, only one set of signals is observed. This suggests that
either only one diastereomer is present or both diastereomers (P or M) exhibit similar
86 4. TcKKA Linked with Azobenzene
resonances for all protons. The latter explanation is only possible if the chiral elements
(protein and linker) are far apart and do not influence each other. A requirement for this
in the cis-TcKKA-azo is flexibility of the side chains of the anchor residues (Lys 2 and
20). In the presented data, we did not observe any interaction between the linker and
the protein, thus the "flexibility" argument is sufficient to explain the lack of observation
of resonances from a second diastereomer in the NMR.
4.2. Discussion of the Properties of TcKKA-azo
The combined spectroscopic data (chemical shifts and the observations in the
1H,1HNOESY spectra) of TcKKA-azo were used to create models of cis- and trans-
TcKKA-azo.
Figure I.4.10.: Possible models of TcKKA-azo with the azobenzene linker in cis (left) and
trans configuration (right) based on the results of the spectroscopic data. The
secondary structure is represented in cartoon style and the side chains of Tyr
and Trp as well as the azobenzene in stick style. The helix is colored in red, the
C-terminal loop in blue and the azobenzene in green.
The evaluation of the combined data for cis-TcKKA-azo suggests a simple model
for the cross-linked protein (left, Figure I.4.10). The azobenzene linker connected to
flexible side chains (Lys residues), is located on the side of the protein. This leads to
no direct interactions between the protein and the linker. In this state, the N-terminal
helix (blue) and the C-terminal cage loop (red) are folded and stabilized.
The spectroscopic data of trans-TcKKA-azo lead to a model, in which the cage loop
(colored blue) is unfolded and flexible (right, Figure I.4.10). Thus, the Trp side chain
is unprotected and exposed to the solvent. While we had expected that this leads
to a complete unfolding of the protein helix, the linker instead interacts with the
aromatic residues and partially shields the Trp-side chain. Furthermore, this is sterically
possible to occur well in the presence of a helical backbone structure, thus stabilizes
the secondary structure and prevents helix unfolding. Therefore, the expected unfolded
state is not completely unfolded as directly evidenced by observed NOEs, which reveal a
specific positioning between the linker and the Trp aromatic side chain. This also leads
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to ring current shift of the phenyl rings of the linker, caused by the aromatic Trp side
chain, explaining the difference in the chemical shifts of the two ring systems in the linker.
The suggested model of cis-TcKKA-azo without direct interactions between the linker
and the folded protein is surprising with respect to the absence of thermal back
relaxation of the linker from the cis to the trans configuration. This is a remarkable
observation, as the Trp-cage fold exhibits a thermodynamic stability at 280K (∆G280KU )
of approximately 12 kJ/mol (5.5 kJ/mol at 298K).43 In contrast, the trans isomer of
the azobenzene is more stable (about 50 kJ/mol) than the cis isomer and the barrier
for a cis to trans isomerization is about 100 kJ/mol.86 Thus, usually a thermal back
relaxation to the ground state (trans) is observed for azobenzene and would be similarly
expected in the context of the protein. The absence of back relaxation demonstrates
that in our cross-linked Trp-cage, the photochromic properties and the stability of the
two isomers of the azobenzene linker are strongly influenced by the protein, even if we
cannot identify the cause in the model.
The putative interaction between the aromatic rings of the linker and protein in
the trans-TcKKA-azo provides a good explanation for the yet another unexpected
observation of the blue shift of the best excitation wavelength for the isomerization from
trans to the cis configuration. Nevertheless, it was proven that the tertiary structure
of the Trp-cage can be influenced differently by the cis or trans configuration of the
linker. Although the helix remains folded in both configurations of the linker, differences
in the convolution or a kink in the helix are likely to be present in the trans configuration.
In conclusion, we showed that the synthesis of cross-linked protein using NHS esters
as reactive groups and Lys side chains as connection points proved to be superior to
the commonly used cross-linking chemistry on Cys residues. The cross-linked Trp-cage
TcKKA-azo is fully soluble in the cis and trans configuration and has no tendency of
aggregation. By irradiation with light, TcKKA-azo can be switched between the trans
and the cis state with an efficiency of 70% and 90%, respectively. In the cis states of
the cross-linker, the protein is folded with an enhanced stabilization compared to the
unlinked Trp-cage. While in the trans configuration the tertiary structure of the protein
is disordered, a helical fold was observed due to interactions between the linker and the
protein. However, the protein also influences the properties of the linker, as we did not
observe a thermal back relaxation from the cis-TcKKA-azo to the trans-TcKKA-azo.
Both properties, the structural and photo-chemical, correlate and have to be optimized
to increase the efficiency of the Trp-cage switching module.

Part II.
The AFP-Cage

91
1. Designing an AFP-Cage
The activity and structure of peptides correlate strongly. For small peptide sequences,
however, the structural propensity is limited. Consequently, these peptides exhibit con-
formational flexibility that reduces the presence of the active conformations. Stabilizing
such sequences is therefore of great interest. Numerous studies with the aim of sta-
bilization have been published, using approaches such as the introduction of hydrogen
bond surrogates,88 lactam bridges,89 or other rigid linkages between side chains. Disad-
vantages of such modifications are often low yields of the additionally required chemical
reaction steps and their incompatibility with large-scale production procedures.
A method that uses standard synthetic methods, does not require chemical modification
steps, and foremost leads to a fully natural peptide is of high interest. In the following
chapters, we present a strategy that utilizes the stability of the Trp-cage folding motif
and confers its fold to short peptide sequences without an intrinsic stable structure.
Attaching the sequence of a biological peptide with helical propensity to the N-terminus
of the Trp-cage should lead to propagation of the existing helical fold into the peptide
sequence.
Figure II.1.1.: Concept for combining the Trp-cage with a biological active peptide sequence in
two alternative approaches: a) chimera (top) and b) fusion approach (bottom).
The secondary structure is represented in cartoon ribbon style. The Trp-cage
residues are marked in red and the residues from the biological peptide in blue.
The sequences can be merged in two different ways, either by a direct fusion or a
chimera approach (Figure II.1.1). In the fusion approach, the existing Trp-cage helix is
N-terminally extended with the peptide’s sequence. For varying the orientation of the
active side of the peptide relative to the Trp-cage loop, additional residues with helical
conformation can be inserted between the Trp-cage helix and the peptide.
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An alternative, more complex strategy is the chimera approach, which is discussed in
detail. In this approach, the proteins are not sequentially fused, but the two helical turns
of the Trp-cage helix are overlapped with the two C-terminal turns of the biological active
peptide. In the Trp-cage helix, the primarily important amino acids for the fold are only
the eponymous Trp and Tyr. These interacting side chains need to be placed with
a separation of three residues and are located on the same side of the helix. Thus,
focusing now on the biological active peptide, only two changes are required in the
implementation of this approach: First, the Trp-cage residues Tyr and Trp need to
replace residues three and six in the peptide, counting from its C-terminus. Second, the
cage loop of twelve residues needs to be attached to the peptide’s C-terminus. Because
of the mixed primary sequence in the overlapping region, where residues originate from
different protein sequences, this sequence-overlapping fusion method is called "chimera"
approach. Its advantage is that the chimera protein length is reduced by eight residues
compared to the fusion approach. Furthermore, it may better stabilize the helical fold of
the biologically active peptide, as the cage stabilization is within the peptide sequence
region. On the other hand, the inserted Trp-cage residues and loop structure may
sterically interfere with the peptide’s biological activity. Thus, the approach can be used
only with peptides, where the residues for activity are in regions of the helix not sterically
affected (covered) by the Trp-cage loop. An example for the latter are AFPs, as their
activity (the ice adsorption surface) is located solely on one side of the helix.
Figure II.1.2.: Concept for the design of a chimera protein of a Trp-cage with one repeat of
the AFP Type 1 HPLC6. The underlined residues in the AFP sequence are the
capping motif and the essential amino acids for the ice-binding. The secondary
structure of the backbone is sketched in ribbon cartoon style. The sequence of
AFP Type 1 HPLC6 is colored in blue and the Trp-cage in red. The backbone of
the resulting AFP-Trp-cage chimera protein (AFP-Tc) is colored by the sequence
either in blue for the AFP or red for the Trp-cage residues.
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The AFPType 1HPLC6 is an alanine rich α-helical member of the diverse antifreeze
protein family. Its active side is formed by an eleven amino acid sequence repeat
consisting of Thr-(Ala)-X-X-Ala-X-X-X-Ala-X-X. The X-positions can be any amino
acid, whereas Ala is the most frequent amino acid type.27,90 AFPType 1HPLC6 exhibits
three repeats of this motif in its sequence (Figure II.1.2, top left). The Thr- and two
Ala-residues (highlighted in bold) are essential for the protein’s ice activity, as they are
located on one side of the helix and form the hydrophobic surface that binds to the ice
surface. Terminal sequence variations serve to cap and stabilize the terminal helical
turns by hydrogen bonds and to minimize the helical dipole effect under physiological
conditions. At the C-terminus, the capping motif consists of an Arg residue, whose
positively charged side chain can partially compensate the negatively charged C-terminus
and the negative dipole moment of the helix. At the N-terminus, the sequence is
terminated by an Asp residue, which reduces the effect of a charge repulsion between
the N-terminal charge and the positive side of the helix-dipole moment.
In our pursued chimera approach, we chose to join the sequences of the first ice binding
repeat including the N-terminal capping structure of AFP HPLC6 with the Trp-cage
motif (Figure II.1.2). In the chosen motif of the AFP, the two essential aromatic
residues for the Trp-cage folding motif, Tyr and Trp, can be inserted at any position,
that is not essential for the activity (Figure II.1.3). Whereby, the Trp and the Tyr
residue have to be inserted in the sequence with a spacing of i,i + 3.
Figure II.1.3.: Left: Sequence pattern of the used ice binding motif including the N-terminal
capping sequence (in brackets). The positions marked in bold are essential and
the positions marked as Xn are arbitrary for the activity and can be replaced.
Right: View along the helix (from N to C) of the chimera protein with marked
orientations (blue lines) of the ice binding surface. The aromatic residues Trp
and Tyr (marked in red) and the salt bridge between Asp-Arg (marked in green)
are conserved.
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Considering the free positions in the chosen ice binding motif and the appropriate
separation of the two aromatic residues, four different variants are possible (Figure II.1.3,
left). For example, the insertion of the Tyr and Trp residue at the position X2 and X4,
respectively, leads to the shortest AFP-Tc chimera AFP-Tc-4 (Figure II.1.3), whereas
the longest chimera AFP-Tc-7 results from the insertion of the Tyr and Trp residue at
the positions X5 and X7, respectively. The AFP-Tc chimera numbering scheme reflects
to the position Xn of the Trp residue.
The resulting four different AFP-Trp-cage chimera proteins differ primarily in the
location of the ice binding surface relative to the cage loop (Figure II.1.3). With the
assumption of an ideal α-helix with 3.6 amino acids per turn, the relative orientation of
the ice binding side in relation to the Trp residue is +200◦ for AFP-Tc-4, +100◦ for AFP-
Tc-5, −100◦ for AFP-Tc-6 and −200◦ for AFP-Tc-7. Thus, the steric position of the ice
binding side of the chimeras AFP-Tc-4 and AFP-Tc-7 is almost opposite the C-terminal
cage loop. Consequently, we expect no sterical interference of the Trp-cage residues
tertiary structure with the AFP activity. In AFP-Tc-5 and AFP-Tc-6, the location of the
ice binding surfaces of AFP-Tc-5 and AFP-Tc-6 are in proximity to the cage loop and
salt bridge. It is expected that interactions in the AFP’s activity can be observed, due to
putative steric interference of the aromatic residues of the Trp-cage and the salt bridge in
the variants AFP-Tc-5 and AFP-Tc-6, respectively. Although, AFP-Tc-4 and AFP-Tc-7
appeared to be the most promising design, we decided to synthesize all four variants in
order to experimentally determine the best chimera and best location of the binding side.
Table II.1.1.: Sequences of the four different AFP-Tc-Xn variants. Replacements within the
Trp-cage helix are marked in bold.
Name Sequence
Regions Helical Extension Chimera Helix Cage Loop
Tc10b DAYAQWLK DGGPSSGRPPPS
AFP-Tc-4 DTASD AAYAAWLT DGGPSSGRPPPS
AFP-Tc-5 DTASDA AAYAAWTA DGGPSSGRPPPS
AFP-Tc-6 DTASDAAA AAYLTWLA DGGPSSGRPPPS
AFP-Tc-7 DTASDAAAA AAYTAWLA DGGPSSGRPPPS
In the following, the different sequence regions of the chimera are named the "helical
extension" (AFP sequence), the "chimera helix" (combination of AFP and Trp-cage
sequence) and the "cage loop" (Trp-cage sequence) (Table II.1.1). The chimera se-
quences are numbered based on the original Trp-cage sequence, starting at residue 1 of
the Tc10b Trp-cage, which is equivalent to the beginning of the chimera helix sequence
and position 9 as the start of the cage loop. The AFP sequence precedes, its residues
are numbered from the N-terminus starting with 1’.
The four designed AFP-Tc proteins were synthesized by S. Rothemund (IZKF,
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Leipzig). Protocols of the syntheses can be found in the Appendix (section 1.3). In
the following chapters, the results of the spectroscopic characterizations of all AFP-Tc
chimera proteins are presented. The characterizations were performed by NMR spec-
troscopy at pH 3 and 7.9 (0.1M NH4HCO3 buffer) at 298K and 274K. Additionally, CD
spectra for each chimera protein were recorded at 274K and pH7.9 in 0.1M NH4HCO3
buffer and ice activity assays were performed.
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1.1. AFP-Tc-7 – DTASDAAAA-AAYTAWLA-DGGPSSGRPPPS
AFP-Tc-7 is with 29 amino acids the longest member of the AFP-Tc chimera family.
The two aromatic residues Tyr and Trp are located in the positions X5 and X7, respec-
tively (Table II.1.2). The helical extension includes nine amino acids formed by the five
residue long capping sequence Asp-Thr-Ala-Ser-Asp of AFP Type 1 HPLC6 and four
Ala residues. The helical sequence is terminated with the C-terminal cage loop.
Table II.1.2.: Sequence of AFP-Tc-7 and Tc10b. Replacements within the Trp-cage helix are
marked in bold.
Numbering 1’ 1 9
AFP-Tc-7 DTASDAAAA-AAYTAWLA-DGGPSSGRPPPS
Tc10b DAYAQWLK-DGGPSSGRPPPS
AFP motif DTASDAXXX-AXXTXXXA
Figure II.1.4.: 1H NMR spectrum of AFP-Tc-7 at 274 K and pH 3 with enlargement of the
indole proton region around 10 ppm.
The 1H NMR spectrum at 274K and pH3 is characteristic for a folded Trp-cage
(Figure II.1.4), as signified by the unique upfield chemical shift (δ = 9.64 ppm) of the
indole proton W6H in the fast folding equilibrium. A similar fold-significant observation
is the Pro (18) Hβ’ resonance at the distinct chemical shift of δ = 0.44 ppm. Relative
to its intrinsic shift, this represents an upfield shift by ≈ 1.6 ppm and is explained by
the atoms position close to and directly above the aromatic ring of the Trp side chain
in the folded protein. Above δ = 10 ppm, signals of cis-Pro unfolded conformations in
slow equilibrium are detected. Integration of the fast equilibrium signal and the cis-Pro
unfolded signals leads to a ratio of 91 : 9. These observations strongly confirm an
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existing and stable cage fold.
Figure II.1.5.: 1H NMR spectrum of AFP-Tc-7 at 274 K and pH 7.9 in 0.1M NH4HCO3 buffer
with enlargement of indole proton region around 10 ppm.
At pH 7.9 in 0.1M NH4HCO3 buffer, the spectrum has a very similar appearance.
The intensity ratio between the indole resonance W6H of the cis-Pro unfolded
conformations above 10 ppm and the equilibrium-folded conformation is with 92 : 8
not altered. The chemical shift of W6H in the fast folding equilibrium is at
δ = 9.67 ppm. Markedly, beside the Pro (18) Hβ’ resonance at δ = 0.30 ppm,
another strongly shifted resonance at δ = 0.68 ppm is clearly visible and is assigned
to the Gly (11) Hα’ proton. All three chemical shifts are indicative for the folded
protein conformation. In particular, the increased upfield shift of Gly (11) Hα’and
Pro (18) Hβ’ relative to pH 3 is an expression of a higher stability of AFP-Tc-7 at pH 7.9.
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Figure II.1.6.: CSD plot of Hα-atoms in AFP-Tc-7 pH 3 (top) and pH 7.9 (bottom) at 274K.
The chemical shift deviation of the Hα is represented as black squares and
the deviation of Hα’ (Gly) as black diamonds. The dashed line at y=-0.1 ppm
represents the cutoff for the presence of a helix. The expected fold is presented
above the plot in the ribbon presentation. The vertical solid line between residue
9’ and 1 separates the CSD of the N-terminal extension (residues 1’-9’) and the
solid line between residue 8 and 9 the Trp-cage helix (residues 1-8) from those
of the Trp-cage loop (residues 9-20) on the right.
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For the purpose of clarity, the fold of the AFP-Tc chimeras is analyzed with a focus
on its three parts: the C-terminal cage loop from residue 9-20, the chimera helix from
residue 1-8 and the helical extension indicated by dashed numbers (1’-9’).
The chemical shift deviations for the cage loop exhibit the unique distribution as observed
for other Trp-cage variants described in Part I. In particular, the Gly (11) Hα’ and Pro
(18) Hα atoms as representatives for the cage loop, and thus for the tertiary structure
exhibit the unusual large negative shift deviation as an effect of a ring-current of the
aromatic indole ring system of the Trp side chain.
The CSDs for the chimera helix (residue 1-8) are continuously negative. Except for the
first two residues, the limit for a helical structure is exceeded. Notably, the deviations for
Tyr (3) and Trp (6) and their neighboring amino acids (i+1) are particularly negative,
which is typical for the tertiary Trp-cage structure. The CSDs for the Hα atoms in the
helical extension (residue 1’ to 9’) are also continuously negative. However, the limit for
an α-helix is not exceeded for all residues.
The comparison of the CSD plot at pH of 3 and 7.9 shows that the CSD plots are
largely alike. Minor differences are observed for the CSDs in the cage loop (residue
9-20), indicating a slight stabilization of the fold at pH 7.9. This is attributed to the
intramolecular salt bridge at neutral pH, which stabilizes the cage loop. Both parts of
the helix, the chimera helix and the helical extension, exhibit only minor changes in the
CSDs, indicating a similar stability of the protein at both pH values.
Table II.1.3.: CSDs for selected protons in the chimera AFP-Tc-7 representing the fold of the
cage loop and chimera helix at 274 K and pH 3 and 7.9.
Cage Loop L7α G11α’ P18α P18β’ P19δ P19δ’
pH ∆δ(ppm) Σ(ppm) χF (%)
3 -1.00 -3.10 -2.21 -1.47 -0.48 -0.64 -8.89 92
7.9 -1.00 -3.45 -2.35 -1.61 -0.50 -0.64 -9.55 99
Chimera Helix A2α Y3α T4α A5α W6α L7α A8α
pH ∆δ(ppm) Σ(ppm) χF (%)
3 0.01 -0.41 -0.45 -0.09 -0.42 -1.00 -0.19 -2.55 85
7.9 0.02 -0.40 -0.44 -0.08 -0.39 -1.00 -0.24 -2.54 85
The quantification of the fast equilibrium folding population was performed as described
in Part 1. The sums of the CSDs were calculated for the cage loop and the chimera
helix, respectively. For the cage loop, the CSDs of Gly (11) Hα’, Pro (18) Hα and
Hβ’, Pro (19) Hδ and Hδ’ and additionally of the Hα of the residue at position 7 were
taken into account (Table II.1.3). For representation of the chimera helix, the sum of
the Hα CSDs from residues 2-8 is calculated. Evaluation of the sums for AFP-Tc-7 at
pH 3 leads to ∆δcage = −8.89 ppm for the C-terminal cage loop (residues 9-20) and
∆δhelix = −2.55 ppm for the chimera helix (residues 2-8).
These sums set in relation to the reference CSDs of J. W. Neidigh’s Trp-cage variant
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Tc10b43 yield a fraction folded in the fast equilibrium χF as described in Part I, which
results for AFP-Tc-7 at pH 3 in a fraction folded for the cage loop of χcageF = 92%
and for the chimera helix of χchim.F = 85%, respectively. At pH 7.9, the fraction
folded for the cage loop is determined to χcageF = 99% and for the chimera helix to
χchim.F = 85%.
These fraction folded are appear paradox. The fraction folded for the cage loop with
χcageF = 99% is completely consistent with the discussed 1H NMR spectrum. Thus, a
fraction folded of only 85% would suggest flexibility (and significantly lower stability).
Structurally, this seems impossible as any helical unfolding necessarily leads to an
abolishment of all tertiary interactions, thus to the complete flexibility of the loop.
Therefore the folding measure for the loop can never be higher than that for the helix.
The fraction folded for the helix based on proton chemical shift deviations (Hα CSD)
seem to underestimate the stability. This is indeed the case, as shown by comparison of
the chemical shifts with those of the parent AFPType 1HPLC6 sequence measured at
nearly identical conditions.91 The published HPLC6 Hα shifts for the first five residues
are identical to our measured values in AFP-Tc-7. Further, in both proteins it is
noticeable that the CSD for Ala residues at best reaches and never exceeds the cut-off
value of −0.1 ppm. As AFPType 1HPLC6 has been shown to be 100% folded at these
conditions (cf. its CD spectra91), the same implies for AFP-TC-7. Accordingly, the Hα
CSD is not a reliable measure of helical content and stability in alanine-rich proteins.
An alternative structural measure that may be used is the 13Cα chemical shift, as
it also experiences typical upfield or downfield changes depending on the backbone
conformation of the respective amino acid.
CSD(13Cα) = δobs − δref (II.1.1)
A method for structural interpretation of the 13Cα shifts was established by D.
Wishart,92 in which the observed chemical shifts are subtracted from reference random
coil shifts, resulting in the CSDs (Equation II.1.1). If the absolute value of the CSD is
larger than 0.7 ppm, the presence of a secondary structure is indicated. In contrast to
the Hα CSD, a positive deviation of the chemical shift indicates α-helicity.
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Figure II.1.7.: 13Cα CSD plot of the helical region from residue 2’ to 8 for AFP-Tc-7 pH 3 (left)
and pH 7.9 (right) at 274K. The horizontal dashed line represents the limit for
α-helicity.
The chemical shift deviations of the 13Cα in the helical region of AFP-Tc-7 from residue
2’ to 8 were evaluated at 274K and pH 3 and 7.9 (Figure II.1.7). AFP-Tc-7 exhibits
consistently positive shift deviations for all residues in the helix at pH 3. All residues
exceed the helical limit, indicating the presence of a continuous helicity. Remarkable are
the large downfield CSDs of Trp and Tyr residues. Both are essential in the cage fold,
and thus not only affected by the secondary structure, but in particular by the tertiary
Trp-cage fold. The Thr residue at position 4 also shows an unusually high deviation,
which is attributed to an effect of the tertiary Trp-cage structure. In contrast, the
CSDs for the residues 2’ and 5’ are significantly lower compared to the other residues,
which might indicate N-terminal fraying.
At pH 7.9, the chemical shift deviations are mostly comparable to pH 3. All residues
exhibit a large positive deviation that exceed the helical limit. Noticeable is the change
of the CSDs for the residues at position 2’ and 5’ to larger values. This indicates that
the N-terminus of the helix stabilizes, which is attributed to the capping effect of the
Asp at position 1’.
∆δ = Σn(CSD)
n
(II.1.2)
To establish a method to quantify the helical fold and enabling comparisons between
the chimeras, the chemical shift deviations of the 13Cα of the entire helix were summed
up and averaged (Equation II.1.2). Furthermore, the helix was divided into the chimera
(residues 1-8) and the helical extension (residues 1’-9’). For each, the 13Cα CSD were
summed up and averaged. The observed average chemical shift deviations ∆δ for AFP-
Tc-7 at pH 7.9 for the complete helix, chimera helix and helical extension are the highest
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observed values for all AFP-Tc chimeras. Moreover, CD spectroscopy determines this
variant to be ≥ 100% helical overall (shown below). Consistently, the Hα CSDs estab-
lished the region of the cage loop to be 99% folded and a comparison of the chemical
shifts with those of the AFPType 1HPLC6 indicates a ≥ 99% folded conformation in
this variant. Thus, we decided to use the 13Cα shifts of AFP-Tc-7 at pH 7.9 and 274 K
as a reference for a 99.5% folded AFP-Tc state.
χF = 0.995 ∗ ∆δobs∆δref
(II.1.3)
With the reference ∆δ from AFP-Tc-7 at pH 7.9 and 274 K, the fraction folded for the
complete helix (χhelixF ), chimera helix (χchim.F ) and helical extension (χexten.F ) can be
determined according to Equation II.1.3.
Table II.1.4.: Average chemical deviations (∆δ, determined by the 13Cα shifts) and fraction
folded (χF ) for the AFP-Tc-7 at 274 K and pH 3 and 7.9 for the complete helix,
the chimera helix and the helical extension. The values of AFP-Tc-7 at pH 7.9
are the reference values and marked in italic.
Helix Chimera Helix Helical Extension
pH ∆δ(ppm) χhelixF (%) ∆δ(ppm) χchim.F (%) ∆δ(ppm) χexten.F (%)
3 2.4 87 2.9 92 2.0 79
7.9 2.8 99.5 3.1 99.5 2.5 99.5
The fraction folded of the entire helix for AFP-Tc-7 at pH 3 displays a decrease of the
helicity (Table II.1.4). By comparison the fraction folded for the chimera helix and the
helical extension it becomes clear that the decrease in helicity of the complete helix is
attributed to the helical extension (χexten.F = 79%). The fraction folded of the chimera
helix is in good agreement with the cage loop’s. Both exhibit a fraction folded of 92%.
In addition to the NMR characterizations, CD spectra were recorded. In CD spec-
troscopy, the UV absorption of the amide in the peptide bond is utilized. In general, two
transitions are responsible for the CD signal, the pipi∗ transition at λ = 222nm and
npi∗ at λ = 208nm. Depending on the chirality of the sample, the absorption of left-
or right polarized light differs. The difference spectrum allows a global determination of
the predominant fold of the protein, averaged over all residues.
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Figure II.1.8.: CD spectra of Tc10b (hollow circles) and AFP-Tc-7 (filled circles) recorded at
274 K and pH 7.9. Plotted is the wavelength against the mean residue molar
ellipticity.
AFP-Tc-7 and for comparison Tc10b were characterized by CD spectroscopy at 274K
and pH7.9 in 0.1M NH4HCO3 (Figure II.1.8). Both proteins exhibit CD-curves with
similar shape. Specifically, the two minima at wavelengths of 208nm and 222nm are
characteristic for helical structure. The latter minimum is usually used for quantification
of helical content.
[θ]222 =
(
1− 1
Nr
)
(−44, 000 + 250T ) (II.1.4)
Following significant prior work, P. Lou and coworkers developed an updated method
to calculate the reference mean residue ellipticity at λ = 222nm [θ]MR for a 100%
folded helix (Equation II.1.4, with Nr=number of residues, T=temperature in ◦C ).93
This reference value is required to convert the measured mean residue ellipticity for a
given protein into a helical content following Equation II.1.5.
Helical content = 100 ∗ [θ]MR(obs)[θ]MR(ref) (II.1.5)
With a measured [θ]MR(obs) = −26, 054 deg cm2 dmol−1 we obtain a helical content
of 62% in AFP-Tc-7. Assuming a 100% stable helix, this implies that ≈18 residues
contribute to the helical content. This agrees well with the expected 17 residues long
helix in AFP-Tc-7. The difference of one amino acid can easily explained by further,
minor contributions of the loop residues to the [θ]MR(obs). Most likely it originates in a
contribution of the C-terminal residue of the helix (D9), which has a helical φ backbone
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angle. However, we excluded this residue from our stated expectation values based on
its non helical CSD value.
In summary, all experimental data characterize AFP-Tc-7 to be a stably, completely
100% folded protein. Excitingly, all aspects of our chimera approach are validated. The
amino acid replacements in the chimera helix are accepted without adverse effects on
the Trp-cage’s moiety. Not only is the chimera helix maximally folded, so is the helical
extension. Thus, the goal of stabilizing the helical structure of the AFP sequence via
the helix propagation mechanism has been achieved to the maximally possible extent.
1.2. AFP-Tc-6 – DTASDAAA-AAYLTWLA-DGGPSSGRPPPS
In the AFP-Tc-6 variant, the folding relevant Tyr and the Trp are inserted in the position
X4 and X6 of the AFP sequence (Table II.1.5). Due to the helical extension of eight
amino acids is the helix 16 residues long overall. The sequence of the AFP is C-terminally
terminated with the cage loop motif and yields the 28 amino acids chimera protein.
Table II.1.5.: Sequence of AFP-Tc-6 and Tc10b. Replacements in AFP-Tc-6 sequence with
Trp-cage residues are marked in bold.
Numbering 1’ 1 9
AFP-Tc-6 DTASDAAA-AAYLTWLA-DGGPSSGRPPPS
Tc10b DAYAQWLK-DGGPSSGRPPPS
AFP motif DTASDAXX-XAXXTAXX
Figure II.1.9.: 1H NMR spectra of AFP-Tc-6 at 274 K and pH 3 with enlargement of the indole
proton region.
The 1H NMR spectrum of AFP-Tc-6 at 274K and pH3 exhibits the typical separation
and shift of the characteristic resonances of the Trp-cage motif (Figure II.1.9). The
1.2. AFP-Tc-6 – DTASDAAA-AAYLTWLA-DGGPSSGRPPPS 105
characteristic upfield shifted indole proton W6H of the Trp side chain is observed at
δ = 9.66 ppm. The ratio between the fast equilibrium signal and the cis-Pro unfolded
conformations is with 88 : 12 in the expected range. Furthermore, the Pro (18) Hβ’
is visible at δ = 0.40 ppm. These three observations establish the presence of a very
stable fold.
Figure II.1.10.: 13Cα CSD plot of the complete helical region from residue 2’ to 8 of AFP-Tc-6
pH 3 (left) and pH 7.9 (right) at 274K.
In order to determine and visualize the structure of the helical region (residue 2’ to
8), the chemical shift deviations for the 13Cα of AFP-Tc-6 were analyzed for AFP-Tc-
6 at 274K and at pH 3 and 7.9. At pH 3, all residues display a positive deviation
(Figure II.1.10, left). The chimera helix and the helical extension up to the beginning of
the capping sequence (residue 6’ to 8) continuously exceed the helical limit. Furthermore,
the important cage loop residues Tyr and Trp show the expected higher shift deviation
in contrast to the other residues. Towards the N-terminus, the CSDs decrease. In
particular, Ser at position 4’ and the second Asp at position 5’ do not exceed the helical
limit. This indicates a less stable fold at he first helical turn and suggests some terminal
fraying.
At pH 7.9, the 13Cα deviation of all residues increases. The complete region exceeds
the helical limit, indicating a significant stabilization of the entire helix at neutral pH.
Particularly, the first turn of the helix experiences a significant stabilization.
We quantify the fraction folded for the structural elements as before using the proton
Hα CSDs for the cage loop and the 13Cα CSDs for the two helical regions. As reference
values serve Tc10b for the loop and AFP-Tc-7 for the helix.
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Table II.1.6.: Sum of the CSDs (1H) for the cage loop and its fraction folded and the average
chemical deviations (∆δ, 13C) and fraction folded (χF ) for the complete helix,
the chimera helix and the helical extension for the AFP-Tc-6 at 274 K and pH 3
and 7.9.
Cage Loop Helix
pH ∆δ(ppm) χcageF (%) ∆δ(ppm) χhelixF (%)
3 -8.86 92 2.2 80
7.9 -9.49 99 2.8 99
Chimera Helix Helical Extension
pH ∆δ(ppm) χchim.F (%) ∆δ(ppm) χexten.F (%)
3 3.0 96 1.4 55
7.9 3.1 99 2.4 96
Evaluation of the fractions folded for AFP-Tc-6 shows a stably folded cage loop at both
pH values (Table II.1.6). The increase of the fraction folded at neutral pH is attributed
to the existing salt bridge in the cage loop. At pH 3, the helix exhibits a smaller fraction
folded value compared to the cage loop. This is a result of the less stable helical extension
(χexten.F = 55%). At pH 7.9, the helical extension is significantly stabilized and leads to
a completely folded helical region (χhelixF = 99%). These trends in stability and fraction
folded at both pH values and different parts in the protein are largely comparable with
the chimera AFP-Tc-7.
Figure II.1.11.: CD spectra of Tc10b (hollow circles) and AFP-Tc-6(filled circles) recorded at
274 K and pH 7.9. Plotted is the wavelength against the mean residue molar
ellipticity.
CD spectra were recorded at 274K in 0.1M NH4HCO3 buffer at pH 7.9. AFP-Tc-6
exhibits a typical helical curve progression with two minima at λ = 208nm and
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λ = 222nm (Figure II.1.11, filled circle). Compared to Tc10b (hollow circles),
the minima values at λ = 208nm and λ = 222nm are significantly smaller, thus
indicating a large increase of helicity per residue.
With the measured [θ]MR(obs) = −24, 696 deg cm2 dmol−1, a helical content of 58%
is obtained (following the method described by Lou), which is equivalent to 16.4 helical
residues in the protein. Considering the expected number of helical residues, including
the C-terminal residue of the helix (D9), we obtain a stability of 96% for AFP-Tc-6.
Overall, the structural characterizations show a successful incorporation of the AFP
sequence in the Trp-cage. The replacements in the Trp-cage helix and the extension
of the helix are well accepted. The chimera protein AFP-Tc-6 is stably folded with a
contiguous helix on the entire expected helix length, which proves the success of the
chimera approach.
1.3. AFP-Tc-5 – DTASDA-AAYAAWTA-DGGPSSGRPPPS
In AFP-Tc-5 are the Tyr and Trp residues located in the position X3 and X5 in the
AFP motif (Table II.1.7). This results in an N-terminal helical extension of six residues.
With the completion of the twelve residue cage loop motif at the C-terminus, AFP-Tc-5
exhibits a total length of 26 amino acids
Table II.1.7.: Sequence of AFP-Tc-5 and Tc10b. Replacements within the Trp-cage sequence
are marked in bold.
Numbering 1’ 1 9
AFP-Tc-5 DTASDA-AAYAAWTA-DGGPSSGRPPPS
Tc10b DAYAQWLK-DGGPSSGRPPPS
AFP motif DTASDA-XXXAXXTA
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Figure II.1.12.: 1H NMR spectra of TcAFP5b at 274 K and pH 3. Magnification of indole
proton region.
The 1H NMR spectrum of AFP-Tc-5 at 274K and pH3 (Figure II.1.12) exhibits the
typical characteristics of a folded Trp-cage. The upfield shifted indole proton W6H of
the Trp side chain is observed at δ = 9.68 ppm. Furthermore, the characteristic Pro
(18) Hβ’ shift resonate at δ = 0.51 ppm. Between 10.0 and 10.4 ppm, the cis-Pro
unfolded conformations are observable and are more prominent and sharper (10.2 and
10.3 ppm) as for AFP-Tc-7 and AFP-Tc-6. The ratio between the folded and unfolded
species is determined to be 67 : 33, which may suggest a largely (but not completely)
stable Trp-cage fold.
Figure II.1.13.: 13Cα CSD plot of the helical region from residue 2’ to 8 for AFP-Tc-5 pH 3
(left) and pH 8 (right) at 274K.
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Analysis of the 13Cα chemical shift deviations of AFP-Tc-5 was performed at 274K at
pH 3 and 7.9, respectively. At pH 3, the deviations for the complete helical region are
positive throughout the whole sequence. The helical limit is exceeded from residue 6’
through the entire chimera helix until residue 8, implying a continuous helical fold. The
N-terminal capping sequence shows decreased helicity, as the CSDs for residue 2’ and
5’ do not exceed the helical limit. This indicates a destabilization or local disturbance
of the secondary structure in these positions near the N-terminus.
At pH 7.9, the chimera helical region from residue 1 to 8 exhibits a similar distribution
and deviation. The N-terminal residues exceed the helical limit and experience a great
stabilization effect relative to pH 3.
As for AFP-Tc-7 and AFP-Tc-6, the fractions folded for the different parts in the chimera
protein were determined using 1H and 13Cα CSDs.
Table II.1.8.: Sum of the CSDs (1H) for the cage loop and its fraction folded and the average
chemical deviations (∆δ, 13C) and fraction folded (χF ) for the complete helix,
the chimera helix and the helical extension for the AFP-Tc-5 at 274 K and pH 3
and 7.9.
Cage Loop Helix
pH ∆δ(ppm) χcageF (%) ∆δ(ppm) χhelixF (%)
3 -8.54 89 2.1 77
7.9 -8.27 85 2.5 90
Chimera Helix Helical Extension
pH ∆δ(ppm) χchim.F (%) ∆δ(ppm) χexten.F (%)
3 2.6 83 1.4 57
7.9 2.8 88 2.1 87
The fraction folded for the helical extension is with χexten.F = 57% at pH 3 and χexten.F =
87% surprisingly low (Table II.1.8). The low stability (and flexibility) of the extension
also impacts the stability of the chimera helix, which exhibits a smaller fraction folded
compared to the cage loop. Thus, we suggest that a destabilizing effect is present in
the N-terminal extension, which influences the first residues in the chimera helix at low
pH. This also affects the stability of the cage loop, in particular at neutral pH, as the
fraction folded is significantly smaller compared to the prior described variants.
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Figure II.1.14.: CD spectra of Tc10b (hollow circles) and AFP-Tc-5(filled circles) recorded at
274 K and pH 7.9. Plotted is the wavelength against the mean residue molar
ellipticity.
The CD spectrum (at 274K and pH7.9) displays a typical helical curvature with two
minima at λ = 208nm and λ = 222nm (Figure II.1.14, filled circles). Compared to
Tc10b (hollow circles), both minima are deeper, signifying a larger helical content per
residue and consequently of the entire protein.
Following the prior described equations of Lou with the observed mean residue molar
ellipticity [θ]MR(obs) = −17, 240 deg cm2 dmol−1, we determined a helical content
of 41% for AFP-Tc-5. In consideration of the sequence length of the chimera, 10.7
residues are in a helical conformation. However, we expected 15 residues to be in a
helical conformation for AFP-Tc-5, including the Asp at position 9. Comparing the
calculated and expected number of helical residues, a protein stability of only 71% is
obtained.
It is apparent that the fraction folded of the helix (90%, NMR) and the helical content
(71%, CD) significantly differ in their magnitude in this variant. In particular, the
fractions folded for the helical extension are unusually and strongly pH dependent. This
suggest that a local effect in this region influences the overall stability of the protein,
which will be pursued in detail later.
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1.4. AFP-Tc-4 – DTASD-AAYAAWLT-DGGPSSGRPPPS
AFP-Tc-4 is with 25 amino acids our shortest design for the junction of the AFP repeat
with two Thr and the Trp-cage motif (Table II.1.9). In the AFP motif, the Tyr and
Trp residues are inserted at the position X2 and X4, respectively. This leads to an
N-terminal extension of five residues. At the C-terminal end of the helix, the cage loop
sequence completes the chimera.
Table II.1.9.: Sequence of AFP-Tc-4 and Tc10b. Replacements within the Trp-cage sequence
are marked in bold.
Numbering 1’ 1 9
AFP-Tc-4 DTASD-AAYAAWLT-DGGPSSGRPPPS
Tc10b DAYAQWLK-DGGPSSGRPPPS
AFP motif DTASD-AXXXAXXT
Figure II.1.15.: 1H-NMR spectra of AFP-Tc-4 at 274 K and pH 3 with enlargement of the
indole proton region.
The 1H NMR at pH 3 spectrum shows all characteristics of a folded Trp-cage, recog-
nizable by the indole resonance W6H at δ = 9.60 ppm (Figure II.1.15). Furthermore,
a upfield shifted resonance at δ = 0.37 ppm is observed. This is assigned to the
Pro β’ at position 18. As observed for AFP-Tc-5, a significant amount of cis-Pro
unfolded protein conformations is present. The ratio between the fast equilibrium
folding conformation and the cis-Pro unfolded conformations is determined to be
73 : 27. These characteristics display in general the Trp-cage fold of the AFP-Tc-4 with
indications for minor destabilizations of the fold.
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Figure II.1.16.: 13Cα CSD plot of the complete helical region from residue 2’ to 8 for AFP-Tc-4
pH 3 (left) and pH 8 (right) at 274K.
Analysis of the CSD plot of the 13Cα atoms for AFP-Tc-4 at pH 3 reveals positive
deviations for all residues (Figure II.1.16, left). From residue 1-8 in the chimera helix,
the 13Cα CSDs exceed the helical limit. Furthermore, both aromatic residues, Tyr and
Trp, exhibit a high chemical shift deviation, induced by the tertiary structure. The N-
terminal helical extension also shows a helical tendency, but the residue Asp at position
5’ does not exceed the helical limit and interrupts an otherwise contiguous helix.
At pH 7.9, the deviations remain continuously positive. The residues 1-8 of the Trp-
cage helix exceed the helical limit, indicating a stable, helical fold. However, the Asp
residue at position 5’ again shows a significantly lower chemical shift and barely reaches
the helical limit. This may indicate that Asp 5’ has an unusual torsion angles, which
minimally lead to a kink in the helix.
The fraction folded were determined for the complete protein as described previously.
Table II.1.10.: Sum of the CSDs (1H) for the cage loop and its fraction folded and the average
chemical deviations (∆δ, 13C) and fraction folded (χF ) for the complete helix,
the chimera helix and the helical extension for the AFP-Tc-4 at 274 K and pH
3 and 7.9.
Cage Loop Helix
pH ∆δ(ppm) χcageF (%) ∆δ(ppm) χhelixF (%)
3 -8.58 91 2.1 76
7.9 -9.24 96 2.6 94
Chimera Helix Helical Extension
pH ∆δ(ppm) χchim.F (%) ∆δ(ppm) χexten.F (%)
3 2.6 83 1.2 48
7.9 3.0 96 1.9 75
The fraction folded for the different parts in the AFP-Tc-4 chimera reveal a stably folded
cage loop that increases its stability at neutral pH. As observed for the other variants,
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the helical extension exhibits a significantly lower fraction folded at pH 3, which indicates
terminal fraying, which also has an impact on the chimera helix. Therefore, the fraction
folded of the chimera helix is lower compared to the cage loop. We suggest that the
flexibility of the helical extension also affects the first N-terminal residues of the chimera
helix. At pH 7.9, the extension increases in stability, attributed to the capping effect
of the first residue at position 1’ (Asp). As a consequence thereof, the chimera helix
is more stable and as such the complete helix. Nevertheless, the increase in stability of
the helical extension is significantly smaller compared to all other variants. This effect
is mainly attributed to the putative kink at position 5’.
Figure II.1.17.: CD spectra of Tc10b (hollow circles) and AFP-Tc-4(filled circles) recorded at
274 K and pH 7.9. Plotted is the wavelength against the mean residue molar
ellipticity.
CD spectra of AFP-Tc-4 and Tc10b for comparison were recorded at 274K and pH7.9
in 0.1M NH4HCO3 buffer (Figure II.1.17). Both proteins exhibit an almost identical
curve progression with two minima at λ = 208nm and at λ = 222nm. This shape is
characteristic for a helical fold. The marginally deeper minimum at λ = 222nm of the
AFP-Tc-4 is unexpected, as the chimera has more residues in a helical conformation by
design compared to Tc10b (13 and 8, respectively).
The helical content for this variant is determined to be 35%, or 8.7 residues in a helical
conformation. For AFP-Tc-4, we expected 14 residues to be helical (including the
D9). Comparing the calculated and expected helical residues, a stability of 62% is
determined. This observation is in strong contradiction to the obtained fraction folded
of the helix (94%), as determined by NMR spectroscopy. Therefore, unknown effects
must be present, reducing the signal and, as such, the helicity.
Overall, the spectroscopic characterization by NMR proves the presence of a mostly
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folded Trp-cage for the AFP-Tc-4. However, the data reveals a partial disruption
and destabilization of the fold in the region of the helical extension. It results from
destabilizing effects at neutral pH, which was also observed for AFP-Tc-5 and is
discussed in the following chapter in detail.
1.5. Discussion of the Fold at Neutral pH
The four chimera proteins surprisingly exhibit differing trends when comparing the sta-
bility at pH 3 and pH 7.9. For AFP-Tc-6 and AFP-Tc-7, a large stabilization effect on
the overall fold is observed at neutral pH. In contrast, AFP-Tc4 and AFP-Tc-5 show
only a smaller increase or even a decrease of stability, respectively. Furthermore, the
determined ratio of the folded fast equilibrium and the unfolded cis-Pro conformations
is significantly higher for the latter variants. Therefore, the 1H NMR spectra of the four
chimera proteins at neutral pH are reviewed in more detail.
Figure II.1.18.: 1 NMR spectra of AFP-Tc-7 (top, left), AFP-Tc-6 (top, right), AFP-Tc-5 (bot-
tom, left) and AFP-Tc-4 (bottom, right) between 9.5 ppm and 10.5 ppm (region
of the indole proton) at pH 7.9 and 274 K .
A comparison of the indole proton region of the four chimera proteins show that the
stably folded AFP-Tc-6 and AFP-Tc-7 exhibit spectra with similar characteristics (Fig-
ure II.1.18). In these spectra, a single, upfield shifted resonance for the folded W6H
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and markedly low amounts of cis-Pro unfolded conformations are observed. Surpris-
ingly, in the spectra of AFP-Tc4 and AFP-Tc-5, a second upfield shifted resonance of
the indole proton is visible. Judged by the chemical shift of this second resonance, it is
assigned to a folded protein in an alternative conformation. This second conformation is
somewhat less stably folded compared to the main conformation, which was described in
the previous chapters. Accompanied with a second, less stably folded conformation, the
cis-Pro unfolded equilibrium is also affected, indicating a higher amount of the unfolded
conformations for these variants compared to AFP-Tc-6 and AFP-Tc-7.
However, the presence of the second folded conformation is surprising. Indications for
its origin can be found by evaluating the chemical shifts of the protein. We observed
a second set of resonances for several residues that are affected by the ring current of
the Trp residue, and foremost, for residues in close proximity to the C-terminus. This
includes residues in the helix, i.e. Asp at position 5’. Due to the visibility in the NMR,
this second folded conformation is in a slow equilibrium, which is only possible in our
proteins with a X-Pro peptide bond in cis configuration. Combined with the second set
of resonances, we assume that one X-Pro peptide bond at the C-terminal end is in a cis
configuration. This is unexpected, as we anticipated that any cis-X-Pro peptide bond
would lead to a complete unfolding of the protein.
In order to estimate the stability, and thus the possibility of a X-Pro peptide bond in cis
configuration, we modelled AFP-Tc-4 and AFP-Tc-5 and their conformers with X-Pro
(position 18 or 19) in cis configuration. Important for the stability of the protein is the
cage loop and therefore the quality of the shielding of the Trp side chain. A measure
for this is the accessible surface area (ASA) of the Trp side chain and the related free
folding energy of the protein. The values were obtained using the web-based VADAR
program (volume, area, dihedral angel reporter).94
Table II.1.11.: Fraction of the ASA of the Trp side chain and the free folding energy of AFP-
Tc-4 and AFP-Tc-5 with the X-Pro peptide bond at position 18 or 19 in trans
or cis configuration using VADAR.94
ASA (Trp) (%) Free folding energy (kJ/mol)
AFP-Tc-4 11 -10.47
AFP-Tc-4-P19cis 12 -10.43
AFP-Tc-4-P18cis 9 -10.44
AFP-Tc-5 21 -8.37
AFP-Tc-5-P19cis 16 -10.18
AFP-Tc-5-P18cis 18 -8.76
The evaluation of the ASA of AFP-Tc-4 shows that the Trp side chain is similarly
inaccessible for the solvent in all conformations. This demonstrates that the Trp residue
is buried in all three different models of AFP-Tc-4. Thus, in all models the hydrophobic
cluster can be formed, being the driving force of the folding. The free folding energy
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for the three models exhibit negative values of similar magnitude. Both criteria suggest
that these models of AFP-Tc-4 are able to fold and likely to be present at neutral pH.
Evaluating the models for AFP-Tc-5 displays the Trp side chain being similarly buried
for all the models. This leads to the conclusion that all modelled structures are able to
form a hydrophobic cluster involving the Trp side chain. This proves that AFP-Tc-5
can form such structured conformations, which may be present at neutral pH.
Energetically, the cis configuration of the X-Pro peptide bond is unfavourable compared
to the trans configuration. Thus, a driving force for this isomerization needs to be
localized in the proteins. As the second conformation is only visible at neutral pH, we
assume that an unfavoured charge-charge interaction is present and scanned the models
for the presence of such. At the N-terminus, two negatively charged Asp residues are
located at position 1’ and 5’. The Asp side chain at position 5’ is in close proximity to
the equally charged carboxyl group of the C-terminus in AFP-Tc-4 and AFP-Tc-5.
Representatively, the models with all trans and with X-Pro (19) in its cis configuration
are depicted.
Figure II.1.19.: Models of AFP-Tc-4 (top) and AFP-Tc-5 (bottom) with the secondary structure
presented in cartoon style. The side chains of Asp (5’), Tyr (3), Trp (6), Pro
(18 and 19) Ser (20) and the free carboxyl group at the C-terminus are sketched
in stick style. The carboxyl group of the Asp side chain and the C-terminus are
colored in red. The distance between the Asp 5’ side chain and the C-terminus
is marked with a yellow dotted line. The Pro (19) is in trans configuration for
the left models, and in cis configuration for the right models.
The models of AFP-Tc-4 and AFP-Tc-5 with all peptide bonds in trans configu-
ration display the close proximity between the Asp side chain and the C-terminus
(Figure II.1.19, left models). The distance between the two carboxyl groups was
determined to be 9.0 Å for AFP-Tc-4 and 6.4 Å for AFP-Tc-5, respectively. Changing
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the configuration of the X-Pro peptide bond to cis (Figure II.1.19, right models), the
distance between the Asp at position 5’ and the free C-terminus is increased to 15.2 Å
for AFP-Tc-4 and 10.4 Å for AFP-Tc-5. As the potential energy between charges is
inversely proportional to the distance, both chimeras can circumvent the repulsive
charge-charge interaction.
Overall, the modelled structures and the determined ASA and free folding energy prove
that alternative folded conformations in the protein are possible. The effect of the
charge-charge interaction favours most likely an isomerization of an X-Pro peptide bond
to the cis configuration. This also affects the remaining X-Pro peptide bonds in the
protein. Their trans to cis equilibrium can be influenced towards the cis configuration,
which in turn yields a higher amount of unfolded cis Pro conformations. Furthermore,
this unfavoured charge-charge interaction possibly leads to a disruption of the fold.
Indications for this disruption were observed for AFP-Tc-4, whose unexpectedly small
CSD for Asp at position 5’ could be caused by a kink in the helix at this position.
AFP-Tc-5, in contrast, exhibits a continuous helix, but the fraction folded for the cage
loop was surprisingly low. We assume that the negative effect of Asp at position 5’ for
AFP-Tc-5 has a greater impact, as the side chain is oriented and in close proximity to
the C-terminus. This might rather lead to a disturbance in the cage loop than in the
helix.
Table II.1.12.: Percentage of cis-Pro unfolded conformations present in the four AFP-Tc
chimeras and their helical content (CD) and fraction folded of the helix (NMR)
χhelixF at 274K and pH 7.9.
Chimera cis-Pro (%) Helical Content (%) Fraction Folded χhelixF (%)
AFP-Tc-4 25 61 94
AFP-Tc-5 18 71 90
AFP-Tc-6 11 96 99
AFP-Tc-7 8 100 99
These observations and interpretations explain also the contrary observations in the
characterizations of the structural properties with different spectroscopic measures
(Table II.1.12). The high amount of unfolded cis-Pro conformations in AFP-Tc-4 and
AFP-Tc-5 has an impact on the determined helical content by CD spectroscopy, as the
CD signal is an average of all conformations and the unfolded conformations do not
contribute to the signal. Therefore, the fraction folded determined by NMR can be
significantly higher compared to the CD signal, as it describes the conformation in the
fast folding equilibrium, in which the cis-Pro unfolded conformations are not included.
In conclusion, the two chimera proteins AFP-Tc-6 and AFP-Tc-7 are both very stably
folded, showing a propagation of the helical fold to the N-terminal extension. This
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results in a contiguous helical fold of the incorporated sequence of the biologically active
peptide. These results show that our pursued concept to join the sequences of the Trp-
cage with those of the AFP is performs extraordinary well. The identified reasons of the
unfavoured interactions that lead to the less stable AFP-Tc-4 and AFP-Tc-5 proteins
will be incorporated in future designs in order to avoid these complications.
1.6. Activity of the AFP-Tc Chimera Proteins
AFPs have the unique ability to bind to different planes of an ice crystal nucleus, i.e. the
prism, pyramidal or basal plane. The crystal growth is retarded at the binding surface
and, dependent on it, the forming (growing) ice crystal develops a characteristic shape.
For AFP Type 1 HPLC6, the AFP variant from which the ice binding repeat used in the
four AFP-Tc chimeras is derived, a hexagonal bypramidal crystal shape is characteristic.
The activity of the AFP Type 1 HPLC6 is known to be strongly structure and length
dependent.30 The minimal sequence required for activity was determined to be 28 out of
37 amino acids.30 In contrast, the AFP-Tc-4 to AFP-Tc-7 variants have a total length
of the ice binding helix from 13 to 17 residues, respectively. The variants are therefore
significantly shorter than the established minimal length. Thus, using this criterion, the
variants would be inactive. However, it was the underlying hypothesis of the chimera
approach that stabilization of the structure of short AFP sequences could facilitate
measurable AFP activity.
A simple assay, particularly in the case of weak AFP activity, is the observation of the
ice crystal morphology.
Table II.1.13.: Sequences of 15 amino acids reference peptides. Differences between the se-
quences are marked in bold. The ratio of measured and theoretical helicity at
the absorption at λ = 222nm in the CD spectra and prediction following Lou
at pH 7.9 and 274K is given and represents the percent of helical content.
Name Sequence Helical Content (%)
15er DTASDAAAAAALTAD-NH2 37
15erYW DTASDAAAYAAWTAD-NH2 21
Two peptides with the AFP sequence repeat used in our design of the AFP-Tc chimera
were synthesized (Table II.1.13). They serve as reference peptides to assess the effect
of the Trp-cage modifications on peptide stability and AFP activity. Therefore, both
peptides are C-terminally amidated to avoid a C-terminal charge that is not present
in the AFP-Tc. The differences between the peptide sequences is the Tyr and Trp
replacement in the AFP repeat, which is similarly in our AFP-Tc variants.
The structural characterization of the peptides by CD spectroscopy shows mostly
flexible peptides. However, the 15er peptide comprising the first 15 residues of AFP
Type 1 HPLC6 has a helical content of 37%. The Trp-cage based replacements made
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in 15erYW reduce the helical content by 16% in agreement with the lower helical
propensity of the aromatic amino acids.
The ice activity assays were performed in 0.1M NH4HCO3 at pH 7.9 with a protein
concentration of 80mg/mL. A detailed description can be found in the Experimental
Section (section 3.9).
Figure II.1.20.: Pictures of reference ice crystals: in the presence of 0.1M NH4HCO3 buffered
water (top, left), Tc10b (top, right), 15er (bottom, left) and 15erYW (bottom
right).
Figure II.1.20 shows four pictures, each of an ice crystal grown from a single ice nucleus
at temperatures slightly below the freezing point and observed under the microscope.
Tc10b (top row, right) shows a perfectly round disk shaped crystal that continuously
grows over time. Shape and rate are identical to ice crystal growth in buffered water.
This proves that the Trp-cage sequence expectedly does not have any ice binding activity.
The AFP peptides 15er and 15erYW (bottom row) lead to ice crystals that are noticeably
not perfectly round, first indications of a shaping effect towards a hexagonal form are
observable. This is more pronounced for the 15er peptide (bottom, left) that also showed
the higher helical content. The slight shaping activity is surprising for a peptide of this
length based on the literature results.
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Figure II.1.21.: Ice crystals during the growth in the presence of AFP-Tc-4 (first column),
AFP-Tc-5 (second column), AFP-Tc-6 (third column) and AFP-Tc-7. Top row
shows the view perpendicular to the basal plane. Bottom row shows pictures
of a tilted side view of the crystals.
In the presence of an AFP-Tc chimeras, the morphology of the growing ice crystal
changes significantly. Hexagonal shaped disks are clearly observed for all four vari-
ants (Figure II.1.21). Occasionally, tilted ice crystals were captured (bottom row Fig-
ure II.1.21). The side view clearly highlights the disk shape of the crystals that results
from a lower growth on the basal plane (in the c-direction) compared to the prism face
growth (in the a-axes direction). Nevertheless, the a-axes growth is reduced as shown
by the clear expression of the hexagonal faces. This was further established by the
measurements of the growth rates (Masters thesis, K. Bamberg). Consequently, one
might expect that the expressed crystal faces represent the binding surface of the AFP-
Tc chimera. The clear prism-like character of the faces may suggest chimera binding to
prism planes (1010). However, the parent AFP Type 1 HPLC6 is known to bind to the
2021 planes, which differ only by their pyramidal tilt towards the c-axis. The difference
between the planes is subtle and could be caused by either the changed length of the
AFP sequence or the short crystal dimensions in the c-direction.
The sharpest edges and thus the strongest shaping effects are observed for AFP-Tc-6 and
AFP-Tc-7, whereas for AFP-Tc-5 and in particular for AFP-Tc-4 more rounded edges
are observed (top row, Figure II.1.21). Nevertheless, all four variants show ice shaping
abilities far more pronounced than the reference peptides, which proves the success of
the chimera design. Further, the strength of the shaping ability appears to correlate
with the stability of the AFP-Tc proteins determined in the previous section (AFP-Tc-7
≈ AFP-Tc-6 > AFP-Tc-5 > AFP-Tc-4). Moreover, as the fold stability is sufficient to
explain the observed activity differences between the variants, other differences in AFP-
Tc chimera must play a smaller role, e.g. AFP sequence length, orientation between
AFP active side and cage loop.
Part III.
Summary and Outlook
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1. Linking and Switching
The goal of this dissertation was the design of a stabilizing and switching module for
α-helical peptides. We aimed to create a protein module, which comprises a highly
stable helical fold and the possibility to incorporate a switchable molecule. Upon fusion
with unstructured, biologically active peptides, this module should be able to induce a
stable helical fold in the fused peptide.
The focus of the first part was to introduce a photo responsive azobenzene cross-linker
in the Trp-cage miniprotein, which was chosen to be the protein platform for the module
concept. Initially, we used the Woolley strategy that employs iodoacetamide as
reactive groups and Cys residues as anchor residues. Several problems were encountered
pursuing this strategy in our platform. The Cys replacements at the chosen positions in
the Trp-cage led to differently folded conformations. During the cross-linking reaction
with the reducing agent TCEP, the linker reacted and formed soluble by-products.
These by-products were not separable by the available purification methods. Therefore,
the cross-linking chemistry was changed to NHS esters, which selectively react with
primary amines, such as Lys residues.
Three amino acid replacements were made in the Trp-cage variant Tc10b and led to
the new variant TcKKA. As anchor points to facilitate cross-linking with NHS esters,
two Lys residues were introduced at position 2 and 20. The NHS chemistry proves to
be exceptionally suitable for cross-linking bifunctional azobenzenes with the TcKKA.
During the linking reaction, no signs for side reactions of the linker were observed.
The cyclized product could easily be separated by HPLC purification from the starting
material and side products, such as multiple linked or uncyclized combinations of linker
and Trp-cage. The first employed linker was the flexible Lomant reagent, which
demonstrated these advantages of the cross-linking chemistry. The ensuing cross-linking
with the synthesized azobenzene to introduce switchability in the Trp-cage module was
successfully performed.
The properties of the generated proteins (linked and unlinked) were characterized with
various spectroscopic methods, such as UV/vis-, CD- and NMR-spectroscopy. With
the latter, the stability of the secondary (helix) and tertiary structure (cage loop) of
the Trp-cage was assessed using chemical shift deviations (CSD) of fold-characteristic
proton resonances. In all NMR-spectra of Trp-cage variants, additional, clearly unfolded
resonances were surprisingly visible. With different approaches, we could assign these
resonances to be Trp-cage conformations with a cis-X-Pro peptide bond. We utilized
the amount of these unfolded conformations as an additional stability criterion of the
Trp-cage fold.
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Table III.1.1.: Summary of the fraction folded χF of the helix and the cage loop of Tc10b and
TcKKA (unlinked and linked with 4,4’-NHS-azobenzene) at pH 3 and 298 K.
Trp-cage χhelixF (%) χ
cage
F (%)
Tc10b 84 71
TcKKA 80 67
cis-TcKKA-azo 92 88
trans-TcKKA-azo 82 16
The structural characterization of the unlinked TcKKA variant demonstrated that all
replacements and modifications in the parent sequence are exceptionally well accepted
and is of similar stability compared to the published parent sequence Tc10b. With the
azobenzene cross-linker incorporated, switchability of structure was introduced in the
protein.
Figure III.1.1.: Possible models of TcKKA-azo with the azobenzene linker in trans (left) and
cis configuration (right) based on the results of the spectroscopic data. The
secondary structure is represented in cartoon style and the side chains of Tyr
and Trp as well as the azobenzene in stick style. The helix is colored in red, the
C-terminal loop in blue and the azobenzene in green.
The spectroscopic results of the cross-linked TcKKA-azo proved that the pursued stra-
tegy to stabilize the protein structure in cis configuration was successful (Figure III.1.1).
The protein is not only correctly folded, but its stability is significantly increased com-
pared to the unlinked Trp-cage. In the trans configuration of the linker, the tertiary
structure of the protein is disrupted, leading to a flexible cage loop (colored blue).
Surprisingly, the resulting absence of tertiary structure interactions did not lead to an
unfolding of the helix. Instead, the azobenzene linker provided an alternative stabiliza-
tion of the helical fold by interactions with the two aromatic residues Tyr and Trp.
TcKKA-azo could be irradiated (switched) multiple times between these two conforma-
tions and we observed no signs of aggregation in both states of the protein. Further, the
excitation wavelength for the trans to cis isomerization is notably hypsochromic shifted.
This is explained by putative interactions between the linker and the aromatic residues
in the Trp-cage. A surprising and interesting observation was the further absence of
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measurable thermal back relaxation. This is advantageous as the protein remains in its
folded conformation, which allows a selective switch between the unfolded and folded
conformation that remains stable over time.
Overall, we demonstrated that the pursued approach of switching the structure of the
Trp-cage is possible, creating a protein module with good and partially surprising pho-
tochromic properties. This module can be fused with peptides to remotely induce or
destabilize their structure.
Some observations of the azobenzene cross-linked TcKKA require further investigations
to better understand the properties of this switching module. Detailed insights into
the mechanism of the switching process for TcKKA-azo are of great interest. The
determination of the chiral properties will provide an understanding of the switching
mechanism and can assessed by CD measurements in the absorption range of the
azobenzene. This experiment will show, if one enantiomer (P or M) of the linker in
its cis configuration is preferred and thus, whether the switching mechanism is bi- or
uni-directional. An excess of one diastereomeric form would indicate that the protein
moiety has an influence on the direction of the photoisomerization. Another well
suited method to gain insights into the switching mechanism is ultrafast time resolved
spectroscopy. Advantageous for these experiments is that the azobenzene linker as well
as the aromatic side chains of Trp and Tyr are observable. The experiments will reveal
if the azobenzene linker is influenced by the protein and if cooperative interactions, such
as electronic coupling of the linker with the protein residues are present. Additional
quantum mechanics/molecular mechanics calculations of the switching and folding
process will support the interpretation of the results of CD spectroscopy and ultrafast
time resolved spectroscopy.
It is possible to improve the switching module and enhance the structural differences
between the protein states or to increase the switching efficiency of the photochrome.
The structural difference between the folded and unfolded states of TcKKA-azo were
smaller than expected due to the surprising presence of residual helical structure in
the unfolded state. This was attributed to interactions between the linker and the
aromatic residues Tyr and Trp. One possibility to reduce these interactions and achieve
unfolding of the helix would be a replacement of the aromatic Tyr residue by an aliphatic
residue. This residue should possess some ability to shield the Trp side chain in the
folded conformation, but should only weakly interact with the azobenzene linker in the
trans-state. Alternatively, one can selectively destabilize the helix of the Trp-cage at one
or more positions with helix breaking residues. A single replacement that accomplishes
both tasks is the replacement of the existing Tyr at position 3 by a Leu or Ile residue.
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In our pursued switching approach, we focused mainly on azobenzene as cross-linker.
However, other photochromic molecules can be employed and may partially possess
superior properties.
Scheme III.1.1.: Scheme of NHS functionalized diazocine. a) current molecule, b) work in
progress.
An alternative switching moiety is diazocine (Scheme III.1.1, synthesis by W. Moor-
man, ongoing work). Preliminary studies revealed that the linking between the Trp-cage
and diazocine can be performed similarly to the cross-linking with azobenzene. However,
it was found that the cross-linker in cis-configuration was too short for stabilization.
Thus, a methylene group will be inserted (diazocine b)) in order to elongate the linker.
This project will be continued in collaboration with W. Moorman from the group of
R. Herges.
Scheme III.1.2.: Top: Scaffold of spiropyran. By irradiation, a ring opening leads to merocya-
nine. Bottom: Scheme of a bifunctionalized spiropyran with NHS ester and
an allylic chloride.
A second applicable scaffold for a cross-linker is a spiropyran (Scheme III.1.2). In
the closed spiropyran form, the linker should stabilize the fold, whereas the open
merocyanine form destabilizes it. This linker possesses advantages in that the linker
geometry is different compared to azobenzene, and that a change in the charge
distribution is present between the two forms. Incorporated into the protein, the
merocyanine form is expected to reduce interactions with the aromatic residues and
thus should lead to a complete unstructured protein state.
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2. AFP-Cage Chimera Proteins
In the second part of this dissertation, a fusion approach linking the Trp-cage module
with a biologically active peptide with α-helical propensity was presented. We chose to
join the sequences of the first eleven amino acid repeat of the AFP Type 1 HPLC6 with
the Trp-cage variant Tc10b. The chosen AFP is known to exhibit a hydrophobic surface,
which can bind to an ice crystal plane. Therefore, we pursued a chimera strategy, which
is distinguished by a sequence overlap of the N-terminal helix of the Trp-cage and the
biologically active peptide. The advantages of this strategy are a reduction of the overall
peptide length, a simplification of the synthesis, and the availability of the complete
helical region of the resulting chimera protein for the ice binding activity. The resulting
chimera protein can be divided into three parts, the N-terminal extension, the chimera
helix and the cage loop.
Figure III.2.1.: Left: Sequence pattern of the used ice binding motif including the N-terminal
capping sequence (in brackets). The positions marked in bold are essential,
whereas the positions marked as Xn are arbitrary for the activity and can be
replaced. Right: View along the helix axis (from N to C) of the chimera protein
with marked orientations (blue lines) of the ice binding surface. The aromatic
residues Trp and Tyr (marked in red) and the salt bridge between Asp-Arg
(marked in green) are conserved.
In order to show the wide applicability of this concept, four different variants with
different orientations of the ice binding surface were designed and synthesized (Fig-
ure III.2.1). All four AFP-Tc chimera proteins were structurally characterized by
NMR and CD spectroscopy to assess their structure. We observed that all variants
exhibit a stable fold and all characteristic properties of the Trp-cage tertiary structure.
Most importantly, all AFP-Tc chimera proteins exhibit a helical fold that completely
propagates through the N-terminal extension proving the success of our concept.
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Minor limitations were observed for the chimera proteins AFP-Tc-4 and AFP-Tc-5 as
they exhibit alternatively folded conformations at neutral pH. These conformations
are attributed to the presence of a charge-charge interaction of the N-terminal helical
extension with the C-terminal cage loop. We found that residues at the junction of
helical extension and chimera helix are oriented in the structure towards the charged
C-terminus and lead to a destabilizing charge-charge repulsion. In future designs,
residues in these positions need to be carefully selected with respect to their charge and
size in order to prevent this interaction.
The activity of the chimera proteins was assessed by observing the morphology of
growing ice crystals via an optical microscope. Astonishingly, all four AFP-Tc chimeras
were active, as we observed hexagonal ice crystals in their presence. Differences in
their activity were indicated by details of the crystal shape. Whereas in the presence
of AFP-Tc-7 and AFP-Tc-6 a perfect hexagonal shape was observed, the hexagonal
crystal in the presence of AFP-Tc-4 and AFP-Tc-5 exhibit somewhat rounded edges.
The differences in the ice-shaping abilities is fully consistent with the determined fold
stability of the variants. This suggests that other design differences, such as orientation
of the active side to the Trp-cage loop is not decisive for activity. It also suggests that
two third of the helix surface is accessible for protein activity.
Overall, the spectroscopic and activity results proved the hypothesis that a structure
stabilization of the conformation of a helical peptide can be used to increase its
biological activity and that this can be achieved by fusion with a highly structured
protein module.
The ice binding properties of the presented AFP-Tc chimera proteins require further
characterization. It is of particular interest to determine the binding planes of the
proteins on the ice crystal surface. The hexagonal shape of the ice crystals in the
presence of the AFP-Tc may suggest a preferred binding to the prism plane of the
crystal. Since the differences between the prism and pyramidal plane are subtle, an
unambiguous statement of a preferred binding plane is not possible with the assay
performed in this work.
One possibility to assess the preferred binding plane are ice-etching experiments ana-
lyzed by fluorescence microscopy. In this experiment, AFPs bind to a single ice crystal
attached to a cooling finger. The pattern of the bound AFPs in the resulting crystal
will be visualized by excitation of a fluorescence label and will reveal the binding plane
and possible orientation of the bound AFPs. This has already been applied to different
AFPs fused with green fluorescent protein (GFP).95,96 Our AFP-Tc are particularly
suitable for such experiments, as the Trp side chain possesses intrinsic fluorescence
properties depending on its local environment, and thus the fold.97 Therefore, no
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additional tagging with a GFP is necessary.
The spectroscopic data of AFP-Tc-4 and AFP-Tc-5 revealed that residues at the junction
of helical extension and chimera helix can interfere with the tertiary structure of the C-
terminal cage loop leading to a reduced stability and alternatively folded conformations.
To avoid such interactions, different strategies are possible. The existing Asp residue at
the appropriate position in the helix can be replaced by an Ala or the C-terminus can
be altered, i.e. amidated, reducing the charge-charge interactions. Alternatively, the
charge-charge interactions between the N-terminal extension and the C-terminus can
also be utilized to enhance the fold stability. Within the helical extension, the residue
oriented towards the C-terminus will be replaced by a side chain bearing a positive
charge, such as Lys. Thus, a salt bridge between this residue and the C-terminus might
form, stabilizing the cage fold and as a consequence the helix. This effect was already
observed for the Trp-cage TcKKA. These studies are currently pursued by K. Bamberg
Although the chimera proteins presented herein showed significant binding to the ice
surface, the activity levels of AFP Type 1 typical bipyramidal crystal could not yet be
reached. One reason might be a different charge distribution at the C-terminal end of
the helix. Whereas AFP Type 1 HPLC6 bears a positively charged Arg, the chimera
proteins have a negatively charged Asp at this position. This Asp residue is involved in
a salt bridge with an Arg residue in the Trp-cage loop. A reversion of the orientation of
this salt bridge will alter the charge at the C-terminal end of the helix while preserving
the fold-stabilizing salt bridge. This change will place the Arg residue into an iden-
tical position as AFP Type 1 HPLC6 and may lead to a different preferred binding plane.
An alternative explanation for the absence of a pyramidal crystal can be slight difference
in the twist of the helix due to the Trp-cage tertiary fold. This would result in a different
ice binding surface, and thus different binding preferences. The reliable detection of
such differences requires structural information at high resolution. Precise protein
structures can be obtained by solution NMR with 13C or 15N labelled proteins and by
X-ray crystallography. Superposition of obtained structures with the crystal structure of
wild-type AFP Type 1 HPLC6 will prove whether the structure is identical in the steric
properties of the ice binding, helical surface.
The chimera concept possesses the advantage of an independent fold and stability
that is conferred to the sequence of the biological peptide. This stabilizing effect can
be utilized to investigate the ice binding side of the AFP by selective replacements in
the sequence, without causing a concurrent change in helical conformation. Foremost,
investigations of length dependency of the ice binding side and determination of the
130 2. AFP-Cage Chimera Proteins
minimal sequence requirement for activity can now be performed under preservation of
the helical fold. An extension of the ice binding sequence is of great interest as this
should to an increased activity. This project and the combination of AFP-Tc chimeras
with GFP label are pursued by J. Gronow.
In the first part, the possibility to introduce a switching function in the Trp-cage
module was presented and in the second part the strategy to fuse the Trp-cage with
the AFP sequence. Merging the switching and chimera concept will be the next step
in this project. Transferring and combining the results of the switching approach to
the functionalized chimera will give access to a switchable AFP in which the antifreeze
activity can be activated or removed. Crucial for a successful combination in the
AFP-Tc chimera is the placement and orientation of the necessary anchor residues for
the linker with respect to the ice binding surface. The cross-linker should not interfere
sterically with the ice binding surface and influence the ice activity. The orientation of
the cross-linker in the present approach is comparable to the existing intra-molecular salt
bridge, and thus should be accommodated well. Accordingly, the presented switch-cage
module appears compatible with all four chimeras.
In preliminary work towards a switchable AFP-Tc, two Lys residues were introduced in
the AFP-Tc-5 chimera sequence, resulting in AFP-Tc-5-KK. This chimera protein was
fully characterized by NMR spectroscopy at pH 3. In addition, CD spectra were recorded
and ice binding assays were performed at pH 7.9 (see Appendix, subsection 1.3.5). The
AFP-Tc-5-KK variant will be cross-linked with the NHS functionalized azobenzene and
the effect of the switching on the ice activity investigated (K. Bamberg, Master’s
thesis, in progress).
A high switching efficiency is a crucial property for effective applications of molecular
switches. Ideally, either a pure on or pure off state of the protein structure and activity
should be reached. The approach presented in this work fulfills several of these ideals.
Almost full conversion to the trans state of the TcKKA-azo can be achieved photochem-
ically and thermally. Advantages in the context of AFP chimera are that this state will
be fully inactive and stable over time. By light induced isomerization to the cis config-
uration, the protein will be switched "on" and structures with high spatial and temporal
control. As the activity is distinctly present only in this state, it is not essential to achieve
full photochemical conversion or that the AFP-Tc chimera need to be fully active AFPs.
This is a direct advantage of our design choosing the fully reachable, thermodynamically
stable state of the photochrome as the "off"-state of protein activity. Coincidentally,
it is very advantageous that the functional "on"-state unexpectedly does not show any
thermal back relaxation. Thus, we succeeded to create a true switch between an "off"-
and an "on"-functional state, in which both states are stable over time.
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3. Other Fusion Partner and Possibilities
Due to the modular approach, the fusion concept can be used not only with AFPs, but
transferred to any peptide sequence of interest with helical propensity. In particular,
antimicrobial peptides (AMPs) are suitable. Initially, A. Simpson and A. Gianesini
worked on a fusion approach of AMP sequences with the Trp-cage.
Figure III.3.1.: Fusion concept for stabilizing helical AMP sequences, examplarly shown for
the 77 residue long protein Amoebapore A. The colored α-helical structures
are: helix I (green), helix II (blue), helix III (yellow), helix IV (cyan), helix V
(orange). (PDB: 1OF9.98) The helix II of Amoebapore is discussed to play a
key roll in the activity of the AMP. Thus, we extract its sequence and fuse it
N-terminally to the Trp-cage module.
In contrast to the chimera approach, pursued in this work, the combination of both
sequences was accomplished by using a direct fusion strategy. Therefore, the AMP
sequence is simply N-terminally added to the Trp-cage without a sequential overlap.
A. Simpson worked on a fusion protein between helix II of the Amoebapore A protein
(Figure III.3.1, blue colored helix) and the Trp-cage TcKKA. Therefore, we decided to
extract the sequence and fuse it N-terminally to the Trp-cage TcKKA. This allows the
characterization and determination of the role in the function of the solely helix. The
work on stabilizing AMP sequences was continued by A. Gianesini during his Master’s
thesis. He fused the short AMP KR-12, truncated from the human LL-37 cathelicidin99
and the scorpions’ AMP IsCT 100 with the Trp-cage TcKKA. Further studies in this
project will be conducted by N. Preußke, who will perform studies of the activity and
in vitro lifetime of the fusion proteins of AMPs and the Trp-cage.
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Figure III.3.2.: Concept for a serial connection of two Trp-cage modules (blue and red) for anti
parallel α-helical dimers (green).
Another advantage of the Trp-cage module concept is that it can be extended to multiple
modules and biological peptides. It then can be used also to pre-orientate intra-molecular
folding domains, such as dimers. For this, multiple possibilities are conceivable. In one
example, the attachment of a second Trp-cage module at the N-terminus of a Trp-cage
fusion protein results in a serial connection (Figure III.3.2). Thereby, the start of the
second Trp-cage sequence (colored in blue) leads to a termination of the first helix, due
to the Pro residues, which are unfavoured in a helical fold. Simultaneously, these Pro
residues will be the transition to the second Trp-cage motif (polyproline-II-helix) and the
starting point of the second helix in opposite direction. This leads to a close proximity
of the two helical regions with an anti parallel orientation. The longitudinal shift and
orientation of both helices can be adjusted by the starting residue of the second Trp-cage.
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Figure III.3.3.: Cartoon representation of the zinc-finger structure. The loops are colored in
green, sheets in yellow, helix in blue, Cys involved for complexation with Zn
(grey) is colored in red and His is colored in orange; PDB: 1ZNF.101
The modular concept of attaching a switching module to short peptides with structural
propensity can be also extended to other short, folded miniproteins. A suitable for a
similar module is the 25 amino acid long zinc-finger (Figure III.3.3).101 The structure of
the zinc finger consists of an anti-parallel β-sheet at the N-terminus and a C-terminal
α-helix. Its fold is not mainly induced and stabilized by hydrophobic shielding in
contrast to the Trp-cage, but by complexation of a zinc ion. With the zinc-finger as
stabilization and folding module, peptide sequences can be fused N-terminally to the
helix of the zinc-finger (in contrast to C-terminal fusion with the Trp-cage that was
pursued here). The helix of the zinc-finger thereby provides a structural nucleation
point and the fold can propagate into the attached sequence, similar to the Trp-cage
concept. As for the Trp-cage, two different strategies are possible to fuse the zinc-finger
with an α-helical peptide: a direct, C-terminal attachment, or sequential overlap of the
C-terminal helix with the N-terminal part of the peptide.
In this dissertation, we showed that the creation of a protein module to stabilize helical
peptide sequences is possible and that switchability is easily incorporated in this module.
The module provides structural stabilization of the biological active peptide, which results
in a significant increase in activity. This concept has enormous potential, as it can be
further developed and tailored for future applications.

Part IV.
Experimental Section
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1. Solid Phase Peptide Synthesis
The peptides were synthesized using Fmoc (Fluorenylmethyloxycarbonyl) based SPPS.
This method was originally invented by R.B. Merrifield102 and allows the synthesis
of sequences up to a length of 50 amino acids. The advantage of the solid phase
synthesis is the possibility of fully automation of the synthesis. In this work, a semi-
automatic approach was used with the semi-automated peptide synthesizer Initiator+
SP Wave by Biotage. In the following, the general procedure is described, details for
each peptide synthesis can be found in the Appendix (chapter 3).
1.1. Preparation of the Resin
As solid phase, a polystyrene-based resin was used with different surface functional-
izations (Scheme IV.1.1). The Wang-Resin for unproblematic amino acids at the C-
terminus, the 2-Chlorotrityl resin for amino acids, which tend to perform racemization
during synthesis (i.e. Cys) and the Rink-Amide resin for an amidated C-terminus.
Scheme IV.1.1.: Used resins for SPPS. Wang resin (top, left), Rink-Amide resin (top, right)
and 2-Chlorotrityl resin (bottom, left).
Prior to the coupling of the amino acids, the resin was swollen in dichloromethane
(DCM) and washed with dimethylformamide (DMF) to increase the volume- and surface-
accessibility. In case of the Rink-Amide resin, a deprotection step of the Fmoc group
with 25% pyridine in DMF is included.
1.2. Coupling Cycle
The coupling was performed at 75 ◦C with microwave assisted heating. Each
coupling step consists of two steps. First, the coupling of the Fmoc protected
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amino acids (5 eq.a) was performed with 1-[Bis(dimethylamino)methylene]-1H-
1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate (HATU) (4.9 eq.a) and
N,N-diisopropylethylamine (DIPEA) followed by a washing cycle with DMF.
Scheme IV.1.2.: Coupling-mechanism with HATU and DIPEA.
The Fmoc-protected amino acid is deprotonated by DIPEA and forms a carboxylate an-
ion. The carboxylate anion attacks HATU and forms the O-acyl(tetramethyl)isouronium
salt. The formed anion reacts with the activated carboxylic acid and tetramethyl urea is
released. An amine group can then react with the formed, activated ester to the amide
peptide bond (Scheme IV.1.2).
Difficult coupling steps with a yield lower than 90% and couplings of unpolar amino
acids (i.e. alanine) were performed twice to improve the overall yield and ease up the
purification process. In case of several unpolar amino acids in a row, a capping step with
acetic anhydride and pyridine was inserted to quench unreacted sides.
aEquivalents per binding side on the resin.
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1.3. Removal of the Fmoc Protecting Group
Scheme IV.1.3.: Mechanism of the removal of the Fmoc protecting group using piperidine.
In a second step, the Fmoc group was removed with 25% piperidine in DMF at 75 ◦C.
This step is extended in case of non-quantitative deprotection. Piperidine attacks the
acidic fluorenyl proton of the Fmoc protected amino acid. This results in a β-elimination
of the fluorenyl ring leading to the dibenzufulvine and elimination of CO2 and there-
fore to the free amine. The highly reactive dibenzufulvine is scavenged by piperidine
(Scheme IV.1.3).
Functional side chains (i.e. carboxylic acids) are protected orthogonally to avoid side
reactions.
1.4. Cleavage and Deprotection of the Peptide
The peptide was cleaved and fully deprotected by treating the resin with trifluoracetic
acid (TFA) and scavengersb at ambient temperature. Afterwards, the resin was filtrated
and the combined filtrates were treated with diethylether to precipitate and wash the
peptide. The crude peptide was dissolved in water and lyophilized. The peptides were
purified using high-performance liquid chromatography (HPLC).
bWang & 2-Chlorotrityl resin: 95 v/v% TFA, 2.5 v/v% water and 2.5 v/v% Triisopropylsilane (TIS).
Rink-Amide resin: 90 v/v% TFA, 5 v/v% 1,3-dimethoxy benzene (DMB), 2.5% water, 2.5 v/v%
TIS.
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1.5. HPLC and ESI-MS
The mobile phase of the HPLC consists of H2O and acetonitril (Acn) with 0.01v/v%
TFA. As a solid phase, poly(styrene-divinylbenzene) (PLRP-S) is used. Detailed
description of the columns and the equipment can be found in the chapter "Methods
and Machines".
Figure IV.1.1.: Solvent profile of the short (left) and long analytical method (right). The grey
area represents the percentage of H2O and the hatched area the percentage of
Acn.
For the analytical approach, an analytical column was used and two different methods
were performed. Polar proteins were characterized with a short method (Figure IV.1.1)
with a flow rate of 1mL/min starting with 95% H2O and 5% Acn for 2.5min, followed
by a linear gradient from 2.5 to 12.5min to 60% Acn. To eluate unpolar species, the
amount of Acn is set to 95% for 3.5min. For re-equilibration, the column is washed
for 1.5min with 95% H2O and 5% Acn.
In the case of unpolar molecules, a longer analytical method was used. This method
with a flow rate of 1mL/min starts with 95% H2O and 5% Acn for 5min followed
by a linear gradient from 5 to 30min to 95% Acn. The column is washed with 95%
Acn for 6min and for re-equilibrating the column 4min with 95% H2O and 5% Acn
(Figure IV.1.1).
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Figure IV.1.2.: Exemplary profile of a preparative run. The grey area represents the percentage
of H2O and the hatched area the percentage of Acn. Fractionized samples were
collected between 35 and 70min.
The purification was performed on a semi-preparative PLRP-S column (see chapter Used
Methods and Machines) and a modified method by Mant was used.103 In this method,
the retention time (tR) of the desired product was determined on the analytical column
and the injection time of 2.5min was subtracted. The corresponding percentage of
Acn was corrected by 12% for the long and 17% for the short analytical method. For
30min, a linear gradient from 5% to the determined percentage Acn, followed by a
linear gradient of 0.1%/min for 35min to eluate the desired product was used. For
washing and re-equilibration, the column was flushed with 95% Acn for 10min followed
by 5% Acn for additional 10min (Figure IV.1.2). During the 0.1% linear gradient, slices
of 0.25− 0.5min were collected.
The collected fractions were analyzed by HPLC and MALDI-ToF or HPLC-ESI-MS to
verify the purity. Subsequently, the pure fractions were flash frozen with liquid nitrogen
and the solvent was removed by lyophilization and a white, fluffy solid was obtained.
Table IV.1.1.: Isolated yields of the peptide synthesis.
Peptide Isolated yield
Tc10b 9mg (4.3µmol, 2.3%)
Tc10b-S20C-21G 4mg (1.9µmol, 2.0%)
Tc10b-A2K-S20C(S-tBu)-21G 8mg (3.5µmol, 4.0%)
Tc10b-A2C(S-tBu)-S20K-21G 9mg (3.9µmol, 4.5%
Tc10b-S20K 4mg (1.9µmol, 2.0%)
TcKKA 11mg (5.1µmol, 5.5%)
15er 13mg (9.7µmol, 6.5%)
15erYW 9mg (6.0µmol, 4.5%)
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1.6. Sequence Difficulties
All the Trp-Cage sequences contain the motif Asp-Gly. This motif causes major problems
during the Fmoc based SPPS.
Scheme IV.1.4.: Mechanism of the base catalyzed aspartimide formation of the Asp residue (red
ellipse) with the prior coupled Gly (black square), followed by a ring-opening
by hydrolysis or deprotection with piperidine.
During the peptide synthesis, the protected side chain of the Asp residue can be
attacked base or acid catalyzed by the amide of the previous amino acid and form a
five membered ring (aspartimide). The ring can either be opened by hydrolysis or by
nucleophilic attack of piperidine during the Fmoc removal, whereas the first result in a
racemic mixture of α- and β-peptide, the latter yields in a racemic mixture of α- and
β-piperidide (Scheme IV.1.4).104–106
The various side products not only significantly decrease the yield, but show similar
retention times on the RP-HPLC and it is therefore impossible to purify those peptides.
To reduce this problem, Asp can be replaced by Glu. However, a similar side reaction
can occur: the protected side chain can be attacked by the amide of the previous
amino acid (see aspartimide) or by the own amide. The second ring closure results
in a capping of the peptide chain and further growth is prevented. Nevertheless, the
yield decreases significantly. Another possibility to prevent this side reaction is the use
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of backbone protected amino acids. In case of Glu, the previous coupled amino acid
and Glu itself must be backbone protected, while in the case of Asp only the previous
amino acid requires a protection. For synthetic reasons and comparability with the
literature, Asp was used and the prevention of the named side reactions was archived
by using the building block Fmoc-Asp(OtBu)-(Dmb)Gly-OH. As an example for this
side reaction, a hexa-peptide with the sequence AT-XY-SK was synthesized. For XY,
either the di-amino acid Fmoc-Asp(OtBu)-(Dmb)Gly-OH, Fmoc-Asp(OtBu)-OH and
Fmoc-Gly-OH, or Fmoc-Glu(OtBu)-OH and Fmoc-Gly-OH were used. The hexapeptides
were synthesized using standard protocol microwave assisted coupling and deprotection
on a Wang-resin as described previously. After the coupling of Lys and Ser, the resin
was split in three equals and separately, I) Fmoc-Asp(OtBu)-(Dmb)Gly-OH moiety, II)
Asp and Gly, III) Glu and Gly were coupled. The three peptides were cleaved from the
resin and deprotected as described elsewhere (section 1.4).
Table IV.1.2.: ESI-MS of the hexa-peptide ATD-GSK, ATDGSK and ATEGSK. First column
indicates detected mass peaks above 400m/z, second column indicates the area
in percent of the peak and third column indicates the assigned molecule. All
peaks >1% were assigned and normalized to 100 %. a) Molecule plus sodium,
b) incomplete deprotection of tBu-groups (one remaining), c) piperidide, d)
aspartimide.
I) ATD-GSK II) ATDGSK III) ATEGSK
Mass Area Assignment Mass Area Assignment Mass Area Assignment
(m/z) (%) (m/z) (%) (m/z) (%)
600.5 0.8 Ma 645.7 3.1 Mc 592.6 9.2 M
578.5 17.8 M 578.5 5.6 M 561.5 1.2 M-Sb
547.5 2.5 M-Sb 560.5 4.5 Md 535.5 3.2 M-G
513.5 2.6 M-Sa 558.5 7.8 M-S c 527.5 1.7 M-Sa
507.5 2.7 M-A 547.5 0.8 M-Sb 521.5 1.3 M-A
498.5 0.9 M-Ta 520.5 0.9 M-G 519.5 1.4 M-Eb
491.5 60.0 M-S 519.5 7.9 M-Db 505.5 35.2 M-S
473.5 2.5 M-K 513.5 1.1 M-Sa 485.5 2.2 M-Ea
420.4 4.5 M-S-A 507.5 1.3 M-A 477.5 1.1 M-A-Tb
406.4 5.7 M-DG 491.5 19.5 M-S 463.5 19.7 M-E
489.5 1.4 M-Ad 448.5 13.0 M-S-G
477.5 0.8 M-T 434.5 1.6 M-A-S
473.5 18.1 M-K / M-Sd 432.5 2.8 M-E-Sb
463.5 16.8 M-D 420.4 1.6 M-A-T
434.5 1.4 M-S-G 406.4 4.7 M-E-G
432.5 2.1 M-S-Db
420.4 2.2 M-S-A
406.4 2.6 M-D-G
402.4 2.3 M-S-Ad
The resulting crude peptides were characterized by ESI-MS (Table IV.1.2) and the masses
above 400 m/z were assigned. First, it is observed that the coupling of Ser on Lys is
incomplete with a yield below 40%. All other coupling steps are in the expected range
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of above 90%. However, these results coincide well with studies of difficult couplings
in SPPS using N,N’-dicyclohexylcarbodiimide (DCC)/Benzotriazol-1-ol (HOBt) as cou-
pling reagents of J.W. van Nispen.107 Secondly, a minor part shows an incomplete
deprotection of tBu groups.
Comparing the crude hexapeptides with separate coupling Gly and Asp and the building
block Asp(OtBu)-(Dmb)Gly shows the problems which occur due to the aspartimide
formation. With the building block, the correct sequence was obtained in a yield of
≈ 18%, while without the building block the yield decreased to a third to 6%. Further,
the side products (piperidide and aspartimide) were identified in a combined yield of
≈ 8%. A replacement of Asp with Glu suppresses the named amide side reactions, with
a yield of ≈ 9%. This is a result of the insufficient coupling steps of Glu on Gly.
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2. Procedure of Cross-Linking the Trp-Cage
2.1. Cross-Linking with Activated Halides on Cys
For the cross-linking of the switchable organic molecule (azobenzene, diazobenzene and
spiropyranes), reaction conditions typical for marking biomolecules were chosen. Iodoac-
etamide groups are the common counterpart for a nucleophilic replacement on the thiol
of a Cys residue and generally react at a pH of 7.9 (0.1 M NH4CO3 buffer) in the
presence of the reducing reagent TCEP to prevent the formation of disulfide bridges
during synthesis. DMSO can be added as co-solvent for the linker if necessary. 1 eq. of
the protein was dissolved in the buffer and stirred with TCEP for 1h. The cross-linker
(1.1 eq.) was solved in DMSO and added drop-wise to the protein and the reaction
mixture was stirred for several hours. Monitoring by HPLC and MALDI-MS determined
the end point of the reaction, when no conversion was observed. The solvent mixture
was removed by lyophilization. The remaining solid was dissolved in water and filtered.
Purification was carried out by HPLC as described elsewhere (section 1.5).
2.2. Cross-Linking with NHS Ester on Lys
The second methodology that was used is the reaction of primary amines with NHS
ester. Reactions with NHS ester were carried out in a mixture of buffered water at pH
7.4 (20 mM PBS buffer and 1M NaCl) and DMSO.
1 eq. of the protein was dissolved in the buffer. The linker was either dissolved in buffer
or in DMSO and drop-wise added to the protein solution. The reaction was monitored
by HPLC-MS. When no further conversion was observed, the reaction mixture was
diluted with water and filtered. The solvent was removed by lyophilization and the
solid redissolved in water. After filtration, the crude product was purified by HPLC as
described elsewhere (section 1.5).
Isolated yield (TcKKA-Lomant): 0.5mg (0.2µmol, 23.1%)
Isolated yield (TcKKA-azo): 1mg (0.4µmol, 45.1%)
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2.3. Linker Synthesis
2.3.1. 4,4’-Bis(2,5-dioxopyrrolodin-1yl)azobenzene
A synthesis by K. Sakurai was adapted and modified as follows:108 4,4’-Dibenzoic
acid azobenzene (0.50 g, 1.9mmol) was dissolved in DMSO (50mL). 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) (0.57 g, 3.7mmol) and N-hydroxysuccinimide
(0.43 g 3.7mmol) were dissolved in 10mL DMSO and added dropwise over the course
of 10min to the solution. The reaction mixture was stirred at 75 ◦C for 20h. The
solvent was evaporated and the crude product was purified by column chromatography
(eluent: chloroform). 0.20 g (0.5mmol, 27%) of a red solid were obtained.
TLC (chloroform, SiOH2): Rf = 0.45
1H NMR (500MHz,CDCl3): δ = 8.34-8.30 (m, 4H, H-3), 8.09-8.06 (m, 4H, H-2),
2.94 (s, 8H, H-10) ppm.
13C NMR (125MHz,CDCl3): δ = 169.0 (C-6), 161.2 (C-5), 155.7 (C-1), 131.8 (C-4),
127.6 (C-3), 123.4 (C-2), 25.7 (C-7) ppm.
HRMS (EI sector): m/z(%) = [M ]+ calcd for [C22H16N4O8]+ 464.0968, found
464.0963 (10%); [M − C4H4NO3]+ calcd for [C18H12N3O5]+ 350.0777, found
350.0771 (100%),.
IR (atr): ν˜ = 3100 (vw), 2923 (w), 1770 (s), 1733 (vs), 1600 (s) 1200 (vs) cm−1.
Melting point T=281 ◦C .
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3. Used Methods and Instrumentation
3.1. HPLC
The purification and analysis of the proteins were carried out by high performance liq-
uid chromatography (HPLC) using a reversed phase column. The HPLC device is a
LaChrom Elite by VWR-Hitachi with a L2400 UV-detector. Additionally, a frac-
tion auto-collector Foxy R1 by Teledyne Isco and an autosampler 717-plus by
Waters complete the HPLC set-up. In this work, different columns were used, which
vary in size and column material. Two columns have an immobile phase of poly(styrene-
divinylbenzene) (PLRP-S) particles, with a particle size of 8µm and pore diameter of
30nm. The dimensions of the analytical column are 150mmx4.6mm and for the
semi-preparative 325mmx30mm by Agilent. The second pair of columns are C-
18 nucleosil column material by Waters with a particle size of 7µm and 100nm
pore diameter was used. The analytical column has the dimensions 250mmx4.6mm,
whereas the semi-preparative column has dimensions of 250mmx32mm. For quanti-
tative detection of the molecules, an UV detector at λ = 200nm or λ = 365nm
detector was used.
3.2. Mass Analysis
For determination of the molecule mass, either a directly connected electron spray ion-
ization mass spectrometer expressionL cms by Advion (ESI-MS) with a hexapol as
separator or manually a matrix-assisted laser desorption ionization (MALDI) with a time
of flight (ToF) mass separator Biflex III by Bruker was used. High resolution mass
was determined using AccuTOF 4GGCV by Jeol with electron ionization (EI) of
70 eV and a ToF mass separator.
3.3. Lyophilizer
Lyophilization of the samples were performed on the lyophilizer Alpha 2-4 by Christ
equipped with a RZ6 vacuum pump by Vacuubrand and a typical vacuum of
0.01mbar.
3.4. UV/vis Spectroscopy
UV/vis spectra were recorded on a Lambda 14 two channel spectrometer by
PerkinElmer. It is equipped with a thermostat by Büchi. All measurements were
performed at 25 ◦C ± 0.1 ◦C and carried out in a quartz cuvettes with a path length of
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10mm by Hellma Analytics. Measurements were performed under the same con-
ditions and with the same stock solution as for the CD measurements to determine their
concentration. The extinction coefficient for the Trp-cages were taken from Neidigh39
to be 278nm = 6760 cm
2
mmol .
In addition for following the tuning of the excitation wavelength of TcKKA-azo, an
UV-2401PC spectrophotometer by Shimadzu was used.
3.5. IR Spectroscopy
Infrared (IR) spectra were measured on a Paragon 1000 FT-IR spectrometer by
Perkin Elmer. The spectrometer is equipped with an A-531-G Golden-Gate
attenuated total reflection (ATR) unit.
3.6. Melting Points
The melting point of the linker was determined on an IA6304 capillary melting point
apparatus by electrothermal. The measured melting point was not further cor-
rected.
3.7. CD Spectroscopy
CD spectra were recorded on a Jasco J-720 spectropolarimeter. The temperature was
adjusted with a thermostat WKL 26 by Haake and a PTC-423S Peltier element by
Jasco. Spectra of TcKKA and its linked variants were recorded at 298K and pH3.
TcAFP4-7 were recorded at 274K and pH7.9 in 0.1M NH4HCO3 buffer.
All measurements were carried out in quartz cuvettes with a path length of 1.0mm by
Hellma Analytics. The lower limit of the spectrum was tested manually, hence it
should not exceed 700V as the data become unreliable. Spectra were recorded with a
data pitch of 2nm and a scanning speed of 5nm/min. Accumulation of three repeats
and background subtraction result in the full spectra.
The resulting signal is converted to mean residue ellipticity [θ]MR (Equation IV.3.1), in
which θ is the measured CD signal, c the concentration, l the path length of the cuvette
and n the number of residues.
[θ]MR =
100 ∗ θ
C ∗ l ∗ n (IV.3.1)
3.8. NMR Spectroscopy
The NMR data were recorded on Fourier transform NMR (FT-NMR) spectrometers AV
III 600 with a frequency of 600MHz equipped with a triple (1H, 13C and 15N) resonance
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cryo probe head and on a DRX500 500MHz spectrometer with a triple resonance
probe head (1H, 13C and nX, with X=any nucleus and n=the corresponding nucleon
number) by Bruker. Both spectrometers are equipped with a variable temperature
unit. The 600MHz spectrometer has a temperature range from 274.2K to 328K. For
higher temperature measurements up to 358K, the 500MHz spectrometer was used.
All samples, if not mentioned elsewhere, were measured in 90/10 ratio H2O/D2O at
pH 3, 7 and 7.9. The pH was adjusted with D2O solutions containing 0.01-1 N NaOD
or DCl. Measurements at pH 7.9 were carried out in 0.1M NH4HCO3 buffer. The pH
was measured with a two point calibration (7.0, 4.0 and 9.8) on accumet model 10
by Fisher Scientific. As internal standard for proton referencing, 4,4-dimethyl-4-
silapentane-1-sulfonic acid (DSS) or 3-timethylsilyl-propionic acid (TSP) were used as
reference in H2O/D2O and tetramethylsilane in organic solvents. 13C and 15N were
referenced indirectly according to the IUPAC recommendations for the frequency ratio
to 1H.109
3.8.1. Protein NMR
All proteins were characterized by 1D 1H NMR, 1H,1Hcorrelation spectroscopy (COSY),
1H,1H total correlation spectroscopy (TOCSY) and 1H,1Hnuclear Overhauser enhanced
spectroscopy (NOESY). For the 1H,1HTOCSY, a DIPSI2 (decoupling in the presence
of scalar interactions) for isotropic mixing of 60ms was used.110 The mixing time in
the 1H,1HNOESY was set to 200ms. The tr-NOESY was recorded as pseudo 2D ex-
periment. For saturation, a low power Gauss-shaped pulse with a length of 75ms was
used. The total saturation time was set to 4 s. All 1H and 1H,1Hcorrelation spec-
tra were recorded using a excitation sculpting with gradient pulses (esgp) for water
suppression.111 1H,13C/15N spectra were recorded as hetero single quantum coherence
(HSQC) with a flip-back pulse for water in the 1H, 15N HSQC and presaturation of
water in the 1H,13C-HSQC.
Assignment of the resonances in the 1H spectra followed the guide of K. Wüthrich.112
Saturation transfer difference spectra (tr-NOESY) were recorded using a Gaussian
shaped excitation pulse.113 Best transfer and selectivity results were obtained with a
saturation time of 4 s and a pulse power of 63.84 − dBW .
3.8.2. Reference Shifts for the Trp-Cage Fold
The published 1H NMR shifts were used and divided according to the folding pattern
they represent.43 The Hα shifts from residue 2 till 8 (Table IV.3.1) serve as reference
for the N-terminal helix. The cage fold is represented by the upfield shifted protons due
to the ring current of Trp: the Hα of Leu (7), Hα’ of Gly (11), α of Pro (18), β’ of
Pro (18) and δ,δ’ of Pro (19). In addition, α and β of Pro (12) and α of Arg (16)
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represent the downfield shifted cage shifts (Table IV.3.2). The shifts are referenced to
the random coil shifts by D. Wishart77 leading to the CSD and summed up resulting
in ∆δ. Thus, the CSDs of Tc10b represents a 99.5% folded Trp-cage and by setting
observed chemical shift deviations of new variants in ratio, the stability for new variants
at any condition can be determined.
Table IV.3.1.: Sum of CSDs for selected protons in the helical region representing the helix fold
of Tc10b at 280 K at pH 7.43
Helix ∆δ (ppm). Σ
A2α Y3α A4α Q5α W6α L7α A8α
pH 7 -0.043 -0.522 -0.200 -0.442 -0.423 -0.953 -0.386 -2.969
Table IV.3.2.: Sum of CSDs for selected protons in the cage structure representing the cage
fold of Tc10b at 280 K at pH 7.43
Cage ∆δ (ppm) Σ
upfield
L7α G11α’ P18α P18β’ P19δ P19δ’
pH 7 -0.953 -3.483 -2.329 -1.697 -0.664 -0.449 -9.575
3.9. Ice Activity Assay
Ice activities were measured using a nanolitre osmomter by Clifton. It is equipped
with a Peltier element cooling station, which is cooled to 10 ◦C by a ministat 230
by Huber with glycol as thermal fluid. The cooling station is mounted on an Eclipse
NI microscope with a D7000 camera by Nikon. Pictures were recorded with 50x
magnification with the Camera Control Pro 2 software by Nikon.
All measurements were carried out at pH 7.9 in 0.1M NH4HCO3 buffer. The sample
holder’s bores are filled with a high viscosity immersion oil (type B) and serves with
20µm as internal reference for the crystal size. With the help of a glass capillary and a
Hamilton syringe a nanoliter sized drop was placed in the bore without touching the
border. The sample was deep-frozen to −40 ◦C. The frozen sample was heated up with
caution until one single crystal remained. For observation of the ice crystal growth, the
temperature was adjusted below the freezing point.26
3.10. Photo-Irradiation Equipment
Irradiation experiments were performed with LED light sources with an optical power
of 1050 mW (Nichia NC4U033A; λ = 365nm) and 900 mW (Luxeon LXML-
PR01; λ = 450nm).
In addition, a FlouroMax-4 spectrofluorometer manufactured by Horiba Jobin
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Yvon was used for tuning of the wavelength for irradiation between λ = 365nm and
λ = 340nm. It is equipped with a 150W ozone-free xenon arc-lamp.
3.11. Molecular Modelling and MD Simulations
Ongoing from the first structure of the NMR ensembles of Tc5b by Neidigh39 (PDB
entry: 1L2Y) all models presented in this work were prepared. With the Swiss-PDB-
viewer SPDBV114 the models were extended.
All structures were prepared in Schrödingers Maestro115 and the structures minimized.
Molecular dynamic simulations were performed with Schrödingers MacroModel.116 Prior
to the simulations, an energy minimization was performed with maximum 2500 iterations
following the Polak-Ribier conjugate gradient (PRCG) method117 and a derivative
convergence. The MD simulation follows stochastic dynamics with a time step of 1.5 fs
at variable temperatures. For side chain conformations, a temperature of 200K was
chosen. Simulations of TcKKA linked with Lomant and azobenzene MD were per-
formed at 350K. The MD simulations runs for a total simulation time of 20,000 ps with
a 10 ps equilibration time. For structure sampling, 100 structures per MD simulation
were saved and minimized as described earlier. All simulations were performed using
the force field Optimized Potentials for Liquid Simulations (OPLS 2005).118
In the simulations, azobenzene was calculated with constraints for the cis conformer.
Thus, the angle of C-N-N (for both rings) were set to 121.9◦, and the dihedral angle
C-N-N-C to 6.5◦ and C-C-N-N to 53.3◦, respectively.119
The energy of the modelled peptides was calculated after a geometry optimization. As
potential, the OPLS 2005 force field was used with extended cut-off for the non-bonded
interactions.
The accessible surface area and free folding energy of the models were determined using
the web-based VADAR program.94 The VADAR program is a compilation of different
algorithms to evaluate protein structures based on the coordinate data. For determi-
nation of the accessible surface area, the Shrake definition for the van der Waals
radii was used.
Pictures of the proteins and protein models were generated using PyMol.120
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1. Spectra and NMR Shifts of the Trp-cage Variants
In the following, the HPLC-profiles, mass spectra (MALDI or ESI), NMR, CD and UV/vis
spectra of all here discussed substances are presented if not already displayed in the
respective chapter. Furthermore, the proton, carbon and nitrogen chemical shifts of all
peptides and proteins in different conditions (pH and temperature) are listed.
Table V.1.1.: Nomenclature of the AFP-Tc chimera proteins used in this dissertation and in the
measurements.
Work Measurement
AFP-Tc-4 TcAFP4
AFP-Tc-5 TcAFP5
AFP-Tc-6 TcAFP7
AFP-Tc-7 TcAFP6
The nomenclature of the here presented AFP-Tc chimera proteins differs from the used
nomenclature of the measurements (Table V.1.1). In this work, the chimera proteins
are named according the sequence and numbered by the position of the Trp residue
in the AFP sequence. For the measurements, the proteins were named "TcAFPX",
whereas "X" is an ascending integer value, depending on the time of design and synthesis.
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1.1. Tc5b and its Variants
1.1.1. Tc5b
Operator:KEYUSER  Timebase:U-3000RS   Sequence:JANUAR2014 Page 1-1
27.02.2017  11:58
428 IZKF Leipzig, Core Unit Peptid-Technologien
 Liebigstraße 21, 04103 Leipzig, e-mail: sven_r@yahoo.com, Tel.: 0341 - 9715898 / 897
 Comment:
Sample Name: AG14_purified Injection Volume: 5.0  
Vial Number: BD8 Channel: UV_VIS_1
Sample Type: unknown Wavelength: 220.0
Control Program: Peptide_3D_basic_short Bandwidth: 4
Quantif. Method: peptide_izkf Dilution Factor: 1.0000  
Recording Time: 25.03.2014 12:23 Operator: KEYUSER
Sample ID: Sample Amount: 1.0000  
Test_His Catenin
No. Ret.Time Peak Name Height Rel.Area Area Amount Type 
min mAU % mAU*min
1  4.00      n.a. 1.1 0.22 0.19 n.a. BMB
2  4.37      n.a. 0.7 0.13 0.11 n.a. BMB
3  4.65      n.a. 0.6 0.10 0.08 n.a. BMB
4  5.50      n.a. 10.0 0.54 0.46 n.a. BM 
5  5.64      n.a. 1011.1 99.02 84.08 n.a.  MB
Total: 1023.536 100.000 84.92    0.000 
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Figure V.1.1.: HPLC chromatogram of purified Trp-cage Tc5b. Synthesis performed by S.
Rothemund.
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Figure V.1.2.: Mass spectrum of the purified Trp-cage Tc5b. Synthesis performed by S.
Rothemund. m/z : [M +H]+ calcd for [Tc5b+H]+ 2170.4, found 2169.6.
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Figure V.1.3.: 1H-NMR spectrum of Tc5b at 298 K and pH 7 with enlargement of the indole
proton region.
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Table V.1.2.: Chemical shifts of Tc5b at 298 K and pH 3.
Residue chemical shift δ (ppm)
NH N α β γ δ  ζ η
1 Asn 4.353 3.083,3.018
7.457,
6.873
2 Leu 8.815 123.32 4.286 1.504 1.682 0.943,0.893
3 Tyr 8.419 122.74 4.300 3.055 7.047 6.820
4 Ile 8.033 118.26 3.869 1.316
1.875,
1.526,
0.833
0.891
5 Gln 7.958 121.44 4.040 2.061 2.356 7.482,6.914
6 Trp 8.026 120.54 4.413 3.468,3.215 7.344
9.845,
7.149
7.225,
7.129 7.336
7 Leu 8.207 121.44 3.7415 1.7177 1.5218 0.8954,0.8393
8 Lys 8.232 121.30 4.064 1.838 1.421,1.507 1.650 2.954 7.533
9 Asp 8.020 121.80 4.689 2.990,2.856
10 Gly 7.872 107.54 3.703,3.384
11 Gly 8.126 110.73 3.384,2.454
12 Pro 4.494 2.392,1.990 2.055
3.653,
3.343
13 Ser 8.067 114.38 4.454 3.904
14 Ser 8.177 117.10 4.326 3.919,3.742
15 Gly 8.122 110.04 4.125,3.898
16 Arg 8.058 120.64 4.773 1.877,1.772 1.683 3.232 7.294
17 Pro 4.658 2.279,1.818 1.996
3.820,
3.611
18 Pro 3.946 1.410,1.117 1.711 3.946
19 Pro 4.393 2.251,1.923 1.965
3.414,
3.252
20 Ser 8.103 118.76 4.327 3.892,3.827
160 1. Spectra and NMR Shifts of the Trp-cage Variants
Table V.1.3.: Chemical shifts of Tc5b at 298 K and pH 8.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1 Asn exch. 3.834 2.801
2 Leu exch. 4.184 1.484 1.809 0.997,0.942
3 Tyr 8.572 4.192 3.171,3.126 7.047 6.846
4 Ile 8.002 3.798 1.966
1.683,
1.388,
0.954
0.952
5 Gln 7.926 3.952 2.112 2.414 7.749,6.905
6 Trp 8.019 4.317 3.563,3.211 7.051
9.761,
7.236
7.248,
7.147 7.163
7 Leu 8.273 3.528 1.920 1.631 0.952,0.863
8 Lys 8.315 3.969 1.916 1.572,1.454 1.650 2.955 exch.
9 Asp 7.961 4.568 2.884,2.719
10 Gly 7.627 4.141,3.537
11 Gly 8.410 3.225,1.228
12 Pro 4.600 2.511,2.063 2.155
3.799,
3.451
13 Ser exch. 4.468 3.927
14 Ser exch. 4.201 3.887,3.564
15 Gly 7.925 4.248,3.852
16 Arg 8.132 4.996 1.870,1.795 1.683
3.320,
3.246 exch.
17 Pro 4.742 2.345,1.814 2.013
3.864,
3.676
18 Pro 2.826 1.424,0.638
1.795,
1.717 3.553
19 Pro 4.364 2.223,1.997 1.878
3.222,
3.044
20 Ser 7.830 4.185 3.795
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1.1.2. Synthesis Details of Tc5b-L2C-S20C
Comment:
Sample Name:
VialNumber:
Sample Type:
ControlProgram:
Quantif. Method:
Recording Time:
Sample lD:
CU13_W2_gereinigt
RE1
unknown
Pe ptid e-3 D-bas ic-s h ort
peptide-izkf
22.10.201310=38
lnjection Volume:
Channel:
Wavetength:
Bandwidth:
Ditution Factor:
Operator:
Sample Amount:
30,0
uv_vts_{
220.0
4
1,0000
Administrator
1,0000
35$,,765 Lei pzig, core U n it Peptid'Tech nolog ie,n
.,. t-ieb,igs nezl, 04103 Leipzig, e-mail: sven-r@yahöo.com, Tel.'t'0341 - 9715898 / 897
Operator:Administrator Timebase:U-3000RS Sequence:JANUAR 2013 Page 1-1
22.10.2013 11:06 AM
Chromeleon (c) Dionex 1996-2006
Version 6.80 SR7 Build 2528 (148369)
JANUAR 2013 #353
No. Ret.Time Peak Name Height Rel.Area Area Amount Type
min mAU % mAU*min
1
2
3
4
5
6
7
8
9
10
4,05
4,40
4,68
4,90
5,50
5,70
6,32
6,77
6,80
9.68
0,9
0,6
0,4
2,2
42,2
2059,2
4,8
1,2
1,3
3,5
0,07
0,04
0,03
0,09
1,09
97,79
0,46
0,06
0,1 1
0,27
0,15
0,08
0,06
0,20
2,41
216,31
1,03
0,13
0,24
0.59
n.a. BMB
BMB
BMB
BMB
BM
M
MB
BM
MB
BMB
n.a n.a
n.a n.a
n.a. n.a
n.a. n.a.
n.a. n.a.
n.a. n.a.
n.a. n.a.
n.a n.a.
n.a n.a.
Total: 21 16,300 100,000 221,20 0,000
IZKFllntegration
Figure V.1.4.: HPLC chromatogram of purified Trp-cage Tc5b-L2C-S20C. Synthesis performed
by S. Rothemund.
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Er. Sven Rothemund, IZKF Leipzig, Liebigstrasse21,04103 Leipzig, Tel.: 0341-9715898, sven_r@yahoo.com
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Figure V.1.5.: m/z : [M +H]+ calcd for [Tc5b− L2C − S20C +H]+ 2176.5, found 2176.9.
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Figure V.1.6.: root-mean-square deviation of atomic positions (RMSD) of the Cα atoms during
the MD simulation of Tc5b-L2C-S20C. The simulation was performed with a total
duration of 20,000 ps and every 200 ps a structure was saved and the RMSD
with respect to the first model determined.
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1.1.3. MALDI-ToF Spectra of Purified Cross-Linked Tc5b-L2C-S20C
Figure V.1.7.: MALDI-ToF spectrum of the fraction collected with a tR=17.8 min, containing
cross-linked Tc5b-L2C-S20C with the Woolley linker. m/z : [M +H]+ calcd
for [Tc5b− L2C − S20C −Woolley − linker +H]+ 2468.1, found 2469.3.
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Figure V.1.8.: 1H NMR spectra between of Tc5b-L2C-S20C cross-linked with the Woolley-
linker (top) in trans (black) and cis (red) at 298 K and pH 3.
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Figure V.1.9.: Enlarged 1H NMR of the indole and amide region of the purified cross-linked
Tc5b-L2C-S20C with the Woolley linker in trans (bottom/black) and cis
(top/red) at 298 K and pH 3.
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Figure V.1.10.: MALDI-ToF spectrum of cross-linked Tc5b-L2C-S20C with 4,4’-dibromomethyl
azobenzene linker. m/z : [M +H]+ calcd for [Tc5b−L2C − S20C − (4, 4′ −
dibromomethylazobenzene) +H]+ 2382.7, found 2382.5
Figure V.1.11.: 1H NMR spectra of Tc5b-L2C-S20C cross-linked with 4,4’-dibromomethyl
azobenzene (top) in trans (black) and cis (red) at 298 K and pH 3.
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1.2. Tc10b and its Variants
1.2.1. Tc10b
Figure V.1.12.: Total ion chromatogram of crude Tc10b (top) and purified (bottom). m/z :
[M + 2H]2+ calcd for [Tc5b− L2C − S20C + 2H]2+ 1044.1, found 1044.1
. Isolated yield: 9mg (4.3µmol, 2.3%).
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Figure V.1.13.: 1H-NMR spectrum of Tc10b at 298 K and pH 7 with enlargement of the indole
proton region.
Table V.1.4.: Sum of CSDs for selected protons in the helical region representing the helix fold
of Tc10b at 280 K at pH 7.43
Helix ∆δ (ppm). Σ
A2α Y3α A4α Q5α W6α L7α A8α
pH 7 -0.043 -0.522 -0.200 -0.442 -0.423 -0.953 -0.386 -2.969
Table V.1.5.: Sum of CSDs for selected protons in the cage structure representing the cage fold
of Tc10b at 280 K at pH 7.43
Cage ∆δ (ppm) Σ
upfield
L7α G11α’ P18α P18β’ P19δ P19δ’
pH 7 -0.953 -3.483 -2.329 -1.697 -0.664 -0.449 -9.575
downfield
P12α P12β R16α
pH 7 0.229 0.251 0.436 0.916
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Table V.1.6.: 1H chemical shifts of Tc10b at 298 K and pH 3.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1 Asp exch. 4.332 3.194,3.053
2 Ala 8.936 4.276 1.471
3 Tyr 8.595 4.116 3.087 7.077 6.813
4 Ala 8.170 4.101 1.512
5 Gln 7.935 4.003 2.143 2.411
6 Trp 8.068 4.292 3.511,3.175 7.283
9.731,
7.094
7.221,
7.113 7.095
7 Leu 8.289 3.514 1.748,1.448 1.539
0.926,
0.858
8 Lys 7.977 4.041 1.880 1.453 1.659 2.972
9 Asp 7.854 4.680 3.050,2.884
10 Gly 7.668 4.111,3.596
11 Gly 8.105 3.116,1.722
12 Pro 4.528 2.451,2.012 2.082
3.685,
3.280
13 Ser 7.885 4.443 3.909
14 Ser 8.146 4.276 3.919,3.682
15 Gly 8.021 4.187,3.864
16 Arg 8.033 4.843 1.895,1.795 1.686 3.250
17 Pro 4.652 2.257,1.794 1.992
3.837,
3.625
18 Pro 3.064 1.464,0.887 1.712
3.064,
3.070
19 Pro 4.385 2.223,1.941 1.855
3.263,
3.066
20 Ser 8.184 4.375 3.916,3.822
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Table V.1.7.: 1H-chemical shifts of Tc10b at 298 K and pH 8
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1 Asp exch. 4.078 2.900 2.869
2 Ala exch. 4.270 1.511
3 Tyr 8.738 4.090 3.197,3.110 7.100 6.804
4 Ala 8.306 4.113 1.561
5 Gln 8.053 3.928 2.228,2.156 2.409 7.810 6.921
6 Trp 8.074 4.264 3.170,3.558 7.010
9.717,
7.036
7.037,
7.221 7.222
7 Leu 8.330 3.436 1.876,1.384 1.636
0.980,
0.867
8 Lys 8.068 3.957 1.959,1.914 1.670 1.510 2.982
9 Asp 7.948 4.546 2.900,2.711
10 Gly 7.528 4.156,3.490
11 Gly 8.433 3.145,0.898
12 Pro 4.621 2.533,2.065 2.171
3.820,
3.450
13 Ser 7.747 4.213 3.781
14 Ser 8.211 4.166 3.864,3.516
15 Gly 7.937 4.280,3.816
16 Arg 8.136 5.034 1.909,1.847 1.676
3.250,
3.316 exch.
17 Pro 4.765 2.346,1.804 2.009
3.870,
3.680
18 Pro 2.582 1.357,0.405
1.761,
1.671 3.52
19 Pro 4.348 2.215,1.982
1.839,
1.852
3.160,
2.968
20 Ser 7.818 4.178 3.787
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Table V.1.8.: 15N and 13C-chemical shifts of Tc10b at 298 K and pH 3.
Residue chemical shift δ (ppm)
15N 13C
NH other α β γ δ  ζ η
1 Asp n.d. 52.70 38.68
2 Ala 124.01 18.40 18.40
3 Tyr 121.63 62.06 38.28 133.01 118.39
4 Ala 121.44 18.40 18.40
5 Gln 118.00 112.88 58.16 28.53 33.79
6 Trp 122.10 131.05 53.29 28.14 127.36 122.68 124.24 114.49,120.93
7 Leu 120.11 57.58 42.18 26.19 25.41,23.66
8 Lys 121.20 n.d. 58.35 31.61 25.02 29.12 42.18
9 Asp 117.29 n.d. 38.28
10 Gly 106.82 44.46
11 Gly 111.51 43.74
12 Pro n.d. 64.79 31.85 27.36 50.36
13 Ser 113.66 58.94 63.62
14 Ser 117.02 59.91 64.79
15 Gly 109.87 45.25
16 Arg 120.26 124.99 n.d. 31.22 26.78 43.54
17 Pro n.d. n.d. 30.68 27.17 50.56
18 Pro n.d. 60.30 29.70 n.d. n.d.
19 Pro n.d. 62.64 n.d. n.d. 49.78
20 Ser 117.18 58.35 64.01
1.2.2. Tc10b-S20C-21G
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Figure V.1.14.: MALDI-ToF spectrum of the crude Tc10b-S20C-21G (left) and purified (right).
m/z : [M +H]+ calcd for [Tc10b−S20C− 21G+H]+ 2160.3, found 2159.7.
Figure V.1.15.: HPLC chromatogram of the crude Tc10b-S20C-21G (left) and purified (right).
Isolated yield 4mg (1.9µmol, 2.0%).
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Figure V.1.16.: 1H NMR of Tc10b-S20C-21G at pH 3 and 298K (top) and pH 7 (bottom).
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Table V.1.9.: 1H chemical shifts of Tc10b-S20C-21G at 298 K and pH 3.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1 Asp exch. 4.335 3.185,3.030
2 Ala 9.004 4.272 1.494
3 Tyr 8.616 4.109 3.121 7.052 6.813
4 Ala 8.224 4.090 1.549
5 Gln 7.939 3.982 2.171 2.431
6 Trp 8.088 4.252 3.549,3.172 7.076
9.697,
7.087
7.261,
7.115 7.223
7 Leu 8.338 3.442 1.783,1.421 1.550
0.918,
0.857
8 Lys 7.989 4.019 1.895 1.491 1.657 2.976 7.536
9 Asp 7.818 4.663 3.050,2.863
10 Gyl 7.590 4.131,3.545
11 Gly 8.152 3.033,1.374
12 Pro 4.547 2.482,2.025 2.105
3.714,
3.284
13 Ser 7.791 4.448 3.917
14 Ser 8.140 4.245 3.909,3.639
15 Gly 7.974 4.228,3.846
16 Arg 8.040 4.892 1.905,1.818 1.702 3.265 7.405
17 Pro 4.677 2.276,1.806 2.000
3.862,
3.645
18 Pro 2.817 1.409,0.625
1.808,
1.685 3.507
19 Pro 4.422 2.103,2.014 1.871
3.184,
2.961
20 Cys 8.013 4.598 3.147,2.970
21 Gly 8.226 3.888
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Table V.1.10.: 15N and 13C-chemical shifts of Tc10b-S20C-21G at 298 K and pH 3.
Residue chemical shift δ (ppm)
15N 13C
NH other α β γ δ  ζ η
1 Asp n.d. n.d. n.d.
2 Ala 123.84 n.d. 18.16
3 Tyr 121.84 n.d. 38.14 132.97 118.15
4 Ala 121.34 n.d. 18.16
5 Gln 117.84 113.34 n.d. n.d. 33.51
6 Trp 122.25 131.31 n.d. n.d. 127.36
7 Leu 119.72 57.55 n.d. 25.41,23.52 120.78 124.20
114.21,
122.54
8 Lys 121.44 n.d. n.d. n.d. n.d. n.d.
9 Asp 117.34 n.d. n.d.
10 Gyl 106.43 44.08
11 Gly 112.22 n.d.
12 Pro n.d. n.d. n.d. n.d. n.d.
13 Ser 113.34 n.d. n.d.
14 Ser 117.06 n.d. n.d.
15 Gly 109.78 45.02
16 Arg 120.00 117.00 n.d. n.d. n.d. n.d.
17 Pro n.d. n.d. n.d.
18 Pro n.d. n.d. 29.38 n.d. n.d.
19 Pro n.d. n.d. n.d. n.d. 49.96
20 Cys 118.00 n.d. n.d.
21 Gly 112.90 n.d.
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Table V.1.11.: 1H-chemical shifts of Tc10b-S20C-21G at 298 K and pH 7.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1 Asp exch. 4.066 2.901,2.874
2 Ala exch. 4.266 1.518
3 Tyr 8.748 4.111 3.201,3.131 7.055 6.817
4 Ala 8.327 4.081 1.551
5 Gln 8.046 3.906 2.232,2.155 2.412
7.813,
6.912
6 Trp 8.065 4.243 3.565,3.164 7.006
9.720,
7.030
7.134,
7.131 7.213
7 Leu 8.326 3.406 1.864,1.353 1.533
0.940,
0.896
8 Lys 8.052 3.935 1.960,1.896 1.653 1.492 2.973
9 Asp 7.933 4.545 2.897,2.702
10 Gyl 7.49 4.155,3.467
11 Gly 8.422 3.111,0.800
12 Pro 4.612 2.530,2.066 2.650
3.815,
3.440
13 Ser 7.954 4.611 3.171,2.936
14 Ser 8.198 4.146 3.869,3.491
15 Gly 7.911 4.281,3.805
16 Arg 8.121 5.046 1.895,1.829
1.829,
1.666
3.312,
3.235 exch.
17 Pro 4.759 2.346,1.801 2.008 3.871
18 Pro 2.524 1.332,0.309
1.787,
1.691 3.531
19 Pro 4.436 2.063 1.865 3.137,2.905
20 Cys 8.005 4.247 1.808,1.683
21 Gly 7.976 3.747,3.667
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1.2.3. Tc10b-A2K-S20C(S-tBu)-21G
Figure V.1.17.: MALDI-ToF spectrum of the crude Tc10b-A2K-S20C(S-tBu)-21G (left) and
purified (right). m/z : [M +H]+ calcd for [Tc10b− A2K −K8A− S20C −
21G+H]+ 2305.6, found 2306.3.
Figure V.1.18.: HPLC-chromatogram of the crude Tc10b-A2K-S20C(S-tBu)-21G (left) and pu-
rified (right). Isolated yield 8mg (3.5µmol, 4.0%).
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Table V.1.12.: 1H-chemical shifts of Tc10b-A2K-S20C-21G at 298 K and pH 3.
Residue chemical shift δ (ppm)
1 Asp exch. 4.336 3.128,2.991
2 Lys 8.888 4.219 1.786 1.412 1.663 2.975 7.537
3 Tyr 8.448 4.241 3.120,3.059 6.811 7.080
4 Ala 8.213 4.100 1.453
5 Gln 7.953 4.033 2.102 2.379
6 Trp 8.008 4.371 3.478,3.205 7.135
9.823,
7.328
7.327,
7.123 7.227
7 Leu 8.205 3.658 1.470 1.690 0.897,0.846
8 Lys 7.989 4.069 1.858 1.450 1.657 2.967
9 Asp 7.950 4.686 3.003,2.865
10 Gyl 7.786 4.077,3.664
11 Gyl 8.088 3.272,2.205
12 Pro 4.503 2.413,2.004 2.054
3.661,
3.313
13 Ser 7.999 4.447 3.910
14 Ser 8.159 4.312 3.92,3.729
15 Gly 8.091 4.140,3.885
16 Arg 8.038 4.823 1.887,1.772 1.682 3.229 7.307
17 Pro 4.650 2.271,1.822 1.998
3.833,
3.616
18 Pro 2.910 1.591,1.203 1.660 4.208
19 Pro 4.427 2.133,1.986 1.909
3.318,
3.144
20 Cys 8.079 4.627 3.162,3.002
1.247
(S-
tBu)
21 Gly 8.252 3.908
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Table V.1.13.: 1H-chemical shifts of Tc10b-A2K-S20C-21G at 298 K and pH 7.
Residue chemical shift δ (ppm)
1 Asp exch. n.d.
2 Lys 8.296 3.9561 1.917,1.501 1.657 2.962 exch.
3 Tyr 8.704 4.173 3.222,3.104 7.123 6.822
4 Ala 8.358 4.08 1.522
5 Gln 8.011 3.931 2.213,2.209 2.420
7.792,
6.906
6 Trp 7.958 4.283 3.541,3.179 7.038
9.720,
7.220
7.487,
7.148 7.636
7 Leu 8.296 3.453 1.842,1.875 1.585
0.940,
0.849
8 Lys 8.042 3.958 1.938,1.886 1.658 1.439 2.969
9 Asp 7.929 4.544 2.878,2.699
10 Gyl 7.535 4.144,2.504
11 Gyl 8.357 3.135,1.058
12 Pro 4.588 2.510,2.054 2.147
3.738,
3.400
13 Ser 7.982 4.639 3.177,2.937
14 Ser 8.183 4.184 3.877,3.542
15 Gly 8.007 3.763,3.687
16 Arg 8.100 4.988 1.863,1.773 1.67
3.31,
3.228 exch
17 Pro 4.745 2.336,1.817 2.004
3.787,
3.673
18 Pro 2.675 1.389,0.550
1.832,
1.728 3.545
19 Pro 4.447 2.288,2.023 1.865
3.116,
2.917
20 Cys 8.181 4.18 3.689,3.544
1.244
(S-
tBu)
21 Gly 7.970 3.755
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1.2.4. Tc10b-A2C(S-tBu)-S20K
Figure V.1.19.: Total ion chromatogram of crude Tc10b-A2C(S-tBu)-S20K (top) and purified
(bottom). m/z : [M+2H]2+ calcd for [Tc10b−A2C−K8A−S20K+2H]2+
1096.2, found 1095.5. Isolated yield 9mg (3.9µmol, 4.5%).
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Table V.1.14.: 1H-chemical shifts of Tc10b-A2C(S-tBu)-S20K at 298 K and pH 3.
Residue chemical shift δ (ppm)
1 D exch. 4.347 3.054,2.937
2 C 8.879 4.632 3.163,3.115
1.320
(S-
tBu)
3 Y 8.619 4.191 3.106,3.061 7.089 6.812
4 A 8.320 4.095 1.473
5 Q 7.904 4.084 2.156 2.393
6 W 8.081 4.3347 3.452 7.116 9.841,7.313
7.219,
7.224 7.123
7 L 8.290 3.604 1.660 1.473 0.895,0.853
8 A 7.975 4.120 1.442
9 D 7.846 4.703 3.015,2.861
10 G 7.763 4.085,3.650
11 G 8.075 3.205,2.119
12 P 4.488 2.408,1.9955 2.4044
3.649,
3.275
13 S 7.975 4.437 3.899
14 S 8.14 4.294 3.911,3.728
15 G 8.074 4.136,3.874
16 R 8.04 4.819 1.869,1.783 1.679 3.223 7.391
17 P 4.658 2.278,1.808 2.001
3.8325,
3.617
18 P 3.413 1.514,1.187
1.753,
1.846
3.519,
3.579
19 P 4.348 2.205 1.856 3.353,3.134
20 K 8.239 4.176 1.774,1.710 1.405 1.642 2.953 7.506
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Table V.1.15.: 15N and 13C-chemical shifts of Tc10b-A2C(S-tBu)-S20K at 298 K and pH 3.
Residue chemical shift δ (ppm)
15N 13C
NH other α β γ δ  ζ η
1 D n.d. n.d.
2 C 118.59 n.d. 42.71
3 Y 124.15 n.d. n.d. 133.12 118.35
4 A 121.63 54.23 18.43
5 Q 118.73 112.64 57.85 28.83 34.23
6 W 121.87 130.66 62.59 28.17 127.32 114.43 122.34 124.23,120.91
7 L 120.52 57.32 42.26 24.73 25.13,23.58
8 A 122.92 53.78 17.98
9 D 116.39 n.d. 38.34
10 G 107.22 44.82
11 G 109.94 44.26
12 P n.d. n.d. 31.83 27.30 50.38
13 S 114.04 59.13 63.49
14 S 117.06 59.50 64.40
15 G 110.88 45.42
16 R 120.55 114.98 n.d. 26.90 n.d.
17 P n.d. n.d. 30.48 27.30 50.45
18 P n.d. n.d. 30.15
19 P n.d. 52.93 n.d. n.d. 50.23
20 K 121.60 56.19 33.14 24.87 n.d. 39.32
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1.2.5. Tc10b-S20K
Figure V.1.20.: Total ion chromatogram of crude Tc10b-S20K (top) and purified (bottom).
m/z : [M + 2H]2+ calcd for [Tc10b − S20K + 2H]2+ 1064.7, found 1065.5.
Isolated yield 4mg (1.9µmol, 2.0%).
1.2. Tc10b and its Variants 185
Table V.1.16.: 1H-chemical shifts of Tc10b-20K at 298 K and pH 3.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1 Asp exch. 4.328 3.251,3.050
2 Ala 9.070 4.253 1.500
3 Tyr 8.838 4.039 3.108 7.098 6.813
4 Ala 8.268 4.115 1.582
5 Gln 8.029 3.971 2.206,2.142 2.435
6 Trp 8.153 4.229 3.562,3.141 7.057
9.684,
7.114
7.121,
7.235 7.228
7 Leu 8.411 3.396 1.815,1.421 1.577
0.964,
0.878
8 Lys 8.033 4.012 1.941,1.882 1.488 1.669 2.976
9 Asp 7.847 4.647 3.059,2.872
10 Gly 7.593 4.155,3.514
11 Gly 8.216 2.998,1.156
12 Pro 4.570 2.496,2.042 4.573
3.738,
3.303
13 Ser 7.826 4.453 3.924
14 Ser 8.191 4.228 3.909,3.619
15 Gly 8.017 4.252,3.848
16 Arg 8.109 4.920 1.891,1.845
1.740,
1.682 3.275 7.512
17 Pro 4.670 2.259,1.781 2.004
3.873,
3.666
18 Pro 2.661 1.334,0.486
1.708
1.748 3.502
19 Pro 4.338 2.204,1.913 1.820
3.194,
2.950
20 Lys 8.269 4.146 1.811,1.679 1.387 1.655 2.947 7.205
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1.2.6. TcKKA
Figure V.1.21.: Total ion chromatogram of crude TcKKA (top) and purified (bottom). m/z :
[M + 2H]2+ calcd for [Tc10b−Ac−A2K −K8A− S20K + 2H]2+ 1085.7,
found 1085.8. Isolated yield 11mg (5.1µmol, 5.5%).
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Table V.1.17.: 1H-chemical shifts of TcKKA at 298 K and pH 3.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1 Asp 8.4062 4.6525 2.8836
2 Lys 8.5063 4.1568 1.8234,1,7703 1.4479 1.6741 2.9905 7.5739
3 Tyr 8.5036 4.1962 3.1441,3.0641 7.0864 6.814
4 Ala 8.1768 4.0992 1.4946
5 Gln 8.0786 4.0712 2.1098 2.4371,2.3452
7.4330,
6.8807
6 Trp 7.9501 4.3055 3.4808,3.2028 7.110
9.7563,
7.1685
7.2974,
7.2239 7.1196
7 Leu 8.3419 3.5222 1.7222,1.4507 1.5465
0.9214,
0.8587
8 Ala 8.0356 4.1108 1.4472
9 Asp 7.7653 4.7132 3.0162,2.8491
10 Gly 7.6995 4.1098,3.6065
11 Gly 8.0797 3.1181,1.7940
12 Pro 4.5144 2.4444,2.0160 2.0724
3.6848,
3.2715
13 Ser 7.8952 4.4367 3.907
14 Ser 8.1334 4.2807 3.9167,3.6947
15 Gly 8.0231 4.1833,3.8635
16 Arg 8.0443 4.8384 1.9033,1.7979 1.6902 3.2473
17 Pro 4.6732 2.2747,1.8088 2.0034
3.8490,
3.6430 7.3373
18 Pro 3.1086 1.4530,0.9392
1.8107,
1.0794 3.5211
19 Pro 4.3303 2.1838,1.8908 1.8591
3.2609,
3.0614
20 Lys 7.9882 4.1376 1.7755,1.6829 1.3739 1.6219 2.9412 7.4731
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Table V.1.18.: 15N and 13C-chemical shifts of TcKKA at 298 K and pH 3.
Residue chemical shift δ (ppm)
15N 13C
NH other α β γ δ  ζ η
1 Asp 125.81 n.d. 39.33
2 Lys 121.56 58.38 n.d. n.d. n.d. 42.10
3 Tyr 122.67 61.34 38.04 133.06 118.38
4 Ala 121.91 54.63 18.10
5 Gln 118.68 112.48 58.29 28.54 33.98
6 Trp 121.94 130.99 n.d. n.d. 127.29 120.90 114.39,124.10 122.38
7 Leu 120.56 57.51 42.59 26.36 25.33,23.56
8 Ala 122.99 54.39 18.10
9 Asp 116.40 n.d. 38.52
10 Gly 106.88 44.72
11 Gly 111.27 43.92
12 Pro n.d. n.d. 31.76 n.d. n.d.
13 Ser 113.73 n.d. 63.14
14 Ser 117.04 59.39 65.12
15 Gly 109.86 45.21
16 Arg 120.38 114.95 n.d. n.d. n.d. 50.43
17 Pro n.d. n.d. 30.85 n.d. n.d.
18 Pro n.d. n.d. 29.74 n.d. n.d.
19 Pro n.d. 62.32 31.59 n.d. n.d.
20 Lys 124.58 57.19 n.d. n.d. n.d. 42.10
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Table V.1.19.: 1H-chemical shifts of TcKKA at 278 K and pH 3.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1 Asp 8.571 4.659 2.930,2.929
2 Lys 8.665 4.153 1.883,1.809
1.586,
1.482 1.697 3.009 7.674
3 Tyr 8.767 4.113 3.114,3.101 7.099 6.816
4 Ala 8.304 4.106 1.548
5 Gln 8.166 4.060 2.144 2.481,2.370
7.371,
7.018
6 Trp 7.993 4.241 3.531,3.169 7.075
9.693,
7.243
7.236,
7.040 7.127
7 Leu 8.510 3.394 1.777,1.443 1.583
0.961,
0.887
8 Ala 8.114 4.107 1.468
9 Asp 7.722 4.709 3.040,2.876
10 Gly 7.649 4.150,3.530
11 Gly 8.151 2.965,1.252
12 Pro 4.558 2.486,2.052
2.111,
2.116 3.272
13 Ser 7.845 4.448 3.918
14 Ser 8.181 4.239 3.913,3.644
15 Gly 8.032 4.241,3.848
16 Arg 8.120 4.909 1.901,1.842
1.728,
1.686
3.296,
3.247 7.497
17 Pro 4.693 2.274,1.793 2.005
3.881,
3.664
18 Pro 2.698 1.351,0.557
1.745,
1.662
3.521,
3.507
19 Pro 4.318 2.199,1.890 1.831
3.188,
2.958
20 Lys 8.167 4.117 1.781,1.655 1.374 1.621 2.931 7.557
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Table V.1.20.: 15N and 13C-chemical shifts of TcKKA at 278 K and pH 3.
Residue chemical shift δ (ppm)
15N 13C
1 Asp 125.68 n.d. 39.01
2 Lys 121.01 58.85 30.64 26.07 41.86
3 Tyr 123.29 62.26 37.88 118.14 133.02
4 Ala 121.06 n.d. 17.75
5 Gln 118.44 112.79 58.25 n.d. 33.82
6 Trp 121.85 130.91 59.92 42.99 127.32 123.83,113.80 122.71 120.69
7 Leu 119.70 57.41 42.05 23.40,25.32
8 Ala 122.52 54.35 17.59
9 Asp 116.01 n.d. n.d.
10 Gly 106.11 n.d.
11 Gly 111.74 n.d.
12 Pro n.d. 31.75 n.d. 27.36 50.54
13 Ser 112.91 n.d. 62.80
14 Ser 116.76 n.d. n.d.
15 Gly 109.48 n.d.
16 Arg 119.69 114.28 n.d. n.d. 28.92 43.18
17 Pro n.d. n.d. 30.69 26.90 50.04
18 Pro n.d. n.d. 29.25 26.53 n.d.
19 Pro n.d. 62.19 31.56 26.87 49.74
20 Lys 124.41 56.53 n.d. 21.50 28.95 41.87
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Table V.1.21.: Chemical shifts, CSD and fraction unfolded for TcKKA at pH 3 from 274.2K to
338K. Shifts marked in bold couldn’t be defined due to broadening or overlap
with H2O.
Temperature / K Proton δ (ppm) ∆δ ppm Proton δ (ppm) ∆δ (ppm)
274.2
K2α 4.162 -0.158 L7α 3.367 -0.973
Y3α 4.096 -0.454 G11α′ 0.983 -3.147
A4α 4.113 -0.207 P18α 2.528 -2.202
Q5α 4.039 -0.311 P18β′ 0.398 -1.512
W6α 4.236 -0.425 P19δ 2.932 -0.668
L7α 3.367 -0.973 P19δ′ 3.154 -0.446
A8α 4.089 -0.232
Σ -2.760 Σ -8.947
χU 0.078 χU 0.070
278
K2α 4.153 -0.167 L7α 3.377 -0.963
Y3α 4.101 -0.449 G11α′ 1.030 -3.101
A4α 4.110 -0.211 P18α 2.556 -2.175
Q5α 4.048 -0.302 P18β′ 0.433 -1.477
W6α 4.249 -0.411 P19δ 2.935 -0.665
L7α 3.377 -0.963 P19δ′ 3.140 -0.460
A8α 4.083 -0.237
Σ -2.739 Σ -8.840
χU 0.085 χU 0.081
283
K2α 4.153 -0.167 L7α 3.385 -0.955
Y3α 4.113 -0.437 G11α′ 1.105 -3.025
A4α 4.113 -0.207 P18α 2.639 -2.091
Q5α 4.040 -0.310 P18β′ 0.494 -1.417
W6α 4.247 -0.413 P19δ 3.175 -0.425
L7α 3.385 -0.955 P19δ′ 2.948 -0.652
A8α 4.080 -0.240
Σ -2.729 Σ -8.564
χU 0.088 χU 0.110
288
K2α 4.154 -0.166 L7α 3.412 -0.928
Y3α 4.138 -0.412 G11α′ 1.195 -2.935
A4α 4.105 -0.215 P18α 2.698 -2.032
Q5α 4.039 -0.311 P18β′ 0.562 -1.349
W6α 4.253 -0.407 P19δ 2.959 -0.642
L7α 3.412 -0.928 P19δ′ 3.157 -0.443
A8α 4.080 -0.240
Σ -2.679 Σ -8.327
χU 0.105 χU 0.135
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Table V.1.22.: Chemical shifts, CSD and fraction unfolded for TcKKA at pH 3 from 274.2K to
338K. Shifts marked in bold couldn’t be defined due to broadening or overlap
with H2O.
Temperature / K Proton δ (ppm) ∆δ ppm Proton δ (ppm) ∆δ (ppm)
293
K2α 4.161 -0.159 L7α 3.439 -0.901
Y3α 4.153 -0.397 G11α′ 1.351 -2.779
A4α 4.099 -0.221 P18α 2.796 -1.935
Q5α 4.045 -0.305 P18β′ 0.666 -1.244
W6α 4.270 -0.390 P19δ 2.980 -0.620
L7α 3.439 -0.901 P19δ′ 3.171 -0.429
A8α 4.084 -0.237
Σ -2.609 Σ -7.908
χU 0.129 χU 0.178
298
K2α 4.159 -0.161 L7α 3.473 -0.868
Y3α 4.168 -0.382 G11α′ 1.489 -2.641
A4α 4.104 -0.217 P18α 2.903 -1.827
Q5α 4.054 -0.296 P18β′ 0.757 -1.153
W6α 4.292 -0.368 P19δ 3.003 -0.597
L7α 3.473 -0.868 P19δ′ 3.193 -0.407
A8α 4.084 -0.236
Σ -2.527 Σ -7.492
χU 0.156 χU 0.221
300
K2α 4.166 -0.154 L7α 3.512 -0.828
Y3α 4.178 -0.372 G11α′ 1.714 -2.416
A4α 4.100 -0.220 P18α 3.050 -1.680
Q5α 4.057 -0.293 P18β′ 0.892 -1.018
W6α 4.299 -0.361 P19δ 3.047 -0.553
L7α 3.512 -0.828 P19δ′ 3.244 -0.356
A8α 4.106 -0.214
Σ -2.441 Σ -6.851
χU 0.185 χU 0.288
303
K2α 4.150 -0.170 L7α 3.513 -0.827
Y3α 4.192 -0.358 G11α′ 1.657 -2.473
A4α 4.103 -0.217 P18α 3.030 -1.700
Q5α 4.052 -0.298 P18β′ 0.875 -1.035
W6α 4.309 -0.351 P19δ 3.040 -0.560
L7α 3.513 -0.827 P19δ′ 3.223 -0.377
A8α 4.097 -0.223
Σ -2.444 Σ -6.973
χU 0.184 χU 0.275
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Table V.1.23.: Chemical shifts, CSD and fraction unfolded for TcKKA at pH 3 from 274.2K to
338K. Shifts marked in bold couldn’t be defined due to broadening or overlap
with H2O.
Temperature / K Proton δ (ppm) ∆δ ppm Proton δ (ppm) ∆δ (ppm)
308
K2α 4.156 -0.164 L7α 3.594 -0.746
Y3α 4.234 -0.316 G11α′ 2.047 -2.083
A4α 4.094 -0.226 P18α 3.297 -1.433
Q5α 4.063 -0.287 P18β′ 1.123 -0.787
W6α 4.336 -0.324 P19δ 3.119 -0.481
L7α 3.594 -0.746 P19δ′ 3.297 -0.303
A8α 4.116 -0.204
Σ -2.267 Σ -5.834
χU 0.243 χU 0.394
313
K2α 4.155 -0.165 L7α 3.622 -0.718
Y3α 4.258 -0.293 G11α′ 2.074 -2.056
A4α 4.097 -0.223 P18α 3.325 -1.405
Q5α 4.078 -0.272 P18β′ 1.142 -0.768
W6α 4.360 -0.300 P19δ 3.128 -0.472
L7α 3.622 -0.718 P19δ′ 3.298 -0.302
A8α 4.122 -0.198
Σ -2.169 Σ -5.721
χU 0.276 χU 0.405
318
K2α 4.153 -0.167 L7α 3.723 -0.618
Y3α 4.310 -0.240 G11α′ 2.515 -1.615
A4α 4.087 -0.234 P18α 3.237 -1.493
Q5α 4.087 -0.264 P18β′ 1.422 -0.488
W6α 4.417 -0.243 P19δ 3.237 -0.363
L7α 3.723 -0.618 P19δ′ 3.393 -0.207
A8α 4.120 -0.200
Σ -1.965 Σ -4.784
χU 0.344 χU 0.503
323
K2α 4.154 -0.166 L7α 3.754 -0.586
Y3α 4.320 -0.230 G11α′ 2.560 -1.570
A4α 4.106 -0.214 P18α 3.762 -0.968
Q5α 4.099 -0.251 P18β′ 1.506 -0.404
W6α 4.430 -0.230 P19δ 3.235 -0.365
L7α 3.754 -0.586 P19δ′ 3.405 -0.195
A8α 4.127 -0.193
Σ -1.870 Σ -4.087
χU 0.376 χU 0.575
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Table V.1.24.: Chemical shifts, CSD and fraction unfolded for TcKKA at pH 3 from 274.2K to
338K. Shifts marked in bold couldn’t be defined due to broadening or overlap
with H2O.
Temperature / K Proton δ (ppm) ∆δ ppm Proton δ (ppm) ∆δ (ppm)
328
K2α 4.154 -0.166 L7α 3.826 -0.514
Y3α 4.354 -0.196 G11α′ 2.809 -1.321
A4α 4.115 -0.205 P18α 3.828 -0.902
Q5α 4.113 -0.237 P18β′ 1.607 -0.303
W6α 4.637 -0.023 P19δ 3.301 -0.299
L7α 3.826 -0.514 P19δ′ 3.452 -0.148
A8α 4.144 -0.176
Σ -1.516 Σ -3.488
χU 0.494 χU 0.638
338
K2α 4.157 -0.163 L7α 3.985 -0.356
Y3α 4.550 0.000 G11α′ 3.328 -0.802
A4α 4.123 -0.197 P18α 4.730 0.000
Q5α 4.147 -0.203 P18β′ 1.910 0.000
W6α 4.648 -0.013 P19δ 3.339 -0.261
L7α 3.985 -0.356 P19δ′ 3.727 0.127
A8α 4.170 -0.150
Σ -1.082 Σ -1.291
χU 0.560 χU 0.768
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Table V.1.25.: 1H-chemical shifts of TcKKA at 274 K and pH 7.9.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1 Asp 8.500 4.589 2.781
2 Lys 8.126 4.083 1.787 1.419 1.690 2.996 exch.
3 Tyr exch. 4.087 3.201,3.102 7.109 6.822
4 Ala 8.445 4.119 1.559
5 Gln 8.171 4.983 2.402 2.2041,2.1126
6 Trp 7.970 4.244 3.524,3.1543 6.998
9.740,
7.225
7.196,
7.182 7.139
7 Leu 8.474 3.378 1.871,1.375 1.627
0.993,
0.877
8 Ala 8.218 4.016 1.480
9 Asp 7.877 4.553 2.916,2.724
10 Gly 7.582 4.177,3.454
11 Gly 8.453 3.119,0.674
12 Pro 4.644 2.533,2.076 2.169
3.847,
3.476
13 Ser exch. 4.482 3.938
14 Ser 8.261 4.137 3.838,3.488
15 Gly 8.003 4.288,3.800
16 Arg 8.189 5.091 1.921,1.811 1.662
3.24,
3.205 exch.
17 Pro 4.775 2.354,1.792 2.010
3.879,
3.688
18 Pro 2.420 1.282,0.248
1.738,
1.663 3.534
19 Pro 4.310 2.168,1.937
1.855,
1.780
3.147,
2.925
20 Lys 8.033 4.056 1.742 1.335 1.626 2.916 exch.
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Table V.1.26.: 15N and 13C-chemical shifts of TcKKA at 274 K and pH 7.9.
Residue chemical shift δ (ppm)
15N 13C
NH other α β γ δ  ζ η
1 Asp 127.23 54.70 41.10 n.d. n.d. n.d.
2 Lys 126.70 57.65 n.d. 18.31
3 Tyr n.d. 62.68 n.d. 118.12 132.89
4 Ala 121.78 55.38 17.82
5 Gln 119.20 58.02 33.53 31.50
6 Trp 122.01 131.74 62.15 27.83 127.46 124.01 122.33 114.21
7 Leu 119.02 57.68 n.d. n.d. 25.78,23.00
8 Ala 124.56 54.94 17.42
9 Asp 117.82 54.58 41.96
10 Gly 105.98 43.94
11 Gly 114.45 42.91
12 Pro n.d. 65.11 32.02 n.d. 50.97
13 Ser 115.80 59.34 63.24
14 Ser 117.59 60.27 65.22
15 Gly 109.79 45.60
16 Arg 119.40 n.d. n.d. n.d. n.d.
17 Pro n.d. n.d. 30.60 n.d. 50.50
18 Pro n.d. 60.03 28.95 n.d. 49.57
19 Pro n.d. 62.29 31.72 n.d. 49.77
20 Lys 126.50 57.63 33.61 19.04 n.d. n.d.
Figure V.1.22.: RMSD of the Cα atoms during the MD simulation of TcKKA. The simulation
was performed with a total duration of 20,000 ps and every 200 ps a structure
was saved and the RMSD with respect to the first model determined.
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1.2.7. TcKKA-Lomant
Figure V.1.23.: Total ion chromatogram of crude TcKKA linked with Lohmannt’s reagent.
m/z : [M+2H]2+ calcd for [TcKKA−Lomant+2H]2+ 1172.8, found 1172.0.
Isolated yield 0.5mg (0.2µmol, 23.1%).
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Table V.1.27.: 1H-chemical shifts of TcKKA-Lomant at 298 K and pH 3.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1 Asp 8.351 4.669 2.872
2 Lys 8.481 4.102 1.828 1.405 1.570,1.537 3.217 8.147
3 Tyr 8.578 4.141 3.182,3.067 7.085 6.832
4 Ala 8.224 4.090 1.567
5 Gln 8.158 4.034 2.153 2.451,2.386
7.480,
6.893
6 Trp 7.953 4.235 3.531,3.186 7.049
9.664,
7.131
7.218,
7.119 7.061
7 Leu 8.463 3.379 1.806,1.410 1.610
0.938,
0.862
8 Ala 8.113 4.076 1.472
9 Asp 7.682 4.673 3.002,2.812
10 Gly 7.565 4.143,3.502
11 Gly 8.201 2.977,1.067
12 Pro 4.721 2.297,1.801 1.991
3.860,
3.650
13 Ser 7.720 4.453 3.923
14 Ser 8.134 4.202 3.895,3.591
15 Gly 7.933 4.250,3.826
16 Arg 8.074 4.929 1.891 3.267 1.751,1.671 3.275 7.499
17 Pro 4.567 2.505,2.049 2.125
3.752,
3.300
18 Pro 2.679 1.387,0.629 1.775 3.513
19 Pro 4.348 2.156,1.905 1.782
3.049,
2.871
20 Lys 7.591 4.115 1.752,1.670 1.292 1.483 3.176 8.061
Lohmant linker 2.758 2.950
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Figure V.1.24.: RMSD of the Cα atoms during the MD simulation of TcKKA-Lomant. The
simulation was performed with a total duration of 20,000 ps and every 200 ps a
structure was saved and the RMSD with respect to the first model determined.
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1.2.8. TcKKA-Azobenzene
Figure V.1.25.: Total ion chromatogram of crude TcKKA linked with azobenzene (top) and
purified (bottom). m/z : [M + 2H]2+ calcd for [TcKKA − azo + 2H]2+
1202.8, found 1203.2. Isolated yield 1mg (0.4µmol, 45.1%).
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Table V.1.28.: 1H-chemical shifts of TcKKA-Azo in trans at 298 K and pH 3.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1 Asp 8.239 4.576 2.726
2 Lys 8.419 4.123 1.895,1.756 1.359
1.672,
1.401
3.525,
3.421 8.655
3 Tyr 8.198 4.172 3.003,2.890 6.823 6.633
4 Ala 7.987 3.926 1.411
5 Gln 8.113 4.023 2.063 2.353,2.287 n.d.
6 Trp 8.054 4.374 3.351,3.200 7.210
10.118,
7.245
7.254,
6.969 7.031
7 Leu 8.089 3.706 1.571 1.366 0.758,0.725
8 Ala 7.796 4.083 1.389
9 Asp 7.989 4.554 2.669
10 Gly 7.913 3.860,3.759
11 Gly 7.997 3.623,3.359
12 Pro 4.409 2.262,1.987 1.987
3.519,
3.394
13 Ser 8.379 4.446 3.910,3.871
14 Ser 8.123 4.371 3.904,3.854
15 Gly 8.296 3.970,3.863
16 Arg 7.908 4.494 1.673 1.578,1.834 2.948 7.000
17 Pro 4.600 2.217,1.759 1.885
3.689,
3.427
18 Pro 4.639 2.294,1.910 1.999
3.726,
3.545
19 Pro 4.386 2.125,1.870 1.806
3.638,
3.478
20 Lys 7.754 4.199 1.893,1.727 1.386
1.730,
1.622 3.449 8.321
Azobenzene
7.992
(02,
2,2’)
7.869
(02,
3,3’)
7.367
(20,
6,6’)
7.652
(20,
7,7’)
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Table V.1.29.: 1H-chemical shifts of TcKKA-Azo in cis at 298 K and pH 3.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1 Asp 8.281 4.605 2.776
2 Lys 8.535 4.116 1.847 1.470,1.400
1.656,
1.609 3.382 8.506
3 Tyr 8.523 4.055 3.121,2.984 6.945 6.752
4 Ala 8.256 4.071 1.559
5 Gln 8.180 4.006 2.169 2.422
6 Trp 7.986 4.283 3.528,3.226 7.112
9.789,
7.217
7.225,
7.073 7.123
7 Leu 8.395 3.394 1.816,1.392 1.595
0.927,
0.922
8 Ala 8.141 4.187 1.479
9 Asp 7.800 4.591 2.866,2.703
10 Gly 7.557 4.140,3.484
11 Gly 8.302 3.054,1.051
12 Pro 4.712 1.956,1.693 1.879
3.867,
3.609
13 Ser 7.724 4.464 3.921
14 Ser 8.139 4.040 3.879,3.565
15 Gly 7.951 4.239,3.817
16 Arg 8.085 4.979 1.874 1.762,1.666 3.198 7.254
17 Pro 4.578 2.142 2.053 3.779.3.360
18 Pro 2.855 1.300,0.507
1.625,
1.519 3.449
19 Pro 4.112 1.976 n.d. 3.126,2.904
20 Lys 7.667 4.064 1.695,1.608 1.264 1.537
3.382,
3.259 8.279
Azobenzene
7.584
(02,
2,2’)
6.822
(02,
3,3’)
6.929
(20,
6,6’)
7.638
(20,
7,7’)
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Figure V.1.26.: RMSD of the Cα atoms during the MD simulation of TcKKA-azo in cis config-
uration of theM (top) enantiomer and P enantiomer (bottom). The simulation
was performed with a total duration of 20,000 ps and every 200 ps a structure
was saved and the RMSD with respect to the first model determined.
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1.3. AFP-Tc Chimera Proteins
1.3.1. 15er Reference Peptide
Figure V.1.27.: Total ion chromatogram of crude 15er reference peptide (top) and purified
(bottom). m/z : [M + 1H]+ calcd for [15er + 1H]1+ 1334.4, found 1334.6.
Isolated yield 13mg (9.7µmol, 6.5%).
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Figure V.1.28.: CD spectrum of 15er reference peptide at 274 K and pH 3.
Figure V.1.29.: 1H-NMR spectra of 15er at 274 K and pH 3 (left) or pH 7.9 (0.1M NH4HCO3
buffer) (right).
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Table V.1.30.: 1H chemical shifts of 15er reference peptide at 274 K and pH 3.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1 Asp exch. 4.387 3.120,3.051
2 Thr 8.764 4.227 4.227 1.264
3 Ala 8.619 4.294 1.437
4 Ser 8.638 4.355 3.983,3.880
5 Asp 8.473 4.643 2.931
6 Ala 8.337 4.244 1.456
7 Ala 8.297 4.238 1.449
8 Ala 8.176 4.233 1.469
9 Ala 8.126 4.223 1.443
10 Ala 8.159 4.245 1.448
11 Ala 8.039 4.244 1.448
12 Leu 7.954 4.326 1.659 1.745 0.955,0.901
13 Thr 8.051 4.228 4.228 1.231
14 Ala 8.231 4.273 1.427
15 Asp 8.335 4.663 2.918
Table V.1.31.: 15N and 13C-chemical shifts of 15er at 274 K and pH 3.
Residue chemical shift δ (ppm)
1 Asp n.d. 52.57 38.95
2 Thr 115.79 63.43 n.d. 21.74
3 Ala 126.07 53.78 18.37
4 Ser 116.30 59.86
5 Asp 123.16 52.58
6 Ala 124.65 53.78 18.37
7 Ala 122.69 53.78 18.37
8 Ala 122.83 53.78 18.37
9 Ala 122.22 53.78 18.37
10 Ala 122.01 53.78 18.37
11 Ala 121.98 53.78 18.37
12 Leu 119.78 56.42 n.d. 24.87,23.24
13 Thr 114.54 63.48 n.d. 21.56
14 Ala 125.33 53.78 18.37
15 Asp 118.33 52.69 38.11
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Table V.1.32.: 1H-chemical shifts of 15er reference peptide at 274 K and pH 7.9.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1 Asp 5.706 4.37 2.629
2 Thr 8.159 4.281 1.263
3 Ala 8.447 4.277 1.458
4 Ser 8.784 4.325 4.010,3.916
5 Asp 8.496 4.515 2.820,2.684
6 Ala 8.262 4.257 1.491
7 Ala 8.192 4.231 1.479
8 Ala 8.128 4.226 1.502
9 Ala 8.016 4.218 1.474
10 Ala 8.049 4.219 1.458
11 Ala 7.891 4.265 1.469
12 Leu 7.839 4.338 1.795 1.649 0.947,0.913
13 Thr 7.992 4.307 4.307 1.237
14 Ala 8254 4.279 1.436
15 Asp 8.332 4.541 2.648
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Table V.1.33.: 15N and 13C-chemical shifts of 15er at 274 K and pH 7.9.
Residue chemical shift δ (ppm)
1 Asp n.d. 56.55 41.18 21.91
2 Thr n.d. 65.06 69.21
3 Ala 125.06 53.20 18.29
4 Ser 117.53 60.91 62.24
5 Asp 125.12 56.49 39.87
6 Ala 124.39 53.26 18.29
7 Ala 122.51 54.35 18.29
8 Ala 122.36 54.35 18.29
9 Ala 121.49 53.89 18.29
10 Ala 121.49 53.89 18.29
11 Ala 121.22 53.20 18.29
12 Leu 119.43 55.99 42.16 26.87 24.93,23.27
13 Thr 113.75 62.29 69.80 21.62
14 Ala 125.88 54.59 18.29
15 Asp 119.84 54.43 41.25
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1.3.2. 15erYW Reference Peptide
Figure V.1.30.: Total ion chromatogram of crude 15er reference peptide (top) and purified
(bottom). m/z : [M +H]+ calcd for [15erY W +1H]1+ 1499.5, found 1499.8.
Isolated yield 9mg (6.0µmol, 4.5%).
210 1. Spectra and NMR Shifts of the Trp-cage Variants
Figure V.1.31.: CD spectrum of 15erYW reference peptide at 274 K and pH 3.
Figure V.1.32.: 1H-NMR spectra of 15erYW at 274 K and pH 3 (left) or pH 7.9 (0.1M
NH4HCO3 buffer) (right).
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Table V.1.34.: 1H-chemical shifts of 15erYW reference peptide at 274 K and pH 3.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1 Asp exch. 4.404 3.011
2 Thr 8.762 4.287 4.219 1.255
3 Ala 8.618 4.289 1.426
4 Ser 8.535 4.369 3.936,3.853
5 Asp 8.451 4.695 2.922
6 Ala 8.288 4.236 1.426
7 Ala 8.302 4.227 1.394
8 Ala 8.155 4.2133 1.364
9 Tyr 8.116 4.415 3.011 7.079 6.798
10 Ala 8.143 4.175 1.3244
11 Ala 8.133 4.207 1.397
12 Trp 8.186 4.523 3.288 7.249 10.183,7.467
7.232,
7.113 7.483
13 Thr 7.796 3.978 3.978 1.018
14 Ala 8.045 4.042 1.369
15 Asp 8.256 4.609 2.890,2.800
Table V.1.35.: 15N and 13C-chemical shifts of 15erYW at 274 K and pH 3.
Residue chemical shift δ (ppm)
15N 13C
1 Asp n.d. 52.46 38.30
2 Thr 115.85 63.07 69.47 21.74
3 Ala 126.64 53.37 18.62
4 Ser 115.68 59.11 63.16
5 Asp 122.15 53.62 38.08
6 Ala 124.32 53.31 18.62
7 Ala 122.62 53.31 18.62
8 Ala 125.17 53.31 18.62
9 Tyr 119.63 58.80 38.55 118.12 133.10
10 Ala 122.68 53.01 18.82
11 Ala 122.68 53.31 18.62
12 Trp 120.45 129.71 58.62 29.03 127.14 114.48 124.58,121.93 120.77
13 Thr 116.26 62.10 69.79 21.20
14 Ala 125.35 53.13 18.62
15 Asp 118.08 52.83 38.11
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Table V.1.36.: 1H-chemical shifts of 15erYW reference peptide at 274 K and pH 7.9.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1 Asp 5.695 4.356 2.640,2.588
2 Thr 8.139 4.289 4.289 1.241
3 Ala 8.496 4.286 1.449
4 Ser 8.3635 4.331 3.985,3.885
5 Asp 8.422 4.535 2.724
6 Ala 8.319 4.219 1.393
7 Ala 8.611 4.333 1.422
8 Ala 8.088 4.225 1.412
9 Tyr 8.137 4.212 3.046 7.107 6.801
10 Ala 8.111 4.178 1.365
11 Ala 8.046 4.235 1.415
12 Trp 8.224 4.546 8.288 7.266 10.187,7.476
7.231,
7.121 7.489
13 Thr 7.759 4.006 4.006 1.029
14 Ala 8.207 4.237 1.463
15 Asp 8.202 4.484 2.651
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Table V.1.37.: 15N and 13C-chemical shifts of 15erYW at 274 K and pH 7.9.
Residue chemical shift δ (ppm)
1 Asp n.d. 56.53 41.34
2 Thr n.d. 61.91 69.39 21.56
3 Ala n.d. 53.94 18.58
4 Ser n.d. 59.07 62.73
5 Asp n.d. 55.61 40.48
6 Ala n.d. 53.48 18.58
7 Ala n.d. 53.02 18.58
8 Ala n.d. 53.02 18.58
9 Tyr n.d. 58.91 38.42 118.23 133.18
10 Ala n.d. 53.12 18.58
11 Ala n.d. 53.02 18.58
12 Trp n.d. n.d. 58.56 29.13 127.17 114.37 124.65,121.97 120.62
13 Thr n.d. 61.76 70.07 21.33
14 Ala n.d. 53.02 18.58
15 Asp n.d. 54.29 41.17
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1.3.3. AFP-Tc-4
J-
:KEYUSER Timebase:U-3000RS Sequence:2016 Page 1-1
24.11.2016 10:34 AM
Chromeleon (c) Dionex 1996-2006
Version 6.80 SR15 Build 4656 (243203)
EM16-purified
RE4
unknown
Peptide_3D_bas ic_short
peptide_izkf
24.11.201610t16
2A,A
uv_vr§_{
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:4
1;0000.
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1
2
3
4
5
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0,7
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0,9
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0,07
0,10
99,69
0,12
0,08
0,09
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139,49
n.a. BMB
BMB
BM
MB
BMB
n.a. n.a.
n.a. n.a.
n.a. n.a.
n.a. n.a.
Total: 1568,295 100,000 139,93 0,000
IZKFllntegration
Figure V.1.33.: HPLC chromatogram of purified AFP-Tc-4, synthesized by S. Rothemund.
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Figure V.1.34.: m/z : [M +H]+ calcd for [TcAFP4]+ 2447.5, found 2448.4.
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Figure V.1.35.: 1H NMR spectrum of AFP-Tc-4 at 274 K and pH 7.9 with enlargement of the
indole proton region.
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Table V.1.38.: 1H-chemical shifts of TcAFP4b at 274K and pH 3.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1’ Asp exch. 4.052 3.162
2’ Thr 8.749 4.208 4.208 1.069
3’ Ala 8.577 4.266 1.427
4’ Ser 8.630 4.370 3.990,3.893
5’ Asp 8.439 4.682 3.036,2.975
1 Ala 8.486 4.279 1.519
2 Ala 8.600 4.274 1.428
3 Tyr 8.457 4.047 3.154 7.099 6.814
4 Ala 8.366 4.168 1.578
5 Ala 8.087 4.146 1.518
6 Trp 7.893 4.206 3.557,3.156 7.073
9.605,
7.244
7.229,
7.114 6.985
7 Leu 8.484 3.413 1.932,1.482 1.647
1.009,
0.914
8 Thr 8.324 4.016 4.313 1.262
9 Asp 7.782 4.735 3.038,2.927
10 Gly 7.721 4.176,3.519
11 Gly 8.163 2.847,1.337
12 Pro 4.527 2.471,2.001 2.080
3.660,
3.107
13 Ser 7.817 4.455 3.919
14 Ser 8.168 4.234 3.929,3.687
15 Gly 8.041 4.253,3.844
16 Arg 8.162 4.916 1.909,1.859
1.725,
1.681 3.285 7.491
17 Pro 4.713 2.291,1.781 2.006
3.883,
3.677
18 Pro 2.534 1.349,0.370
1.727,
1.634 3.49
19 Pro 4.379 2.235,1.972 1.854
3.156,
2.919
20 Ser 8.315 4.315 3.898,3.805
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Table V.1.39.: 15N and 13C-chemical shifts of AFP-Tc-4 at 274 K and pH 3.
Residue chemical shift δ (ppm)
15N 13C
1’ Asp n.d. n.d. n.d.
2’ Thr 115.67 63.89 69.51 21.90
3’ Ala 125.76 54.30 18.47
4’ Ser 116.44 62.49 n.d.
5’ Asp 123.24 54.53 n.d.
1 Ala 122.27 54.60 17.89
2 Ala 125.75 54.82 18.47
3 Tyr 122.94 62.64 n.d. 118.29 132.98
4 Ala 121.07 54.97 17.94
5 Ala 120.54 54.87 17.89
6 Trp 121.27 131.21 63.63 27.81 127.35 114.16 124.29,123.17 120.79
7 Leu 119.45 57.96 41.88 25.57,23.55
8 Thr 116.29 65.15 69.08 21.90
9 Asp 119.57 n.d. n.d.
10 Gly 106.59 44.45
11 Gly 112.36 44.06
12 Pro n.d. n.d. 31.85 27.23 50.62
13 Ser 112.95 n.d. 63.20
14 Ser 117.20 n.d. 64.79
15 Gly 110.02 44.87
16 Arg 120.36 114.74 n.d. n.d. n.d. 43.48
17 Pro n.d. n.d. 30.54 27.23 50.62
18 Pro n.d. 59.91 29.38 26.88 49.71
19 Pro n.d. 60.06 31.70 27.13 50.02
20 Ser 117.49 n.d. 63.95
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Table V.1.40.: 1H-chemical shifts of TcAFP4b at 298K and pH 3.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1’ Asp exch. 4.100 3.126
2’ Thr 8.630 4.298 4.218 1.239
3’ Ala 8.419 4.292 1.420
4’ Ser 8.378 4.391 3.959,3.882
5’ Asp 8.307 4.724 2.996
1 Ala 8.385 4.249 1.492
2 Ala 8.343 4.260 1.483
3 Tyr 8.250 4.116 3.115 7.073 6.811
4 Ala 8.234 4.127 1.511
5 Ala 8.017 4.149 1.495
6 Trp 7.841 4.252 3.522,3.191 7.094
9.675,
7.278
7.290,
7.221 7.106
7 Leu 8.347 3.518 1.843,1.490 1.589
0.956,
0.883
8 Thr 8.197 4.049 4.289 1.257
9 Asp 7.814 4.733 3.018,2.897
10 Gly 7.717 4.116,3.590
11 Gly 8.085 3.010,1.761
12 Pro 4.492 2.440,1.998 2.058
3.649,
3.198
13 Ser 7.841 4.447 3.917
14 Ser 8.126 4.336 3.896,3.814
15 Gly 8.009 4.198,3.856
16 Arg 8.059 4.854 1.919,1.806 1.701 3.251 7.339
17 Pro 4.672 2.288,1.800 2.005
3.856,
3.644
18 Pro 2.924 1.426,0.742
1.776,
1.676 3.501
19 Pro 4.379 2.224,1.946 1.855
3.216,
2.998
20 Ser 8.118 4.272 3.926,3.709
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Table V.1.41.: 1H-chemical shifts of TcAFP4b at 274K and pH 7.9. Residues marked in italic
belong to the second folded conformation with Pro (19) in cis.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1’ Asp 5.708 4.371 2.657,2.595
2’ Thr exch. 4.120 4.198 1.301
3’ Ala exch. 4.282 1.476
4’ Ser 8.779 4.347 4.055,3.921
5’ Asp 8.518 4.568 2.888,2.769
5’ Asp 8.441 4.603 2.785
1 Ala 8.410 4.173 1.570
2 Ala 8.346 4.331 1.562
3 Tyr 8.565 4.087 3.227 7.141 6.846
4 Ala 8.369 4.197 1.586
5 Ala 8.117 4.181 1.546
6 Trp 7.882 4.237 3.566,3.140 7.007
9.689,
7.219
7.210,
7.135 6.970
7 Leu 8.433 3.426 2.012,1.402 1.683
1.033,
0.877
8 Thr 8.531 3.889 4.323 1.262
9 Asp 7.784 4.578 2.847,2.700
9 Asp 7.764 4.579 2.856,2.698
10 Gly 7.580 4.158,3.456
10 Gly 7.609 4.154,3.475
11 Gly 8.413 3.108,0.821
12 Pro 4.623 2.518,2.070 2.154
3.805,
3.435
13 Ser 8.161 4.228 3.850
14 Ser 8.247 4.156 3.858,3.506
15 Gly 8.044 4.276,3.803
16 Arg 8.219 5.049 1.917 1.815,1.649
3.290,
3.219 7.650
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Table V.1.42.: Continued 1H-chemical shifts of TcAFP4b at 274K and pH 7.9. Residues marked
in italic belong to the second folded conformation with Pro (19) in cis.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
17 Pro 4.760 2.346,1.792 1.984
3.868,
3.685
18 Pro 2.441 1.368,0.284
1.723,
1.663 3.521
19 Pro 4.312 2.222,2.045
1.970,
1.824
3.140,
2.962
20 Ser 7.904 4.151 3.783
Table V.1.43.: 15N and 13C-chemical shifts of AFP-Tc-4 at 274 K and pH 8
Residue chemical shift δ (ppm)
15N 13C
1’ Asp n.d. n.d. n.d.
2’ Thr n.d. 65.26 69.13 21.82
3’ Ala n.d. 54.71 17.68
4’ Ser 117.81 60.75 62.48
5’ Asp 125.15 54.71 n.d.
1 Ala n.d. 55.13 17.68
2 Ala 122.63 55.05 17.68
3 Tyr 123.24 62.62 n.d. 118.27 133.04
4 Ala 120.99 54.88 17.68
5 Ala 120.99 54.80 17.68
6 Trp 121.14 131.63 62.45 27.65 127.58 123.84 114.17,122.74 120.64
7 Leu 119.43 58.02 41.65 25.67,23.12
8 Thr 119.11 66.28 68.64 21.87
9 Asp 121.13 44.24 n.d.
10 Gly 105.90 43.26
11 Gly 114.22 n.d.
12 Pro n.d. n.d. 31.82 27.36 50.86
13 Ser 117.59 n.d. 65.13
14 Ser n.d. n.d. 64.71
15 Gly 109.94 45.33
16 Arg 119.82 n.d. n.d. n.d. n.d. n.d.
17 Pro n.d. n.d. 30.51 27.13 50.56
18 Pro n.d. 60.18 28.81 26.52 49.58
19 Pro n.d. 62.71 31.51 27.05 49.87
20 Ser 120.93 n.d. 64.73
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Table V.1.44.: 1H-chemical shifts of TcAFP4b at 298K and pH 7.9. Shifts marked with an
asterisk are averaged.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1’ Asp 5.604 4.352 2.618
2’ Thr exch. 4.236 4.236 1.266
3’ Ala exch. 4.283* 1.480*
4’ Ser exch. 4.384 3.998,3.908
5’ Asp exch. 4.578 2.782,2.703
1 Ala exch. 4.283* 1.480*
2 Ala exch. 4.283* 1.480*
3 Tyr 8.396 4.149 3.164 7.096 6.831
4 Ala 8.241 4.135 1.518
5 Ala 8.012 4.157 1.502
6 Trp 7.842 4.300 3.517,3.179 7.049
9.744,
7.271
7.253,
7.221 7.118
7 Leu 8.307 3.551 1.883,1.440 1.619
0.967,
0.853
8 Thr 8.317 3.970 4.293 1.237
9 Asp 7.784 4.606 2.795,7.662
10 Gly 7.652 4.106,3.555
11 Gly 8.283 3.229,1.052
12 Pro 4.564 2.461,2.021 2.111
3.751,
3.390
13 Ser exch. 4.468 3.914
14 Ser exch. 4.378 3.983,3.878
15 Gly 7.808 4.164,3.788
16 Arg 8.121 4.992 1.844 1.777,1.650 3.239
17 Pro 4.721 2.320,1.810 1.999
3.846,
3.652
18 Pro 2.917 1.466,0.738
1.787,
1.703 3.538
19 Pro 4.332 2.208,1.999
1.931,
1.849
3.208,
3.060
20 Ser 7.769 4.175 3.794
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Figure V.1.36.: Hα CSD plot of AFP-Tc-4 at pH 3 (top) and pH 7.9 (bottom) at 274 K. Hα
as black squares and Hα’ as black diamonds. The dashed line at y=-0.1 ppm
represents the helical limit. Solid line between residue 5’ and 1 represents the
junction of the N-terminal extension and the solid line between residue 8 and
9 the conjunction of the helix to the C-terminal cage fold.
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Figure V.1.37.: Hα CSD plot of AFP-Tc-4 at pH 3 (top) and pH 7.9 (bottom) at 298 K. Hα as
black squares and Hα’ as black diamonds. Averaged Hα shifts for certain Ala
are represented as non-filled squares. The dashed line at y=-0.1 ppm represents
the helical limit. Solid line between residue 5’ and 1 represents the junction
of the N-terminal extension and the solid line between residue 8 and 9 the
conjunction of the helix to the C-terminal cage fold.
1.3. AFP-Tc Chimera Proteins 225
Table V.1.45.: CSDs for selected protons in the cage structure representing the cage fold of
TcAFP4b at 298 K and 274 K and at pH 3 and 7.9.
Cage ∆δ (ppm). Σ
upfield
L7α G11α’ P18α P18β’ P19δ P19δ’
pH 3, 274 K -0.927 -2.794 -2.197 -1.540 -0.444 -0.681 -8.582
pH 3, 298 K -0.822 -2.369 -1.806 -1.168 -0.384 -0.602 -7.152
pH 7.9, 274 K -0.914 -3.310 -2.289 -1.626 -0.460 -0.638 -9.237
pH 7.9, 298 K -0.789 -3.078 -1.813 -1.172 -0.392 -0.540 -7.784
downfield
P12α P12β R16α
pH 3, 274 K 0.107 0.181 0.266 0.554
pH 3, 298 K 0.072 0.150 0.204 0.426
pH 7.9, 274 K 0.203 0.228 0.398 0.829
pH 7.9, 298 K 0.144 0.171 0.342 0.657
Table V.1.46.: CSDs for selected protons in the helical region representing the helix fold of
TcAFP4b at 298 K and 274 K and at pH 3 and 7.9.
Helix ∆δ (ppm). Σ
A2α Y3α A4α A5α W6α L7α T8α
pH 3, 274 K -0.046 -0.503 -0.152 -0.175 -0.454 -0.927 -0.334 -2.591
pH 3, 298 K -0.060 -0.434 -0.193 -0.171 -0.408 -0.822 -0.302 -2.390
pH 7.9, 274 K 0.011 -0.463 -0.123 -0.139 -0.424 -0.914 -0.461 -2.512
pH 7.9, 298 K -0.037 -0.401 -0.185 -0.163 -0.360 -0.789 -0.380 -2.315
Table V.1.47.: CSDs for selected protons in the helical extension representing the N-terminal
helix fold of TcAFP4b at 298 K and 274 K and at pH 3 and 7.9.
Helix ∆δ (ppm). Σ
T2’α A3’α S’4α D5’α A1α
pH 3, 274 K -0.143 -0.054 -0.100 0.042 -0.041 -0.295
pH 3, 298 K -0.052 -0.028 -0.079 0.084 -0.071 -0.146
pH 7.9, 274 K -0.230 -0.039 -0.123 -0.072 -0.147 -0.610
pH 7.9, 298 K -0.114 -0.037 -0.086 -0.062 -0.037 -0.336
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Table V.1.48.: CSDs for the 13Cα atoms in the helix representing the helix fold of AFP-Tc-4
at 274 K and at pH 3 and 7.9. The ∆δ and the χF for the helix, chimera
and helical extension are calculated. The χF was determined using the CSD of
AFP-Tc-7 at pH 7.9 and 274 K as reference.
TcAFP4
pH 3. pH 8
δ (ppm) δ (ppm)
Helical Extension 0.79 2.16
1.80 2.21
1.76 2.45
0.43 0.61
Chimera Helix 2.10 2.63
2.32 2.55
4.04 4.02
2.47 2.38
2.37 2.30
3.14 4.65
2.26 2.32
2.05 3.18
Helix ∆δ (ppm) 2.13 2.62
χhelixF (%) 76 94
Chimera Helix ∆δ (ppm) 2.59 3.00
χchimeraF (%) 83 96
Helical Extension ∆δ (ppm) 1.20 1.85
χexten.F (%) 48 75
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AFP-Tc-4 VADAR Statistics
                     ********************************** 
                     *           VADAR STATS          * 
                     ********************************** 
                     ** Using atomic radii from Shrake ** 
 
 (The expected values represent those numbers which would be expected 
  for highly refined Xray and NMR protein structures. 
  See the help pages for more information on expected values.) 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
| # Helix                      |     13   ( 52%)     |         -           | 
| # Beta                       |      0   (  0%)     |         -           | 
| # Coil                       |     12   ( 48%)     |         -           | 
|------------------------------|---------------------|---------------------| 
| # Turn                       |      4   ( 16%)     |         -           | 
|------------------------------|---------------------|---------------------| 
 
                               HYDROGEN BONDS (hbonds) 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Mean hbond distance         |      2.3 sd=0.4     |      2.2 sd=0.4     | 
|  Mean hbond energy           |     -1.4 sd=1.0     |     -2.0 sd=0.8     | 
|  # res with hbonds           |     20   ( 80%)     |     18   ( 75%)     | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Morris AL, MacArthur MW, Hutchinson EG and 
Thornton JM. Proteins. 1992 Apr;12(4):345-364. 
 
                                   DIHEDRAL ANGLES 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Mean Helix Phi              |    -67.8 sd=10.7    |    -65.3 sd=11.9    | 
|  Mean Helix Psi              |    -34.5 sd=13.2    |    -39.4 sd=25.5    | 
|  # res with Gauche+ Chi      |      7   ( 53%)     |      7   ( 55%)     | 
|  # res with Gauche- Chi      |      2   ( 15%)     |      2   ( 20%)     | 
|  # res with Trans Chi        |      4   ( 30%)     |      3   ( 25%)     | 
|  Mean Chi Gauche+            |    -56.2 sd=11.6    |    -66.7 sd=15.0    | 
|  Mean Chi Gauche-            |     66.0 sd=23.2    |     64.1 sd=15.7    | 
|  Mean Chi Trans              |    169.7 sd=14.1    |    168.6 sd=16.8    | 
|  Std. dev of chi pooled      |        14.14        |        15.70        | 
|  Mean Omega (|omega|>90)     |    178.3 sd=7.1     |    180.0 sd=5.8     | 
|  # res with |omega|<90       |      1   (  4%)     |         -           | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Morris AL, MacArthur MW, Hutchinson EG and 
Thornton JM.  Proteins. 1992 Apr;12(4):345-364. 
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                             ACCESSIBLE SURFACE AREA (ASA) 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Total ASA                   |    1971.7 Angs**2   |    1927.5 Angs**2   | 
|  ASA of backbone             |     258.5 Angs**2   |         -           | 
|  ASA of sidechains           |    1713.2 Angs**2   |         -           | 
|  ASA of C                    |    1341.4 Angs**2   |         -           | 
|  ASA of N                    |      51.1 Angs**2   |         -           | 
|  ASA of N+                   |      40.4 Angs**2   |         -           | 
|  ASA of O                    |     428.9 Angs**2   |         -           | 
|  ASA of O-                   |     110.0 Angs**2   |         -           | 
|  ASA of S                    |       0.0 Angs**2   |         -           | 
|  Exposed nonpolar ASA        |    1333.7 Angs**2   |    1202.8 Angs**2   | 
|  Exposed polar ASA           |     355.8 Angs**2   |     394.3 Angs**2   | 
|  Exposed charged ASA         |     282.2 Angs**2   |     374.6 Angs**2   | 
|  Side exposed nonpolar ASA   |    1330.4 Angs**2   |         -           | 
|  Side exposed polar ASA      |     150.6 Angs**2   |         -           | 
|  Side exposed charged ASA    |     232.2 Angs**2   |         -           | 
|  Fraction nonpolar ASA       |         0.68        |      0.61 sd=0.03   | 
|  Fraction polar ASA          |         0.18        |      0.20 sd=0.05   | 
|  Fraction charged ASA        |         0.14        |      0.19 sd=0.05   | 
|  Mean residue ASA            |     78.9 sd=38.2    |         -           | 
|  Mean frac ASA               |      0.5 sd=0.2     |         -           | 
|  % side ASA hydrophobic      |        41.40        |         -           | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Miller S, Janin J, Lesk AM and Chothia C. 
J Mol Biol. 1987 Aug 5;196(3):641-656.. 
 
                             ACCESSIBLE SURFACE AREA FOR EXTENDED CHAIN 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Extended nonpolar ASA       |    2348.1 Angs**2   |         -           | 
|  Extended polar ASA          |    1060.8 Angs**2   |         -           | 
|  Extended charged ASA        |     358.4 Angs**2   |         -           | 
|  Extended side nonpolar ASA  |    2328.6 Angs**2   |         -           | 
|  Extended side polar ASA     |     231.0 Angs**2   |         -           | 
|  Extended side charged ASA   |     321.4 Angs**2   |         -           | 
|------------------------------|---------------------|---------------------| 
 
                                      VOLUME 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Total volume (packing)      |    2537.0 Angs**3   |    2472.1 Angs**3   | 
|  Mean residue volume         |    101.5 sd=39.5    |    125.0 sd=40.0    | 
|  Mean frac volume            |      0.9 sd=0.1     |      1.0 sd=0.1     | 
|  Molecular weight            |      2447.62        |         -           | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Richards FM. Annu Rev Biophys Bioeng. 1977; 
6:151-176. 
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                     ******************************** 
                     * STEREO/PACKING QUALITY INDEX * 
                     ******************************** 
 
                              ( 3 = best  ) 
                              ( 0 = worst ) 
                     ( * = indicates possible problem ) 
 
 
PRBLM...:   *                         * 
SEQUENCE:   DTASDAAYAA WLTDGGPSSG RPPPS      25 
TORSION.:   3333333333 3333333333 33333 
OMEGA...:   0333333333 3333333333 33320 
VDW.....:   3333333333 3333333333 33333 
--------------------------------------- 
TOTAL...:   6999999999 9999999999 99986 
 
 
 
                     *************************** 
                     * 3D PROFILE QUALITY INDEX * 
                     **************************** 
 
                             ( 9 = best  ) 
                             ( 0 = worst ) 
                   ( * = indicates possible problem ) 
 
 
PRBLM...:                               
SEQUENCE:   DTASDAAYAA WLTDGGPSSG RPPPS      25 
ENV.....:   7665666666 6677776677 76777 
 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Resolution                  |         -           |         -           | 
|  R Value                     |         -           |         -           | 
|  # res in phipsi core        |     25   (100%)     |     23   ( 90%)     | 
|  # res in phipsi allowed     |      0   (  0%)     |      2   (  7%)     | 
|  # res in phipsi generous    |      0   (  0%)     |      0   (  1%)     | 
|  # res in phipsi outside     |      0   (  0%)     |      0   (  0%)     | 
|  # res in omega core         |     22   ( 88%)     |     24   ( 96%)     | 
|  # res in omega allowed      |      1   (  4%)     |      1   (  3%)     | 
|  # res in omega generous     |      0   (  0%)     |      0   (  0%)     | 
|  # res in omega outside      |      2   (  8%)     |      0   (  1%)     | 
|  # packing defects           |          0          |          1          | 
|  Free energy of folding      |       -10.47        |        -8.73        | 
|  # res 95% buried            |          1          |          0          | 
|  # buried charges            |          0          |          0          | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from 1. Morris AL, MacArthur MW, Hutchinson EG and 
Thornton JM. Proteins. 1992 Apr;12(4):345-364. 2. Chiche L., Gregoret LM, 
Cohen FE and Kollman PA. Proc Natl Acad Sci U S A. 1990 Apr;87(8):3240-3243  
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                     ********************************** 
                     *      SIDE CHAIN INFO PANEL     * 
                     ********************************** 
 
 
 
RES. RES.   SCND   BTURN    SIDE       FRAC.    SFE   CHI1   ENV.  DISULF  S-S   
NUM. NAME   STRUC  BTURN  SURF(ASA)  SURF(ASA)  SFE   ANGLE  CLASS  BOND   DIST  
-------------------------------------------------------------------------------- 
Chain  A   
5    ASP      C             130.4      1.10    -1.1   -53.8  E0C        
6    THR      H             113.0      1.00    -0.4   -39.5  E0H        
7    ALA      H              83.5      0.98    -0.0   360.0  E0H        
8    SER      H              41.6      0.44    -0.7   -67.9  P1H        
9    ASP      H              71.2      0.60    -0.7   -47.4  P2H        
10   ALA      H              57.8      0.67    -0.4   360.0  E0H        
11   ALA      H              28.5      0.33    -0.9   360.0  P1H        
12   TYR      H             112.6      0.55    -1.5  -179.7  P2H        
13   ALA      H              51.7      0.60    -0.5   360.0  E0H        
14   ALA      H              58.3      0.68    -0.4   360.0  E0H        
15   TRP      H              25.0      0.11    -2.9   176.5  B1H        
16   LEU      H              78.6      0.46    -1.5   -72.5  P1H        
17   THR      H              97.5      0.86    -0.1    49.6  E0H        
18   ASP      H              56.8      0.48    -1.3  -148.8  P1H        
19   GLY      C              32.6      0.62    -0.3   360.0  E0C        
20   GLY      C               0.8      0.02    -0.8   360.0  P1C        
21   PRO      C     III      94.3      0.71    -0.6    26.2  E0C        
22   SER      C     III      76.6      0.82    -0.3   -51.8  E0C        
23   SER      C     III      10.8      0.12    -0.8  -173.6  P1C        
24   GLY      C     III      41.9      0.80    -0.2   360.0  E0C        
25   ARG      C             131.2      0.64    -2.3    82.5  P2C        
26   PRO      C             108.5      0.82    -0.4    28.0  E0C        
27   PRO      C              65.7      0.50    -1.1    23.2  P2C        
28   PRO      C              57.5      0.43    -1.2    29.7  P1C        
29   SER      C              86.8      0.92    -0.3   -60.6  E0C        
 
 
 
 
                                   *************** 
                                   *  END VADAR  * 
                                   *************** 
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AFP-Tc-4-P18cis VADAR Statistics
                     ********************************** 
                     *           VADAR STATS          * 
                     ********************************** 
                     ** Using atomic radii from Shrake ** 
 
 (The expected values represent those numbers which would be expected 
  for highly refined Xray and NMR protein structures. 
  See the help pages for more information on expected values.) 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
| # Helix                      |     13   ( 52%)     |         -           | 
| # Beta                       |      0   (  0%)     |         -           | 
| # Coil                       |     12   ( 48%)     |         -           | 
|------------------------------|---------------------|---------------------| 
| # Turn                       |      4   ( 16%)     |         -           | 
|------------------------------|---------------------|---------------------| 
 
                               HYDROGEN BONDS (hbonds) 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Mean hbond distance         |      2.2 sd=0.4     |      2.2 sd=0.4     | 
|  Mean hbond energy           |     -1.8 sd=1.1     |     -2.0 sd=0.8     | 
|  # res with hbonds           |     20   ( 80%)     |     18   ( 75%)     | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Morris AL, MacArthur MW, Hutchinson EG and 
Thornton JM. Proteins. 1992 Apr;12(4):345-364. 
 
                                   DIHEDRAL ANGLES 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Mean Helix Phi              |    -65.1 sd=9.8     |    -65.3 sd=11.9    | 
|  Mean Helix Psi              |    -36.9 sd=12.9    |    -39.4 sd=25.5    | 
|  # res with Gauche+ Chi      |      7   ( 53%)     |      7   ( 55%)     | 
|  # res with Gauche- Chi      |      2   ( 15%)     |      2   ( 20%)     | 
|  # res with Trans Chi        |      4   ( 30%)     |      3   ( 25%)     | 
|  Mean Chi Gauche+            |    -50.4 sd=15.0    |    -66.7 sd=15.0    | 
|  Mean Chi Gauche-            |     66.6 sd=22.4    |     64.1 sd=15.7    | 
|  Mean Chi Trans              |    170.9 sd=15.3    |    168.6 sd=16.8    | 
|  Std. dev of chi pooled      |        16.20        |        15.70        | 
|  Mean Omega (|omega|>90)     |    178.2 sd=7.2     |    180.0 sd=5.8     | 
|  # res with |omega|<90       |      2   (  8%)     |         -           | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Morris AL, MacArthur MW, Hutchinson EG and 
Thornton JM.  Proteins. 1992 Apr;12(4):345-364. 
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                             ACCESSIBLE SURFACE AREA (ASA) 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Total ASA                   |    1999.9 Angs**2   |    1927.5 Angs**2   | 
|  ASA of backbone             |     241.0 Angs**2   |         -           | 
|  ASA of sidechains           |    1758.8 Angs**2   |         -           | 
|  ASA of C                    |    1347.7 Angs**2   |         -           | 
|  ASA of N                    |      48.5 Angs**2   |         -           | 
|  ASA of N+                   |      43.6 Angs**2   |         -           | 
|  ASA of O                    |     420.4 Angs**2   |         -           | 
|  ASA of O-                   |     139.7 Angs**2   |         -           | 
|  ASA of S                    |       0.0 Angs**2   |         -           | 
|  Exposed nonpolar ASA        |    1339.9 Angs**2   |    1219.9 Angs**2   | 
|  Exposed polar ASA           |     339.6 Angs**2   |     400.0 Angs**2   | 
|  Exposed charged ASA         |     320.4 Angs**2   |     380.0 Angs**2   | 
|  Side exposed nonpolar ASA   |    1377.0 Angs**2   |         -           | 
|  Side exposed polar ASA      |     139.1 Angs**2   |         -           | 
|  Side exposed charged ASA    |     242.8 Angs**2   |         -           | 
|  Fraction nonpolar ASA       |         0.67        |      0.61 sd=0.03   | 
|  Fraction polar ASA          |         0.17        |      0.20 sd=0.05   | 
|  Fraction charged ASA        |         0.16        |      0.19 sd=0.05   | 
|  Mean residue ASA            |     80.0 sd=37.1    |         -           | 
|  Mean frac ASA               |      0.5 sd=0.2     |         -           | 
|  % side ASA hydrophobic      |        39.83        |         -           | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Miller S, Janin J, Lesk AM and Chothia C. 
J Mol Biol. 1987 Aug 5;196(3):641-656.. 
 
                             ACCESSIBLE SURFACE AREA FOR EXTENDED CHAIN 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Extended nonpolar ASA       |    2309.6 Angs**2   |         -           | 
|  Extended polar ASA          |    1060.8 Angs**2   |         -           | 
|  Extended charged ASA        |     396.9 Angs**2   |         -           | 
|  Extended side nonpolar ASA  |    2328.6 Angs**2   |         -           | 
|  Extended side polar ASA     |     231.0 Angs**2   |         -           | 
|  Extended side charged ASA   |     321.4 Angs**2   |         -           | 
|------------------------------|---------------------|---------------------| 
 
                                      VOLUME 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Total volume (packing)      |    2491.6 Angs**3   |    2472.1 Angs**3   | 
|  Mean residue volume         |     99.7 sd=36.9    |    125.0 sd=40.0    | 
|  Mean frac volume            |      0.9 sd=0.0     |      1.0 sd=0.1     | 
|  Molecular weight            |      2447.62        |         -           | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Richards FM. Annu Rev Biophys Bioeng. 1977; 
6:151-176. 
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                     ******************************** 
                     * STEREO/PACKING QUALITY INDEX * 
                     ******************************** 
 
                              ( 3 = best  ) 
                              ( 0 = worst ) 
                     ( * = indicates possible problem ) 
 
 
PRBLM...:                          *  * 
SEQUENCE:   DTASDAAYAA WLTDGGPSSG RPPPS      25 
TORSION.:   3333333333 3333333333 33333 
OMEGA...:   1333333333 3333333233 30220 
VDW.....:   3333333333 3333333333 33333 
--------------------------------------- 
TOTAL...:   7999999999 9999999899 96886 
 
 
 
                     *************************** 
                     * 3D PROFILE QUALITY INDEX * 
                     **************************** 
 
                             ( 9 = best  ) 
                             ( 0 = worst ) 
                   ( * = indicates possible problem ) 
 
 
PRBLM...:                               
SEQUENCE:   DTASDAAYAA WLTDGGPSSG RPPPS      25 
ENV.....:   6655656666 6677777677 76777 
 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Resolution                  |         -           |         -           | 
|  R Value                     |         -           |         -           | 
|  # res in phipsi core        |     25   (100%)     |     23   ( 90%)     | 
|  # res in phipsi allowed     |      0   (  0%)     |      2   (  7%)     | 
|  # res in phipsi generous    |      0   (  0%)     |      0   (  1%)     | 
|  # res in phipsi outside     |      0   (  0%)     |      0   (  0%)     | 
|  # res in omega core         |     19   ( 76%)     |     24   ( 96%)     | 
|  # res in omega allowed      |      3   ( 12%)     |      1   (  3%)     | 
|  # res in omega generous     |      1   (  4%)     |      0   (  0%)     | 
|  # res in omega outside      |      2   (  8%)     |      0   (  1%)     | 
|  # packing defects           |          0          |          1          | 
|  Free energy of folding      |       -10.44        |        -8.73        | 
|  # res 95% buried            |          1          |          0          | 
|  # buried charges            |          0          |          0          | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from 1. Morris AL, MacArthur MW, Hutchinson EG and 
Thornton JM. Proteins. 1992 Apr;12(4):345-364. 2. Chiche L., Gregoret LM, 
Cohen FE and Kollman PA. Proc Natl Acad Sci U S A. 1990 Apr;87(8):3240-3243  
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                     ********************************** 
                     *      SIDE CHAIN INFO PANEL     * 
                     ********************************** 
 
 
 
RES. RES.   SCND   BTURN    SIDE       FRAC.    SFE   CHI1   ENV.  DISULF  S-S   
NUM. NAME   STRUC  BTURN  SURF(ASA)  SURF(ASA)  SFE   ANGLE  CLASS  BOND   DIST  
-------------------------------------------------------------------------------- 
Chain  A   
5    ASP      C             130.2      1.10    -1.2   -62.9  E0C        
6    THR      H             112.6      0.99    -0.4   -36.7  E0H        
7    ALA      H              85.9      1.00     0.0   360.0  E0H        
8    SER      H              73.8      0.79    -0.5   -55.2  E0H        
9    ASP      H              73.5      0.62    -0.8   -51.2  P2H        
10   ALA      H              58.6      0.68    -0.4   360.0  E0H        
11   ALA      H              58.5      0.68    -0.4   360.0  E0H        
12   TYR      H             120.4      0.59    -1.4  -178.5  P2H        
13   ALA      H              52.5      0.61    -0.5   360.0  E0H        
14   ALA      H              58.7      0.69    -0.4   360.0  E0H        
15   TRP      H              19.8      0.09    -3.0   179.7  B1H        
16   LEU      H              77.9      0.46    -1.5   -69.6  P1H        
17   THR      H              99.1      0.87    -0.1    50.8  E0H        
18   ASP      H              58.6      0.50    -1.4  -148.1  P1H        
19   GLY      C              31.8      0.61    -0.3   360.0  E0C        
20   GLY      C     III       0.8      0.01    -0.8   360.0  P1C        
21   PRO      C     III      35.7      0.27    -1.6    25.5  P1C        
22   SER      C     III      74.6      0.79    -0.3   -51.2  E0C        
23   SER      C     III      10.2      0.11    -0.8   177.4  P1C        
24   GLY      C              41.4      0.79    -0.2   360.0  E0C        
25   ARG      C             133.1      0.65    -2.3    82.5  P2C        
26   PRO      C              91.5      0.69    -0.7    28.2  P2C        
27   PRO      C              84.3      0.64    -0.8    31.7  P2C        
28   PRO      C              77.2      0.58    -0.9    34.6  P2C        
29   SER      C              98.1      1.04    -0.3   -25.8  E0C    
 
 
 
                                   *************** 
                                   *  END VADAR  * 
                                   *************** 
•
1.3. AFP-Tc Chimera Proteins 235
AFP-Tc-4-P19cis VADAR Statistics
                     ********************************** 
                     *           VADAR STATS          * 
                     ********************************** 
                     ** Using atomic radii from Shrake ** 
 
 (The expected values represent those numbers which would be expected 
  for highly refined Xray and NMR protein structures. 
  See the help pages for more information on expected values.) 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
| # Helix                      |     13   ( 52%)     |         -           | 
| # Beta                       |      0   (  0%)     |         -           | 
| # Coil                       |     12   ( 48%)     |         -           | 
|------------------------------|---------------------|---------------------| 
| # Turn                       |      4   ( 16%)     |         -           | 
|------------------------------|---------------------|---------------------| 
 
                               HYDROGEN BONDS (hbonds) 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Mean hbond distance         |      2.2 sd=0.4     |      2.2 sd=0.4     | 
|  Mean hbond energy           |     -2.0 sd=1.2     |     -2.0 sd=0.8     | 
|  # res with hbonds           |     20   ( 80%)     |     18   ( 75%)     | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Morris AL, MacArthur MW, Hutchinson EG and 
Thornton JM. Proteins. 1992 Apr;12(4):345-364. 
 
                                   DIHEDRAL ANGLES 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Mean Helix Phi              |    -60.5 sd=10.5    |    -65.3 sd=11.9    | 
|  Mean Helix Psi              |    -40.9 sd=21.0    |    -39.4 sd=25.5    | 
|  # res with Gauche+ Chi      |      7   ( 53%)     |      7   ( 55%)     | 
|  # res with Gauche- Chi      |      2   ( 15%)     |      2   ( 20%)     | 
|  # res with Trans Chi        |      4   ( 30%)     |      3   ( 25%)     | 
|  Mean Chi Gauche+            |    -55.8 sd=10.5    |    -66.7 sd=15.0    | 
|  Mean Chi Gauche-            |     43.7 sd=3.8     |     64.1 sd=15.7    | 
|  Mean Chi Trans              |    169.8 sd=11.8    |    168.6 sd=16.8    | 
|  Std. dev of chi pooled      |         9.84        |        15.70        | 
|  Mean Omega (|omega|>90)     |    176.4 sd=5.5     |    180.0 sd=5.8     | 
|  # res with |omega|<90       |      2   (  8%)     |         -           | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Morris AL, MacArthur MW, Hutchinson EG and 
Thornton JM.  Proteins. 1992 Apr;12(4):345-364. 
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                             ACCESSIBLE SURFACE AREA (ASA) 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Total ASA                   |    1905.9 Angs**2   |    1927.5 Angs**2   | 
|  ASA of backbone             |     211.2 Angs**2   |         -           | 
|  ASA of sidechains           |    1694.6 Angs**2   |         -           | 
|  ASA of C                    |    1310.5 Angs**2   |         -           | 
|  ASA of N                    |      41.5 Angs**2   |         -           | 
|  ASA of N+                   |      46.3 Angs**2   |         -           | 
|  ASA of O                    |     396.9 Angs**2   |         -           | 
|  ASA of O-                   |     110.5 Angs**2   |         -           | 
|  ASA of S                    |       0.0 Angs**2   |         -           | 
|  Exposed nonpolar ASA        |    1304.9 Angs**2   |    1162.6 Angs**2   | 
|  Exposed polar ASA           |     308.4 Angs**2   |     381.2 Angs**2   | 
|  Exposed charged ASA         |     292.5 Angs**2   |     362.1 Angs**2   | 
|  Side exposed nonpolar ASA   |    1330.7 Angs**2   |         -           | 
|  Side exposed polar ASA      |     124.9 Angs**2   |         -           | 
|  Side exposed charged ASA    |     239.0 Angs**2   |         -           | 
|  Fraction nonpolar ASA       |         0.68        |      0.61 sd=0.03   | 
|  Fraction polar ASA          |         0.16        |      0.20 sd=0.05   | 
|  Fraction charged ASA        |         0.15        |      0.19 sd=0.05   | 
|  Mean residue ASA            |     76.2 sd=36.3    |         -           | 
|  Mean frac ASA               |      0.5 sd=0.2     |         -           | 
|  % side ASA hydrophobic      |        42.03        |         -           | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Miller S, Janin J, Lesk AM and Chothia C. 
J Mol Biol. 1987 Aug 5;196(3):641-656.. 
 
                             ACCESSIBLE SURFACE AREA FOR EXTENDED CHAIN 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Extended nonpolar ASA       |    2309.6 Angs**2   |         -           | 
|  Extended polar ASA          |    1060.8 Angs**2   |         -           | 
|  Extended charged ASA        |     396.9 Angs**2   |         -           | 
|  Extended side nonpolar ASA  |    2328.6 Angs**2   |         -           | 
|  Extended side polar ASA     |     231.0 Angs**2   |         -           | 
|  Extended side charged ASA   |     321.4 Angs**2   |         -           | 
|------------------------------|---------------------|---------------------| 
 
                                      VOLUME 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Total volume (packing)      |    2504.5 Angs**3   |    2472.1 Angs**3   | 
|  Mean residue volume         |    100.2 sd=37.9    |    125.0 sd=40.0    | 
|  Mean frac volume            |      0.9 sd=0.1     |      1.0 sd=0.1     | 
|  Molecular weight            |      2447.62        |         -           | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Richards FM. Annu Rev Biophys Bioeng. 1977; 
6:151-176. 
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                     ******************************** 
                     * STEREO/PACKING QUALITY INDEX * 
                     ******************************** 
 
                              ( 3 = best  ) 
                              ( 0 = worst ) 
                     ( * = indicates possible problem ) 
 
 
PRBLM...:                           * * 
SEQUENCE:   DTASDAAYAA WLTDGGPSSG RPPPS      25 
TORSION.:   3333333333 3332333333 33333 
OMEGA...:   2333333333 3333333333 33020 
VDW.....:   3333333333 3333333233 33333 
--------------------------------------- 
TOTAL...:   8999999999 9998999899 99686 
 
 
 
                     *************************** 
                     * 3D PROFILE QUALITY INDEX * 
                     **************************** 
 
                             ( 9 = best  ) 
                             ( 0 = worst ) 
                   ( * = indicates possible problem ) 
 
 
PRBLM...:                               
SEQUENCE:   DTASDAAYAA WLTDGGPSSG RPPPS      25 
ENV.....:   7665666666 6676766677 76777 
 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Resolution                  |         -           |         -           | 
|  R Value                     |         -           |         -           | 
|  # res in phipsi core        |     24   ( 96%)     |     23   ( 90%)     | 
|  # res in phipsi allowed     |      1   (  4%)     |      2   (  7%)     | 
|  # res in phipsi generous    |      0   (  0%)     |      0   (  1%)     | 
|  # res in phipsi outside     |      0   (  0%)     |      0   (  0%)     | 
|  # res in omega core         |     21   ( 84%)     |     24   ( 96%)     | 
|  # res in omega allowed      |      2   (  8%)     |      1   (  3%)     | 
|  # res in omega generous     |      0   (  0%)     |      0   (  0%)     | 
|  # res in omega outside      |      2   (  8%)     |      0   (  1%)     | 
|  # packing defects           |          0          |          1          | 
|  Free energy of folding      |       -10.43        |        -8.73        | 
|  # res 95% buried            |          1          |          0          | 
|  # buried charges            |          0          |          0          | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from 1. Morris AL, MacArthur MW, Hutchinson EG and 
Thornton JM. Proteins. 1992 Apr;12(4):345-364. 2. Chiche L., Gregoret LM, 
Cohen FE and Kollman PA. Proc Natl Acad Sci U S A. 1990 Apr;87(8):3240-3243  
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                     ********************************** 
                     *      SIDE CHAIN INFO PANEL     * 
                     ********************************** 
 
 
 
RES. RES.   SCND   BTURN    SIDE       FRAC.    SFE   CHI1   ENV.  DISULF  S-S   
NUM. NAME   STRUC  BTURN  SURF(ASA)  SURF(ASA)  SFE   ANGLE  CLASS  BOND   DIST  
-------------------------------------------------------------------------------- 
Chain  A   
5    ASP      C             122.5      1.04    -1.3   -71.0  E0C        
6    THR      H             115.5      1.02    -0.3   -39.3  E0H        
7    ALA      H              84.1      0.98    -0.0   360.0  E0H        
8    SER      H              70.3      0.75    -0.4   -48.1  E0H        
9    ASP      H              77.4      0.66    -0.9   -57.3  P2H        
10   ALA      H              60.0      0.70    -0.4   360.0  E0H        
11   ALA      H              34.3      0.40    -0.8   360.0  P1H        
12   TYR      H             112.4      0.55    -1.5  -178.0  P2H        
13   ALA      H              53.0      0.62    -0.5   360.0  E0H        
14   ALA      H              46.9      0.55    -0.6   360.0  E0H        
15   TRP      H              26.4      0.12    -2.9  -177.2  B1H        
16   LEU      H              80.2      0.47    -1.4   -62.8  P1H        
17   THR      H              97.7      0.86    -0.1    46.4  E0H        
18   ASP      H              59.7      0.51    -1.4  -152.7  P1H        
19   GLY      C              35.6      0.68    -0.3   360.0  E0C        
20   GLY      C     III       1.9      0.04    -0.8   360.0  P1C        
21   PRO      C     III      97.1      0.73    -0.6    27.4  E0C        
22   SER      C     III      79.3      0.84    -0.3   -51.4  E0C        
23   SER      C     III      10.9      0.12    -0.8  -171.2  P1C        
24   GLY      C              43.2      0.82    -0.1   360.0  E0C        
25   ARG      C             125.0      0.61    -2.3    41.0  P2C        
26   PRO      C             106.3      0.80    -0.4    29.7  E0C        
27   PRO      C              64.0      0.48    -1.1    22.1  P2C        
28   PRO      C              59.9      0.45    -1.2    36.7  P2C        
29   SER      C              30.9      0.33    -0.9   -60.6  P1C 
 
 
 
 
 
                                   *************** 
                                   *  END VADAR  * 
                                   *************** 
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1.3.4. AFP-Tc-5
I
nistrator Timebase:U-3000RS Sequence:2016 Page 1-1
22.6.2016 11:53 AM
IZKF Leipzig, Core Unit peptid-Technologien
Liebigstraße 21, 04103 Leipzig, e-mail: sven_r@yahoo.com, Tel.: 0341 - 971s89g / 897
Sampte Name:
ViatNumber:
Sampte Type:
ControtProgram:
Quantif. Method:
Recording Time:
Sampte tD:
CE16_purified
GEl
unknown
Pe ptid e-3 D_bas i c_s h o rt
peptide-izkf
22.6.201611:34
lnjection Valume:
Channel:
Wavelength:
Bandwidth:
Dilution Factor:
Operator:
Sample Amount:
{0,0
UV_VIS-{
220.0
4
1,0000
Administrator
1,0000
No. Ret.Time
min
Peak Name Height Rel.Area
mAU Yo
Area Amount
mAU*min
Type
1
2
3
4
5
3,85
4,48
4,74
5,23
5,63
n.a 2,5 0,39
1,2 0,16
1,1 0,14
1383,0 99,23
0,38
0,16
0,13
97.41
n.a BMB
BMB
BMB
BM
MB
n.a. n.a
n.a n.a.
n.a. n.a.
n.a. 0,8 0,08 0,08 n.a.
Total: 1388,599 100,000 98,17 0,000
Chromeleon (c) Dionex 1996-2006
Version 6.80 SR7 Build 2528 (14S369)IZKFllntegration
Figure V.1.38.: HPLC chromatogram of purified AFP-Tc-5, synthesized by S. Rothemund
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, Tel.: 0341-971 , sven_r@yahoo.com
2000
1500
0
1000
s00
5000 6000 mlz1000
Acquisition Parameter
Date of acquisition
Acquisition method name
Aquisition operation mode
Voltage pobfty
Number of shots
Name of spectrum used for calibration
Calibration reference /tsf used
Instrument lnfo
User
lnstrument
lnstrument type
20 1 6-06-23T 1 2: 00 : 52. 000
D:\Möthods\fl exControlMethods\LP-PepMix. par
Linear
POS
100
PeptideCalibStandardlnsulin2 monoAv
IZKF
FLEX-PC
microtlex
6\GE{ 6_purified\0-E8\2
Figure V.1.39.: m/z : [M +H]+ calcd for [TcAFP5]+ 2476.5, found 2477.2.
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Figure V.1.40.: 1H NMR spectrum of AFP-Tc-5 at 274 K and pH 7.9 with enlargement of the
indole proton region.
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Table V.1.49.: 1H-chemical shifts of TcAFP5b at 274 K and pH 3.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1’ Asp exch. 4.384 3.003
2’ Thr 8.749 4.204 4.204 1.273
3’ Ala 8.607 4.283 1.445
4’ Ser 8.717 4.351 4.020
5’ Asp 8.426 4.680 2.959,2.886
6’ Ala 8.326 4.312 1.555
1 Ala 8.506 4.312 1.599
2 Ala 8.295 4.268 1.547
3 Tyr 8.618 4.072 3.204,3.110 7.118 6.786
4 Ala 8.437 4.305 1.533
5 Ala 8.119 4.224 1.518
6 Trp 8.029 4.249 3.450,3.201 7.045
9.678,
7.209
7.218,
7.118 7.048
7 Thr 8.713 3.242 4.290 1.210
8 Ala 8.277 4.151 1.474
9 Asp 7.620 4.752 3.036,2.868
10 Gly 7.623 4.136,3.535
11 Gly 8.087 3.082,1.120
12 Pro 4.570 2.488,2.034 2.128
3.743,
3.403
13 Ser 7.866 4.449 3.925
14 Ser 8.212 4.223 3.902,3.627
15 Gly 8.042 4.232,3.843
16 Arg 8.118 4.900 1.895,1.832
1.735,
1.590 3.264 7.505
17 Pro 4.715 2.300,1.785 1.998
3.857,
3.652
18 Pro 2.615 1.353,0.505
1.758,
1.698 3.502
19 Pro 4.327 2.216,1.958 1.795
3.071,
2.833
20 Ser 8.267 4.318 3.885,3.784
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Table V.1.50.: 15N and 13C-chemical shifts of AFP-Tc-5 at 278 K and pH 3.
Residue chemical shift δ (ppm)
15N 13C
1’ Asp n.d. 52.51 n.d.
2’ Thr 115.51 63.78 69.49 21.74
3’ Ala 125.68 54.47 17.87
4’ Ser 116.57 60.03 62.49
5’ Asp 123.51 54.46 n.d.
6’ Ala 122.78 54.75 17.87
1 Ala 123.22 54.53 17.87
2 Ala 124.25 54.53 17.87
3 Tyr 122.34 62.33 n.d. 118.55 133.01
4 Ala 122.61 54.53 17.87
5 Ala 122.22 54.56 17.87
6 Trp 120.76 131.31 61.50 27.99 127.29 124.08 114.05,121.07 122.42
7 Thr 116.28 66.36 68.88 21.45
8 Ala 125.62 54.38 17.87
9 Asp 115.95 n.d. n.d.
10 Gly 106.37 44.41
11 Gly 112.38 43.95
12 Pro n.d. 64.61 31.79 27.36 50.65
13 Ser 113.61 59.44 63.03
14 Ser 117.30 59.92 64.70
15 Gly 109.95 45.25
16 Arg 120.20 114.78 n.d.
17 Pro n.d. 62.48 30.59 27.10 50.57
18 Pro n.d. 60.24 29.29 26.59 n.d.
19 Pro n.d. 63.96 31.70 27.01 49.78
20 Ser 117.33 58.15 64.01
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Table V.1.51.: 1H-chemical shifts of TcAFP5b at 298K and pH 3.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1 Ala 8.288 4.258 1.468
2 Ala 8.118 4.254 1.446
3 Tyr 8.281 4.247 3.146,3.054 7.098 6.796
4 Ala 8.250 4.247 1.482
5 Ala 8.009 4.205 1.459
6 Trp 7.992 4.389 3.393,3.245 7.120
9.818,
7.297
7.310,
7.216 7.119
7 Thr 8.312 3.580 4.197 1.143
8 Ala 8.112 4.147 1.435
9 Asp 7.821 4.739 2.995,2.854
10 Gly 1.790 4.072,3.680
11 Gly 8.027 3.379,2.228
12 Pro 4.689 2.281,1.817 1.994
3.818,
3.605
13 Ser 8.020 4.441 3.906
14 Ser 8.168 4.300 3.916,3.726
15 Gly 8.093 4.122,3.880
16 Arg 8.038 4.756 1.883 1.769,1.672 3.229 7.288
17 Pro 4.494 2.400,2.018 2.075
3.677,
3.405
18 Pro 3.409 1.547,1.220 1.824
3.6009,
3.509
19 Pro 4.357 2.221,1.934 1.846
3.297,
3.106
20 Ser 8.132 4.368 3.896,3.819
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Table V.1.52.: 1H-chemical shifts of TcAFP5b at 274 K and pH 7.9. Residues marked in italic
belong to the second folded conformation with Pro (19) in cis.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1’ Asp 5.699 4.362 2.643,2.600
2’ Thr exch. 4.126 4.183 1.828
3’ Ala exch. 4.2863 1.4567
4’ Ser 8.779 4.335 4.031,3.936
5’ Asp 8.524 4.550 2.813,2.747
5’ Asp 8.444 4.533 2.721
6’ Ala 8.332 4.302 1.559
1 Ala 8.605 4.321 1.418
2 Ala 8.327 4.337 1.576
3 Tyr 8.489 4.125 3.197,3.146 7.126 6.809
3 Tyr 8.464 4.135 3.152 7.104 6.793
4 Ala 8.501 4.313 1.588
5 Ala 8.145 4.233 1.522
6 Trp 7.969 4.299 3.429,3.211 7.024
9.748,
7.220
7.213,
7.176 7.115
6 Trp 8.000 4.324 3.399,3.214 7.043
9.806,
n.d. n.d. n.d.
7 Thr 8.616 3.291 4.262 1.174
8 Ala 8.343 4.096 1.501
9 Asp 7.656 4.625 2.849,2.682
9 Asp 7.732 4.612 2.823,2.675
10 Gly 7.642 4.132,3.516
10 Gly 7.712 4.109,3.516
11 Gly 8.243 3.255,1.472
12 Pro 4.739 2.339,1.793 1.990
3.846,
3.659
13 Ser exch. 4.176 3.848,3.537
14 Ser 8.149 4.271 3.837
15 Gly 8.097 4.2256,3.823
16 Arg 8.197 4.980 1.856,1.791 1.646 3.285
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Table V.1.53.: Continued 1H-chemical shifts of TcAFP5b at 274 K and pH 7.9. Residues
marked in italic belong to the second folded conformation with Pro (19) in cis.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
17 Pro 4.614 2.493,2.069 2.150
3.792,
3.538
18 Pro 2.676 1.416,0.557 1.734 3.571
19 Pro 4.297 2.217,2.001
1.915,
1.807
3.125,
2.933
20 Ser 7.862 4.135 3.794
Table V.1.54.: 15N and 13C-chemical shifts of AFP-Tc-5 at 274 K and pH 7.9.
Residue chemical shift δ (ppm)
15N 13C
1’ Asp n.d. n.d. n.d.
2’ Thr n.d. 64.849 69.3477 21.568
3’ Ala n.d. 54.5155 17.8529
4’ Ser n.d. 60.862 62.2272
5’ Asp n.d. 56.3869 n.d.
6’ Ala n.d. 54.5968 17.8529
1 Ala n.d. 53.9357 17.8529
2 Ala n.d. 54.4341 17.8529
3 Tyr n.d. 62.2453 n.d. 118.2419133.0221
4 Ala n.d. 54.5968 17.8529
5 Ala n.d. 54.4341 17.8529
6 Trp n.d. n.d. 61.3386 28.2757 127.4273123.8367114.15,120.77 122.4171
7 Thr n.d. 66.2322 69.2445 21.3616
8 Ala n.d. 54.5968 17.8529
9 Asp n.d. n.d.
10 Gly n.d. 44.0647
11 Gly n.d. n.d.
12 Pro n.d. 61.1492 30.546 27.0373 50.4628
13 Ser n.d. n.d. 64.7039
14 Ser n.d. n.d. n.d.
15 Gly n.d. 44.9934 n.d.
16 Arg n.d. n.d. n.d. n.d. n.d. n.d.
17 Pro n.d. 64.9494 31.7844 27.3469 50.6692
18 Pro n.d. n.d. 29.3077 26.5214 49.9468
19 Pro n.d. 62.5866 31.578 26.7278 49.5341
20 Ser n.d. n.d. 64.7039
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Table V.1.55.: 1H-chemical shifts of TcAFP5b at 298 K and pH 7.9. Shifts marked with an
asterisk are averaged.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1’ Asp 5.599 4.350 2.614
2’ Thr exch. 4.260 4.220 1.249
3’ Ala exch. 4.231* 1.443*
4’ Ser exch. 4.364 3.932,3.860
5’ Asp exch. 4.603 2.737,2.661
6’ Ala exch. 4.231* 1.443*
1 Ala exch. 4.231* 1.443*
2 Ala exch. 4.318 1.425
3 Tyr 8.141 4.289 3.104,3.047 7.100 6.805
4 Ala exch. 4.231* 1.443*
5 Ala exch. 4.231* 1.443*
6 Trp 7.971 4.482 3.354,3.257 7.134
9.915,
7.356
7.344,
7.214 7.123
7 Thr exch. 3.745 4.182 1.113
8 Ala exch. 4.117 1.427
9 Asp 7.871 4.595 2.749,2.644
10 Gly exch. 3.81,3.608
11 Gly exch. 3.196,1.662
12 Pro 4.497 2.367,2.006 2.063
3.678,
3.714
13 Ser exch. 4.318 3.887,3.714
14 Ser exch. 4.451 3.899
15 Gly exch. 4.092,3.888
16 Arg exch. 4.748 1.797,1.759 1.656
3.216,
3.186
17 Pro 4.699 2.308,1.838 1.995
3.797,
3.607
18 Pro 3.118 1.653,1.480 1.874
3.675,
3.544
19 Pro 4.364 2.239,1.976 1.907
3.422,
3.275
20 Ser 7.834 4.198 3.816
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Figure V.1.41.: Hα CSD plot of AFP-Tc-5 at pH 3 (top) and pH 7.9 (bottom) at 274 K. Hα
as black squares and Hα’ as black diamonds. The dashed line at y=-0.1 ppm
represents the helical limit. Solid line between residue 6’ and 1 represents the
junction of the N-terminal extension and the solid line between residue 8 and
9 the conjunction of the helix to the C-terminal cage fold.
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Figure V.1.42.: Hα CSD plot of AFP-Tc-5 at pH 3 (top) and pH 7.9 (bottom) at 298 K. Hα as
black squares and Hα’ as black diamonds. Averaged Hα shifts for certain Ala
are represented as non-filled squares. The dashed line at y=-0.1 ppm represents
the helical limit. Solid line between residue 6’ and 1 represents the junction
of the N-terminal extension and the solid line between residue 8 and 9 the
conjunction of the helix to the C-terminal cage fold.
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Table V.1.56.: CSDs for selected protons in the cage structure representing the cage fold of
TcAFP5b at 298 K and 274 K and at pH 3 and 7.9.
Cage ∆δ (ppm). Σ
upfield
T7α G11α’ P18α P18β’ P19δ P19δ’
pH 3, 274 K -1.109 -3.010 -2.115 -1.405 -0.529 -0.767 -8.935
pH 3, 298 K -0.771 -1.902 -1.321 -0.363 -0.303 -0.494 -5.155
pH 7.9, 274 K -1.059 -2.658 -2.055 -1.353 -0.475 -0.667 -8.267
pH 7.9, 298 K -0.606 -2.4679 -1.612 -0.430 -0.178 -0.325 -5.618
downfield
P12α P12β R16α
pH 3, 274 K 0.150 -0.073 0.250 0.598
pH 3, 298 K 0.269 -0.198 0.106 0.365
pH 7.9, 274 K 0.319 0.045 0.330 0.698
pH 7.9, 298 K 0.077 0.077 0.098 0.252
Table V.1.57.: CSDs for selected protons in the helical region representing the helix fold of
AFP-Tc-5 at 298 K and 274 K and at pH 3 and 7.9.
Helix ∆δ (ppm) Σ
A2α Y3α A4α A5α W6α T7α A8α
pH 3, 274 K -0.052 -0.478 -0.351 -0.100 -0.411 -1.109 -0.169 -2.349
pH 3, 298 K -0.066 -0.303 -0.093 -0.115 -0.271 -0.771 -0.173 -1.792
pH 7.9, 274 K 0.017 -0.425 -0.027 -0.087 -0.361 -1.056 -0.224 -2.166
pH 7.9, 298 K -0.002 -0.261 -0.109* -0.059 -0.178 -0.606 -0.203 -1.448
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Table V.1.58.: CSDs for selected protons in the helical extension representing the N-terminal
helix fold of TcAFP5b at 298 K and 274 K and at pH 3 and 7.9.
Helix ∆δ (ppm) Σ
T2’α A3’α S’4α D5’α A6’α
pH 3, 274 K -0.146 -0.037 -0.120 0.040 -0.008 -0.271
pH 3, 298 K -0.020 -0.015 -0.106 0.074 0.090 -0.156
pH 7.9, 274 K -0.225 -0.034 -0.135 -0.090 -0.018 -0.501
pH 7.9, 298 K -0.130 -0.089 -0.106 -0.037 -0.089 -0.452
Table V.1.59.: CSDs for the 13Cα atoms in the helix representing the helix fold of AFP-Tc-5
at 274 K and at pH 3 and 7.9. The ∆δ and the χF for the helix, chimera
and helical extension are calculated. The χF was determined using the CSD of
AFP-Tc-7 at pH 7.9 and 274 K as reference.
TcAFP5
pH 3 pH 8
δ (ppm) δ (ppm)
Helical Extension 0.68 1.75
1.97 2.02
1.73 2.56
0.6 2.29
2.25 2.10
Chimera Helix 2.03 2.10
2.03 2.07
3.73 3.99
2.03 2.10
2.06 1.93
3.70 4.61
3.26 3.13
2.01 2.10
Helix ∆δ (ppm) 2.14 2.52
χhelixF (%) 77 90
Chimera Helix ∆δ (ppm) 2.61 2.75
χchimeraF (%) 83 88
Helical Extension ∆δ (ppm) 1.40 2.14
χexten.F (%) 57 87
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AFP-Tc-5 VADAR Statistics
                     ********************************** 
                     *           VADAR STATS          * 
                     ********************************** 
                     ** Using atomic radii from Shrake ** 
 
 (The expected values represent those numbers which would be expected 
  for highly refined Xray and NMR protein structures. 
  See the help pages for more information on expected values.) 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
| # Helix                      |     14   ( 53%)     |         -           | 
| # Beta                       |      0   (  0%)     |         -           | 
| # Coil                       |     12   ( 46%)     |         -           | 
|------------------------------|---------------------|---------------------| 
| # Turn                       |      8   ( 30%)     |         -           | 
|------------------------------|---------------------|---------------------| 
 
                               HYDROGEN BONDS (hbonds) 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Mean hbond distance         |      2.2 sd=0.3     |      2.2 sd=0.4     | 
|  Mean hbond energy           |     -1.7 sd=1.0     |     -2.0 sd=0.8     | 
|  # res with hbonds           |     20   ( 76%)     |     19   ( 75%)     | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Morris AL, MacArthur MW, Hutchinson EG and 
Thornton JM. Proteins. 1992 Apr;12(4):345-364. 
 
                                   DIHEDRAL ANGLES 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Mean Helix Phi              |    -66.1 sd=9.6     |    -65.3 sd=11.9    | 
|  Mean Helix Psi              |    -35.2 sd=12.5    |    -39.4 sd=25.5    | 
|  # res with Gauche+ Chi      |      8   ( 66%)     |      6   ( 55%)     | 
|  # res with Gauche- Chi      |      1   (  8%)     |      2   ( 20%)     | 
|  # res with Trans Chi        |      3   ( 25%)     |      3   ( 25%)     | 
|  Mean Chi Gauche+            |    -57.6 sd=19.6    |    -66.7 sd=15.0    | 
|  Mean Chi Gauche-            |     50.5 sd=-nan    |     64.1 sd=15.7    | 
|  Mean Chi Trans              |    165.8 sd=13.7    |    168.6 sd=16.8    | 
|  Std. dev of chi pooled      |         -nan        |        15.70        | 
|  Mean Omega (|omega|>90)     |    177.3 sd=8.6     |    180.0 sd=5.8     | 
|  # res with |omega|<90       |      1   (  3%)     |         -           | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Morris AL, MacArthur MW, Hutchinson EG and 
Thornton JM.  Proteins. 1992 Apr;12(4):345-364. 
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                             ACCESSIBLE SURFACE AREA (ASA) 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Total ASA                   |    2076.5 Angs**2   |    1943.8 Angs**2   | 
|  ASA of backbone             |     281.6 Angs**2   |         -           | 
|  ASA of sidechains           |    1794.8 Angs**2   |         -           | 
|  ASA of C                    |    1448.0 Angs**2   |         -           | 
|  ASA of N                    |      55.0 Angs**2   |         -           | 
|  ASA of N+                   |      38.2 Angs**2   |         -           | 
|  ASA of O                    |     432.7 Angs**2   |         -           | 
|  ASA of O-                   |     102.6 Angs**2   |         -           | 
|  ASA of S                    |       0.0 Angs**2   |         -           | 
|  Exposed nonpolar ASA        |    1437.7 Angs**2   |    1266.6 Angs**2   | 
|  Exposed polar ASA           |     363.1 Angs**2   |     415.3 Angs**2   | 
|  Exposed charged ASA         |     275.7 Angs**2   |     394.5 Angs**2   | 
|  Side exposed nonpolar ASA   |    1414.6 Angs**2   |         -           | 
|  Side exposed polar ASA      |     151.7 Angs**2   |         -           | 
|  Side exposed charged ASA    |     228.6 Angs**2   |         -           | 
|  Fraction nonpolar ASA       |         0.69        |      0.61 sd=0.03   | 
|  Fraction polar ASA          |         0.17        |      0.20 sd=0.05   | 
|  Fraction charged ASA        |         0.13        |      0.19 sd=0.05   | 
|  Mean residue ASA            |     79.9 sd=37.7    |         -           | 
|  Mean frac ASA               |      0.6 sd=0.3     |         -           | 
|  % side ASA hydrophobic      |        43.14        |         -           | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Miller S, Janin J, Lesk AM and Chothia C. 
J Mol Biol. 1987 Aug 5;196(3):641-656.. 
 
                             ACCESSIBLE SURFACE AREA FOR EXTENDED CHAIN 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Extended nonpolar ASA       |    2350.6 Angs**2   |         -           | 
|  Extended polar ASA          |    1097.2 Angs**2   |         -           | 
|  Extended charged ASA        |     358.4 Angs**2   |         -           | 
|  Extended side nonpolar ASA  |    2330.2 Angs**2   |         -           | 
|  Extended side polar ASA     |     231.0 Angs**2   |         -           | 
|  Extended side charged ASA   |     321.4 Angs**2   |         -           | 
|------------------------------|---------------------|---------------------| 
 
                                      VOLUME 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Total volume (packing)      |    2535.0 Angs**3   |    2501.4 Angs**3   | 
|  Mean residue volume         |     97.5 sd=38.2    |    125.0 sd=40.0    | 
|  Mean frac volume            |      0.9 sd=0.1     |      1.0 sd=0.1     | 
|  Molecular weight            |      2476.62        |         -           | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Richards FM. Annu Rev Biophys Bioeng. 1977; 
6:151-176. 
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                     ******************************** 
                     * STEREO/PACKING QUALITY INDEX * 
                     ******************************** 
 
                              ( 3 = best  ) 
                              ( 0 = worst ) 
                     ( * = indicates possible problem ) 
 
 
PRBLM...:   *                         ** 
SEQUENCE:   DTASDAAAYA AWTADGGPSS GRPPPS      26 
TORSION.:   3233333333 3333333333 333333 
OMEGA...:   0333333333 3333333333 333300 
VDW.....:   3333333333 3333333333 233333 
---------------------------------------- 
TOTAL...:   6899999999 9999999999 899966 
 
 
 
                     *************************** 
                     * 3D PROFILE QUALITY INDEX * 
                     **************************** 
 
                             ( 9 = best  ) 
                             ( 0 = worst ) 
                   ( * = indicates possible problem ) 
 
 
PRBLM...:                                
SEQUENCE:   DTASDAAAYA AWTADGGPSS GRPPPS      26 
ENV.....:   6666676667 7777777777 777777 
 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Resolution                  |         -           |         -           | 
|  R Value                     |         -           |         -           | 
|  # res in phipsi core        |     25   ( 96%)     |     23   ( 90%)     | 
|  # res in phipsi allowed     |      1   (  3%)     |      2   (  7%)     | 
|  # res in phipsi generous    |      0   (  0%)     |      0   (  1%)     | 
|  # res in phipsi outside     |      0   (  0%)     |      0   (  0%)     | 
|  # res in omega core         |     23   ( 88%)     |     25   ( 96%)     | 
|  # res in omega allowed      |      0   (  0%)     |      1   (  3%)     | 
|  # res in omega generous     |      0   (  0%)     |      0   (  0%)     | 
|  # res in omega outside      |      3   ( 11%)     |      0   (  1%)     | 
|  # packing defects           |          1          |          1          | 
|  Free energy of folding      |        -8.37        |        -9.72        | 
|  # res 95% buried            |          1          |          0          | 
|  # buried charges            |          0          |          0          | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from 1. Morris AL, MacArthur MW, Hutchinson EG and 
Thornton JM. Proteins. 1992 Apr;12(4):345-364. 2. Chiche L., Gregoret LM, 
Cohen FE and Kollman PA. Proc Natl Acad Sci U S A. 1990 Apr;87(8):3240-3243  
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                     ********************************** 
                     *      SIDE CHAIN INFO PANEL     * 
                     ********************************** 
 
 
 
RES. RES.   SCND   BTURN    SIDE       FRAC.    SFE   CHI1   ENV.  DISULF  S-S   
NUM. NAME   STRUC  BTURN  SURF(ASA)  SURF(ASA)  SFE   ANGLE  CLASS  BOND   DIST  
-------------------------------------------------------------------------------- 
Chain  1   
1    ASP      C             131.9      1.12    -1.1   -57.2  E0C        
2    THR      H             111.8      0.99    -0.4   -34.1  E0H        
3    ALA      H              84.0      0.98    -0.0   360.0  E0H        
4    SER      H              72.7      0.77    -0.5   -62.5  E0H        
5    ASP      H              62.5      0.53    -0.6   -37.0  P1H        
6    ALA      H              55.8      0.65    -0.5   360.0  E0H        
7    ALA      H              57.1      0.67    -0.5   360.0  E0H        
8    ALA      H              39.4      0.46    -0.7   360.0  P1H        
9    TYR      H              99.7      0.49    -1.5   -95.8  P1H        
10   ALA      H              58.5      0.68    -0.4   360.0  E0H        
11   ALA      H              59.5      0.70    -0.4   360.0  E0H        
12   TRP      H              48.7      0.21    -2.6   173.8  B1H        
13   THR      H      I       80.5      0.71    -0.4   -56.8  E0H        
14   ALA      H      I       67.5      0.79    -0.3   360.0  E0H        
15   ASP      H      I       61.5      0.52    -1.3  -150.0  P2H        
16   GLY      C      I       29.6      0.56    -0.4   360.0  E0C        
17   GLY      C     III       3.5      0.07    -0.8   360.0  P1C        
18   PRO      C     III     102.0      0.77    -0.5   -23.6  E0C        
19   SER      C     III      76.6      0.81    -0.4   -47.9  E0C        
20   SER      C     III       7.3      0.08    -0.9  -173.6  P1C        
21   GLY      C              42.3      0.81    -0.2   360.0  E0C        
22   ARG      C             137.2      0.67    -2.0    50.5  P2C        
23   PRO      C             108.2      0.82    -0.4    28.1  E0C        
24   PRO      C              46.7      0.35    -1.4    25.8  P1C        
25   PRO      C              47.0      0.35    -1.4    28.2  P1C        
26   SER      C             103.5      1.10    -0.1   -69.2  E0C   
 
 
 
 
                                   *************** 
                                   *  END VADAR  * 
                                   *************** 
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AFP-Tc-5-P18cis VADAR Statistics
                     ********************************** 
                     *           VADAR STATS          * 
                     ********************************** 
                     ** Using atomic radii from Shrake ** 
 
 (The expected values represent those numbers which would be expected 
  for highly refined Xray and NMR protein structures. 
  See the help pages for more information on expected values.) 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
| # Helix                      |     14   ( 53%)     |         -           | 
| # Beta                       |      0   (  0%)     |         -           | 
| # Coil                       |     12   ( 46%)     |         -           | 
|------------------------------|---------------------|---------------------| 
| # Turn                       |      4   ( 15%)     |         -           | 
|------------------------------|---------------------|---------------------| 
 
                               HYDROGEN BONDS (hbonds) 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Mean hbond distance         |      2.1 sd=0.3     |      2.2 sd=0.4     | 
|  Mean hbond energy           |     -2.0 sd=1.1     |     -2.0 sd=0.8     | 
|  # res with hbonds           |     20   ( 76%)     |     19   ( 75%)     | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Morris AL, MacArthur MW, Hutchinson EG and 
Thornton JM. Proteins. 1992 Apr;12(4):345-364. 
 
                                   DIHEDRAL ANGLES 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Mean Helix Phi              |    -56.2 sd=16.3    |    -65.3 sd=11.9    | 
|  Mean Helix Psi              |    -43.1 sd=11.7    |    -39.4 sd=25.5    | 
|  # res with Gauche+ Chi      |      8   ( 66%)     |      6   ( 55%)     | 
|  # res with Gauche- Chi      |      1   (  8%)     |      2   ( 20%)     | 
|  # res with Trans Chi        |      3   ( 25%)     |      3   ( 25%)     | 
|  Mean Chi Gauche+            |    -54.4 sd=14.8    |    -66.7 sd=15.0    | 
|  Mean Chi Gauche-            |     64.5 sd=-nan    |     64.1 sd=15.7    | 
|  Mean Chi Trans              |    162.9 sd=21.8    |    168.6 sd=16.8    | 
|  Std. dev of chi pooled      |         -nan        |        15.70        | 
|  Mean Omega (|omega|>90)     |    176.3 sd=6.8     |    180.0 sd=5.8     | 
|  # res with |omega|<90       |      2   (  7%)     |         -           | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Morris AL, MacArthur MW, Hutchinson EG and 
Thornton JM.  Proteins. 1992 Apr;12(4):345-364. 
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                             ACCESSIBLE SURFACE AREA (ASA) 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Total ASA                   |    2101.4 Angs**2   |    1943.8 Angs**2   | 
|  ASA of backbone             |     236.8 Angs**2   |         -           | 
|  ASA of sidechains           |    1864.6 Angs**2   |         -           | 
|  ASA of C                    |    1448.8 Angs**2   |         -           | 
|  ASA of N                    |      44.4 Angs**2   |         -           | 
|  ASA of N+                   |      41.0 Angs**2   |         -           | 
|  ASA of O                    |     425.3 Angs**2   |         -           | 
|  ASA of O-                   |     141.9 Angs**2   |         -           | 
|  ASA of S                    |       0.0 Angs**2   |         -           | 
|  Exposed nonpolar ASA        |    1439.9 Angs**2   |    1281.8 Angs**2   | 
|  Exposed polar ASA           |     338.6 Angs**2   |     420.3 Angs**2   | 
|  Exposed charged ASA         |     322.9 Angs**2   |     399.3 Angs**2   | 
|  Side exposed nonpolar ASA   |    1475.4 Angs**2   |         -           | 
|  Side exposed polar ASA      |     138.6 Angs**2   |         -           | 
|  Side exposed charged ASA    |     250.6 Angs**2   |         -           | 
|  Fraction nonpolar ASA       |         0.69        |      0.61 sd=0.03   | 
|  Fraction polar ASA          |         0.16        |      0.20 sd=0.05   | 
|  Fraction charged ASA        |         0.15        |      0.19 sd=0.05   | 
|  Mean residue ASA            |     80.8 sd=35.5    |         -           | 
|  Mean frac ASA               |      0.6 sd=0.2     |         -           | 
|  % side ASA hydrophobic      |        43.14        |         -           | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Miller S, Janin J, Lesk AM and Chothia C. 
J Mol Biol. 1987 Aug 5;196(3):641-656.. 
 
                             ACCESSIBLE SURFACE AREA FOR EXTENDED CHAIN 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Extended nonpolar ASA       |    2312.1 Angs**2   |         -           | 
|  Extended polar ASA          |    1097.2 Angs**2   |         -           | 
|  Extended charged ASA        |     396.9 Angs**2   |         -           | 
|  Extended side nonpolar ASA  |    2330.2 Angs**2   |         -           | 
|  Extended side polar ASA     |     231.0 Angs**2   |         -           | 
|  Extended side charged ASA   |     321.4 Angs**2   |         -           | 
|------------------------------|---------------------|---------------------| 
 
                                      VOLUME 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Total volume (packing)      |    2495.8 Angs**3   |    2501.4 Angs**3   | 
|  Mean residue volume         |     96.0 sd=36.9    |    125.0 sd=40.0    | 
|  Mean frac volume            |      0.9 sd=0.1     |      1.0 sd=0.1     | 
|  Molecular weight            |      2476.62        |         -           | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Richards FM. Annu Rev Biophys Bioeng. 1977; 
6:151-176. 
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                     ******************************** 
                     * STEREO/PACKING QUALITY INDEX * 
                     ******************************** 
 
                              ( 3 = best  ) 
                              ( 0 = worst ) 
                     ( * = indicates possible problem ) 
 
 
PRBLM...:                           *  * 
SEQUENCE:   DTASDAAAYA AWTADGGPSS GRPPPS      26 
TORSION.:   3233333333 3333333333 333333 
OMEGA...:   1333333333 3333333323 330210 
VDW.....:   3333333333 3332333333 333333 
---------------------------------------- 
TOTAL...:   7899999999 9998999989 996876 
 
 
 
                     *************************** 
                     * 3D PROFILE QUALITY INDEX * 
                     **************************** 
 
                             ( 9 = best  ) 
                             ( 0 = worst ) 
                   ( * = indicates possible problem ) 
 
 
PRBLM...:                                
SEQUENCE:   DTASDAAAYA AWTADGGPSS GRPPPS      26 
ENV.....:   5666676667 7777777777 777777 
 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Resolution                  |         -           |         -           | 
|  R Value                     |         -           |         -           | 
|  # res in phipsi core        |     25   ( 96%)     |     23   ( 90%)     | 
|  # res in phipsi allowed     |      1   (  3%)     |      2   (  7%)     | 
|  # res in phipsi generous    |      0   (  0%)     |      0   (  1%)     | 
|  # res in phipsi outside     |      0   (  0%)     |      0   (  0%)     | 
|  # res in omega core         |     20   ( 76%)     |     25   ( 96%)     | 
|  # res in omega allowed      |      2   (  7%)     |      1   (  3%)     | 
|  # res in omega generous     |      2   (  7%)     |      0   (  0%)     | 
|  # res in omega outside      |      2   (  7%)     |      0   (  1%)     | 
|  # packing defects           |          1          |          1          | 
|  Free energy of folding      |        -8.76        |        -9.72        | 
|  # res 95% buried            |          1          |          0          | 
|  # buried charges            |          0          |          0          | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from 1. Morris AL, MacArthur MW, Hutchinson EG and 
Thornton JM. Proteins. 1992 Apr;12(4):345-364. 2. Chiche L., Gregoret LM, 
Cohen FE and Kollman PA. Proc Natl Acad Sci U S A. 1990 Apr;87(8):3240-3243  
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                     ********************************** 
                     *      SIDE CHAIN INFO PANEL     * 
                     ********************************** 
 
 
 
RES. RES.   SCND   BTURN    SIDE       FRAC.    SFE   CHI1   ENV.  DISULF  S-S   
NUM. NAME   STRUC  BTURN  SURF(ASA)  SURF(ASA)  SFE   ANGLE  CLASS  BOND   DIST  
-------------------------------------------------------------------------------- 
Chain  1   
1    ASP      C             131.4      1.11    -1.2   -64.0  E0C        
2    THR      H             118.8      1.05    -0.3   -42.4  E0H        
3    ALA      H              83.6      0.98    -0.0   360.0  E0H        
4    SER      H              67.9      0.72    -0.4   -37.1  E0H        
5    ASP      H              68.1      0.58    -1.0   -55.0  P1H        
6    ALA      H              62.9      0.74    -0.4   360.0  E0H        
7    ALA      H              62.9      0.73    -0.4   360.0  E0H        
8    ALA      H              58.6      0.68    -0.4   360.0  E0H        
9    TYR      H             147.0      0.72    -1.1   -84.6  P2H        
10   ALA      H              60.7      0.71    -0.4   360.0  E0H        
11   ALA      H              61.1      0.71    -0.4   360.0  E0H        
12   TRP      H              39.8      0.18    -2.7   176.5  B1H        
13   THR      H              81.9      0.72    -0.4   -53.9  E0H        
14   ALA      H              67.4      0.79    -0.3   360.0  E0H        
15   ASP      H              59.9      0.51    -1.3  -137.8  P2H        
16   GLY      C              32.2      0.61    -0.3   360.0  E0C        
17   GLY      C     III       3.3      0.06    -0.8   360.0  P1C        
18   PRO      C     III      37.9      0.29    -1.5    36.4  P1C        
19   SER      C     III      79.1      0.84    -0.2   -46.1  E0C        
20   SER      C     III      13.2      0.14    -0.8  -174.5  P1C        
21   GLY      C              40.9      0.78    -0.2   360.0  E0C        
22   ARG      C             123.5      0.60    -2.5    64.5  P2C        
23   PRO      C             102.8      0.77    -0.5    28.7  E0C        
24   PRO      C              69.6      0.52    -1.0    28.7  P1C        
25   PRO      C              97.1      0.73    -0.6    28.9  E0C        
26   SER      C              93.0      0.99    -0.3   -51.8  E0C     
 
 
 
 
                                   *************** 
                                   *  END VADAR  * 
                                   *************** 
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AFP-Tc-5-P19cis VADAR Statistics
                     ********************************** 
                     *           VADAR STATS          * 
                     ********************************** 
                     ** Using atomic radii from Shrake ** 
 
 (The expected values represent those numbers which would be expected 
  for highly refined Xray and NMR protein structures. 
  See the help pages for more information on expected values.) 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
| # Helix                      |     14   ( 53%)     |         -           | 
| # Beta                       |      0   (  0%)     |         -           | 
| # Coil                       |     12   ( 46%)     |         -           | 
|------------------------------|---------------------|---------------------| 
| # Turn                       |      4   ( 15%)     |         -           | 
|------------------------------|---------------------|---------------------| 
 
                               HYDROGEN BONDS (hbonds) 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Mean hbond distance         |      2.3 sd=0.4     |      2.2 sd=0.4     | 
|  Mean hbond energy           |     -1.4 sd=1.0     |     -2.0 sd=0.8     | 
|  # res with hbonds           |     22   ( 84%)     |     19   ( 75%)     | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Morris AL, MacArthur MW, Hutchinson EG and 
Thornton JM. Proteins. 1992 Apr;12(4):345-364. 
 
                                   DIHEDRAL ANGLES 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Mean Helix Phi              |    -66.8 sd=9.7     |    -65.3 sd=11.9    | 
|  Mean Helix Psi              |    -35.4 sd=9.5     |    -39.4 sd=25.5    | 
|  # res with Gauche+ Chi      |      7   ( 58%)     |      6   ( 55%)     | 
|  # res with Gauche- Chi      |      2   ( 16%)     |      2   ( 20%)     | 
|  # res with Trans Chi        |      3   ( 25%)     |      3   ( 25%)     | 
|  Mean Chi Gauche+            |    -57.0 sd=15.0    |    -66.7 sd=15.0    | 
|  Mean Chi Gauche-            |     63.9 sd=9.7     |     64.1 sd=15.7    | 
|  Mean Chi Trans              |    165.3 sd=12.6    |    168.6 sd=16.8    | 
|  Std. dev of chi pooled      |        13.51        |        15.70        | 
|  Mean Omega (|omega|>90)     |    177.6 sd=6.8     |    180.0 sd=5.8     | 
|  # res with |omega|<90       |      2   (  7%)     |         -           | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Morris AL, MacArthur MW, Hutchinson EG and 
Thornton JM.  Proteins. 1992 Apr;12(4):345-364. 
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                             ACCESSIBLE SURFACE AREA (ASA) 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Total ASA                   |    1971.1 Angs**2   |    1943.8 Angs**2   | 
|  ASA of backbone             |     285.5 Angs**2   |         -           | 
|  ASA of sidechains           |    1685.6 Angs**2   |         -           | 
|  ASA of C                    |    1350.1 Angs**2   |         -           | 
|  ASA of N                    |      22.2 Angs**2   |         -           | 
|  ASA of N+                   |      40.6 Angs**2   |         -           | 
|  ASA of O                    |     445.6 Angs**2   |         -           | 
|  ASA of O-                   |     112.6 Angs**2   |         -           | 
|  ASA of S                    |       0.0 Angs**2   |         -           | 
|  Exposed nonpolar ASA        |    1342.2 Angs**2   |    1202.4 Angs**2   | 
|  Exposed polar ASA           |     373.1 Angs**2   |     394.2 Angs**2   | 
|  Exposed charged ASA         |     255.8 Angs**2   |     374.5 Angs**2   | 
|  Side exposed nonpolar ASA   |    1338.0 Angs**2   |         -           | 
|  Side exposed polar ASA      |     140.2 Angs**2   |         -           | 
|  Side exposed charged ASA    |     207.4 Angs**2   |         -           | 
|  Fraction nonpolar ASA       |         0.68        |      0.61 sd=0.03   | 
|  Fraction polar ASA          |         0.19        |      0.20 sd=0.05   | 
|  Fraction charged ASA        |         0.13        |      0.19 sd=0.05   | 
|  Mean residue ASA            |     75.8 sd=33.2    |         -           | 
|  Mean frac ASA               |      0.5 sd=0.2     |         -           | 
|  % side ASA hydrophobic      |        44.53        |         -           | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Miller S, Janin J, Lesk AM and Chothia C. 
J Mol Biol. 1987 Aug 5;196(3):641-656.. 
 
                             ACCESSIBLE SURFACE AREA FOR EXTENDED CHAIN 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Extended nonpolar ASA       |    2350.6 Angs**2   |         -           | 
|  Extended polar ASA          |    1097.2 Angs**2   |         -           | 
|  Extended charged ASA        |     358.4 Angs**2   |         -           | 
|  Extended side nonpolar ASA  |    2330.2 Angs**2   |         -           | 
|  Extended side polar ASA     |     231.0 Angs**2   |         -           | 
|  Extended side charged ASA   |     321.4 Angs**2   |         -           | 
|------------------------------|---------------------|---------------------| 
 
                                      VOLUME 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Total volume (packing)      |    2577.6 Angs**3   |    2501.4 Angs**3   | 
|  Mean residue volume         |     99.1 sd=39.5    |    125.0 sd=40.0    | 
|  Mean frac volume            |      0.9 sd=0.1     |      1.0 sd=0.1     | 
|  Molecular weight            |      2476.62        |         -           | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from Richards FM. Annu Rev Biophys Bioeng. 1977; 
6:151-176. 
 
  •
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                     ******************************** 
                     * STEREO/PACKING QUALITY INDEX * 
                     ******************************** 
 
                              ( 3 = best  ) 
                              ( 0 = worst ) 
                     ( * = indicates possible problem ) 
 
 
PRBLM...:   *                        * * 
SEQUENCE:   DTASDAAAYA AWTADGGPSS GRPPPS      26 
TORSION.:   3333333333 3333333333 333332 
OMEGA...:   0333333333 3333333333 333030 
VDW.....:   3333333333 3332333333 233333 
---------------------------------------- 
TOTAL...:   6999999999 9998999999 899695 
 
 
 
                     *************************** 
                     * 3D PROFILE QUALITY INDEX * 
                     **************************** 
 
                             ( 9 = best  ) 
                             ( 0 = worst ) 
                   ( * = indicates possible problem ) 
 
 
PRBLM...:                                
SEQUENCE:   DTASDAAAYA AWTADGGPSS GRPPPS      26 
ENV.....:   6666676666 7666677667 776666 
 
 
|------------------------------|---------------------|---------------------| 
| Statistic                    | Observed            | Expected            | 
|------------------------------|---------------------|---------------------| 
|  Resolution                  |         -           |         -           | 
|  R Value                     |         -           |         -           | 
|  # res in phipsi core        |     25   ( 96%)     |     23   ( 90%)     | 
|  # res in phipsi allowed     |      1   (  3%)     |      2   (  7%)     | 
|  # res in phipsi generous    |      0   (  0%)     |      0   (  1%)     | 
|  # res in phipsi outside     |      0   (  0%)     |      0   (  0%)     | 
|  # res in omega core         |     23   ( 88%)     |     25   ( 96%)     | 
|  # res in omega allowed      |      0   (  0%)     |      1   (  3%)     | 
|  # res in omega generous     |      0   (  0%)     |      0   (  0%)     | 
|  # res in omega outside      |      3   ( 11%)     |      0   (  1%)     | 
|  # packing defects           |          2          |          1          | 
|  Free energy of folding      |       -10.18        |        -9.72        | 
|  # res 95% buried            |          1          |          0          | 
|  # buried charges            |          0          |          0          | 
|------------------------------|---------------------|---------------------| 
 
Expected values obtained from 1. Morris AL, MacArthur MW, Hutchinson EG and 
Thornton JM. Proteins. 1992 Apr;12(4):345-364. 2. Chiche L., Gregoret LM, 
Cohen FE and Kollman PA. Proc Natl Acad Sci U S A. 1990 Apr;87(8):3240-3243  
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                     ********************************** 
                     *      SIDE CHAIN INFO PANEL     * 
                     ********************************** 
 
 
 
RES. RES.   SCND   BTURN    SIDE       FRAC.    SFE   CHI1   ENV.  DISULF  S-S   
NUM. NAME   STRUC  BTURN  SURF(ASA)  SURF(ASA)  SFE   ANGLE  CLASS  BOND   DIST  
-------------------------------------------------------------------------------- 
Chain  1   
1    ASP      C             132.4      1.12    -1.1   -56.7  E0C        
2    THR      H             117.2      1.03    -0.3   -39.9  E0H        
3    ALA      H              85.1      0.99    -0.0   360.0  E0H        
4    SER      H              74.1      0.79    -0.4   -59.9  E0H        
5    ASP      H              63.2      0.54    -0.8   -48.9  P1H        
6    ALA      H              55.4      0.65    -0.5   360.0  E0H        
7    ALA      H              59.1      0.69    -0.4   360.0  E0H        
8    ALA      H              26.9      0.31    -0.9   360.0  P1H        
9    TYR      H             124.5      0.61    -1.4   -87.3  P2H        
10   ALA      H              57.7      0.67    -0.4   360.0  E0H        
11   ALA      H              51.4      0.60    -0.5   360.0  E0H        
12   TRP      H              35.8      0.16    -2.8   173.5  B1H        
13   THR      H              79.6      0.70    -0.5   -57.0  E0H        
14   ALA      H              66.6      0.78    -0.3   360.0  E0H        
15   ASP      H              55.2      0.47    -1.2  -150.8  P2H        
16   GLY      C              29.2      0.56    -0.4   360.0  E0C        
17   GLY      C               2.8      0.05    -0.8   360.0  P1C        
18   PRO      C      I       99.3      0.75    -0.5   -22.3  E0C        
19   SER      C      I       75.5      0.80    -0.4   -49.2  E0C        
20   SER      C      I       14.8      0.16    -0.8  -171.5  P1C        
21   GLY      C      I       40.8      0.78    -0.2   360.0  E0C        
22   ARG      C              89.8      0.44    -2.4    70.8  P1C        
23   PRO      C             111.2      0.84    -0.3    28.8  E0C        
24   PRO      C              49.5      0.37    -1.3    27.5  P1C        
25   PRO      C              52.6      0.40    -1.3    33.7  P2C        
26   SER      C              35.9      0.38    -0.4    57.0  P2C     
 
 
 
 
                                   *************** 
                                   *  END VADAR  * 
                                   *************** 
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1.3.5. AFP-Tc-5-KK
IZKF Leipzig, Core Unit Peptid-Technologien
Liebigstraße 2'l,O41O3Leipzig, e-mail: sven-r@yahoo.com, Tel.: 0341 - 9715898 / 897
Administrator Timebase: U-3000RS Sequence:2016 Page 1-1
1.7 .2016 10:57 AM
Chromeleon (c) Dionex 1996-2006
Version 6.80 SR7 Build 2528 (148369)
Sample Name:
VialNumber:
Sampte Type:
ControlProgram:
Quantif. Method:
Recording Time:
Sample lD:
GF16_purified
GE8
unknown
Pe pti d e_3 D_bas ic-s h ort
peptide_izkf
1.7.201610:24
lnjection Volume:
Channel:
Wavelength:
Bandwidth:
Ditution Factor:
Operator:
Sample Amount:
5,0
UV_VIS_1
220.0
4
1,0000
Administrator
1,0000
No. Ret.Time Peak Name Height Rel.Area Area Amount Type
min mAU % mAU*min
1
2
3
4
5
4,01
4,32
4,61
4,88
5,29
n.a 1,8
1,0
1,1
628,2
1.2
0,66
0,29
0,30
98,41
0,34
0,29
0,13
0,13
42,55
0,15
n.a BMB
BMB
BM
M
MB
n.a n.a
n.a. n.a
n_4. n.a
n.a n.a
Total: 633,188 100,000 43,23 0,000
IZKFllntegration
Figure V.1.43.: HPLC chromatogram of purified TcAFP5-KK, synthesized by S. Rothemund
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und, lzKF
CF1O_purified
MW:av2574,8
21, 04103 Leipzig, Tel.: 1 5898, sven*r@yahoo.com
0
1000
Acquisition Parameter
Date of acquisition
Acquisition method name
Aq u i siti on operatio n mode
Voltage polaity
Number of shots
Name of spectrum used for calibration
Calibntion reference /isf used
lnstrument !nfo
User
lnstrument
lnstrument type
201 6-07-01 T09:38:26.391 +02:00
D :\lvlethods\flexControl Methods\LP_PepM ix. par
Linear
POS
100
PeptideCalibStandardlnsulin2 monoAv
IZKF
FLEX.PC
microflex
Figure V.1.44.: m/z : [M +H]+ calcd for [TcAFP5−KK]+ 2574.7, found 2575.7.
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Figure V.1.45.: CD spectra of Tc10b (hollow circles) and AFP-Tc-5-KK (filled circles) at 274
K and pH 3.
Figure V.1.46.: 1H-NMR spectra of AFP-Tc-5-KK at 274 K and pH 3 (left) or pH 7.9 (0.1M
NH4HCO3 buffer) (right). Magnification of indole proton region.
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Table V.1.60.: 1H-chemical shifts of AFP-Tc-5-KK at 274K and pH 3.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1’ Asp 8.425 4.603 2.864
2’ Thr 8.792 4.240 4.240 1.28
3’ Ala 8.613 4.285 1.449
4’ Ser 8.65 4.356 4.071,3.947
5’ Asp 8.452 4.56 2.871
6’ Ala 8.38 4.267 1.520
1 Ala 8.266 4.285 1.520
2 Lys 8.329 4.1334 1.79 1.672 1.388 2.959 7.637
3 Tyr 8.342 4.213 3.191,3.076 6.781 7.090
4 Ala 8.455 4.276 1.511
5 Ala 8.104 4.231 1.485
6 Trp 8.024 4.373 3.431,3.209 7.123
9.819,
7.262
7.211,
7.106 7.244
7 Thr 8.475 3.449 3.956 1.601
8 Ala 8.212 4.142 1.449
9 Asp 7.806 4.756 3.005,2.862
10 Gly 7.803 4.089,3.636
11 Gly 8.070 3.245,1.947
12 Pro 4.508 2.427,2.022 2.082
3.681,
3.377
13 Ser 8.086 4.45 3.899
14 Ser 8.245 4.293 3.920,3.727
15 Gly 8.159 4.154,3.885
16 Arg 8.137 4.800 1.865,1.785 1.674 3.236 7.398
17 Pro 4.675 2.275,1.808 1.999
3.851,
3.629
18 Pro 2.958 1.401,1.629
1.778,
1.690 4.120
19 Pro 4.376 2.215,1.920 1.863
3.430,
3.236
20 Lys 8.329 4.1334 1.790 1.672 1.388 2.949 7.590
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1.3.6. AFP-Tc-7
693 IZKF Leipzig, Cöre Unit Peptid-Technologien
Liebigstraße21, 04103 teipzig, e-mail: sven-r@yahoo.com, Tel.: 034'l - 9715898 / 897
Timebase:U-3000RS Sequence:2016 Page 1-1
18.11.2016 8:24 AM
Chromeleon (c) Dionex 1996-2006
Version 6.80 SR15 Build 4656 (243203)
EK{6-purified' lnje-gtion Volume:
Channel:
,Wavelength:
Bandwidth:
Ditution Factor:
Operator
Sample Amou'nt:
?0;0
uv._vts_l
22A.0
4
{,0000 ,
KEYUSER
1,0000
BE4
unknown
Pepti deJD-bas ic:sho rt
Peptide_3D_basic
17.11.201616=45
No. Ret.Time Peak Name Height Rel.Area Area Amount Type
min mAU % mAU*min
5 78 n.a. 1224.8 100.00 97.22 n.a. BMB*
Total: 1224,808 100,000 97,22 0,000
IZKFllntegration
Figure V.1.47.: HPLC chromatogram of purified AFP-Tc-7, synthesized by S. Rothemund
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IZKF Leipzig, Liebigstrasse 21, 04103 Leipzig, .:0341-9715898, sven
EK1G_purified
MW:av2731,9
2732.353
0
1 000
Acquisition Parameter
Date of acquisition
Acq u isitio n method n a me
Aquisition operation mode
Voltage polaity
Number of shots
Name of spectrum used for calibration
Calibration reference /rsf used
lnstrument lnfo
User
lnstrument
lnstrument type
2016-1 1-'18T1 0:22:25.858+01 :00
D:\Methods\fl exControlMethods\LP_PepMix. par
Linear
POS
100
PeptideCalibStandardlnsulin2 monoAv
IZKF
FLEX-PC
microflex
Figure V.1.48.: m/z : [M +H]+ calcd for [TcAFP6]+ 2731.9, found 2732.4.
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Table V.1.61.: 1H-chemical shifts of TcAFP6b at 274K and pH 3.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1’ Asp exch. 4.388 3.194,3.056
2’ Thr 8.757 4.200 4.230 1.287
3’ Ala 8.627 4.277 1.446
4’ Ser 8.713 4.343 4.002,3.904
5’ Asp 8.449 4.607 3.003,2.902
6’ Ala 8.387 4.262 1.514
7’ Ala 8.335 4.262 1.514
8’ Ala 5.181 4.223 1.526
9’ Ala 8.236 4.249 1.564
1 Ala 8.205 4.336 1.551
2 Ala 8.270 4.325 1.570
3 Tyr 8.457 4.144 3.297,3.166 7.128 6.846
4 Thr 8.710 3.094 4.350 1.339
5 Ala 8.127 4.23 1.520
6 Trp 8.001 4.243 3.577,3.190 7.078
9.636,
7.237
7.232,
7.123 7.017
7 Leu 8.568 3.336 1.903,1.407 1.615
0.993,
0.877
8 Ala 8.188 4.126 1.502
9 Asp 7.566 4.780 3.056 2.870
10 Gly 7.626 4.158,3.507
11 Gly 8.102 2.930,1.032
12 Pro 4.591 2.510,2.051 2.124
3.753,
3.277
13 Ser 7.826 4.454 3.934
14 Ser 8.181 4.283 3.917,3.636
15 Gly 8.035 4.259,3.840
16 Arg 8.148 4.933 1.921,1.849
1.735,
1.685 3.284 7.513
17 Pro 4.715 2.298,1.789 1.999
3.875,
3.673
18 Pro 2.525 1.352,0.441
1.727,
1.644 3.494
19 Pro 4.340 2.233,2.021
1.918,
1.857
3.125,
2.959
20 Ser 8.306 4.362 3.910,3.795
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Table V.1.62.: 15N and 13C-chemical shifts of AFP-Tc-7 at 274 K and pH 3.
Residue chemical shift δ (ppm)
15N 13C
1’ Asp n.d. 52.51 n.d.
2’ Thr 115.67 64.20 69.36 21.86
3’ Ala 125.58 54.69 18.26
4’ Ser 116.79 60.43 n.d.
5’ Asp 123.94 55.07 n.d.
6’ Ala 124.61 54.79 17.86
7’ Ala 122.62 54.79 17.86
8’ Ala 122.95 54.75 17.86
9’ Ala 121.62 54.93 17.86
1 Ala 122.85 54.92 17.86
2 Ala 121.95 54.76 17.86
3 Tyr 123.26 62.91 n.d. 118.29 132.97
4 Thr 117.01 67.23 68.65 21.89
5 Ala 124.44 54.79 17.86
6 Trp 121.54 131.62 61.47 n.d. 127.52 114.31 120.41 123.87,122.91
7 Leu 120.39 57.79 41.94 25.93,23.30
8 Ala 121.71 54.41 17.86
9 Asp 116.03 n.d. n.d.
10 Gly 106.30 44.48
11 Gly 112.33 44.06
12 Pro n.d. 65.36 31.81 27.21 50.87
13 Ser 113.30 n.d. n.d.
14 Ser 117.26 n.d. n.d.
15 Gly 109.96 45.19
16 Arg 120.13 114.77 n.d. n.d. n.d. n.d.
17 Pro n.d. 60.96 30.73 27.01 50.67
18 Pro n.d. 59.99 29.00 26.61 49.76
19 Pro n.d. 62.58 31.54 26.91 49.96
20 Ser 116.96 57.98
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Table V.1.63.: 1H-chemical shifts of TcAFP6b at 298 K and pH 3.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1’ Asp 4.166 3.252,3.166
2’ Thr 8.646 4.295 4.239 1.261
3’ Ala 8.454 4.298 1.423
4’ Ser 8.425 4.375 3.959,3.888
5’ Asp 8.319 4.666 2.937
6’ Ala 8.292 4.231 1.481
7’ Ala 8.233 4.224 1.481
8’ Ala 8.051 4.250 1.484
9’ Ala 8.112 4.319 1.529
1 Ala 8.183 4.289 1.533
2 Ala 8.166 4.250 1.536
3 Tyr 8.365 4.180 3.249,3.168 7.098 6.837
4 Thr 8.515 3.910 4.323 1.331
5 Ala 8.020 4.205 1.509
6 Trp 7.937 4.245 3.555,3.195 7.086
9.647,
7.2582
7.226,
7.112 7.094
7 Leu 8.453 3.381 1.850,1.421 1.606
0.953,
0.858
8 Ala 8.136 4.114 1.484
9 Asp 7.580 4.779 3.038,2.867
10 Gly 7.613 4.124,3.543
11 Gly 8.044 2.972,1.328
12 Pro 4.549 2.483,2.042 2.107
3.717,
3.247
13 Ser 7.788 4.451 3.919
14 Ser 8.109 4.362 3.897,3.800
15 Gly 7.972 4.228,3.849
16 Arg 8.058 4.875 1.931,1.821 1.689 3.270 7.367
17 Pro 4.697 2.279,1.801 1.997
3.858,
3.649
18 Pro 2.766 1.404,0.661
1.760,
1.653 3.491
19 Pro 4.350 2.227,1.961 1.869
3.145,
2.985
20 Ser 8.118 4.251 3.929,3.667
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Table V.1.64.: 1H-chemical shifts of TcAFP6b at 274 K and pH 7.9.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1’ Asp 5.710 4.372 2.659,2.593
2’ Thr exch. 4.090 4.186 1.303
3’ Ala 8.427 4.278 1.477
4’ Ser 8.843 4.318 4.046,3.936
5’ Asp 8.546 4.507 2.855,2.713
6’ Ala 8.311 4.292 1.543
7’ Ala 8.253 4.274 1.524
8’ Ala 8.241 4.303 1.552
9’ Ala 8.179 4.279 1.560
1 Ala 8.224 4.250 1.567
2 Ala 8.278 4.343 1.584
3 Tyr 8.490 4.151 3.306,3.190 7.151 6.872
4 Thr 8.724 3.910 4.360 1.340
5 Ala 8.161 4.235 1.536
6 Trp 7.793 4.267 3.546,3.181 7.019
9.675,
7.213
7.227,
7.151 7.001
7 Leu 8.535 3.339 1.949,1.366 1.655
1.019,
0.868
8 Ala 8.262 4.081 1.508
9 Asp 7.543 4.656 2.891,2.671
10 Gly 7.581 4.159,3.455
11 Gly 8.302 3.098,0.679
12 Pro 4.658 2.536,2.0827 2.173
3.847,
3.461
13 Ser 8.249 4.153 3.858,3.497
14 Ser 7.865 4.135 3.782
15 Gly 8.033 4.292,3.800
16 Arg 8.233 5.067 1.921,1.829 1.665
3.297,
3.247 7.677
17 Pro 4.771 2.350,1.790 1.992
3.868,
3.685
18 Pro 2.384 1.365,0.296
1.719,
1.684 3.517
19 Pro 4.300 2.220,2.079
1.993,
1.828
3.104,
2.962
20 Ser 7.759 4.502 3.934
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Table V.1.65.: 15N and 13C-chemical shifts of AFP-Tc-7 at 274 K and pH 3.
Residue chemical shift δ (ppm)
15N 13C
1’ Asp n.d. n.d. n.d.
2’ Thr n.d. 65.38 69.04 21.94
3’ Ala 124.80 54.84 18.15
4’ Ser 117.97 61.28 62.17
5’ Asp 125.71 56.80 n.d.
6’ Ala 124.53 54.89 17.84
7’ Ala 122.86 54.84 17.84
8’ Ala 123.33 54.89 17.84
9’ Ala 122.75 54.84 17.84
1 Ala 121.57 55.00 17.84
2 Ala 122.10 55.00 17.84
3 Tyr 123.51 62.98 38.17 118.37 133.04
4 Thr 117.09 67.13 68.86 21.94
5 Ala 124.65 54.95 17.84
6 Trp 121.43 131.89 62.16 27.72 127.60 114.31 120.47 123.63,122.96
7 Leu 119.79 57.79 41.92 26.14,23.05
8 Ala 123.80 54.73 17.84
9 Asp 117.71 54.11 n.d.
10 Gly 105.78 43.98
11 Gly 113.98 43.08
12 Pro 64.94 31.71 27.35 51.12
13 Ser 117.59 n.d. 65.05
14 Ser 120.72 n.d. 64.79
15 Gly 109.91 45.31
16 Arg 119.76 n.d. n.d. n.d. n.d. n.d.
17 Pro n.d. 61.28 30.35 27.17 50.50
18 Pro n.d. 60.08 28.78 n.d. 49.47
19 Pro n.d. 62.71 31.57 26.89 49.63
20 Ser 113.10 n.d. 63.17
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Table V.1.66.: 1H-chemical shifts of TcAFP6b at 298 K and pH 7.9. Shifts marked with an
asterisk are averaged.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1’ Asp 5.603 4.351 2.799,2.623
2’ Thr exch. 4.229 4.229 1.270
3’ Ala exch. 4.239* 1.511*
4’ Ser exch. 4.359 3.983,3.896
5’ Asp exch. 4.660 2.850,2.653
6’ Ala exch. 4.239* 1.511*
7’ Ala exch. 4.239* 1.511*
8’ Ala exch. 4.239* 1.511*
9’ Ala exch. 4.239* 1.511*
1 Ala 8.133 4.247 1.521
2 Ala 8.110 4.313 1.535
3 Tyr 8.389 4.185 3.260,3.180 7.125 6.861
4 Thr 8.535 3.916 4.329 1.338
5 Ala 8.056 4.211 1.513
6 Trp 7.918 4.281 3.536,3.198 7.037
9.686,
7.215
7.227,
7.119 7.084
7 Leu 8.424 3.403 1.880,1.382 1.628
0.971,
0.846
8 Ala 8.185 4.074 1.496
9 Asp 7.533 4.653 2.847,2.650
10 Gly 7.596 4.141,3.494
11 Gly 8.225 3.126,1.051
12 Pro 4.598 2.510,1.053 2.150
3.798,
3.418
13 Ser exch. 4.327 3.926
14 Ser exch. 4.183 3.879,3.550
15 Gly 7.923 4.240,3.833
16 Arg 8.148 4.994 1.861,1.798 1.664 3.269 exch.
17 Pro 4.744 2.340,1.809 1.998
3.852,
3.677
18 Pro 2.657 1.403,0.559
1.761,
1.685 3.522
19 Pro 4.300 2.209,2.022
1.939,
1.840
3.129,
2.996
20 Ser 7.726 4.153 3.782
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Figure V.1.49.: Hα CSD plot of AFP-Tc-7 at pH 3 (top) and pH 7.9 (bottom) at 298 K. Hα
as black squares and Hα’ as black diamonds. The dashed line at y=-0.1 ppm
represents the helical limit. Solid line between residue 9’ and 1 represents the
junction of the N-terminal extension and the solid line between residue 8 and
9 the conjunction of the helix to the C-terminal cage fold.
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Table V.1.67.: CSDs for selected protons in the cage structure representing the cage fold of
TcAFP6b at 298 K and 274 K and at pH 3 and 7.9.
Cage ∆δ (ppm) Σ
upfield
pH L7α G11α’ P18α P18β’ P19δ P19δ’
3 -0.959 -2.802 -1.965 -1.249 -0.455 -0.615 -8.045
7.9 -0.937 -3.079 -2.073 -1.351 -0.471 -0.604 -8.515
downfield
P12α P12β R16α
3 0.129 0.193 0.225 0.547
7.9 0.178 0.220 0.344 0.742
cage-helix
multicolumn8c|
A2α Y3α T4α A5α W6α L7α A8α
3 -0.070 -0.370 -0.440 -0.115 -0.415 -0.959 -0.206 -2.575
7.9 -0.007 -0.365 -0.434 -0.109 -0.379 -0.937 -0.246 -2.476
Table V.1.68.: CSDs for selected protons in the helical extension representing the N-terminal
helix fold of TcAFP6b at 274 K and at pH 3 and 7.9.
Helix ∆δ (ppm). Σ
T2’α A3’α S’4α D5’α A6’α
pH 3, 298 K -0.055 -0.022 -0.095 0.026 -0.089 -0.235
pH 7.9, 298 K -0.121 -0.081 -0.111 0.020 -0.081 -0.374
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Table V.1.69.: CSDs for the 13Cα atoms in the helix representing the helix fold of AFP-Tc-7
at 274 K and at pH 3 and 7.9. The ∆δ and the χF for the helix, chimera
and helical extension are calculated. The χF was determined using the CSD of
AFP-Tc-7 at pH 7.9 and 274 K as reference (marked with an asterisk).
TcAFP6
pH 3 pH 8
δ (ppm) δ (ppm)
Helical Extension 1.10 2.28
2.19 2.34
2.13 2.98
0.97 2.70
2.29 2.39
2.29 2.34
2.25 2.39
2.43 2.34
Chimera Helix 2.42 2.50
2.26 2.50
4.31 4.38
4.13 4.03
2.29 2.90
3.67 4.36
2.09 2.09
1.91 2.23
Helix ∆δ (ppm) 2.42 2.80*
χhelixF (%) 87 99.5
Chimera Helix ∆δ (ppm) 2.89 3.12*
χchimeraF (%) 92 99.5
Helical Extension ∆δ (ppm) 1.96 2.47*
χexten.F (%) 79 99.5
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1.3.7. AFP-Tc-6
Operator:KEYUSER Timebase:U-3000RS Sequence:2016 Page 1-1
21.11.2016 2:04 PM
Chromeleon (c) Dionex 1996-2006
Version 6.80 SR15 Build 4656 (243203)
Comment:
Sample Nam1e:
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Control:'Program:
Quantif 'Method:
Reeording:Time:
SamPle lDi:
ELl6-purified
GEz
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0,5
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0,05
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0,06
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n.a BMB
BMB
BMB
BMB
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n.a. n.a
n.a. n.a.
n.a. n.a.
n.a. n.a.
n.a. n.a.
n.a
Total: 1446,527 100,000 131 ,39 0,000
IZKFllntegration
Figure V.1.50.: HPLC chromatogram of purified AFP-Tc-6, synthesized by S. Rothemund
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, IZKF Leipzig, Liebigstrasse 21, 04103 Leipzig, T 1 5898, sven_r@yahoo.com
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Figure V.1.51.: m/z : [M +H]+ calcd for [TcAFP7]+ 2702.9, found 2703.8.
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Table V.1.70.: 1H-chemical shifts of AFP-Tc-6 at 274 K and pH 3.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1’ Asp exch. 4.385 3.189,3.048
2’ Thr 8.760 4.192 4.226 1.290
3’ Ala 8.609 4.276 1.447
4’ Ser 8.702 4.346 4.010,3.907
5’ Asp 8.454 4.605 2.995,2.904
6’ Ala 8.348 4.239 1.508
7’ Ala 8.263 4.276 1.486
8’ Ala 8.150 4.305 1.584
1 Ala 8.325 4.246 1.562
2 Ala 8.141 4.236 1.551
3 Tyr 8.343 4.128 3.229,3.176 7.063 6.827
4 Leu 8.227 4.113 2.071,1.640 1.999
1.018
(both)
5 Thr 8.347 3.930 4.245 1.247
6 Trp 7.979 4.178 3.593,3.141 7.045
9.663,
7.237
7.235,
7.129 7.042
7 Leu 8.590 3.341 1.872,1.408 1.618
0.973,
0.882
8 Ala 8.294 4.112 1.513
9 Asp 7.824 4.7035 3.111,2.900
10 Gly 7.649 4.170,3.501
11 Gly 8.2119 2.9068,1.0298
12 Pro 4.584 2.504,2.052 2.122
3.746,
3.269
13 Ser 8.185 4.222 3.903,3.617
14 Ser 7.821 4.463 3.931
15 Gly 8.036 4.256,3.834
16 Arg 8.130 4.950 1.902,1.862
1.747,
1.673 3.278 7.558
17 Pro 4.719 2.300,1.792 1.998
3.877,
3.670
18 Pro 2.547 1.340,0.396
1.711,
1.606 3.472
19 Pro 4.351 2.241,1.999
1.912,
1.860
3.162,
2.977
20 Ser 8.310 4.353 3.903,3.796
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Table V.1.71.: 15N and 13C-chemical shifts of AFP-Tc-6 at 274 K and pH 3.
Residue chemical shift δ (ppm)
15N 13C
1’ Asp
2’ Thr 115.67 64.02 69.01 21.94
3’ Ala 125.55 54.36 17.83
4’ Ser 116.73 58.97
5’ Asp 123.85 54.62
6’ Ala 118.84 54.42 17.83
7’ Ala 122.74 54.36 17.83
8’ Ala 122.74 54.29 17.83
1 Ala 120.89 54.74 17.83
2 Ala 121.45 54.55 17.83
3 Tyr 122.53 63.34 118.31 133.09 122.59,123.83 120.15
4 Leu 119.16 58.34 41.01 23.57,25.56 114.10
5 Thr 124.50 66.49 62.92 21.94
6 Trp 123.91 131.59 62.70 27.84 126.98
7 Leu 119.81 58.01 41.70 25.87,23.44
8 Ala 123.70 54.16 17.83
9 Asp 116.35
10 Gly 106.53 45.29
11 Gly 112.74 43.35
12 Pro 66.43 32.06 27.58 50.17
13 Ser 117.29 60.45
14 Ser 113.21 58.85
15 Gly 109.96 45.09
16 Arg 119.95 114.97
17 Pro 31.19 27.16 49.98
18 Pro 60.01 28.83 27.06 49.43
19 Pro 61.53 31.78 27.06 49.70
20 Ser 117.32 58.05 63.87
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Table V.1.72.: 1H-chemical shifts of AFP-Tc-6 at 298 K and pH 3.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1’ Asp exch. 4.391 3.015
2’ Thr 8.651 4.298 4.252 1.252
3’ Ala 8.448 4.301 1.441
4’ Ser 8.421 4.369 3.975,3.884
5’ Asp 8.317 4.658 2.928
6’ Ala 8.256 4.222 1.467
7’ Ala 8.034 4.288 1.522
8’ Ala 8.191 4.094 1.499
1 Ala 8.105 4.223 1.521
2 Ala 8.263 4.223 1.535
3 Tyr 8.222 4.131 3.201 7.025 6.817
4 Leu 8.220 4.112 2.013,1.621 1.949 1.000
5 Thr 8.244 3.937 4.233 1.237
6 Trp 7.911 4.180 3.573,3.163 7.060
9.658,
7.251
7.215,
7.119 7.103
7 Leu 8.512 3.361 1.800,1.439 1.595
0.934,
0.863
8 Ala 8.175 4.237 1.452
9 Asp 7.781 4.711 3.080,2.867
10 Gly 7.616 4.150,3.535
11 Gly 8.137 2.921,1.282
12 Pro 4.547 2.489,2.031 2.099
3.705,
3.216
13 Ser 7.769 4.445 3.922
14 Ser 8.109 4.354 3.891,3.800
15 Gly 7.970 4.225,3.831
16 Arg 8.041 4.8929 1.9268,1.8282 1.6992 3.2695 7.3926
17 Pro 4.694 2.280,1.800 2.000
3.857,
3.651
18 Pro 2.753 1.364,0.587
1.724,
1.608 3.467
19 Pro 4.338 2.221,1.949 1.865
3.155,
2.980
20 Ser 8.117 4.251 3.922,3.656
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Table V.1.73.: 1H-chemical shifts of AFP-Tc-6 at 274 K and pH 7.9.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1’ Asp 5.709 4.376 2.661,2.599
2’ Thr exch. 4.112 4.194 1.302
3’ Ala 8.323 4.268 1.552
4’ Ser 8.805 4.329 4.045,3.937
5’ Asp 8.529 4.524 2.866,2.733
6’ Ala 8.308 4.270 1.534
7’ Ala 8.213 4.283 1.509
8’ Ala 8.180 4.296 1.600
1 Ala 8.098 4.254 1.552
2 Ala 8.323 4.268 1.548
3 Tyr 8.394 4.133 3.241 7.117 6.870
4 Leu 8.157 4.137 2.067 1.985 1.017
5 Thr 8.349 3.966 4.249 1.250
6 Trp 7.965 4.210 3.567,3.139 6.984
9.715,
7.233
7.198,
7.162 7.030
7 Leu 8.530 3.375 1.922,1.364 1.655
1.010,
0.880
8 Ala 8.322 4.064 1.559
9 Asp 7.943 4.570 2.866,2.700
10 Gly 7.607 4.169,3.452
11 Gly 8.454 3.109,0.676
12 Pro 4.658 2.540,2.083 2.183
3.846,
3.492
13 Ser 8.264 4.126 3.844,3.467
14 Ser 7.880 4.129 3.775
15 Gly 8.029 4.301,3.800
16 Arg 8.223 5.096 1.927,8.175 1.652
3.292,
3.212 7.757
17 Pro 4.781 2.366,1.786 1.997
3.875,
3.683
18 Pro 2.403 1.346,0.254
1.710,
1.646 3.523
19 Pro 4.308 2.228,2.069
1.982,
1.833
3.142,
2.971
20 Ser 7.753 4.501 3.934
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Table V.1.74.: 15N and 13C-chemical shifts of AFP-Tc-6 at 274 K and pH 7.9.
Residue chemical shift δ (ppm)
15N 13C
1’ Asp n.d. n.d. n.d.
2’ Thr n.d. 65.25 69.06 21.93
3’ Ala 124.91 54.73 17.83
4’ Ser 117.73 61.18 n.d.
5’ Asp 125.38 56.65 n.d.
6’ Ala 124.53 54.73 17.83
7’ Ala 122.95 54.81 17.83
8’ Ala 122.83 54.85 17.83
1 Ala 121.46 54.76 17.83
2 Ala 125.06 54.73 17.83
3 Tyr 122.75 62.69 n.d. 118.39 132.85
4 Leu 119.05 59.46 41.21 n.d. 23.21
5 Thr 118.73 66.59 68.73 22.02
6 Trp 123.68 131.83 62.61 27.63 127.54 114.28 123.85,122.92 120.61
7 Leu 119.02 57.85 41.89 n.d. 25.70,22.97
8 Ala 121.10 54.85 17.83
9 Asp 118.17 54.54 n.d.
10 Gly 105.95 43.91
11 Gly 114.63 40.99
12 Pro n.d. n.d. 31.86 27.38 50.92
13 Ser 117.65 n.d. 64.79
14 Ser 120.75 n.d. 64.53
15 Gly 109.91 45.37
16 Arg 119.58 n.d. n.d. n.d. n.d. n.d.
17 Pro n.d. n.d. 30.59 27.14 50.75
18 Pro n.d. 60.11 28.55 n.d. 49.28
19 Pro n.d. n.d. 31.62 27.08 49.63
20 Ser 113.10 59.07 62.90
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Table V.1.75.: 1H-chemical shifts of AFP-Tc-6 at 298 K and pH 7.9. Shifts marked with an
asterix are averaged.
Residue chemical shift δ (ppm)
NH α β γ δ  ζ η
1’ Asp 5.605 4.359 2.635,2.589
2’ Thr exch. 4.241 4.241 1.268
3’ Ala exch. 4.227* 1.508*
4’ Ser exch. 4.370 3.967,3.905
5’ Asp exch. 4.591 2.812,2.691
6’ Ala exch. 4.227* 1.508*
7’ Ala exch. 4.227* 1.508*
8’ Ala exch. 4.227* 1.508*
1 Ala exch. 4.227* 1.508*
2 Ala exch. 4.227* 1.508*
3 Tyr 8.270 4.165 3.208 7.084 6.859
4 Leu 8.156 4.117 2.012,1.616 1.943 0.996
5 Thr 8.239 3.974 4.252 1.271
6 Trp 7.893 4.243 3.554,3.169 7.011
9.713,
4.234
7.214,
7.130 7.117
7 Leu 8.452 3.410 1.852,1.400 1.622
0.956,
0.857
8 Ala 8.185 4.073 1.531
9 Asp 7.853 4.592 2.829,2.676
10 Gly 7.606 4.136,3.500
11 Gly 8.330 3.133,1.038
12 Pro 4.589 2.509,2.062 2.151
3.788,
3.407
13 Ser exch. 4.245 3.982
14 Ser exch. 4.245 3.982,3.866
15 Gly 7.922 4.225,3.831
16 Arg 8.138 5.004 1.880,1.826 1.647
3.285,
3.231 exch.
17 Pro 4.741 2.333,1.989 1.799
3.849,
3.661
18 Pro 2.666 1.383,0.511
1.746,
1.645 3.492
19 Pro 4.302 2.203,2.010
1.926,
1.857
3.156,
3.012
20 Ser 7.742 4.157 3.771
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Figure V.1.52.: 1H-NMR spectrum of AFP-Tc-6 at 274 K and pH 7.9 with enlargement of the
indole proton region.
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Figure V.1.53.: Hα CSD plot of AFP-Tc-6 at pH 3 (top) and pH 7.9 (bottom) at 274 K. Hα
as black squares and Hα’ as black diamonds. The dashed line at y=-0.1 ppm
represents the helical limit. Solid line between residue 8’ and 1 represents the
junction of the N-terminal extension and the solid line between residue 8 and
9 the conjunction of the helix to the C-terminal cage fold.
1.3. AFP-Tc Chimera Proteins 289
Figure V.1.54.: Hα CSD plot of AFP-Tc-7 at pH 3 (top) and pH 7.9 (bottom) at 298 K. Hα as
black squares and Hα’ as black diamonds. Averaged Hα shifts for certain Ala
are represented as non-filled squares. The dashed line at y=-0.1 ppm represents
the helical limit. Solid line between residue 8’ and 1 represents the junction
of the N-terminal extension and the solid line between residue 8 and 9 the
conjunction of the helix to the C-terminal cage fold.
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Table V.1.76.: CSDs for selected protons in the cage structure representing the cage fold of
AFP-Tc-6 at 298 K and 274 K and at pH 3 and 7.9.
Cage ∆δ (ppm) Σ
upfield
L7α G11α’ P18α P18β’ P19δ P19δ’
pH 3, 274 K -1.000 -3.100 -2.183 -1.514 -0.438 -0.623 -8.857
pH 3, 298 K -0.980 -2.848 -1.977 -1.323 -0.445 -0.621 -8.193
pH 7.9, 274 K -0.966 -3.454 -2.328 -1.656 -0.458 -0.629 -9.490
pH 7.9, 298 K -0.930 -3.092 -2.064 -1.399 -0.444 -0.589 -8.517
downfield
P12α P12β R16α
pH 3, 274 K 0.164 0.214 0.300 0.678
pH 3, 298 K 0.127 0.199 0.243 0.568
pH 7.9, 274 K 0.238 0.250 0.446 0.934
pH 7.9, 298 K 0.169 0.250 0.354 0.773
Table V.1.77.: CSDs for selected protons in the helical region representing the helix fold of
AFP-Tc-6 at 298 K and 274 K and at pH 3 and 7.9.
Helix ∆δ (ppm). Σ
A2α Y3α L4α T5α W6α L7α A8α
pH 3, 274 K -0.084 -0.422 -0.227 -0.420 -0.482 -1.000 -0.208 -2.844
pH 3, 298 K -0.097 -0.420 -0.228 -0.413 -0.480 -0.980 -0.083 -2.701
pH 7.9, 274 K -0.052 -0.417 -0.203 -0.384 -0.450 -0.966 -0.256 -2.726
pH 7.9, 298 K -0.093 -0.385 -0.223 -0.376 -0.417 -0.930 -0.247 -2.671
Table V.1.78.: CSDs for selected protons in the helical extension representing the N-terminal
helix fold of AFP-Tc-6 at 298 K and 274 K and at pH 3 and 7.9. Shifts marked
with an asterisk are averaged.
Helix ∆δ (ppm). Σ
T2’α A3’α S’4α D5’α A6’α
pH 3, 274 K -0.158 -0.044 -0.124 -0.035 -0.081 -0.441
pH 3, 298 K -0.052 -0.019 -0.101 0.018 -0.098 -0.252
pH 7.9, 274 K -0.238 -0.052 -0.141 -0.116 -0.050 -0.597
pH 7.9, 298 K -0.109 -0.093* -0.100 -0.049 -0.093* -0.445
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Table V.1.79.: CSDs for the 13Cα atoms in the helix representing the helix fold of AFP-Tc-6
at 274 K and at pH 3 and 7.9. The ∆δ and the χF for the helix, chimera
and helical extension are calculated. The χF was determined using the CSD of
AFP-Tc-7 at pH 7.9 and 274 K as reference.
TcAFP7
pH 3 pH 8
δ (ppm) δ (ppm)
Helical Extension 0.92 2.15
1.86 2.23
0.67 2.88
0.52 2.55
1.92 2.23
1.86 2.31
1.79 2.35
Chimera Helix 2.24 2.26
2.05 2.23
4.74 4.09
2.64 3.76
3.39 3.49
4.90 4.60
2.31 2.15
1.66 2.24
Helix ∆δ (ppm) 2.23 2.77
χhelixF (%) 80 99
Chimera Helix ∆δ (ppm) 2.99 3.10
χchimeraF (%) 96 99
Helical Extension ∆δ (ppm) 1.36 2.38
χexten.F (%) 55 96
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1.4. 4,4’-Bis(2,5-Dioxopyrrolodin-1-yl)Azobenzene
Figure V.1.55.: 1H and 13C NMR of 4,4’-bis(2,5-dioxopyrrolodin-1yl)azobenzene
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2. UV/vis-Spectra and Concentrations and Helical Content
(CD)
For determination of the concentration for the CD samples, UV/vis spectra were used.
For peptides with the aromatic amino acids Trp and Tyr in the Trp-cage fold, an ex-
tinction coefficient of 278nm = 6770 cm2mmol−1 was used. Exctinction coefficients
for peptides with aromatic residues but not in a Trp-cage fold were calculated using Ex-
PASy’s ProtParam.103 For peptides without aromatic residues, the extinction coefficient
of the backbone at 214 nm was calculated using a method by Kuipers121 Table V.2.1.
Table V.2.1.: Extinction coefficient, corresponding absorption and resulting concentrations of
the solutions for CD spectroscopy.
Sequence Tc10b TcKKA AFP-Tc-4 AFP-Tc-5 AFP-Tc-5-KK
 6770 6770 6770 6770 6770
278 nm 0.435 0.471 0.470 4.356 0.316
214 nm
Conc. mol/m3 0.064 0.070 0.070 0.643 0.047
Sequence AFP-Tc-7 AFP-Tc-6 15er 15erYW
 6770 6770 39320 6990
278 nm 0.316 0.253 0.344 1.554
214 nm 0.611
Conc. mol/m3 0.037 0.051 0.040 0.090
Table V.2.2.: Observed and theoretical values of the mean residue ellipticity at 222 nm of AFP-
Tc-7 to AFP-Tc-4 and the resulting helical content.
Chimera AFP-Tc-7 AFP-Tc-6 AFP-Tc-5 AFP-Tc-4
[θ]MR(obs) (deg cm2 dmol−1) -26,054 -24,696 -17,240 -14,582
[θ]MR(ref) (deg cm2 dmol−1) -42,241 -42,188 -42,067 -42,000
Helical Content (%) 99 96 71 61
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Figure V.2.1.: UV/vis spectrum of Tc10b at 298K and pH7.9 in 0.1M NH4HCO3 buffer. The
spectrum was measured to 600 nm, displayed only to 320 nm.
Figure V.2.2.: UV/vis spectrum of TcKKA at 298K and pH7.9 in 0.1M NH4HCO3 buffer. The
spectrum was measured to 600 nm, displayed only to 320 nm.
Figure V.2.3.: UV/vis spectrum of 15erYW reference peptide at 298K and pH7.9 in 0.1M
NH4HCO3 buffer. The spectrum was measured to 600 nm, displayed only to
320 nm.
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Figure V.2.4.: UV/vis spectrum of 15erYW reference peptide at 298K and pH7.9 in 0.1M
NH4HCO3 buffer. The spectrum was measured to 600 nm, displayed only to
320 nm.
Figure V.2.5.: UV/vis spectrum of AFP-Tc-4 at 298K and pH7.9 in 0.1M NH4HCO3 buffer.
The spectrum was measured to 600 nm, displayed only to 320 nm.
Figure V.2.6.: UV/vis spectrum of AFP-Tc-5 at 298K and pH7.9 in 0.1M NH4HCO3 buffer.
The spectrum was measured to 600 nm, displayed only to 320 nm.
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Figure V.2.7.: UV/vis spectrum of AFP-Tc-5-KK at 298K and pH7.9 in 0.1M NH4HCO3
buffer. The spectrum was measured to 600 nm, displayed only to 320 nm.
Figure V.2.8.: UV/vis spectrum of AFP-Tc-6 at 298K and pH7.9 in 0.1M NH4HCO3 buffer.
The spectrum was measured to 600 nm, displayed only to 320 nm.
Figure V.2.9.: UV/vis spectrum of AFP-Tc-7 at 298K and pH7.9 in 0.1M NH4HCO3 buffer.
The spectrum was measured to 600 nm, displayed only to 320 nm.
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3. Synthesises
3.1. Tc10b
Table V.3.1.: Tc10b
Sequence N to C DAYAQWLKDGGPSSGRPPPS
MW peptide (g/mol) 2086.25
Peptide amount (g) / (mmol) 0.5 0.240
Resin Type Wang
Resin capacity (mmol/g) 0.85
Resin amount (g) 0.282
Capping: Pyridine (mL) 1.133
Aceticanhydride (mL) 1.133
C to N Double Single Annotation
4.9 eq. HATU (g) 0.893 0.446
10 eq. DIPEA (mL) 0.835 0.417
5 eq. amino acids (g) S 0.919 0.459 single
P 0.809 0.404 single
P 0.809 0.404 single
P 0.809 0.404 single
R 1.555 0.777 single/ext.
G 0.713 0.356 double
S 0.919 0.459 single
S 0.919 0.459 single
P 0.809 0.404 single
G 0.713 0.356 double/ext.
DG 1.483 0.741 single
K 1.123 0.561 single
L 0.847 0.423 double
W 1.262 0.631 single
Q 1.464 0.732 single
A 0.746 0.373 double
Y 1.101 0.551 double
A 0.746 0.373 double
D 0.986 0.493 single
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Table V.3.2.: Tc10b-S20K
Sequence N to C DAYAQWLKDGGPSSGRPPPK
MW peptide (g/mol) 2127.06
Peptide amount (g) / (mmol) 0.1 0.047
Resin Type Wang
Resin capacity (mmol/g) 0.85
Resin amount (g) 0.055
Capping: Pyridine (mL) 0.222
Aceticanhydride (mL)
C to N Double Single Annotation
4.9 eq. HATU (g) 0.175 0.088
10 eq. DIPEA (mL) 0.164 0.082
5 eq. amino acids (g) K 0.220 0.110 single
P 0.159 0.079 single
P 0.159 0.079 single
P 0.159 0.079 single
R 0.305 0.153 single/ext.
G 0.140 0.070 double
S 0.180 0.090 single
S 0.180 0.090 single
P 0.159 0.079 single
G 0.140 0.070 double/ext
DG 0.291 0.145 single
K 0.220 0.110 single
L 0.166 0.083 double
W 0.248 0.124 single
Q 0.287 0.144 single
A 0.146 0.073 double
Y 0.216 0.108 double
A 0.146 0.073 double
D 0.193 0.097 single
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Table V.3.3.: Tc10b-A2K-S20C(S-tBu)G
Sequenz N to C DKYAQWLADGGPSSGRPPPC(StBu)G
MW Peptide (g/mol) 2216.43
Peptid Menge (g) / (mol) 0.2 0.090
Resin Type Wang
Resin Capacity (mmol/g) 0.85
Resin amount / (g) 0.106
Aceticanhydride (mL) 0.426
Pyridine (mL) 0.426
C to N Double Single Annotation
4.9 eq HATU / g 0.336 0.168
10 eq DIPEA / ml 0.314 0.157
5 eq. amino acids (g) G 0.268 0.134 double
C 0.389 0.195 single
P 0.304 0.152 single
P 0.304 0.152 single
P 0.304 0.152 single
R 0.585 0.293 single/ext.
G 0.268 0.134 double
S 0.346 0.173 single
S 0.346 0.173 single
P 0.304 0.152 single
G 0.268 0.134 double/ext.
DG 0.558 0.279 double
A 0.281 0.140 double
L 0.319 0.159 single
W 0.475 0.238 single
Q 0.551 0.276 single
A 0.281 0.140 double
Y 0.415 0.207 single
K 0.423 0.211 single
D 0.371 0.186 single
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Table V.3.4.: Tc10b-S20C-21G
Sequence N to C DAYAQWLADGGPSSGRPPPCG
MW Peptide (g/mol) 2159.34
Peptid Menge (g) / (mol) 0.2 0.093
Resin Type Wang
Resin Capacity (mmol/g) 0.85
Resin amount / (g) 0.109
Aceticanhydride (mL) 0.438
Pyridine (mL) 0.438
C to N Double Single Annotation
4.9 eq HATU / g 0.345 0.172
10 eq DIPEA / ml 0.323 0.161
5 eq. amino acids (g) G 0.275 0.138 double
C 0.542 0.271 single
P 0.313 0.156 single
P 0.313 0.156 single
P 0.313 0.156 single
R 0.601 0.300 single/ext.
G 0.275 0.138 double
S 0.355 0.178 single
S 0.355 0.178 single
P 0.313 0.156 single
G 0.275 0.138 double/ext.
DG 0.573 0.287 double
A 0.288 0.144 double
L 0.327 0.164 single
W 0.488 0.244 single
Q 0.566 0.283 single
A 0.288 0.144 double
Y 0.426 0.213 single
A 0.288 0.144 single
D 0.381 0.191 single
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Table V.3.5.: Tc10b - TcKKA
Sequence N to C Ac-DKYAQWLADGGPSSGRPPPK
MW peptide (g/mol) 2169.38
Peptide amount (g/mmol) 0.4 0.184
Resin Type Wang
Resin capacity (mmol/g) 0.85
Resin amount (g) 0.217
Capping: Pyridine (mL) 0.871
Aceticanhydride (mL) 0.871
C to N Double Single Annotation
4.9 eq. HATU (g) 0.687 0.343
10 eq. DIPEA (mL) 0.642 0.321
5 eq. amino acids (g) K 0.864 0.432 single
P 0.622 0.311 single
P 0.622 0.311 single
P 0.622 0.311 single
R 1.196 0.598 single/ext.
G 0.548 0.274 double
S 0.707 0.353 single
S 0.707 0.353 single
P 0.622 0.311 single
G 0.548 0.274 double/ext.
DG 1.141 0.570 single
A 0.574 0.287 single
L 0.652 0.326 double
W 0.971 0.485 single
Q 1.126 0.563 single
A 0.574 0.287 double
Y 0.847 0.424 double
K 0.864 0.432 double
D 0.759 0.379 single

303
4. List of Chemicals
Dichloromethane and diethyl ether were distilled under reduced pressure before use. All
other commercial chemicals were used without further purification.
Table V.4.1.: List of used chemicals and their purity and supplier.
Substance Supplier
Acetonitrile Chromasolv gradient grade for HPLC Sigma-Aldrich
Acetic anhydride, 99% Acros
Ammonium hydrogen carbonate, 98% Alfa Aesar
Azobenzene-4,4’-dicarboxylic Acid, 99% TCI
Deuterium oxide, 99.9% Euriso-top
Dichloromethane BCD Chemie
Diethyl ether BCD Chemie
Dimethylformamide, 99.5 % Grüssing
DSS Deutero
Fmoc-Ala-OH, 95.0 % Aldrich Chemistry
Fmoc-Arg(Pbf)-OH, 99.15 % ChemPep
Fmoc-Asp(OtBu)-(Dmb)Gly-OH, 96.3 % ChemPep
Fmoc-Asp(OtBu)-OH, 99.33 % ChemPep
Fmoc-Gln(Trt)-OH, 99.12 % ChemPep
Fmoc-Gly-OH, 99.93 % ChemPep
Fmoc-Leu-OH, ≥ 99.0 % Aldrich Chemistry
Fmoc-Lys(Boc)-OH, 99.07 % ChemPep
Fmoc-Pro-OH, ≥ 99.0 % (HPLC) Aldrich Chemistry
Fmoc-Ser(tBu)-OH, 99.76 % ChemPep
Fmoc-Trp(Boc)-OH, 99.10 % ChemPep
Fmoc-Tyr(tBu)-OH, 99.2 % ChemPep
HATU, 99.8 % ChemPep
Immersion Oil Type B Ted Pella Inc.
N,N’-Dicyclohexylcarbodiimid, 99% Sigma-Aldrich
N,N-Diisopropylethylamine, ≥ 99 % Sigma-Aldrich
Piperidine (Peptide Grade), 99 % abcr
Pyridine, 99.5 % Grüssing
Sodium hydrogen phosphate, 99% Grüssing
Sodium dihydrogen phosphate, 99% Grüssing
Trifluoroacetic Acid, > 99.0 % TCI
Triisoproylsilane, > 98.0 % TCI
Wang-Resin, 200-400 mesh, 0.86 mmol/g ChemPep
Water Chromasolv Plus for HPLC Sigma-Aldrich
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Abbreviations
∆δ sum of the chemical shift deviation
χF fraction folded
δ chemical shift
λ wavelength
Acn acetonitril
AFGP antifreeze glycoprotein
AFP antifreeze protein
AMP antimicrobial peptide
ASA accessible surface area
CD circular dichroism
COSY correlation spectroscopy
CSD chemical shift deviation
DCC N,N’-dicyclohexylcarbodiimide
DCM dichloromethane
DIPEA N,N-diisopropylethylamine
DMB 1,3-dimethoxy benzene
DMF dimethylformamide
DMSO dimethyl sulfoxide
ESI electron spray ionization
Fmoc Fluorenylmethyloxycarbonyl
GFP green fluorescent protein
GLP-1 glucagon-like-peptide-1
HATU 1-[Bis(dimethylamino)methylene]-
1H-1,2,3-triazolo[4,5-b]pyridinium
3-oxid hexafluorophosphate
HOBt Benzotriazol-1-ol
HPLC high pressure liquid chromatogra-
phy
HSQC hetero single quantum coherence
IBP ice binding protein
IR infrared
MALDI matrix assisted laser desorption
ionization
MD molecular dynamics
MS mass spectrometry
NHS N-hydroxysuccinimide ester
NMR nuclear magnetic resonance
NOE nuclear Overhauser effect
NOESY nuclear Overhauser effect spec-
troscopy
PBS Phosphate buffered saline
PLRP-S poly(styrene-divinylbenzene)
PSS photo stationary state
RMSD root-mean-square deviation of
atomic positions
RP reverse-phase
SPPS solid phase peptide synthesis
TM melting point
tR retention time
TCEP tris-(2-carboxyethyl)-phosphin
TFA trifluoracetic acid
TH thermal hysteresis
TIS Triisopropylsilane
TOCSY total correlation spectroscopy
ToF time of flight
UV ultra violet
UV/vis ultra violet and visible light
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List of the 20 Proteinogenic Amino Acids
